2016 2016 ACVIM Forum Research Abstract Program 4
2016 2016 ACVIM Forum Research Abstract Program 4
CARDIOLOGY
9:00 am C01 Bryan Eason Sinus Rate Approximation with VVI, VVIR, and VDD in Dogs with Third Degree
Atrioventricular Block (ACVIM Resident Research Award Eligible)
9:15 am C02 Janne Lyngby Validation of a Method for Quantitation of Clopidogrel and Clopidogrel Active
Metabolite in Feline Plasma (ACVIM Resident Research Award Eligible)
9:30 am C03 Dar Ozer Efficacy of Bronchial Stenting in Dogs With Myxomatous Mitral Valve Disease and
Bronchial Collapse (ACVIM Resident Research Award Eligible)
9:45 am C04 J.D. Rhinehart Study of Echocardiographic Variability in Estimating Pulmonary Artery Pressure and
Pulmonary Vascular Resistance in Dogs (ACVIM Resident Research Award Eligible)
10:30 am C05 Kursten Roderick Changes in NT-PROBNP Associated with Treatment and Survival Time in Cats with
Congestive Heart Failure (ACVIM Resident Research Award Eligible)
10:45 am C06 Courtney Smith Right Ventricular Outflow Tract Obstruction and Coronary Anatomy in French and
English Bulldogs with PS (ACVIM Resident Research Award Eligible)
11:00 am C07 Melissa Tropf Cardiac Function and Metabolic Parameters in Obese Dogs (ACVIM Resident Research
Award Eligible)
11:15 am C08 Darcy Adin Comparison of Furosemide Infusion Diluted with 2.4% Hypertonic Saline Vs. Dextrose
5% in Water (D5W)
11:30 am C09 Amelie Beaumier Medical Management and Survival Time Associated with Congestive Heart Failure
Stage D: A Retrospective Study
11:45 am C10 A. Ray Dillon MRI 7T Resonance Spectroscopy (MRS) Predicts Cardiac Energetic Reserves in Dogs
with Preclinical Mitral Insufficiency
12:00 pm C11 Chris Lam Immunohistochemical Study of the Pro-Natriuretic Peptide Convertase Corin in Severe
Canine Myxomatous Mitral Valve Disease
12:15 pm C12 Giulio Menciotti Anatomic Regurgitant Orifice Area Using 3D-Echocardiography in Dogs with
Myxomatous Mitral Valve Disease
2:15 pm C13 Takeshi Mizuno Analysis of Mitral Valve Morphology with Real-Time 3-Dimensional Echocardiography
in Dogs Undergoing Mitral Valve Repair
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1408 2016 ACVIM Abstracts
2:30 pm C14 Lisbeth Olsen Low-Density Lipoprotein Oxidation Is Breed and Gender Dependent in Dogs with
Myxomatous Mitral Valve Disease
2:45 pm C15 Nicole LeBlanc Cardiac Output Measured By Echocardiography and Cardiac-Gated Computed
Tomography Compared to Thermodilution
3:00 pm C16 Kathryn Meurs Angiotensin Converting Enzyme Activity and Response to Enalapril in Dogs with an
Ace Gene Polymorphism
3:15 pm C17 Kathryn Meurs Angiotensin Converting Enzyme Activity in Cavalier King Charles Spaniels with an
Ace Gene Polymorphism
3:30 pm C18 Laura Nafe Prevalence of Dirofilaria immitis Antigen in Client-Owned Pet Dogs Before and After
Serum Heat Treatment
3:45 pm C19 Lena Pelander Cardiac Biomarkers Troponin I and N-Terminal Pro-B-Type Natriuretic Peptide in
Canine Chronic Kidney Disease Patients
4:30 pm C20 Rebecca Tracey Establishing Normal 24 Hour Holter Monitor Values in Healthy Puppies
4:45 pm C21 Jessica Ward Distribution of Alveolar-Interstitial Syndrome in Dyspneic Veterinary Patients Assessed
By Lung Ultrasound Versus Thoracic Radiographs
ONCOLOGY
9:00 am O01 Zachary Neuman The Association of Endothelin-1 Signaling with Bone Alkaline Phosphatase Expression
and Pro-tumorigenic Activities in Canine Osteosarcoma (VCS Award Winner)
9:15 am O02 MacKenzie Pellin Safety Evaluation of Combination Doxorubicin and Toceranib Phosphate (Palladia) in
Tumor Bearing Dogs: a Phase I Dose Finding Study (VCS Award Winner)
9:30 am O03 Jerome Calvalido Comparison of Serum Cytokine Levels Between Dogs with Multicentric Lymphoma
and Healthy Dogs (ACVIM Resident Research Award Eligible)
9:45 am O04 Zachary Crouse Post-Chemotherapy Perforation in Cats with a Diagnosis of Intermediate or High
Grade Gastrointestinal Lymphoma (ACVIM Resident Research Award Eligible)
10:30 am O05 Sindy Piscoya A Retrospective Study on the Incidence of Proteinuria Associated with the Use of
Toceranib Phosphate (ACVIM Resident Research Award Eligible)
10:45 am O06 Krystal Harris Growth Pathways in Feline Oral Squamous Cell Carcinoma
11:00 am O07 Michelle Turek A Retrospective Analysis of Multimodality Treatment for Canine Oral Melanoma: 126
Cases
11:15 am O08 Lucia Borlle Enhancement of Doxorubicin Effectiveness When Combined with Salinomycin in FISS
Cell Lines
11:30 am O09 Martha MaloneyHuss Clinical Advancement of a RNA-Transfected CD40-B Cell Vaccine for the Treatment
of Canine Non-Hodgkin’s Lymphoma
11:45 am O10 Nicole Weidner Vitamin D Status and Acute Phase Protein Concentrations in Canine Cancer Patients
12:00 pm O11 Jenny Ellis Retrospective Evaluation of Metronomic Cyclophosphamide in Epithelial and
Mesenchymal Malignant Tumours
NEUROLOGY
9:00 am N01 Michele Provencher Kinematic Magnetic Resonance Imaging for Evaluation of Disc-Associated Cervical
Spondylomyelopathy in Doberman Pinschers (ACVIM Resident Research Award
Eligible)
9:15 am N02 Melissa Carpentier-Anderson 3D Magnetic Resonance Imaging of the Dog Spine in Hansen Type I Intervertebral
Disk Disease (ACVIM Resident Research Award Eligible)
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1409
9:30 am N03 Aude Castel Clinical Characteristics of Dogs with Progressive Myelomalacia Following Acute
Intervertebral Disc Herniation (ACVIM Resident Research Award Eligible)
9:45 am N04 Serene Lai In Vitro Anti-Tubulin Effects of Benzimidazole Anthelmintics Mebendazole and
Fenbendazole on Canine Glioblastoma Cells (ACVIM Resident Research Award
Eligible)
10:30 am N05 Ilyssa Meren Subarachnoid-Subarachnoid Shunting for Treatment of Subarachnoid Cerebrospinal
Fluid Flow Obstruction in 9 Dogs (ACVIM Resident Research Award Eligible)
10:45 am N06 Jessica Rivera 11-Dehydro Thromboxane B2 As a Biomarker for Intracranial Neoplasia in Dogs
(ACVIM Resident Research Award Eligible)
11:00 am N07 Christine Sibigtroth Lumbar Fractalkine and M2 Microglia Increase Throughout Disease Progresssion in
Canine Degenerative Myelopathy (ACVIM Resident Research Award Eligible)
11:15 am N08 Christine Sibigtroth Increased Phosphorylated Neurofilament Heavy in Cerebrospinal Fluid As a Disease
Marker of Canine Degenerative Myelopathy (ACVIM Resident Research Award
Eligible)
11:30 am N09 Muna Qahwash Etiology of Feline Juvenile Onset Seizures (ACVIM Resident Research Award Eligible)
11:45 am N10 Samantha Vitale Comparison of Serum Trace Nutrient Concentration in Dogs with Primary Genetic
Epilepsy Versus Healthy Dogs
12:00 pm N11 Devon Hague Lactate As a Prognostic Factor in Dogs and Cats with Head Trauma: 93 Cases (2003–
2014)
12:15 pm N12 Nick Jeffery Comparison of Fecal Microbiomes Between Dogs with Meningoencephalomyelitis of
Unknown Origin and Controls
2:15 pm EN01 Nubia Lopes Glucose Homeostasis Deteriorates More Rapidly with Age in Burmese Cats Compared
to Non-Burmese
2:30 pm EN02 Arnon Gal Perturbations in Serum Fructosamine Level in Diabetic Hyperthyroid Cats – A
Retrospective Study
2:45 pm EN03 Hannah Pipe-Martin Pharmacodynamic and Pharmacokinetic Properties of Insulin Aspart Following
Subcutaneous and Intramuscular Injection in Cats (ACVIM Resident Research Award
Eligible)
3:00 pm EN04 Isabelle Rast The Effect of Tetra-Hydroxylated Bile Acid on Adipocyte Size and Insulin Sensitivity in
Healthy Cats (ACVIM Resident Research Award Eligible)
3:15 pm EN05 Chen Gilor The Effect of Adiposity and Diet on Secretion of Incretin Hormones in Cats
3:30 pm EN06 Victoria Crossley Breed, Coat Colour and Hair Length As Risk Factors for Feline Hyperthyroidism
3:45 pm EN07 Allison Rowland Does a Limited Iodine Diet Affect the Response to Radioactive Iodine Therapy in
Hyperthyroid Cats?
4:30 pm EN08 Vincent Ziglioli Effects of Levothyroxine Adminstration and withdrawal on the Hypothalamic-Pituitary-
Thyroid Axis in Euthyroid Dogs (ACVIM Resident Research Award Eligible)
4:45 pm EN09 Alisdair Boag Variability of P450scc Autoantibody Persistence in Dogs Affected with
Hypoadrenocorticism
5:00 pm EN10 Emily Brown Juvenile Hypoadrenocorticism in the Nova Scotia Duck Tolling Retriever: A Recessive
Monogenic Autoimmune Disease
5:15 pm EN11 Arnon Gal Variability in Post ACTH Stimulation Serum Cortisol Following Administration of
Cortisone Acetate in Healthy Dogs
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1410 2016 ACVIM Abstracts
5:30 pm EN12 Muzzammil Sayyid Ionized Hypercalcemia in Cats: Etiologies and Associated Clinical Signs
**Also See Small Animal Internal Medicine – Endocrinology abstracts, Friday, June 10.
2:15 pm GI01 Lauren Cochran Serum Pancreatic Lipase Immunoreactivity Concentrations in Dogs with
Gastrointestinal Foreign Bodies (ACVIM Resident Research Award Eligible)
2:30 pm GI02 Sarah Cocker Serum Pancreatic Lipase Immunoreactivity Concentrations After Chronic
Administration of Supraphysiologic Doses of Glucocorticoids to Dogs (ACVIM
Resident Research Award Eligible)
2:45 pm GI03 Agostino Buono Serum Il-2, Il-6, Il-8, and TNF-a Concentrations in Dogs with Increased Serum Spec
CPL SupÒ Concentrations
3:00 pm GI04 Micah Bishop Fishhook Foreign Bodies in Dogs and Cats: 107 Cases (2004–2015)
3:15 pm GI05 Alana Redfern-Allen Perturbations of the Intestinal Microbiota and Bile Acid Metabolism in Dogs with
Diabetes Mellitus (ACVIM Resident Research Award Eligible)
3:30 pm GI06 J.B. Honneffer Variation of the Microbiome and Metabolome Along the Canine Gastrointestinal Tract
3:45 pm GI07 Jan Suchodolski Effects of Hydrolyzed Protein and Metronidazole on the Fecal Microbiome and
Metabolome in Healthy Dogs
4:30 pm GI08 Blake Guard Altered Fecal Bile Acid Metabolism in Dogs with Chronic Enteropathy
4:45 pm GI09 J.B. Honneffer Altered Fecal Sterol Profiles in Dogs with Chronic Inflammatory Enteropathy
5:00 pm GI10 Jan Suchodolski The Fecal Microbiome of Dogs with Exocrine Pancreatic Insufficiency
5:15 pm GI11 Adam Rudinsky Effect of Weight Loss and Diet on Fecal Microbiota and Fecal Metabolomics in Cats
5:30 pm GI12 Albert Jergens Probiotic Mixture Vsl#3 Increases Beneficial Fecal and Mucosal Microbiota in Canine
Inflammatory Bowel Disease
5:45 pm GI13 Julien Dandrieux Changes in Intestinal Macrophage Populations Following Clinical Resolution in Dogs
with Chronic Enteropathy
6:00 pm GI14 Sara Wennogle Histopathologic Characteristics of Intestinal Biopsies From Dogs with Chronic
Enteropathy with and without Hypoalbuminemia (ACVIM Resident Research Award
Eligible)
**Also See Small Animal Internal Medicine – Gastroenerology abstracts, Friday, June 10.
9:00 am HM01 Beno^ıt Cuq Reproducibility, Stability and Biological Variability of Thrombin Generation Using
Calibrated Automated Thrombography in Healthy Dogs (ACVIM Resident Research
Award Eligible)
9:15 am HM02 Kelly Makielski Development and Validation of a Novel Canine Immune Thrombocytopenia Bleeding
Score (ACVIM Resident Research Award Eligible)
9:30 am HM03 Natalie McLewee Effects of Aspirin Dose Escalation on Canine Platelet Function and Urinary
Thromboxane and Prostacyclin Levels (ACVIM Resident Research Award Eligible)
9:45 am HM04 Jessica Pritchard B Cell Activating Factor As a Biomarker in Dogs with Primary Immune Mediated
Thrombocytopenia
10:30 am HM05 Sophie Saati Comparison of Multiplate, Platelet Function Analyzer-200, and Plateletworks in Dogs
Treated with Aspirin and Clopidogrel (ACVIM Resident Research Award Eligible)
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1411
10:45 am HM06 Jenny Ellis Evaluation of the Risk of Relapse of Canine Immune-Mediated Thrombocytopenia
After Routine Vaccination
11:00 am HM07 Rachel Hegedus Predicting In Vivo Response to Low-Dose Aspirin in Healthy Dogs Using In Vitro
Platelet Aggregometry
11:15 am HM08 Cyril Parachini-Winter Retrospective Evaluation of Anemia and Erythrocyte Morphology in Dogs with
Lymphoma and Inflammatory Bowel Disease
11:30 am HM09 Michele Wilkinson An In-Vitro Assessment of Canine to Feline Red Blood Cell Xenotransfusion
11:45 am HM10 James Swann Characterization of the Immunophenotype of Dogs with Immune-Mediated Hemolytic
Anemia (ACVIM Resident Research Award Eligible)
12:00 pm HM11 Masahiko Sato A Retrospective Study on Use of Leflunomide in Dogs with Immune Mediated
Diseases (ACVIM Resident Research Award Eligible)
12:15 pm HM12 Samantha Muro Effects of Leukoreduction and Storage on Eicosanoid Concentrations in Units of
Canine Packed Red Cells (ACVIM Resident Research Award Eligible)
2:15 pm ID01 Elena Contreras Evidence for Genetic Predispositon to Borrelia burgdorferi Infection in Purpose Bred
Beagles
2:30 pm ID02 Kirsten Cooke Rapid Diagnosis of Babesia gibsoni Using Point-of-Care Insulated Isothermic
Polymerase Chain Reaction Assay
2:45 pm ID03 Robert Six Prevention of Borrelia burgdorferi and Anaplasma phagocytophilum Transmission From
Ixodes scapularis to Dogs By Sarolaner
3:00 pm ID04 Milica Kovacevic Filipovic Molecular and Serological Analysis of Canine Vector Borne Disease Prevalence in Most
Populated Serbian Area
3:15 pm ID05 Diana Scorpio Enhanced Serologic Surveillance to Detect Prevalence of Canine Vector-Borne
Infections on St. Kitts, West Indies
3:30 pm ID06 Julie Levy Performance of Point-of-Care Assays for FELV and FIV
3:45 pm ID07 Cynda Crawford Does a Diva Test Exist for Differentiating FIV Infection From FIV Vaccination?
4:30 pm ID08 Morihiro Tateno An Epidemiological Study of Gammaherpesviruses in Domestic Cats in Japan
4:45 pm ID09 Nyssa Reine-Salz Canine Influenza H3N2 Infection in Four Dogs
5:00 pm ID10 Rhonda LaFleur Demonstration of Protection Against Canine Influenza Virus H3N2 Infection Following
Vaccination with Inactivated CIV H3N2
5:15 pm ID11 Nyssa Reine-Salz Prevalence of Canine Infectious Respiratory Disease Complex Pathogens in Dogs in
Georgia and North Carolina
5:30 pm ID12 Jason Stull Frequency, Benefits and Health Risks of Animals in Nursing Homes: Cross-Sectional
Study of Ohio Facilities
5:45 pm ID13 Modest Vengust Effect of Quorum Quenching with Azithromycin on Pseudomonas aeruginosa Associated
Otitis Externa/Media in Dogs
9:00 am NM01 Hanna Mila Effect of the Hyper-Immune Egg Yolk Supplementation on Weight Gain in Neonate
Puppies
9:15 am NM02 Yuanlong Pan Effects of Dietary Medium Chain Triglycerides on Voluntary Activity in Dogs and Cats
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1412 2016 ACVIM Abstracts
9:30 am NM03 Dagmar Tarkosova Effects of Dietary Macronutrient Content and Feeding Pattern on Leptin
Concentrations in Lean Healthy Cats
9:45 am NM04 Hui Xu Effect of High Sodium Diet on Blood Pressure and Cardiac Function in Healthy Adult
Dogs.
9:00 am NU01 Sarah Guess Longitudinal Evaluation of Serum Symmetric Dimethylarginine (SDMA) and
Creatinine (SCR) in Dogs with Early CKD (ACVIM Resident Research Award Eligible)
9:15 am NU02 Julie Cross SDMA Correlates Better with Creatinine Than High Throughput Immunoturbidometric
Cystatin C Assay in Feline Serum
9:30 am NU03 Laura Harjes Fibroblast Growth Factor-23 in Canine Chronic Kidney Disease (ACVIM Resident
Research Award Eligible)
9:45 am NU04 E. Hathaway Fiocchi The Use of Darbepoetin Alfa to Stimulate Erythropoiesis in Dogs with Chronic Kidney
Disease (ACVIM Resident Research Award Eligible)
10:30 am NU05 Fernanda Chacar Vitamin D-Binding Protein – Early Marker of Tubular Injury in Dogs with Chronic
Kidney Disease
10:45 am NU06 Stacie Summers Assessment of Repeated Administration of a Feline FVRCP Vaccine As a Model for
Interstitial Nephritis (ACVIM Resident Research Award Eligible)
11:00 am NU07 Ellen Behrend Comparison of Visual and Automated Interpretation of Urinary Dipsticks with
Glucose:Creatinine Ratio and Glucose Concentration
11:15 am NU08 Kanae Takada Impact of Canine Pancreas-Specific Lipase on the Outcome of Dogs with Hemodialysis-
Dependent Acute Kidney Injury
11:30 am NU09 Jonathan Foster Characterization of Subclinical Bacteriuria, Urinary Tract Infection, and Pyelonephritis
in Dogs with Chronic Kidney Disease
11:45 am NU10 Ewan Wolff Initial Outcomes and Complications of the Subcutaneous Ureteral Bypass Procedure at
Two University Hospitals (2012–2015) (ACVIM Resident Research Award Eligible)
12:00 pm NU11 Melanie Puchot Occult Urinary Tract Infection in Cats: Prevalence and Findings on Contemporaneous
Urinalysis (ACVIM Resident Research Award Eligible)
12:15 pm NU12 Romy Heilmann Diagnostic Performance of Urinary Canine Calgranulins in Dogs with Lower Urinary
Tract Carcinoma
10:30 am P01 Leanne Fowler Itraconazole Absorption From Proprietary and Compounded Formulations in Healthy
Cats
10:45 am P02 David Griffin Bioavailability of a Novel Formulation of S-Adenosylmethioine Given with Food in
Beagle Dogs
11:00 am P03 Dianne Mawby Posaconazole Pharmacokinetics in Cats After oral and IV Administration
11:15 am P04 J.E. Slovak Evaluation of Intravenous Mycophenolate Mofetil Use in Healthy Cats
11:30 am R01 Kimberly Hooi Comparison of Bronchoalveolar Lavage Techniques for Sampling Lower Airways in
Cats (ACVIM Resident Research Award Eligible)
11:45 am R02 Aida Vientos-Plotts Characterization of the Feline Respiratory Microbiome (ACVIM Resident Research
Award Eligible)
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1413
EQUINE**
9:00 am E01 Kate Echeverria Pulmonary Disposition and Pharmacokinetics of Oral Minocycline in the Adult Horse
(ACVIM Resident Research Award Eligible)
9:15 am E02 Teresa Burns Intravenous Administration of Cobalt Chloride Is Associated with Hemodynamic
Alterations in Horses
9:30 am E03 Andrew Gestrich The Pharmacokinetics of Intravenous Gentamicin in Healthy Young-Adult Versus
Geriatric Horses
9:45 am E04 Nicholas Parkinson Endotoxin-Induced Microrna Expression in Equine Peripheral Blood Mononuclear
Cells (ACVIM Resident Research Award Eligible)
10:30 am E05 Nicolas Herteman Severe Equine Asthma (Heaves) Is Associated with an Increased Number of Circulating
Low-Density Granulocytes
10:45 am E06 Amy Santonastaso Can Levamisole Upregulate the Equine Cell-Mediated Immune Response In Vitro?
11:00 am E07 Helena Carstensen Novel Pharmacological Treatment Regimes in Equine Atrial Fibrillation
11:15 am E08 Linda Frellstedt Can Exercising Electrocardiography Predict Performance in Young Standardbred
Horses at the Start of Training?
11:30 am E09 Eva Hesselkilde Is ECG in Horses Only for Dysrhythmia Diagnosis? Introducing a New Method for 12-
Lead ECG
11:45 am E10 Kate Hepworth-Warren Humoral Hypercalcemia of Malignancy in Horses: A Retrospective Study (2010–2015)
12:00 pm E11 Goncßalo Silva Development of a Technique for Determination of Pulmonary Artery Pulse Wave
Velocity in Horses (ACVIM Resident Research Award Eligible)
12:15 pm E12 Olivia Lorello Repeated Measurements of Autonomic Tone Markers Over a Training Season in
Eventing and Endurance Horses
12:30 pm E35 Breanna Sheahan Normal Ultrasonographic Pleural Thickness in Clinically Healthy Adult Horses
(ACVIM Resident Research Award Eligible)
2:15 pm E13 Steven Grubbs Epidemiological Characteristics of Horses with Hyperinsulinemia in a Large Population
of Horses
2:45 pm E15 Nicholas Frank Development of an Octreotide Response Test for Detection of Insulin Dysregulation in
Horses
3:00 pm E16 Nicholas Frank Insulin and Incretin Hormone Concentrations in Horses During an Oral Sugar Test
and Pasture Challenge
3:15 pm E17 Katarzyna Dembek Association of Androgens and Pregnanes Response to ACTH Stimulation with Adrenal
Dysfunction in Hospitalized Foals
3:30 pm E18 Katarzyna Dembek Association of Oxytocin and Neurosteroids with Neonatal Maladjustment Syndrome
(NMS) in Hospitalized Foals
3:45 pm E19 Elaine Norton Identification of Genetic Loci Underlying Equine Metabolic Syndrome and Laminitis
Risk in Welsh Ponies
4:30 pm E20 Ramiro Toribio The Fibroblast Growth Factor-23/Klotho Axis in Healthy and Hospitalized Foals
4:45 pm E21 Jennifer Brown Effect of RRR-Alpha-Tocopherol Formulation on Serum and CSF Alpha-Tocopherol
Concentrations in Vitamin E Deficient Horses (ACVIM Resident Research Award
Eligible)
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1414 2016 ACVIM Abstracts
5:00 pm E22 Ann Kemper Differential Gene Expression in Equine Subcutaneous and Internal Adipose Depots
(ACVIM Resident Research Award Eligible)
5:15 pm E23 Elizabeth Nelson Effects of a Commercial Anionic Supplement on Urinary Acidification in Horses
(ACVIM Resident Research Award Eligible)
5:30 pm E24 Katherine Williamson Effects of Abrupt Concentrate Increase and Prebiotic Supplementation on Equine Cecal
pH and Lactate
5:45 pm E25 Frank Andrews Effects of a Supplement (Alfa-Lox ForageÒ) on Equine Gastric Ulcer Scores and
Gastric Juice pH
6:00 pm E26 Angelika Schoster Changes of the Equine Neonatal Intestinal Microbiota Associated with Age and
Diarrhea
6:15 pm E27 Daniela Luethy Comparison of Tube, Gel, and Immunochromatographic Strip Methods for Evaluation
of Equine Blood Transfusion Compatibility (ACVIM Resident Research Award Eligible)
FOOD ANIMAL
9:00 am F01 Veronique Bernier Gosselin Prevalence of Coagulase-Negative Staphylococci Species in Intramammary Infection in
Dairy Goats (ACVIM Resident Research Award Eligible)
9:15 am F02 Diego Gomez Assessment of an Antimicrobial-Use Algorithm for Treatment of Diarrhea in Dairy
Calves
9:30 am F03 Diego Gomez Prevalence of Bovine Coronavirus in Feces of Healthy and Diarrheic Calves
9:45 am F04 Joe Smith Use of an Alivecor Heart Monitor for Heart Rate and Rhythm Evaluation in Domestic
Goats
10:30 am F05 Rachel Oman Left Displacement of te Abomasum in Four Beef Calves (ACVIM Resident Research
Award Eligible)
10:45 am F06 Jennifer Halleran Apparent Efficiency of Colostral Immunoglobulin Absorption in Holstein Heifers
(ACVIM Resident Research Award Eligible)
11:00 am F07 Kevin Washburn Concentrations of Chlortetracycline in Fetal Tissues Following Oral Administration in
the Ewe
11:15 am F08 Vincent Dore Hyperketonemia As a Tool to Predict Mortality in Dairy Goat During Last Month of
Pregnancy (ACVIM Resident Research Award Eligible)
11:30 am F09 Christie Balcomb Efficacy and Pharmacokinetics of Intravenous Famotidine in Adult Cattle
11:45 am F10 Andrew Gestrich The Pharmacokinetics of Intravenous Gentamicin in Healthy Young-Adult Versus
Aged Alpacas
EQUINE
2:15 pm E28 Amanda Adams Influenza-Specific Immune Responses to a Combination Vaccine in Na€ıve Ponies
2:30 pm E29 Amanda Adams WNV-Specific Immune Responses to a Combination Vaccine in Na€ıve Ponies
2:45 pm E30 Brandy Burgess Characteristics of Infection Control Practices at North American Veterinary Teaching
Hospitals
3:00 pm E31 Sandra Taylor Anti-Endotoxic Properties of Ketorolac Tromethamine and Flunixin Meglumine in
Horses
3:15 pm E32 Amy Stieler Effects on Sweating of Chloramphenicol and the Macrolide Gamithromycin:
Comparison with Erythromycin
3:30 pm E33 Arlie Manship Comparison of the Clinicopathologic Signatures of Equine Coronavirus and Salmonella
enterocolitis
3:45 pm E34 JunJie Liu Phenotypic Characterization of Sarcocystis neurona Lesions in Gravely Affected Horses
4:30 pm E36 Jacquelyn Bowser Syringe Versus Mechanical Suction with N-Butylscopolammonium Effects on BAL
Parameters in Horses with Pasture RAO
4:45 pm E37 Julie Dauvillier Prevalence of Fungi in Respiratory Samples of Horses with Inflammatory Airway
Disease
5:00 pm E38 Cyprianna Swiderski Intravenous Magnesium Sulfate As a Rescue Therapeutic for Bronchoconstriction in
Horses
5:15 pm E39 Emily Medlin Martin Investigation of Misoprostol As a Novel Anti-Inflammatory in Equine Leukocytes
5:30 pm E40 Sian Durward-Akhurst Do Endocrine Disrupting Chemicals Play a Role in Horses with Equine Metabolic
Syndrome?
5:45 pm E41 Jane Manfredi Evaluation of an Oral Sugar Test for Dynamic Assessment of Five Equine Breeds’
Insulin Response/Sensitivity
9:00 am GI15 Karin Allenspach Human Granulocyte Immunofluorescence Assay for Anti-Neutrophil Antibodies Shows
Strong Association with Canine Food Responsive Diarrhea
9:15 am GI16 Jonathan Lidbury Serum Citrulline Concentrations in Dogs with Chronic Enteropathy
9:30 am GI17 Linda Toresson Oral Versus Parenteral Cobalamin Supplementation in Dogs with Chronic
Enteropathies and Hypocobalaminemia
9:45 am GI18 Nozomu Yokoyama Plasma Essential Trace Element Concentrations in Dogs with Chronic Enteropathy
2:15 pm GI19 Roman Husnik Validation of Ultrasonographic Measurement of Gastric Emptying Time in Healthy
Cats Using Radionuclide Scintigraphy
2:30 pm GI20 Toshiaki Kakimoto Effect of Mosapride on Postprandial Gallbladder Motility and Plasma Levels of
Motilin in Dogs
2:45 pm GI21 M. Katherine Tolbert Evaluation of the Presence and Role of Cysteine Protease 30 in Feline T. foetus
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1416 2016 ACVIM Abstracts
3:00 pm GI22 Emily Gould Evaluation of the Effect of Omeprazole on Serum Calcium, Magnesium, Gastrin and
Bone in Cats
3:15 pm GI23 Jillian Haines Gravity-Assisted Esophageal Transit Characteristics in Dogs with Megaesophagus
3:30 pm GI24 Jonathan Lidbury Feasibility of Measuring Gastrointestinal Transit Time in Healthy Dogs Using ALICAM
3:45 pm GI25 Jill Pomrantz Comparison of Gastric Transit Time in Healthy Dogs and Dogs with Signs of Gastric
Hypomotility
4:00 pm GI26 Jill Pomrantz Feasibility of a Novel Gastrointestinal Imaging Device for Use in Dogs
8:00 am HP01 Sara Wennogle Fluorescence in Situ Hybridization Identifies Occult Bacterial Infection in Gallbladder
Mucoceles (ACVIM Resident Research Award Eligible)
8:15 am HP02 Kathleen Aicher Association of Gallbladder Mucocele Formation with Occult Hypothyroidism in Dogs:
A Matched Case-Controlled Study (ACVIM Resident Research Award Eligible)
8:30 am HP03 Jonathan Lidbury Interobserver Agreement for Histological Scoring of Canine Hepatic Fibrosis
8:45 am HP04 Matthias Schneider Embolization of Intratrahepatic Portosystemic Shunts in Dogs with a Prototype Coil
8:00 am OT01 Alison Khoo Effect of Three Resuscitative Fluid Protocols on N-Terminal Prohormone Brain
Natriuretic Peptide in Healthy Dogs (ACVIM Resident Research Award Eligible)
8:15 am OT02 Mira Korpivaara Dexmedetomidine Oromucosal Gel for Alleviation of Acute Anxiety and Fear
Associated with Noise in Dogs
8:30 am OT03 Katherine Scotti Prognostic Indicators in Cats with Septic Peritonitis: 55 Cases (2002–2015)
8:45 am OT04 Franck Jolivet Reliability of Thermometer Protective Sheaths for Measurement of Rectal Temperature
in Dogs
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1417
POSTER PRESENTATIONS
On Display: Thursday, June 9, 9:30 am–5:00 pm Friday, June 10, 9:30 am–5:00 pm
CARDIOLOGY
C22 SeungWoo Jung Circulating Plasma Mirna As Novel Molecular Biomarkers in Congestive Heart Failure
C23 Randolph Winter A Multicenter Evaluation of Signalment and Comorbid Conditions Associated with
Aortic Thrombosis in 291 Dogs
C24 Marlos Goncalves Right Ventricular Systolic Function in Dogs with Post-Capillary Pulmonary
Sousa Hypertension
C25 Marlos Goncalves Vasovagal Tonus Index in Dogs with Myxomatous Mitral Valve Disease
Sousa
C26 Maria Helena Sick Sinus Syndrome and Sinus Node Dysfunction: Case Series Reports of FMVZ-USP
Matiko Akao Cardiology Service (2007-2015)
Larsson
C27 Kensuke Nakamura The Utility of Spectral Doppler of the Hepatic Veins in Dogs with Tricuspid
Regurgitation
C28 Emily Menzen Cutaneous Use of an Implantable Loop Recorder (Reveal LINQTM) for Cardiac Event
Monitoring in Dogs
C29 Lilian Shen Aortoseptal Angle and Response to Balloon Valvuloplasty in Dogs Affected with
Severe Subaortic Stenosis
C30 Melissa Wilson Evaluation of Pulmonary Hypertension in Cats with Cardiac Disease and Pleural
Effusion Versus Pulmonary Edema
C31 Junseok Lee Post-Operative Dysrhythmias After Cardiac Surgery Under Cardiopulmonary Bypass
NEUROLOGY
N13 Jourdan Brune Characterization of Iatrogenic Blood Contamination on Lactate Dehydrogenase and
Creatine Kinase in Canine Cerebrospinal Fluid
N14 Lorenzo Mari Outcome Comparison in Dogs with Thoracolumbar Acute Non-Compressive Nucleus
Pulposus Extrusion or Fibrocartilaginous Embolic Myelopathy
N15 Katia Marioni- Morphology of the Caudal Fossa in Mesaticephalic and Brachycephalic Cats and
Henry Associated Clinical Signs
N16 Pablo Amengual Diagnostic Investigation in 13 Cats with Suspected Feline Hyperesthesia Syndrome
N18 Michele Provencher Evaluation of Kinematic Magnetic Resonance Imaging in Dogs with Osseous-
Associated Cervical Spondylomyelopathy (ACVIM Resident Research Award Eligible)
N19 Lisa Bartner Bartonella Spp. PCR Assay Results Using Cerebrospinal Fluid of Dogs with Central
Nervous System Disease
N20 Hilary Levitin Preictal, Postictal and Interictal Behavioral Changes in Dogs with Genetic Epilepsy
Compared to Control Dogs
ONCOLOGY
O12 Erika Berger Evaluation of Toceranib Phosphate (PalladiaÒ) in the Treatment of Feline Mast Cell
Neoplasia: 53 Cases
O13 Valter de Medeiros Expression of P Glycoprotein (ABCB1) in Cats with T-Cell Lymphocytic
Winkel Gastrointestinal Lmyphoma
O14 Tracy Gieger Early Experiences with Stereotactic Radiation Therapy for the Treatment of Canine
Non-Lymphomatous Nasal Tumors
O15 Tracy Gieger Treatment of Canine Appendicular Osteosarcoma with Amputation, Carboplatin, and
Toceranib Phosphate
O16 J. Paul Woods Safety Assessment of a Novel Oncolytic Maraba Virus in Cats
O17 Daniel Regan Role of Monocyte Recruitment in Hemangiosarcoma Metastasis in Dogs (VCS Award
Winner)
O18 Nicholas Szigetvari Phase I Clinical Trial of the Targeted Chemotherapeutic Drug, Folate-Tubulysin, in
Dogs with Urinary Tract Transitional Cell Carcinoma (VCS Award Winner)
EN13 Ashley Gold Evaluation of Basal Cortisol Concentrations for the Diagnosis of Hypoadrenocorticism
in Dogs (ACVIM Resident Research Award Eligible)
EN14 Christina Marino Thyroid Profiles in Healthy Kittens Aged Two to Sixteen Weeks of Age (ACVIM
Resident Research Award Eligible)
EN15 Eileen Seage Spectrophotometry and Ultracentrifugation for Measurement of Plasma Lipids in Dogs
with Diabetes Mellitus (ACVIM Resident Research Award Eligible)
EN16 Hye-Ryung Choo Effect of Hydrocortisone Administration on Leptin and Adiponectin Synthesis in
Healthy Dogs
EN17 Jon Fletcher Using Purified Feline Insulin to Evaluate Cross-Reactivity with a Human Insulin
Analog Elisa
EN19 Mia Reeve-Johnson Metabolite Differences Between Senior Burmese and Non-Burmese Cats, and
Associations with Measures of Glucose Metabolism
EN20 Yaiza Forcada A Genome-wide Association Study Identifies Novel Candidate Genes for Susceptibility
to Diabetes Mellitus in DSH Cats (ESVE Award Winner)
GI27 Alison Manchester Correlation Between Novel Immunohistochemical Markers, Histopathology and
Clinical Scores in Cats with Chronic Enteropathy (ACVIM Resident Research Award
Eligible)
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1419
GI28 Amanda Blake Fecal D-/L-Lactate Concentrations and Abundance of Lactic Acid Bacteria in Dogs
with Exocrine Pancreatic Insufficiency
GI29 Gena Esposito Evaluation of Serum Beta-Hydroxybutyrate Concentrations in Dogs with Chronic
Enteropathies
GI30 Ellen Everson Effect of Serum Creatinine on Feline Serum DGGR-Lipase and Serum Pancreatic
Lipase Immunoreactivity
GI31 Roman Husnik Prevalence of Helicobacter Species and Their Association with Gastric Pathology in
Dogs with Gastrointestinal Disease
GI32 Jill Pomrantz Normal and Abnormal Findings in the Canine Gastrointestinal Tract Using
Ambulatory Light-Based Imaging
GI33 Joerg Steiner Fecal a1-Proteinase Inhibitor Concentrations in Dogs with Cardiac Disease
GI34 Rebecca Timmons Evaluation of the Effects of Pre-Conditioning on Female Canine Adipose-Derived
Mesenchymal Stem Cell Cytokine Production
HM13 Ian McClure Incidence of DEA 5 in Canine Population Using Novel Canine Antisera
HM14 Keitaro Morishita Prospective Study in the Treatment of Nonregenerative Immune-Mediated Anemia in 8
Dogs
HM15 Hyeri Shin Validation of Rapid Thromboelastographic Analysis on Citrated and Native Whole
Blood From Healthy Dogs
HM16 Sarah Shropshire Serial Evaluation of Thromboelastography and Platelet Aggregometry in Healthy Dogs
HP05 Daniel Langlois Investigation of Hepatic Copper Accumulation in Dogs From Two Time Periods (1982-
1988 and 2009-2015)
ID14 Melissa Beall Comparative Evaluation of Five In-Clinic Rapid Tests for Feline Leukemia Virus
Infection
ID15 Ramaswamy Detection of Giardiasis in Dogs: Comparison of Three Rapid Diagnostic Tests
Chandrashekar
ID16 Jesse Buch Seroprevalence of Antibodies to Anaplasma phagocytophilum and Borrelia burgdorferi in
Domestic Cats
ID17 Jesse Buch Validation of a High-Throughput Serological Elisa Method for FELV P27 Antigen
Detection
ID18 Amber Caress Investigation of Whether Leptospira Vaccinal Antibodies React with Borrelia Peptides
Used in a Commercial Assay
ID19 Elena Contreras Clinical and Laboratory Findings in Dogs with Ixodes-Induced Chronic Anaplasma
phagocytophilum Infection After Prednisolone Administration
ID20 Michael Lappin Serum Neutralization of Feline Caliviviruses Using Sera From Kittens Administered a
Vaccine Containing Two Strains
ID21 Michael Lappin Risk Factors Associated with Giardia and Cryptosporidium in Pet Dogs and Cats in the
USA
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1420 2016 ACVIM Abstracts
ID22 Jiayou Liu Significant Differences in Sensitivity Levels of Rapid Tests for Antibodies to Anaplasma
Spp. in Dogs
ID23 Katie MacMillan Prevalence of Select Infectious Disease Agents in Client Owned Cats in Moscow, Russia
ID24 Alison Manchester Coxiella burnetii DNA Not Identified in Fleas From Domestic Cats in Australia and
the USA
ID25 Kirk Miller Risk of Heartworm Infection in Domestic Canines of Northwestern oregon
ID26 Cody Minor Ectoparasites and Vector-Borne Pathogens of Dogs in Baja California Sur
ID27 Jason Stull Identifying Agreement and Barriers to Proposed Canine Infectious Disease Guidelines
for Dog Group Settings
ID28 Julia Veir Correlation of Mycoplasma Quantitative PCR to Severity of Conjunctivitis in Cats
NM05 Aparecido Camacho Determining the Lactate and Glucose Thresholds and the Acid-Base Imbalances in
Beagles Dogs
NM06 Dennis Jewell When Fed Foods with Similar Palatability, Cats Choose 30%, Dogs 23% of Calories
As Protein
NM07 Jennifer MacLeay A Double Masked Clinical Trial of a Therapeutic Food in the Management of Canine
Atopy
NU13 Crystal Cooley Survey of Subcutaneous Fluid Practices in Cats with Chronic Kidney Disease (ACVIM
Resident Research Award Eligible)
NU14 Ryan Dulaney Quantifying Urine Elimination Behaviors in Cats Using a Video Recording System
(ACVIM Resident Research Award Eligible)
NU15 Alisdair Boag Evaluation of the Effect of Urine Dip Versus Urine Drip on Multitest Strip Results
NU16 Jean Hall Positive Impact of Nutritional Interventions in Client-Owned Dogs with Iris Stage-1
Chronic Kidney Disease
NU17 Marcia Kogika Fibroblast Growth Factor 23 (FGF-23) in Dogs with Naturally Occurring Chronic
Kidney Disease
NU18 Maciej Parys Serum Cytokine Profiles of Cats with Idiopathic Cystitis
NU19 Camille Torres- Cystolith Dissolution in Cats Using a Commercially Available Diet
Henderson
OT05 Katrina Stewart Isolation and Identification of Microrna From the Mature Feline Erythrocyte: A Pilot
Study (ACVIM Resident Research Award Eligible)
OT06 Laura McPhee Effects of Sedation and Anesthesia on Canine Hematologic and Serum Biochemical
Analyses During Preventive Healthcare
OT07 Igor Yankin Does Fine Needle Aspiration Affect Management of Dogs with Incidental Splenic
Nodules or Heterogeneous Parenchyma?
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1421
P05 Darren Berger The Accuracy, Precision and Stability of Compounded Milbemycin Oxime in Aqueous
Suspension
P06 Andrea Herndon Pharmacokinetics of Intravenous and Subcutaneous Dolasetron and Pharmacodynamics
of Subcutaneous Dolasetron in Purpose-Bred Cats
P07 Lara Zajic Investigation of the Pharmacokinetics of Transdermal Ondansetron in Normal Purpose-
Bred Cats
EQUINE
E43 Kamila Gravena Matrix Metalloproteinase-2 and -9 Levels in Horses with Experimental Small Colon
Intraluminal Obstruction
E44 Michael Keowen Effects of Collagen Hydrolysates on Equine Gastric Ulcer Scores and Gastric Juice Ph
in Horses
E45 James Prutton Safety, Humoral Immune Response and Fecal Shedding of Modified-Live Bovine
Coronavirus Vaccines Given to Horses
E46 Sarah Elzinga Do Horses with Equine Metabolic Syndrome Have Reduced Immune Responses to
Vaccination?
E47 Melissa Siard Immunological Comparisons of Aged Horses with Vs. without Pituitary Pars
Intermedia Dysfunction
E49 Martha Mallicote Effects of Erythromycin on Responses Induced in Foals By Intravenous Epinephrine
E50 Barbara Qurollo Equine Vector-Borne Diseases Determined By Serological and Molecular Methods
E51 Andrew Allen Selenium Deficiency Associated with the Deaths of Fifteen Adult Horses
E52 Frank Garza, Jr. Effects of Alfa-Lox ForageÒ on Blood Glucose and Insulin Activity After Grain
Feeding in Horses
E53 Breanna Sheahan Venous Blood Gas, Electrolyte and Metabolite Findings in Healthy Neonatal Foals
Receiving Sodium Lactate Infusions (ACVIM Resident Research Award Eligible)
E54 Randolph Winter Growth and Function of Equine Endothelial Progenitor Cells Labeled with
Semiconductor Quantum Dots
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1422 2016 ACVIM Abstracts
C01 C02
SINUS RATE APPROXIMATION WITH VVI, VVIR, AND VALIDATION OF A METHOD FOR QUANTITATION
VDD IN DOGS WITH THIRD DEGREE ATRIOVENTRICULAR OF CLOPIDOGREL AND CLOPIDOGREL ACTIVE
BLOCK. Bryan Eason1, Dan Hogan1, Ryan Baumwart2. 1Purdue METABOLITE IN FELINE PLASMA. Janne G. Lyngby,
University, West Lafayette, IN, USA, 2Oklahoma State University, Michael H. Court, Pamela M. Lee. Program in Individualized
Stillwater, OK, USA Medicine (PrIMe), Department of Veterinary Clinical Sciences,
College of Veterinary Medicine, Washington State University,
The purpose of this study was to investigate which pacing Pullman, WA, USA
modality (VVI, VVIR, or VDD) most closely approximates the
intrinsic sinus rate in dogs with third degree AV block (3AVB) Clopidogrel is considered mainstay therapy for the prevention
over a range of typical daily activities. A secondary aim of the of cardiogenic thromboemboli in cats and has been shown to be
study was to determine if echocardiographic parameters were dif- superior to aspirin. Clopidogrel is a pro-drug and requires hepatic
ferent between pacing modalities. We hypothesized that VDD bioactivation through cytochrome p450 for formation of the clopi-
would most closely track the intrinsic sinus rate for all activities dogrel active metabolite (CAM), which is unstable and challenging
and that echocardiographic dimensions would be different between to quantitate. After bioactivation, CAM binds to the ADP-
AV asynchronous (VVI, VVIR) and AV synchronous (VDD) pac- receptor on platelets and inhibits platelet aggregation. Recently, a
ing modalities. method to stabilize CAM in human plasma has been developed by
Dogs were prospectively recruited following implantation of a adding 2-bromo-3’methoxyacetophenone (BMAP) to blood tubes.
St. Jude dual-chamber pacemaker system for 3AVB; dogs with evi- Once stabilized, the derivatized CAM (CAM-D) can be quanti-
dence of sinus node dysfunction or clinically important arrhyth- tated using high-performance liquid chromatography and tandem
mias other than 3AVB were excluded. All dogs were programmed mass spectrometry (HPLC-MS/MS).
to VDD at study entry. The average, lowest and highest heart Our aim is to validate HPLC-MS/MS for the detection of clopi-
rates during VDD pacing were determined; the average heart rate dogrel, CAM-D, and other metabolites in feline plasma. We
was programmed as the base rate for VVI and VVIR. The highest hypothesized that HPLC-MS/MS is both accurate and precise.
heart rate was programmed as the upper tracking rate for VVIR The quantitation of CAM is the first step in determining if cats
with a threshold of 2.5, slope of 16, and fast reaction and recovery can consistently metabolize clopidogrel or if significant interindi-
times. The rest function was used for all pacing modalities and vidual variation exists as in humans with genetic polymorphisms
was programmed to the lowest heart rate during VDD pacing; if of hepatic cytochrome P450. Furthermore, having an accurate and
the lowest heart rate was at the lower rate limit, then the rest rate precise method for measuring the plasma concentration of CAM
was programmed 20% slower. Dogs were randomly assigned to will allow safer use of clopidogrel by potentially establishing a
VVI or VVIR after initial VDD interrogation and echocardiogra- therapeutic index and by evaluating whether coadministration of
phy (2D, Doppler, TDI). Ambulatory ECGs were recorded for drugs like omeprazole inhibit CAM formation in cats.
36 hours and the owners were instructed to record the time and FDA guidelines to assess accuracy and precision were followed.
duration of 5 specific activities: (1) urination/defecation, (2) eating, The in vitro stability of clopidogrel, CAM-D, and clopidogrel acid
(3) sleeping, (4) walking, and (5) play. After three months, in both citrate and EDTA feline plasma was evaluated at room
echocardiography was repeated, the dog was crossed over to VVI temperature, 4°C, 20°C and 80°C at 0, 6, 12, 24, 48, 72 hours,
or VVIR pacing, and ambulatory ECG monitoring was repeated. and 7 days. Linear regression was performed on an 8 point stan-
After three additional months, echocardiography was repeated, the dard curve (clopidogrel and CAM-D at 1–100 ng/mL, clopidogrel
pacing modality was programmed to VDD and ambulatory ECG acid at 0.2–20 µg/mL). To evaluate clinical application, two
monitoring was repeated. Atrial rate, ventricular rate, and atrial- healthy cats were given clopidogrel (Plavix) at the clinically used
to-ventricular ratio were determined for each of the 5 activities dose of 18.75 mg orally once daily. Blood was taken prior to
after an initial 12 hours acclimatization period. clopidogrel administration and at 20, 40, 60, 90 minutes, 4 hours,
This is an ongoing study and currently 6 dogs are enrolled where 6 hours, 8 hours, and 12 hours post clopidogrel administration.
5 dogs have completed the VVI phase, 4 dogs have completed the All blood samples were collected aseptically into 2 mL cryotubes
VVIR phase, 4 dogs have completed both the VVI and VVIR containing 10 uL of 500 mM BMAP and 20 uL of 500 mM
phases, and 1 dog has completed all VVI, VVIR, and VDD phases. EDTA and then centrifuged. The supernatant was then transferred
Atrial rates and atrial-to-ventricular ratios for VVI, VVIR, and to new cryotubes and stored at 80°C. All samples were analyzed
VDD at each activity are as follows: urination/defecation using HPLC-MS/MS in duplicate with a standard curve.
(156.0 42.9, 2.01 0.39),(134.4 24.0, 0.95 0.14), (105.7, In vitro samples were stable at all temperatures for a minimum
1.0); eating (116.4 20.8, 1.51 0.23),(126.2 11.7, 0.97 0.22), of 72 hours. No difference was appreciated in the stability of
(95.7, 1.0); sleeping (99.1 38.3, 1.32 0.62),(79.8 15.7, clopidogrel and its metabolites between EDTA and citrated
0.88 0.30), (51.5, 0.76); walking (183.2 24.7, 2.4 0.41), plasma. Standard curves showed linearity for clopidogrel, CAM-
(157.4 38.9, 1.09 0.12), (91.4, 1.0); play (125.4 38.3, D, and clopidogrel acid (r = 0.99). The assay measured clopido-
1.66 0.61),(105.8 17.0, 0.83 0.07), (108.9, 1.0). Echocardio- grel, CAM-D, and clopidogrel acid with an accuracy of <18.7%
graphic data is available for all 6 dogs in VDD, 4 dogs in VVIR, and and a precision within runs of <7%. Plasma concentrations of
2 dogs in VVI. The left ventricle appears to be larger in diastole and clopidogrel, CAM-D, and clopidogrel acid were readily detected in
systole for VVI (LVAd/Ao = 6.85 0.76, EDV/Ao = 26.08 plasma from healthy cats receiving clopidogrel.
2.80, LVAs/Ao = 2.74 0.19, ESV/Ao = 9.23 0.08) and This is the first simultaneous quantitation of clopidogrel, CAM-
VVIR (LVAd/Ao = 5.24 0.57, EDV/Ao = 24.78 3.04, LVAs/ D, and clopidogrel acid in feline plasma. HPLC-MS/MS is an
Ao = 2.38 0.47, ESV/Ao = 10.65 3.21) than VDD pacing accurate and precise method for simultaneous quantitation of
(LVAd/Ao = 5.14 1.38, EDV/Ao = 23.13 7.46, LVAs/Ao = clopidogrel and metabolites in feline plasma both in vitro and from
2.30 0.84, ESV/Ao = 7.43 4.27). healthy cats receiving oral clopidogrel.
As the study is ongoing no final conclusions can be made
although synchronous VDD pacing appears to more closely
approximate sinus rate and have slower atrial rates than asyn-
chronous VVI or VVIR pacing. All dogs will have completed the
study within the next two months at which time final conclusions
can be made. C03
EFFICACY OF BRONCHIAL STENTING IN DOGS
WITH MYXOMATOUS MITRAL VALVE DISEASE AND
BRONCHIAL COLLAPSE. Dar Ozer1, Samantha Siess2, Brienne
Williams1, Nikki Gaudette1, George Kramer1. 1Atlantic Coast
Veterinary Specialists, Bohemia, NY, USA, 2Stony Brook Univer-
sity, Stony Brook, NY, USA
airway disease. The purpose of this study was to review outcomes from 3.15 0.71 m/s to 3.51 0.83 m/s; increase observed in
in dogs that had bronchial stents placed due to bronchial collapse. 55% dogs) whereas 6-MWT had no effect (3.16 0.75 m/s,
It was hypothesized that moderate to severe MMVD or the pres- P > 0.05). HR declined after sedation (mean reduction
ence of pulmonary hypertension would not have a negative effect 13 19 bpm; P < 0.05) and increased after 6MWT (mean
on lifespan after stent placement. increase 30 28 bpm; P < 0.05) but had no correlation to TVFV
Medical records of 18 small breed dogs that had bronchial stent or PVR. 6-MWT did not influence TRFV and PVR.
placement for chronic coughing secondary to bronchial collapse These data document relevant variability of DE estimates of PH
were reviewed. A hierarchical multiple linear regression analysis that deserve clinical consideration.
was conducted to predict lifespan after bronchial stent placement
based on age at time of stent placement, severity of MMVD and
the presence of pulmonary hypertension.
Eighteen dogs had bronchial stents placed over a period of
7 years. Age at the time of stent placement ranged from 6.5 years
to 14 years of age (M = 10.47 1.85). Breeds represented C05
included Cavalier King Charles spaniel (2), beagle (2), Chihuahua CHANGES IN NT-PROBNP ASSOCIATED WITH
(4), Pomeranian (3), toy poodle (2), Yorkshire terrier (2), Maltese TREATMENT AND SURVIVAL TIME IN CATS WITH
(1), Coton de Tulear (1) and shih tzu (1). There were 11 males and CONGESTIVE HEART FAILURE. Kursten Roderick, John
7 females. Twelve dogs (66.67%) had evidence of moderate to sev- Rush, Lisa Freeman, Vicky Yang, Suzanne Cunningham.
ere MMVD and 4 (22.22%) had evidence of pulmonary hyperten- Cummings School of Veterinary Medicine at Tufts University,
sion. Six dogs (33.33%) had CHF prior to stent placement and 6 North Grafton, MA, USA
dogs (33.33%) had CHF after stent placement. Syncope was
reported in 6 dogs prior to stent placement and 5 dogs after stent Survival time in cats with congestive heart failure (CHF) is
placement. The average lifespan after stent placement was variable, and predictors of outcome would be useful to help
203.56 250.72 days. Three dogs are currently alive post-stent guide treatment and patient assessment. In people with CHF,
placement (1013, 559 and 411 days). the change in NT-proBNP concentrations after initiating treat-
A hierarchical multiple linear regression was calculated to pre- ment and/or targeting NT-proBNP concentrations below an
dict lifespan after placement of a bronchial stent based on age at absolute level provide valuable information that can be used to
the time of stent placement, the presence of pulmonary hyperten- help guide treatment. The change in NT-proBNP concentrations
sion, and severity of MMVD. In stage one, age at the time of stent in cats with CHF after treatment and their association with sur-
placement significantly predicted lifespan after placement of a vival have not been reported. Therefore, the purpose of this
bronchial stent (b = 7.10, P < .02); with lifespan decreasing by study was to measure the change in NT-proBNP in cats with
7.10 days for each additional month of age at the time of stent CHF after treatment and to determine whether serial NT-
placement. The presence of pulmonary hypertension did not signif- proBNP measurements provide prognostic information in this
icantly predict lifespan (b = 235.32, P = .10). Severity of MMVD population.
did not contribute significantly to the model in stage two Client-owned cats presenting with new onset CHF secondary to
(b = 101.38, P = 0.43). cardiomyopathy were eligible for enrollment. Blood was collected
Results from this study indicate that the severity of MMVD or for NT-proBNP analysis within 4 hours of admission, on the day
the presence of pulmonary hypertension did not negatively affect of discharge, and at the re-evaluation 7–10 days later.
lifespan after bronchial stent placement. As such, moderate to sev- Thirty-two cats were enrolled (25 male, 7 female; all neutered),
ere MMVD and the presence of pulmonary hypertension should with a median age of 9.6 years (range 1.1 to 18.0 years). Thirty-
not be viewed as exclusion criteria when assessing candidates for one (97%) cats survived to discharge and 28 cats (88%) survived
possible bronchial stenting. Prospective studies should be con- to the 7–10 day re-evaluation. Median NT-proBNP concentrations
ducted to further investigate the clinical benefit of bronchial stent- at admission and hospital discharge were 1,713 pmol/L (range, 160
ing in dogs with severe bronchial collapse. to 3,784 pmol/L) and 902 pmol/L (range, 147 to 3,223 pmol/L),
respectively. Median NT-proBNP concentration at re-evaluation
was 1,124 pmol/L (range, 111 to 2,727 pmol/L). Median NT-
proBNP concentrations decreased significantly from admission to
discharge (P < 0.001) and from admission to re-evaluation
(P < 0.001), but not from discharge to re-evaluation (P = 0.28).
C04 Median survival time was 109 days (range, 1 to 606 days), with 6
STUDY OF ECHOCARDIOGRAPHIC VARIABILITY IN cats (19%) still alive at the time of analysis. Cats that received
ESTIMATING PULMONARY ARTERY PRESSURE AND pimobendan had a significantly greater decrease in NT-proBNP
PULMONARY VASCULAR RESISTANCE IN DOGS. concentrations [821 pmol/L (range, 2,163 to 267 pmol/L)
JD Rhinehart, JD Bonagura, BA Scansen, KE Schober. College of from admission to discharge compared to cats that did not receive
Veterinary Medicine, The Ohio State University, Columbus, OH, pimobendan [561 pmol/L (range, 2137 to 889 pmol/L);
USA P = 0.045]. Cats whose owners had difficulty administering medi-
cations (n = 11) had a shorter survival time [median 60 days
Pulmonary hypertension (PH) is important in clinical practice (range, 2 to 234 days)] compared to owners who did not report
and is related to clinical symptoms and prognosis. We hypothe- difficulty [n = 21, median 115 days (range, 1 to 606 days)]; how-
sized that Doppler echocardiographic (DE) indices of PH and pul- ever this was not statistically significant (P = 0.12).
monary vascular resistance (PVR) are influenced by a variety of The association between pimobendan and a larger decrease in
independent factors leading to clinically important variability of NT-proBNP concentration warrants additional research. Larger
DE-based pressure estimates in dogs. studies are needed to determine whether NT-proBNP can be used
Dogs with naturally acquired tricuspid regurgitation (TR) were to help guide treatment in cats with CHF.
studied prospectively. All dogs had degenerative valve disease.
Target variables were acquired during 4 study periods (dogs in lat-
eral recumbency or standing, after a 6-minute walk test [6-MWT]
and after sedation [0.25 mg/kg butorphanol, IM]), and by two dif-
ferent observers. Heart rate (HR), TR flow velocity (TRFV),
PVR, estimates of right atrial pressure, stroke volume, cardiac out- C06
put, and 23 other variables were quantified. Statistical methods RIGHT VENTRICULAR OUTFLOW TRACT OBSTRUCTION
included repeated-measures ANOVA and mixed model analysis. AND CORONARY ANATOMY IN FRENCH AND ENGLISH
P < 0.05 was considered significant. BULLDOGS WITH PULMONIC STENOSIS. Courtney Smith,
Thirty-two dogs of 10 small breeds with varying TRFVs (1.9– Katherine Scollan, David Sisson, Nicole LeBlanc. Oregon State
5.28 m/s) and PVR (2.9–33.0 WU) were studied. There was a sig- University, Corvallis, OR, USA
nificant effect of observer (P < 0.05), respiration (P < 0.01), and
image quality (P < 0.05) on outcome variables whereas imaging Pulmonic stenosis (PS) is one of the most common congenital
position (dogs lying versus standing) did not cause differences cardiac defects in dogs. Stenotic lesions described range from a
(P > 0.20). Sedation significantly increased mean TRFV (P < 0.05, normal pulmonic annulus with domed leaflets to a hypoplastic
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1424 2016 ACVIM Abstracts
pulmonary annulus with thickened leaflets. Additionally, anoma- to assess the presence of cardiac dysfunction in obese dogs
lous coronary artery anatomy (commonly described as an R2A) compared to dogs with ideal body composition and second, to
has been reported impinging on the right ventricular outflow tract compare metabolic parameters including lipid analysis and inflam-
(RVOT) in English Bulldogs and a Boxer dog with PS. The aim of matory markers in obese versus normal dogs.
this study was to investigate the stenotic lesion morphology and Healthy dogs weighing less than 25 pounds with ideal body con-
coronary artery anatomy in French Bulldogs in comparison to dition (n = 17) and obese body condition (n = 29) were enrolled.
English Bulldogs to assess similarities and/or differences between All dogs had normal physical exam and thoracic auscultation with
the breeds. no evidence of systemic illness on routine laboratory diagnostics.
Medical records were reviewed for French and English Bulldogs A body composition using a validated 9 point scale, systolic arte-
presented to Oregon State University for heart murmur evaluation rial Doppler blood pressure, a 6-lead electrocardiogram, and an
or imaging prior to balloon valvuloplasty (BVP). Dogs were echocardiogram (M-mode, B-mode, Doppler and strain imaging)
included if they had severe PS (pressure gradient >80 mmHg esti- were obtained. Finally, metabolic parameters including a lipid pro-
mated via echocardiography) and confirmation of their coronary file (cholesterol, triglyceride, HDL, LDL), insulin, adiponectin,
artery anatomy by either angiography or computed tomography and a canine inflammatory marker ELISA panel (GM-CSF, IL2-
(CT). Echocardiographic, angiographic, and CT images were 18, TNF-alpha, INF-gamma, TNF-gamma CRP, MCP-1, IP-10,
reviewed. The pulmonic annulus (PA), aortic annulus (Ao), PA:Ao KC-like) were evaluated. Paired T tests were performed to com-
ratio, valvular anatomy, and coronary anatomy were assessed on pare the study groups and a P-value of less than 0.05 considered
each imaging modality by three observers (CS, KS, DDS) and statistically significant.
averaged. Tricuspid regurgitation (TR) was assessed on echocar- Compared to dogs with ideal body condition scores, obese dogs
diographic and angiographic studies. Breed medians or means had significantly increased septal wall thickness, increased systolic
were compared by Mann-Whitney U test or unpaired t-tests as function measures, and significantly reduced diastolic function
indicated. In the dogs that had both CT and angiographic studies, measures. Obese dogs had significantly increased insulin, insulin:
values were compared by paired t-tests. glucose ratio, cholesterol, triglyceride, and HDL levels. The
Twenty-six dogs were reviewed and 6 dogs (all English Bull- remaining metabolic parameters including adiponectin were not
dogs) were excluded due to lack of definitive coronary artery anat- significantly different between the groups. IL-8 and KC-like
omy imaging. Of the 20 included dogs, 7 were English (7 male) inflammatory markers were significantly higher in the obese group.
and 13 were French Bulldogs (4 female and 9 male). Mean weight While the mean blood pressure was higher in obese patients, the
was 13.8 4.5 kg in the English and 8.9 3.9 kg in the French difference was not statistically significant. A number of obese dogs
Bulldogs (P = 0.02). CT and angiographic imaging was performed (n = 6) were confirmed to have systemic hypertension on subse-
on 6/7 and 2/7 English, and 9/13 and 12/13 French Bulldogs, quent examinations.
respectively. An R2A coronary artery anomaly was definitively In conclusion, obese dogs do have alterations in cardiac struc-
identified in 6/7 English Bulldogs and 0/13 French Bulldogs. ture and function as well as dyslipidaemia, altered insulin sensitiv-
Median PA:Ao annulus ratio was not statistically different ity, and elevated inflammatory markers. These findings warrant
between the English (0.88, range 0.64–1.0) and French Bulldogs additional studies to investigate inflammation, dyslipidaemia, or
(0.89, range 0.85–1.1; P = 0.37). In addition, no difference was possibly systemic hypertension as potential etiologies of altered
found between CT and angiographic measurements of the PA:Ao cardiac function.
ratio (P = 0.38). The mean PA annulus indexed to body weight to
the 1/3 power was not different between English (0.54 0.07) and
French Bulldogs (0.53 0.04; P = 0.73). TR was noted in 9/13
French Bulldogs (4 mild, 2 moderate, 3 severe) while 3/7 English
Bulldogs had TR (1 mild, 1 moderate, 1 severe).
Anomalous development of the coronary arteries was not C08
observed in any of the French Bulldogs evaluated in this study, COMPARISON OF FUROSEMIDE INFUSION DILUTED
whereas the R2A coronary anomaly was identified in 6/7 English WITH 2.4% HYPERTONIC SALINE VERSUS DEXTROSE
Bulldogs with a RVOT obstruction. Marked thickening of the pul- 5% IN WATER (D5W). Darcy Adin1, Teresa DeFrancesco1,
monic valve leaflets with markedly reduced leaflet mobility was Clarke Atkins1, Kari Kurtz1, Manoela Penteado2. 1North Carolina
observed in all of the French Bulldogs and annular hypoplasia State University, Raleigh, NC, USA, 22University of Sao Paulo,
was not present or was very modest in both breeds. In the dogs Sao Paulo, Brazil
with R2A anomalies, the curvature and degree of encroachment
from the left coronary artery on the RVOT was markedly vari- Continuous rate infusion (CRI) of furosemide causes more
able. A combination of valvular and supravalvular obstruction diuresis than intermittent bolus administration, but can exacerbate
was identified in the only English Bulldog with normal coronary dehydration and renal dysfunction. The co-administration of
anatomy. hypertonic saline (HS) may mitigate this, however, volume expan-
sion could be detrimental in heart failure.
Furosemide CRI with D5W (FCRI-D5W) was compared to
furosemide CRI with 2.4% hypertonic saline (FCRI-HS) in 6 nor-
mal dogs, in a randomized, blinded, crossover study. Furosemide
was diluted to 2.2% with either 1.5 mL/kg D5W for the FCRI-
C07 D5W treatment or with 1.0 mL/kg D5W and 0.5 mL/kg of 7.2%
CARDIAC FUNCTION AND METABOLIC PARAMETERS IN hypertonic saline for the FCRI-HS treatment. The furosemide
OBESE DOGS. Melissa Tropf, O. Lynne Nelson, Pamela Lee. CRI rate was 0.66 mg/kg/hr for 5 hours in equal volume for both
Washington State University, Pullman, WA, USA treatments and was preceded by a 0.66 mg/kg furosemide IV
bolus.
In people, obesity is an independent risk factor for the develop- Mean PCV and %increase in BUN were less for FCRI-HS ver-
ment of obesity related cardiac dysfunction (ORCD) characterized sus FCRI-D5W (P = 0.046 both). Mean CVP decreased over time
by systolic dysfunction, diastolic dysfunction, and/or vascular (P < 0.001), with no treatment difference (P = 0.4). Urine output,
endothelial dysfunction. Components of metabolic syndrome water intake, and creatinine increased significantly, while serum
including dyslipidemias, elevated inflammatory markers, and insu- osmolality, serum/urine electrolytes, urine furosemide, and body
lin resistance are believed to play an important role in the patho- weight decreased significantly, without differences between treat-
physiology of ORCD. Obesity is reaching epidemic proportions in ments. The %decrease in serum potassium (P = 0.09) and %in-
dogs and it is estimated that approximately 34% of dogs are over- crease in urinary sodium (P = 0.08) trended higher in FCRI-HS.
weight and 5% are obese in the United States. Recent studies per- Plasma furosemide was stable and not different between treat-
formed in dogs suggest that metabolic syndrome also exists in ments. Urinary neutrophil gelatinase-associated lipocalin (NGAL)
obese dogs, warranting further investigation into the risk for was unchanged, while both treatments doubled urinary aldos-
ORCD. terone excretion suggesting similar activation of RAAS.
We hypothesized that obese dogs have cardiac dysfunction and Diuresis was similar for both treatments however, FCRI-HS
have elevations in inflammatory markers, altered insulin sensitiv- appeared to produce less dehydration (lower PCV, smaller %in-
ity, and dyslipidemia consistent with metabolic syndrome when crease in BUN). Absence of intravascular volume expansion, based
compared with non-obese dogs. The aims of this study were first, on CVP, suggests FCRI-HS may be safe in heart failure.
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1425
C13
ANALYSIS OF MITRAL VALVE MORPHOLOGY WITH
REAL-TIME 3-DIMENSIONAL ECHOCARDIOGRAPHY IN
DOGS UNDERGOING MITRAL VALVE REPAIR. Takeshi
Mizuno, Masashi Mizuno, Kayoko Harada, Hiroshi Takano,
Arane Takahashi, Kazuya Mamada, Junsoek Lee, Sayaka Takeu-
chi, Ayaka Chen, Tamotsu Sawada, Takahiro Mizukoshi, Asako
Shinoda, Shuhei Uchida, Takurou Mori, Kazuki Takamura,
Junichirou Takeuchi, Masami Uechi. JASMINE Veterinary Car-
diovascular Medical Center, Yokohama, Kanagawa, Japan
fluctuation, or inaccuracies of TD. One of the major limitations of ACE inhibitor therapy has also been observed in human beings
this study is the small number of patients, which allows prelimi- with heart disease and has been attributed to a polymorphism in
nary conclusions only. A larger prospective study is needed to the ACE gene. We have previously demonstrated a polymorphism
delineate the benefits and constraints of these methods. in the canine ACE gene in small breed dogs.
We hypothesized that the polymorphism would be common in
CKCS dog and that this would impact ACE activity.
We collected DNA and plasma samples from CKCS with
MMVD. All dogs were genotyped for the known ACE polymor-
phism. Plasma samples were collected and analyzed for ACE activ-
C16 ity measurement with a radioimmunoassay. A t test was used to
ANGIOTENSIN CONVERTING ENZYME ACTIVITY AND compare ACE activity in the wildtype (control sequence) and
RESPONSE TO ENALAPRIL IN DOGS WITH AN ACE GENE DNA variant groups.
POLYMORPHISM. Kathryn Meurs1, Darcy Adin1, Brent Aona1, Sixty-two dogs were evaluated. Genotypes of 38 (61%) dogs
Teresa DeFrancesco1, Bruce Keene1, Yamir Reina2, Josh Stern1, were homozygous for the DNA variant, 3 (5%) were heterozygous
Sandy Tou3, Jess Ward1, Kate Woodruff1, Clarke Atkins1. 1North and 21 (34%) were homozygous for the wild type (normal canine
Carolina State University, Raleigh, NC, USA, 2University of Cali- sequence). Samples from 40 dogs were submitted for ACE analysis
fornia, Davis, Davis, CA, USA, 3Iowa State University, Ames, IA, including 20 homozygous for the wild type and 20 homozygous
USA for the variant. Median baseline ACE activity was significantly
lower for dogs homozygous for the DNA variant (25.0 U/L) than
Myxomatous mitral valve disease (MMVD) is the most com- for dogs with the wildtype sequence (31.0 U/L) (P = 0.02).
mon heart disease in the dog. Angiotensin converting enzyme We conclude that the ACE polymorphism appears to be com-
(ACE) inhibitors are frequently recommended for management of mon in the CKCS and dogs that are homozygous for the ACE
dogs with MMVD and asymptomatic cardiac enlargement. How- variant have lower baseline levels of ACE activity. Further study
ever, the benefit of ACE inhibition in dogs before the onset of is warranted to evaluate the clinical importance of these findings.
congestive heart failure (CHF) is controversial, with different stud-
ies showing conflicting results. A variable response to ACE inhibi-
tor therapy has also been observed in human beings with heart
disease and in some cases this has been attributed to a polymor-
phism in the ACE gene. We have previously demonstrated a poly-
morphism in the canine ACE gene, although the clinical C18
significance of this finding is unknown. PREVALENCE OF DIROFILARIA IMMITIS ANTIGEN IN
We hypothesized that dogs with MMVD, cardiac enlargement CLIENT-OWNED PET DOGS BEFORE AND AFTER SERUM
and the ACE gene polymorphism would be less responsive to HEAT TREATMENT. Laura Nafe, Susan Little, Paul DeMars,
ACE inhibition with enalapril, as measured by plasma ACE activ- Ryan Baumwart, Nalani Yamada, Eileen Johnson. Oklahoma
ity, than dogs without the polymorphism. State University, Stillwater, OK, USA
We evaluated dogs with pre-CHF MMVD and a vertebral heart
score of ≥ 11, presenting to the NCSU CVM in the last 18 months. Pet dogs are routinely screened for heartworm disease as a com-
Dogs were genotyped for the ACE polymorphism. Serum samples ponent of annual wellness evaluation. Recent evidence suggests
were collected and analyzed for ACE activity measurement by that antigen-antibody complexes in canine serum may preclude
radioimmunoassay. Dogs were prescribed enalapril, 0.5 mg/kg accurate diagnosis of heartworm disease with commercially avail-
orally twice a day, and revaluated in 14–21 days with a second able Dirofilaria immitis antigen assays. The objective of this study
measurement of ACE activity. A t test was used to compare ACE was to determine whether normal dogs presenting to the Okla-
activity in the wildtype (normal canine sequence) and DNA variant homa State Veterinary Teaching Hospital Community Practice
groups at baseline and after therapy. A paired t test was used to Service for annual veterinary care warrant heat treatment of serum
compare each genotype’s ACE activity before and after therapy. to confirm a negative heartworm antigen test by 4DX Snap
Thirty-one dogs were evaluated. Genotypes included 12 homozy- (Idexx). Serum and EDTA samples were collected from 201 client-
gous for the DNA variant and 19 homozygous for the wild type. owned pet dogs between December 2014 and October 2015. Dogs
Median baseline ACE activity was significantly lower for dogs ranged in age from 10 months to 15 years (median 4 yrs) and
homozygous for the DNA variant (18.05 U/L) than for dogs with included 108 males and 93 females. Complete survey results (avail-
the wildtype sequence (27.4 U/L) (P = 0.01). Twenty-seven dogs able for 194/201 dogs) revealed 139 dogs (72%) received heart-
returned for re-evaluation in 14–21 days. Both genotypes showed a worm preventative regularly over the past year. All EDTA
significant suppression of ACE activity on enalapril, (P = 0.0065 samples were evaluated for microfilaria and serum samples for D.
DNA variant dogs; P < 0.0001 wildtype dogs). Median post ther- immitis antigen before and after heat treatment using a commeri-
apy ACE Activity was not different for the two genotypes (DNA cial assay (DiroCHEK, Zoetis). Four dogs (2%) tested positive for
variant, < 5.0 U/L; wildtype dogs <5.0 U/L) (P = 0.24)). D. immitis antigen on 4DX Snap Test (Idexx) and 2 were microfi-
We conclude that dogs that are homozygous for the ACE vari- laremic. On DiroCHEK antigen testing 2 dogs were positive
ant have lower baseline levels of ACE activity but still demon- before and after heat treatment, 1 dog was positive after heat
strate ACE inhibition in response to enalapril. Further study is treatment only, and 1 dog was negative before and after heat
warranted to evaluate the clinical importance of these findings. treatment despite being microfilaremic. One dog received heart-
worm preventative (Heartgard; Merial) regularly (2/12 doses
missed). Heat treatment does not appear to improve detection of
D. immitis antigen in asymptomatic pet dogs undergoing routine
heartworm disease testing with 4DX Snap Test (Idexx).
C17
ANGIOTENSIN CONVERTING ENZYME ACTIVITY IN
CAVALIER KING CHARLES SPANIELS WITH AN ACE
GENE POLYMORPHISM. Kathryn Meurs1, Maria Josefine
Reimann2, Lisbeth Heier Olsen2. 1North Carolina State University, C19
Raleigh, NC, USA, 2University of Copenhagen, Copenhagen, CARDIAC BIOMARKERS TROPONIN I AND N-TERMINAL
Denmark PRO-B-TYPE NATRIURETIC PEPTIDE IN CANINE
CHRONIC KIDNEY DISEASE PATIENTS. Lena Pelander, Jens
The Cavalier King Charles Spaniel is one of the most com- H€aggstr€
om, Ingrid Ljungvall. Department of Small Animal Clini-
monly reported breeds of dogs affected with myxomatous mitral cal Sciences, Swedish University of Agricultural Sciences, Uppsala,
valve disease (MMVD). Angiotensin converting enzyme (ACE) Sweden
inhibitors are frequently recommended for management of dogs
with MMVD. However, the benefit of ACE inhibition in MMVD Increased concentrations of N-terminal pro brain natriuretic
before congestive heart failure has developed is controversial with peptide (NT-proBNP) and cardiac Troponin I (cTnI) in azotemic
different studies showing conflicting results. A variable response to dogs, cats and people have been repeatedly reported. Knowledge
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1429
of the mechanisms behind increased concentrations of these car- a heart murmur on auscultation. Puppies with physiologic heart
diac biomarkers in azotemic dogs is warranted for correct interpre- murmurs were included in the study while puppies with structural
tation of test results. The aim of this study was to investigate the heart disease were excluded. A 24 hours 3-channel Holter monitor
association between measured glomerular filtration rate (GFR) was placed on all puppies included in the study. Holter placement
and plasma concentrations of cTnI and NT-proBNP in stable followed established methods from the WSU Veterinary Holter
canine CKD patients. Service.
Fifty client-owned dogs were prospectively included into the A total of 44 puppies representing 20 breeds were included in
study: Twenty-seven dogs with a diagnosis of CKD (structural this study. Minimum, average, and maximum Holter heart rates
and/or functional abnormalities of one or both kidneys that had were higher in puppies compared to healthy adult dogs. The num-
persisted for at least 3 months) and without signs of other signifi- ber of supraventricular complexes seen in puppies were less than
cant disease and twenty-three healthy dogs were included as con- in healthy adult dogs. The range of ventricular complexes in pup-
trols. All dogs were investigated by a physical examination, pies were higher than in healthy adult dogs. Minimum and average
repeated blood pressure measurements, a complete urinalysis, a Holter heart rate decreased with increasing age while maximum
full hematology and biochemistry panel, an echocardiographic Holter heart rate was not correlated with age. No correlation
examination, an ultrasound examination of the entire urinary between minimum, average, and maximum Holter heart rates and
tract, and a scintigraphic examination for estimation of kidney weight was appreciated. There was a statistically significant differ-
glomerular filtration rate (GFR). Plasma from each dog was ence between maximum Holter heart rate and different breed clas-
stored in 70°C and assayed in batch. sifications by size (small versus medium versus large versus giant
Median age of included dogs was 6 years (range 0.5–14 years). breed). No correlation between minimum and average Holter heart
Median bodyweight was 19.5 kg (range 2–42 kg). There was no rate and breed classifications was identified in healthy puppies.
difference in age or weight between healthy and CKD dogs. This study is the first study to evaluate normal ambulatory elec-
Among dogs with CKD, 16 had a decreased GFR and 11 had a trocardiographic values in healthy puppies. This information can
GFR within the normal range. Dogs with CKD and a GFR in the be used to potentially screen puppies at an earlier age for cardiac
normal range had other evidence of kidney disease such as persis- disease. The number of ventricular arrhythmias considered normal
tent renal proteinuria or morphological abnormalities. for healthy adult dogs is thought to vary with dog breed. Whether
Univariate analyses were performed to evaluate associations or not this breed variation is true in puppies is unknown. Now
between dog characteristics and cTnI and NT-proBNP, respec- that a normal baseline has been established for puppies, further
tively. Age (r = 0.59; P < 0.0001), body weight (BW; r = 0.29; studies can be conducted to evaluate for breed variation.
P = 0.04), creatinine (r = 0.29; P = 0.04) and systolic blood pres-
sure (SBP; r = 0.42; P = 0.06) were associated with cTnI concen-
tration. Creatinine (r = 0.46; P = 0.001), GFR (r = 0.39;
P = 0.0063), albumin (r = 0.35; P = 0.0141), and erythrocyte vol-
ume fraction (EVF; r = 0.35; P = 0.0072) were associated with
NT-proBNP concentration. C21
All variables that were associated with cTnI or NT-proBNP DISTRIBUTION OF ALVEOLAR-INTERSTITIAL SYNDROME
concentration, respectively, with a P-value of <0.2 were included IN DYSPNEIC VETERINARY PATIENTS ASSESSED BY
in the multiple regression analysis (except creatinine because of LUNG ULTRASOUND VERSUS THORACIC RADIOGRAPHS.
covariance with GFR). Age, BW and SBP were the variables Jessica Ward1, Gregory Lisciandro2, Teresa DeFrancesco3. 1Iowa
remaining in the final model for cTnI (adjusted R-square 0.50, State University, Ames, IA, USA, 2Hill Country Veterinary
P < 0.0001). GFR, BW and serum albumin concentration were Specialists, San Antonio, TX, USA, 3North Carolina State
the variables remaining in the final model for NT-proBNP (ad- University, Raleigh, NC, USA
justed R-square 0.29, P < 0.0001).
In conclusion, plasma concentration of cTnI in dogs with stable Lung ultrasound (LUS) is a point-of-care imaging technique
CKD was not influenced by a decreased GFR. Plasma concentra- that identifies alveolar-interstitial syndrome (AIS) through the
tion of NT-proBNP in stable canine CKD patients on the other observation of ultrasound artifacts called B-lines. This study
hand, appeared to be influenced by GFR. assessed distribution of AIS detected by LUS compared to tho-
racic radiographs (TXR) in a population of 100 acutely dyspneic
C20 veterinary patients (76 dogs and 24 cats).
ESTABLISHING NORMAL 24 HOUR HOLTER MONITOR Patients underwent LUS and TXR within 6 hours. LUS images
VALUES IN HEALTHY PUPPIES. Rebecca Tracey1, Dongyun were scored for presence of B-lines at 4 sites on each hemithorax.
Wang2, Pamela Lee1. 1Washington State University, Pullman, An individual LUS site was scored positive if >3 B-lines were
WA, USA, 2University of Idaho, Moscow, ID, USA observed within a single intercostal space at that site. TXR were
scored for presence of alveolar-interstitial infiltrates at 4 sites on
Currently, published literature focuses on the normal 24 hours each hemithorax, analogous to LUS. An individual TXR site was
Holter monitor values of adult dogs greater than 1 year of age. scored positive if infiltrate was present in least 25% of the site. Med-
Studies have shown that normal healthy adult dogs may have ical records were evaluated for final diagnosis. Agreement in distri-
occasional ventricular premature complexes (VPCs) and that more bution of positive sites between LUS and TXR was compared using
frequent or sequential VPCs on Holter monitoring may indicate a Cohen’s Kappa coefficient. Patterns of distribution of AIS among
cardiac or clinical disease. This poses a problem for cardiac evalu- different final diagnoses were compared using Fisher’s exact tests.
ation of puppies for veterinarians. This lack of information inhi- When considered site-by-site, agreement in distribution of AIS
bits the ability to screen puppies for indicators of cardiac disease. between LUS and TXR was poor to fair (Κ = 0.25–0.5). How-
This is especially important in breeds that tend to have inherited ever, when considering larger spatial quadrants, agreement
cardiac arrhythmias such as German Shepherd puppies. The pur- between LUS and TXR was good (Κ = 0.45–0.65). Distribution
pose of this study is to establish normal ambulatory ECG values of AIS differed significantly based on final diagnosis for both car-
using Holter monitors in puppies in an effort to enhance the abil- diogenic and noncardiogenic causes of dyspnea. Dogs with mitral
ity to screen puppies for cardiac disease. valve disease were more likely to have a caudal distribution of
The primary objective was to determine the minimum, average, AIS (P = 0.0031), while dogs with dilated cardiomyopathy were
and maximum heart rate and incidence of arrhythmias for healthy more likely to have diffuse AIS (P = 0.0008). Patients with airway
puppies. The secondary objective was to evaluate the correlation disease were more likely to have absence of AIS in all sites
between Holter heart rate and age, weight or breed. We hypothe- (P = 0.0006), while patients with pneumonia were more likely to
sized that healthy puppies will have less arrhythmias and higher have unilateral AIS (P = 0.0055).
Holter minimum, average, and maximum heart rates than healthy LUS was useful for detecting AIS apparent on TXR. Agree-
adult dogs. ment between the two modalities improved when considering lar-
Eligible puppies had to be healthy and between the ages of 12– ger spatial quadrants rather than smaller focal sites. Distribution
51 weeks. History, physical exam, and thorough auscultation were of AIS differed based on final diagnosis, suggesting that a pattern-
performed. An echocardiogram was performed on any puppy with based LUS approach may prove diagnostically useful.
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1430 2016 ACVIM Abstracts
C22 Signalment data including age, sex, and weight were not signifi-
CIRCULATING PLASMA MIRNA AS NOVEL MOLECULAR cantly different in dogs diagnosed with AT compared to dogs not
BIOMERKERS IN CONGESTIVE HEART FAILURE. diagnosed with AT. Dogs with AT were commonly diagnosed con-
SeungWoo Jung, Amy Bohan. Auburn University, Auburn, AL, currently with PLN. Contrary to previous reports, cardiac disease
USA was not a common concurrent diagnosis in the dogs with AT
included in this study.
Congestive heart failure (CHF) carries poor prognosis in dogs
with myxomatous mitral valve disease (MMVD). Early identifica-
tion of dogs predisposed to developing CHF is critical to improve
long term survival outcome. The aim of this study is to character-
ize plasma molecular profiles in dogs with CHF secondary to
MMVD and to develop novel molecular biomarkers via liquid C24
biopsy. MicroRNAs (miRNAs) are small, non-coding RNAs and RIGHT VENTRICULAR SYSTOLIC FUNCTION IN DOGS
have been known to regulate expression levels of target genes WITH POST-CAPILLARY PULMONARY HYPERTENSION.
involved in human CHF. Regulatory networks of miRNAs in dogs Amalia Turner Giannico1, Gustavo Dittrich1, Bruna Cristina
with MMVD need to be established to further enhance our under- Bruler1, Tilde Rodrigues Froes1, Aparecido Antonio Camacho2,
standing of CHF pathogenesis. The hypothesis tested in the study Marlos Goncalves Sousa1. 1Federal University of Parana,
was that plasma miRNAs may be differentially expressed in dogs Curitiba, PR, Brazil, 2Sao Paulo State University, Jaboticabal, SP,
with CHF secondary to MMVD. Brazil
A minimum of seven dogs in each group (normal versus CHF)
were needed to demonstrate the statistical power with a probabil- The function of right ventricle (RV) has gained increased recog-
ity of 0.9 and type one error of P < 0.05 based on previous publi- nition over the past years. In pulmonary hypertension (PH)
cations. Blood was collected in EDTA tubes from 9 normal patients, this led to the reconceptualization of the RV as part of
geriatric dogs (free of heart murmur and absent history of CHF) right ventricular pulmonic circulation unit and the acknowledge-
and 8 dogs with CHF secondary to MMVD (confirmed by clinical ment that RV function is a major determinant of prognosis in pul-
signs, chest x-ray and echocardiography). Plasma samples were monary arterial hypertension. With this in mind, we sought to
subjected to isolation of miRNAs with a miRNeasy Plasma Kit investigate the RV systolic function in dogs with post-capillary PH
(Qiagen) and subsequently reverse-transcription reaction with a ascribed to mitral valve disease (MVD). Twenty nine dogs with
miScript II RT Kit (Qiagen). Validated canine primers of 12 can- PH (2.5–17.2 kg; 7–15 years) and 51 dogs without PH (1.5–
didate miRNAs and miR-39 (spike-in control) were employed to 32.0 kg; 2–16 years) were recruited into this prospective cross-sec-
quantify relative expression levels of each miRNA between normal tional observational study. The PH group was subdivided into
and CHF dogs via real time PCR (miScript SYBR Green PCR mild PH (n = 19), moderate PA (n = 6), and severe PH (n = 4).
Kit, Qiagen). Several breeds were represented. All animals underwent a complete
Canine specific miRNAs were successfully isolated from plasma echocardiogram, which included the measurement of RV fractional
and amplified. Plasma miR-21 (P = 0.015), miR-133 (P = 0.01), area change (RV FAC); tricuspid annular plane systolic excursion
and miR-1 (P = 0.01) were differentially expressed in CHF dogs (TAPSE); RV free-wall longitudinal systolic velocity (tricuspid
with statistical significance when compared to normal dogs. These annular S´ wave), and RV fractional shortening (RV FS%). For
miRNAs are known to be involved in extracellular matrix remod- improved statistical analysis and normalization of data according
eling and the regulation of fibrotic genes such as TGF-b and to animal size, a body weight-indexed TAPSE (TAPSEBW-indexed)
Smad. The results suggest that alterations in the interaction was created. Some standard echocardiographic indices of conges-
between miRNAs expression profiles and their downstream target tion and LV function, including early-to-late LV filling velocities
genes may play a role in cardiac progression to CHF in dogs with ratio (E/A), isovolumic relaxation time (IVRT), E-to-IVRT ratio
MMVD. Further investigation remains warranted to determine (E/IVRT), left atrium-to-aorta ratio (LA/Ao), and LV fractional
their diagnostic potential as molecular biomarkers for early detec- shortening (LV FS%) were recorded as well. The data was not nor-
tion of CHF in dogs with MMVD. mally distributed. The Mann-Whitney test showed no differences
(P > 0.05) to exist for RV FAC, RV FS%, TAPSE, TAPSEBW-
index, and tricuspid annular S´ wave between dogs with PH and
those without PH. Also, the analysis of the subdivided PH group
showed no statistical difference between the three degrees of PH.
Spearman correlation coefficients between RV systolic data and
C23 LV indices of congestion and function showed a significant posi-
A MULTICENTER EVALUATION OF SIGNALMENT AND tive correlation between TAPSE and E/IVRT (R = 0.3917,
COMORBID CONDITIONS ASSOCIATED WITH AORTIC P = 0.0003), TAPSE and LA/Ao (R = 0.3298, P = 0.0029), and
THROMBOSIS IN 291 DOGS. Randolph L. Winter1,2, Christine TAPSEBW-indexed and LV FS% (R = 0.2757, P = 0.0166). Finally,
M. Budke1,2. 1Auburn University, College of Veterinary Medicine, a significant positive correlation was documented between RV
Auburn, AL, USA, 2Department of Veterinary Integrative Bio- FAC and RV FS% (R = 0.3507, P = 0.0100), as well as between
sciences, Texas A&M University, College Station, TX, USA TAPSE and tricuspid annular S´ wave (R = 0.4575, P < 0.0001).
Because only a few animals with severe PH were recruited into this
Aortic thrombotic disease is a primary disease or secondary study, the absence of association between the severity of PH and
complication of a systemic disease state with devastating effects to the identification of RV systolic impairment needs further investi-
both dogs and cats. Cats with aortic thromboembolism often have gation. Nevertheless, we observed a downward trend for RV FS
significant concurrent cardiac disease. While there is a substantial %, TAPSE, TAPSEBW-indexed, and tricuspid annular S´ wave along
amount of information available about cats with this disease pro- with the aggravation of PH. Our study found correlations between
cess, aortic thrombosis (AT) is not well characterized in dogs. a few congestion and LV function parameters, which may prove
In order to assess signalment and concurrent disease processes useful in monitoring RV function in dogs with severe MVD and
in dogs diagnosed with aortic thrombotic disease, a retrospective overt signs of post-capillary PH. Since the majority of PH cases
review was performed of records available through the Veterinary were mild, it is likely that only a few had reactive PH, which may
Medical Database of dogs examined between 1985 and 2011. explain why RV function of either group behaved very similarly.
Information on age, sex, breed, weight, and concurrent disease Also, it is not clear whether RV remodeling and impairment
processes in dogs reported with AT were reviewed. Five control would be stronger if pre-capillary PH dogs had been included in
dogs without a diagnosis of AT were selected for each AT case. this investigation.
AT was diagnosed in 291 of 984,973 dogs included in the
VMDB from 1985 to 2011. The odds of a dog having AT did not
differ significantly by sex (P = 0.0593), age (P = 0.9833), or weight
(P = 0.7766). Compared to mixed breed dogs, Shetland sheepdogs
had a significantly higher odds (OR=2.44, P = 0.0027) of being
diagnosed with AT. Protein-losing nephropathy was the most
commonly reported disease occurring concurrently in dogs with
AT (64/291).
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1431
C28 C29
CUTANEOUS USE OF AN IMPLANTABLE LOOP AORTOSEPTAL ANGLE AND RESPONSE TO BALLOON
RECORDER (REVEAL LINQTM) FOR CARDIAC EVENT VALVULOPLASTY IN DOGS AFFECTED WITH SEVERE
MONITORING IN DOGS. Emily Menzen, Amara Estrada, SUBAORTIC STENOSIS. Lilian Shen1, Amara Estrada1, Etienne
Brandy Winter, Melanie Powell. University of Florida, College of ote2, Brandy Winter1, Kenneth Lamb3. 1University of Florida,
C^
Veterinary Medicine, Gainesville, FL, USA Gainesville, Florida, USA, 2University of Prince Edward Island,
Charlottetown, Prince Edward Island, Canada, 3Lamb Consulting,
Event monitors are a useful diagnostic tool for evaluating West St. Paul, Minnesota, USA
patients with episodic cardiac events. The ideal event monitor for
use in veterinary practice would be non-invasive, affordable, accu- Subaortic stenosis (SAS) is the most common congenital cardiac
rate and reusable. Such devices are becoming increasing difficult to defect identified in dogs. While it is not difficult to diagnose severe
obtain. This study aimed to prospectively evaluate the feasibility of forms of this disease, treatment and decisions on when to consider
using the Medtronic Reveal LINQTM human implantable cardiac interventional therapy remain a challenge. It has been suggested
monitor (ICM) for cutaneous event monitoring for up to 5 days in that SAS, in some breeds, may be related to an abnormally steep
14 clinically healthy canines (21.5 kg, range 13.4–31.2 kg; 4.5 years aortoseptal angle (AoSA) - a quality which may limit efficacy of
range 1.5–13 years old) and two canines with reported collapse epi- ballooning methods. If an abnormally steep AoSA contributes to
sodes (4.7 and 6.4 kg, 2.5 and 11 years old). The study consisted of SAS and is not remedied by ballooning, it is possible that the
developing a method to secure the low-profile device without caus- magnitude of the AoSA may serve as a useful criterion for deter-
ing discomfort at the location generating the strongest signal, mining which dogs will respond better to balloon valvuloplasty
adjusting the auto activation parameters, activating the device and are therefore better candidates for the procedure.
manually, and assessing the recordings for accuracy. This study investigated the relationship between the measured
Reveal LINQTM wireless cardiac device were obtained via dona- AoSA and response to combined cutting and high pressure bal-
tion following explantation from human patients and the battery loon valvuloplasty (CB/HPBV), in dogs with severe SAS. Retro-
life assessed prior to use in each canine patient using a Medtronic spective evaluation of angiographic and echocardiographic video
CarelinkÒ programmer with appropriate software loaded. An area loops of 22 client-owned dogs of various breeds affected with sev-
on the left lateral thorax was clipped and alcohol was used to ere SAS (PG mean 143.36 mmHg; range 80.49–322.5 mmHg) who
remove oils. Adhesive electro-conductive gel pads were applied underwent CB/HPBV were evaluated at the baseline time point
underneath the device and it was placed within the 4th intercostal immediately prior to the procedure. Two board-certified veterinary
space parallel to the ribs and then slowly moved in a grid pattern cardiologists and 1 novice evaluated these video loops to identify
to find the most consistent electrocardiogram (ECG) on the pro- still frame images to be used to measure the AoSA. Each evalua-
grammer screen. The device was then secured to the thorax using tor was blinded to the other 2 evaluators’ selected images and sub-
TegadermTM film, gauze, and ElastikonÒ. It was then taped sequent measurements of the AoSA. All evaluators were blinded
around the thorax with 2 inch white tape and VetrapTM and the to initial PG and patient outcomes following the procedure. The
patients were fitted with a Holter monitor vest to reduce likelihood percentage decrease in PG at 24 hours, 6 months, and 12 months
of device tampering or consumption of bandage materials and after ballooning was then calculated and correlated to the mea-
device. The device was programmed with the patient’s information sured AoSA at each recheck and for each imaging plane.
and the pre-programmed manufacturer heart rate parameters The inter-observer variability analysis suggested significant
Patients wore the ICM for 4 to 5 days and owners were asked to mean differences for the novice observer when compared to the 2
activate the monitor manually for 4 total recordings during differ- cardiologists for all angle types. Significant differences were
ent activities and to keep a diary. Accuracy was assessed based on observed between the cardiologists for left apical echocardio-
quality of ECG tracings (consistent ability to measure heart rate, graphic (P = 0.0163) AoSA measurements, while no significant dif-
visualization of entire p-QRS-T waves) and presence of a record- ferences were observed for angiographic (P = 0.1042) or right
ing during manual activation. Two dogs were fitted with 24 hour sided long axis LVOT echocardiographic AoSA (P = 0.7058) mea-
Holter monitors as a control. surements or for all measurements of AoSA combined combined
Of the sixteen patients, two were unable to be fitted with a (P = 0.1937).
device due to a weak signal, one client terminated the study after Based on right sided long axis LVOT echocardiographic AoSA
1 day, and the device moved out of place and stopped recording measurements made by the cardiologists, greater mean differences
on one dog. The remaining twelve dogs had at least 3 out of 4 of PG reduction ratio were observed for angles >160° compared to
interpretable tracings from manually activated recordings. The angles <160°. At 24 hours, significantly greater (P = 0.003) mean
auto-activated recordings triggered by pre-set parameters were of differences of PG ratio were observed in the >160° (54.45 SE
good quality. After each set of auto-activated recordings were 3.8) compared to the mean in the <160° (39.88 SE 2.09). This
reviewed, the parameters were adjusted to define the outer range difference persisted at 6 months (>160° mean 57.73 SE 10.9;
of normal and recorded rhythms were reclassified. Over the course <160° mean 28.22 SE 3.42) and at 12 months (>160° mean
of the study patient heart rates did not exceed 222 bpm for 32 76.11 SE 17.5; <160° mean 27.61 SE 6.44).
beats or reach 30 bpm for 12 consecutive beats. Fewer auto-acti- The findings of this study suggest that dogs with severe SAS
vations occurred per dog when the pause parameter was set at with an AoSA >160° as measured on right sided long axis LVOT
4.5 seconds than 3 seconds. One symptomatic patient had three echocardiographic imaging respond to CB/HPBV better than dogs
episodes while wearing the device however there was no indication with an AoSA <160°. The difference in response to the same pro-
of a rhythm abnormality in the manually activated recordings. cedure by the two sets of dogs suggests that the magnitude of the
The other symptomatic patient did not have an episode while AoSA does play a role in SAS and its treatment, and it is possible
wearing the monitor and the device incorrectly logged an atrial fib- that measurement of the AoSA may be helpful in the screening
rillation episode. During this time period, the ECG from the ICM process and determination of prognosis following CB/HPBV.
was not of sufficient quality to identify p waves but the control However, further investigation of the effect of LVOT PG reduc-
Holter recording clearly showed a sinus arrhythmia was present. tion on survival times and quality of life is warranted in order to
The device was still recording at time of removal in all but one determine if AoSA is truly a suitable criterion for selecting candi-
dog. Five dogs had self-limiting, mild skin irritation after removal dates for CB/HPBV.
of the device.
The Medtronic Reveal LINQTM ICM is a viable option for
cutaneous cardiac monitoring in dogs for up to 5 days. Veterinary
parameters for auto-activation of the device should be pro-
grammed at the upper and lower limits of the auto-activated
parameters to reduce the number of incorrectly labelled recordings
and all recordings should be reviewed by a veterinarian familiar
with normal cardiac rhythms.
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1433
spinal cord width, spinal cord area, and vertebral canal height. A with more variability due to evaluator variability than to differ-
Fischer’s exact test was used to evaluate the morphologic data and ences between the two systems, and similar internal (intra-rater)
mixed-effects linear regression was used to analyse the morphomet- variabilities between the two systems. The degree of compression,
ric data. Interobserver and intraobserver analyses were performed. as measured by the standard mild/medium/severe rating protocol
Due to space constraints, only part of the results is presented. shows significantly positive association between the two methods,
With neutral positioning, 14 total compressions were noted; 5/9 although not as strong as that between the two methods for the
patients had 1 compression, 3 patients had 2 compressions, and 1 CLR measurements.
patient had 3 compressions. With flexion, 12 total compressions The MRI sequence SPACE was able to positively identify Han-
were noted; 1 patient had no compressions, 5 patients had 1 com- sen Type I Intervertebral disk disease in the canine thoracolumbar
pression, 2 patients had 2 compressions, and 1 patient had 3 com- spine as confirmed via surgery with equal accuracy to standard
pressions. With extension, 26 total compressions were noted; 1 T2-weighted imaging.
patient had 1 compression, 6 patients had 2 compressions, 3
patients had 3 compressions, and 1 patient had 4 compressions. In
neutral, the majority of lesions were mild (11/14) and located ven-
trally (9/14). Extension was associated with worsening of compres-
sions in 7 out of 14 sites and the presence of severe compressions
(4/26). It was also associated with multiple directions of compres- N03
sion; there was ventral and dorsal compression at 12/26 sites with CLINICAL CHARACTERISTICS OF DOGS WITH
extension. Morphometric results revealed a decrease in spinal cord PROGRESSIVE MYELOMALACIA FOLLOWING ACUTE
height at C6–C7 (midsagittal images) from neutral to extension INTERVERTEBRAL DISC HERNIATION. Aude Castel,
(P = 0.003) and from flexion to extension (P = 0.001). Natasha Olby. North Carolina State University, College of
This study supports the use of kMRI to evaluate the dynamic Veterinary School, Raleigh, NC, USA
component of DA-CSM. Results suggest that extension is most
useful; not only did it demonstrate worsening of multiple compres- Progressive myelomalacia (PMM) is a catastrophic disease asso-
sions but it was also able to detect new compressions not visual- ciated with acute intervertebral disc herniation (IVDH). Published
ized in a neutral position. data on the clinical characteristics of this disease are limited. The
aim of this retrospective study was to describe the onset and pro-
gression of clinical signs of PMM in a large case cohort.
Dogs with confirmed IVDH and either a histopathologic diag-
nosis of PMM or a high clinical suspicion (acute paraplegia, loss
of nociception, loss of patellar reflex and cranial advancement of
N02 the cutaneous trunci muscle reflex inconsistent with location of
3D SOLITARY SEQUENCE MAGNETIC RESONANCE disc herniation) were identified by medical record search.
IMAGING OF THE DOG SPINE IN HANSEN TYPE I INTER- Forty-eight cases were identified, 16 confirmed via histopathol-
VERTEBRAL DISK DISEASE. Melissa Carpentier-Anderson1, ogy, and 32 suspected based on clinical signs and imaging. The
Fred Wininger2, Shannon Holmes3, Daniela Mauler2. 1Veterinary majority of dogs were chondrodystrophic, including 24 Dachs-
Specialty Servies, Manchester, MO, USA, 2University of Missouri hunds. Onset of PMM signs ranged from present at first evalua-
Veterinary Health Center, Columbia, MO, USA, 3University of tion (n = 16) to 5 days after presentation, with 43/48 developing
Georgia College of Veterinary Medicine, Athens, GA, USA signs within 3 days. Progression of signs from onset to euthanasia,
excluding 10 cases euthanized at presentation, ranged from 1 to
SPACE (Sampling Perfection with Application optimized Con- 13 days with 32 being euthanized within 72 hours. Systemic signs
trasts using different flip angle Evolutions) is a T2-weighted three- (depression, anorexia, abnormal temperature and diffuse pain)
dimensional magnetic resonance imaging sequence. Currently, 2 were documented in 34 dogs. Focal disc herniation was present in
dimensional T2-weighted spin echo imaging is the gold standard 35 dogs, while 7 dogs had extensive herniations.
diagnostic imaging for thoracolumbar intervertebral disk disease. In summary, the majority of dogs that develop PMM do so
SPACE is potentially advantageous to standard MRI in that it is within 3 days of presentation and progress to euthanasia within
a single acquisition, faster, technically easier modality with higher another 3 days. However, onset can be delayed up to 5 days after
resolution and the potential to reconstruct the image set in any presentation with progression to death taking as long as 2 weeks.
plane of section. The purpose of this study is to determine the Non-specific systemic signs are commonly reported.
agreement between SPACE and T2-weighted standard spin echo
imaging sequences in the presence of Hansen Type I intervertebral
disk disease in the thoracolumbar spine of dogs to determine if
SPACE is a viable imaging sequence in the canine patient. Our
hypothesis was that the MRI sequence SPACE is able to positively
identify Hansen Type 1 intervertebral disk disease with equal accu- N04
racy to standard T2-weighted spin echo imaging. IN VITRO ANTI-TUBULIN EFFECTS OF BENZIMIDAZOLE
This was a double blinded controlled study of dogs with an ANTHELMINTICS MEBENDAZOLE AND FENBENDAZOLE
acute onset T3-L3 compressive myelopathy secondary to Hansen ON CANINE GLIOBLASTOMA CELLS. Serene Lai1, Jennifer
Type I intervertebral disk disease. All patients had standard pre- Koehler2. 1Department of Clinical Sciences, Auburn University
anesthetic screening and underwent magnetic resonance imaging of College of Veterinary Medicine, Auburn, AL, USA, 2Department
the T3-L3 spine using a Siemens 1.5T scanner. Images were of Pathobiology, Auburn University College of Veterinary Medi-
obtained, in at least, the following sequences: standard T2-W sagit- cine, Auburn, AL, USA
tal and transverse, STIR dorsal, and SPACE. All dogs underwent a
decompressive hemilaminectomy based on the imaging findings. Benzimidazole anthelmintic drugs have been reported to have
The MRI sequences were randomized and three blinded individuals antiproliferative effects on several cancers both in vitro and in vivo,
interpreted the MR images a total of three times. The evaluators with reduced off-target toxicity as compared to other microtubule-
were of different skill levels, including one ECVN diplomate, one disrupting drugs. In addition, these small, lipophilic drugs readily
ACVR diplomate, and a third year neurology resident. The stan- cross the blood-brain barrier. The purpose of this study was to
dard T2-weighted and SPACE sequences were individually evalu- evaluate the in vitro chemosensitivity of canine glioblastoma J3T
ated for site, side, and degree of compression as well as surgical cells to mebendazole (MBZ) and fenbendazole (FBZ).
recommendation and subjective confidence of imaging findings. Cells were exposed to drugs for 72 hours, and cell viability was
23 dogs met the inclusion criteria. There was statistically signifi- evaluated using the MTT assay. The half-maximal inhibitory con-
cant agreement for both site and side (P-Value <0.001) between centration (IC50) of MBZ and FBZ was calculated using a four-
the standard T2-weighted spin echo imaging and SPACE. There parameter variable slope curve fit nonlinear regression analysis.
was complete agreement by all three researchers concerning both The IC50 was compared between the two drugs. Western blot was
the site and side of disk herniation (comparing standard T2- used to compare the ratio of polymerized to depolymerized tubulin
weighted standard spin echo imaging and SPACE) for 20 of the between drug-treated cells and untreated controls. Immunocyto-
23 dogs, and partial agreement for the other 3 dogs. Compressive chemistry was performed on treated and untreated cells to visual-
Length Ratio (CLR) estimates by the two methods were similar, ize effects of treatment on tubulin.
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1435
The mean IC50 of MBZ and FBZ were 0.026 µM 0.03 and N06
0.55 µM 0.02 respectively. Treatment with MBZ and FBZ 11-DEHYDRO THROMBOXANE B2 AS A BIOMARKER FOR
resulted in increased depolymerization of tubulin compared to the INTRACRANIAL NEOPLASIA IN DOGS. Jessica A. Rivera1,
untreated control. Immunocytochemical studies showed disruption Elizabeth Hurst2, James L. Mobley2, Peter J. Dickinson1. 1Univer-
of tubulin and evidence of apoptotic bodies after only 2 hours of sity of California, Davis, Davis, CA, USA, 2Cayman Chemical
treatment. Company, Ann Arbor, MI, USA
Our in vitro data suggest that MBZ and FBZ may be good can-
didates for treatment of canine glioblastomas. Further in vivo stud- Meningiomas and gliomas are the most common intracranial
ies are required. neoplasms in dogs, and definitive diagnosis is often problematic
due to the cost and invasiveness of an intracranial biopsy.
Biomarkers in serum, urine, and/or CSF can provide adjunctive
diagnostic data in conjunction with standard techniques such as
magnetic resonance imaging. The cycloogygenase pathway has
been identified as a key player in cancer progression, and several
N05 pathway products including thromboxane A2 (TxA2) are over
SUBARACHNOID-SUBARACHNOID SHUNTING FOR expressed in a variety of human cancers, including gliomas.
TREATMENT OF SUBARACHNOID CEREBROSPINAL The purpose of this pilot study was to determine levels of 11-
FLUID FLOW OBSTRUCTION IN 9 DOGS. Ilyssa Meren, dehydro-thromboxane B2 (11TxB2) (a stable hydrolysis product of
Jessica Chavera, Nick Jeffery. Iowa State University, Ames, IA, TxA2) in dogs with a variety of neurological and non-neurological
USA diseases, using an enzyme immunoassay. Urine, serum, and CSF
samples were stored immediately following collection at 20°C (or
Cerebrospinal fluid (CSF) flow in the subarachnoid space can at 4°C for up to 7 days prior to 20°C storage).
be impeded by developmental anomalies of the subarachnoid space 11TxB2 was reliably detected in urine, but not in serum or CSF.
(i.e. diverticula) or acquired adhesions in older animals. Develop- Storage at 4°C up to 7 days did not significantly affect urine TxB2
mental lesions can occur in any type of dog and clinical signs typi- levels, and concurrent corticosteroid or non-steroidal anti-inflam-
cally present in animals less than one year old; acquired lesions matory medication did not apparently affect levels within the study
appear to be most common in middle-aged and older small dogs, group as a whole. Overlap of 11TxB2 urine levels was seen
notably pugs. Clinical signs include progressive proprioceptive between clinically normal and neurological animal groups.
ataxia and, at later stages, fecal and urinary incontinence. Tradi- Although some of the highest 11TxB2 values were seen in animals
tional surgical treatment of acquired subarachnoid adhesions (con- with intracranial neoplasia, overlap with other neurological disease
strictive myelopathy) is associated with unreliable outcomes. Here groups was present. Assay of 11TxB2 is feasible; however, addi-
we report on the surgical procedure and outcome using subarach- tional analysis of a large study population will be necessary to
noid-subarachnoid shunting as a means of bridging the area of determine whether a threshold urine 11TxB2 level may be useful as
adhesion. a diagnostic biomarker.
Nine dogs were treated by this technique at Iowa State Univer-
sity between November 2013 and August 2015. The spinal cord
was exposed via routine dorsal laminectomy in 8 cases (thora-
columbar spinal cord) and via C2 laminotomy in one. A durotomy
was made over the lesion site using a hypodermic needle bevel and N07
expanded laterally to disrupt adhesions between the pia mater and LUMBAR FRACTALKINE AND M2 MICROGLIA INCREASE
arachnoid mater. A shunt tube consisting of the ventricular cathe- THROUGHOUT DISEASE PROGRESSSION IN CANINE
ter from a ventriculoperitoneal shunt kit or a red rubber catheter DEGENERATIVE MYELOPATHY. Christine Sibigtroth1, Maria
of appropriate diameter was trimmed to span the lesion plus Jones2, Virginia Garcia2, Gayle Johnson3, Joan Coates1, Eric Vil-
~5 mm on either side of the adhesion and secured within the sub- on2, Michael Garcia2. 1Department of Veterinary Medicine and
lal
arachnoid space using 5/0 non-absorbable (polypropylene [Pro- Surgery, College of Veterinary Medicine, University of Missouri,
lene]) sutures. The dura was then closed over the shunt. Columbia, MO, USA, 2Division of Biological Sciences, College of
One patient had a developmental subarachnoid diverticulum (the Arts and Sciences, University of Missouri, Columbia, MO, USA,
patient with a C2 laminotomy), and the remaining 8 had an acquired 3
Department of Veterinary Pathobiology, College of Veterinary
adhesion (constrictive myelopathy) documented at surgery. Four Medicine, Univeristy of Missouri, Columbia, MO, USA
patients showed improvement of clinical signs, of which three
showed complete recovery. The one patient that has not shown a Canine degenerative myelopathy (DM) is an adult-onset neu-
complete recovery in this group was the young patient with a devel- rodegenerative disorder. Clinical progression is homogeneous
opmental subarachnoid diverticulum, but is continuing to improve within and across breeds, thus four distinct disease stages have
at 3 months post-operatively. One patient had mixed success: been identified (Kanazono et al., 2013; Coates and Wininger,
improvement of fecal control, but deterioration in gait (although 2010). DM shares similarities with some forms of amyotrophic lat-
with subsequent gradual improvement). Three patients did not show eral sclerosis (ALS), including underlying mutations in superoxide
major improvement after surgery. Of these, one showed mild dismutase-1 (SOD1). SOD1-mutant microglia play a central role in
improvement after surgery but acute progression of paraparesis at ALS progression in rodent models. Microglia behavior is complex,
10 months prompted euthanasia (cause of acute paraparesis was not as expression patterns of classic M1 and M2 molecules are vari-
ascertained because of lack of post mortem examination). The other able throughout disease and between species studied. The mecha-
two cases showed unchanged clinical signs at 7 and 24 months post nism(s) underlying microglial phenotype determination within ALS
operatively. The last remaining case improved immediately post- is not known. Fractalkine, a neuronally produced chemokine, has
operatively, but was lost to long-term follow-up. been shown to suppress SOD1 mutant microglial-mediated neuro-
Obstruction of CSF flow in the subarachnoid space can be asso- toxicity in vitro. Thus, fractalkine is a possible contributor to
ciated with severe and life-threatening (fecal incontinence is a com- microglial phenotype determination in ALS. Increased spinal cord
mon reason for euthanasia) neurologic deficits. Our results suggest microglia have been documented in end-stage DM-affected dogs,
that subarachnoid-subarachnoid shunting can be an effective surgi- however, their response and phenotype throughout disease pro-
cal technique to ameliorate or prevent progression of associated gression is unknown. The goals of this study were to (1) quantify
clinical signs. and phenotype microglial cells in close proximity to lumbar spinal
cord motor neurons of DM-affected dogs at each disease stage
and compare these findings to age-matched, neurologically normal
dogs and (2) correlate microglial phenotype with fractalkine pro-
tein levels in lumbar spinal cord throughout disease progression.
Spinal cord tissue was collected post-mortem from client-owned
dogs donated to the University of Missouri for research purposes.
Lumbar spinal cord microglia analyses were conducted with
immunofluorescence and confocal microscopy. To identify micro-
glia in close proximity to motor neurons (MNs), concentric circles
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1436 2016 ACVIM Abstracts
with increasing radii of 6 lM were applied to MNs of DM- and specificity for diagnosis of DM were 0.83 and 0.95, respectively.
affected dogs at each disease stage (stage 1 n = 120; stage 2 Area under the receiver operator characteristic curve was 0.911.
n = 118; late DM (3&4) n = 149) and age-matched control dogs These preliminary findings suggest that pNF-H in CSF is a sen-
(n = 145). Cells with positive immunoreactivity for Iba-1/iNOS sitive and specific disease marker for DM. These data warrant fur-
(M1 microglia), or Iba-1/arginase-1 (M2 microglia), were ther study of pNF-H in CSF and serum for diagnosis of disease
quantified in a double-blind manner. Data were analyzed via and longitudinal monitoring of therapeutic efficacy in DM.
Kruskal-Wallis ANOVA on ranks with post-hoc Dunn’s method.
Fractalkine total protein was quantified via western blot analysis
of lumbar spinal cord from DM-affected dogs (stage 1 n = 2; stage
2 n = 4; late DM n = 3) and age-matched control dogs (n = 3).
Relative optical densities were normalized to control dogs. Data
were analyzed via ANOVA with post-hoc Holm-Sidak method. N09
A progressive increase in total microglia closely associated with ETIOLOGY OF FELINE JUVENILE ONSET SEIZURES.
lumbar motor neurons was observed in DM-affected dogs (stage1: Muna Qahwash, Heidi Barnes Heller. University of Wisconsin,
19 0.7; stage 2: 25 0.9; late DM: 28 0.9; P < 0.05) com- School of Veterinary Medicine, Madison, WI, USA
pared to age-matched controls (13 0.4; P < 0.05). Total M2
microglia were increased in stage 2 (7.5 0.5) and late DM- Seizure etiology are well documented in adult cats. Despite this
affected dogs (6.2 0.5) compared to age-matched controls awareness, little is published about the etiology and outcome of
(3.3 0.7; P < 0.05). No differences were observed in total M1 juvenile onset seizures in cats. Juvenile onset seizures are defined
microglia throughout disease progression. Lumbar spinal cord as seizures starting prior to 12 months of age for this study. The
fractalkine protein was increased in stage 1 (2.2 0.2) and late aims of this study were to 1) identify the common etiology and 2)
DM-affected dogs (2.2 0.3) compared to age-matched controls describe the outcome (dead or alive) in cats with juvenile onset sei-
(1 0.1; P < 0.05). zures. Inclusion criteria were 1) a confirmed or suspected seizure
These data suggest that M2, but not M1, microglia are progres- before 12 months of age and 2) complete medical records includ-
sively recruited to motor neurons during disease progression. ing a final diagnosis. The diagnosis was reclassified for each cat
Increased lumbar spinal cord fractalkine correlates with progres- according to the 2010 ILAE guidelines. Fifteen cats met the inclu-
sive M2 microglia in DM-affected dogs. sion criteria. Median age at onset was 24 weeks (range, 0.4 –
40 weeks). Six cats (40%) were diagnosed with structural epilepsy,
5 cats (33%) were diagnosed with unknown epilepsy, and 4 cats
(26%) were diagnosed with reactive seizures. Generalized seizures
were documented in 9 cats, 4 cats had focal seizures and 2 cats
had both focal and generalized seizures. Six cats (40%) had cluster
N08 seizures, and status epilepticus was documented for 1 cat. Overall
INCREASED PHOSPHORYLATED NEUROFILAMENT 8 cats (53%) were alive, 6 cats were dead and 1 cat was lost to fol-
HEAVY IN CEREBROSPINAL FLUID AS A DISEASE low up. (Follow up 16 – 173 months after diagnosis) Three cats
MARKER OF CANINE DEGENERATIVE MYELOPATHY. died, or were euthanized, secondary to seizures or the underlying
Christine Sibigtroth1, Virginia Garcia2, Gerry Shaw3, Joan diagnosis and 3 cats died or were euthanized unrelated to their sei-
Coates1, Patrick Pithua1, Michael Garcia2. 1Department of zures or seizure diagnosis and 1 cat died due to unknown causes.
Veterinary Medicine and Surgery, College of Veterinary Medicine,
University of Missouri, Columbia, MO, USA, 2Division of
Biological Sciences, College of Arts and Sciences, University of
Missouri, Columbia, MO, USA, 3EnCor Biotechnology,
Gainesville, FL, USA
N10
Canine degenerative myelopathy (DM) is an adult-onset neu- COMPARISON OF SERUM TRACE NUTRIENT
rodegenerative disorder with four defined disease stages. DM ini- CONCENTRATION IN DOGS WITH PRIMARY GENETIC
tially manifests as spastic upper motor neuron paraparesis and EPILEPSY VERSUS HEALTHY DOGS. Samantha Vitale,
general proprioceptive ataxia (stage 1). Progressive neurodegenera- Devon Hague, Laura Selmic. University of Illinois Veterinary
tion results in non-ambulatory paraparesis/paraplegia (stage 2) and Clinical Medicine, Urbana, IL, USA
thoracic limb paresis (stage 3). End-stage disease culminates in flac-
cid tetraplegia, widespread muscle atrophy and signs of brainstem Primary genetic epilepsy is the most common cause of seizures
dysfunction (stage 4). The clinical spectrum of DM is homogeneous in dogs, reportedly affecting 0.5–5.7% of the population. There
within and across breeds. Phosphorylated neurofilament heavy have been several investigations regarding the serum concentra-
(pNF-H), a major structural protein of myelinated motor axons, tions of trace nutrients, including copper, selenium, zinc, man-
has shown promise as a prognostic biomarker in other diseases of ganese, and iron in human epileptics and animal models.
the nervous system such as amyotrophic lateral sclerosis (ALS). However, no research of this nature is available in dogs with pri-
The goals of this study were to 1) quantify the concentration of mary genetic epilepsy. This is a prospective pilot study, designed
pNF-H in the CSF of DM-affected dogs throughout disease pro- to compare the serum concentrations of several trace nutrients in
gression and compare these finding to age-matched, neurologically non-epileptic dogs compared to dogs with epilepsy.
normal dogs with and without SOD1 mutations and 2) compare Blood samples were collected from 7 healthy control dogs and 8
CSF concentrations of pNF-H between DM-affected and dogs with dogs with primary genetic epilepsy. Serum was evaluated for
other chronic spinal cord disease that mimic DM. concentrations of copper, selenium, zinc, cobalt, manganese,
Using an enzyme-linked immunosorbent assay (ELISA), we molybdenum, and iron using inductively coupled plasma mass
measured pNF-H concentration in CSF from aged control dogs spectroscopy. Mann U Whitney tests were used to compare nor-
(n = 10) and DM-affected dogs at all stages (stage 1 n = 9; stage 2 mal and epileptic dog serum levels of the trace nutrient. A signifi-
n = 6; stage 3 n = 6; stage 4 n = 3). Data were analyzed using cantly higher level of copper (P = 0.006), selenium (P = 0.018),
Kruskal-Wallis ANOVA on ranks with post-hoc Dunn’s method. and manganese (P = 0.017) were found in epileptic dogs compared
Additionally, CSF pNF-H concentration was compared between to normal dogs. No significant differences were found in levels of
DM-affected dogs (n = 24) and dogs with other chronic spinal zinc (P = 0.64), cobalt (P = 0.82), molybdenum (P = 0.60), or iron
cord disease (n = 7). Those data were analyzed by the student’s t (P = 0.95). These results suggest that there are differences in the
test. To evaluate diagnostic performance, a receiver operating concentrations of some trace nutrients in epileptic dogs compared
characteristic curve was generated. to normal dogs, which warrants further investigation.
CSF concentrations of pNF-H were increased in DM-affected
dogs at all disease stages compared to aged control dogs
(P = 0.002); pNF-H concentrations did not differ between DM dis-
ease stages (P = 0.704). DM-affected dogs had increased CSF
pNF-H compared to dogs with other chronic spinal disease
(P < 0.001). Using a cut-off concentration of 1.5 ng/mL, sensitivity
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1437
The medical records of dogs presented to the Animal Health Feline brain MRI studies at two referral centres were reviewed
Trust between May 2006 and April 2015 and diagnosed with for cases without visible disease that could alter anatomic
ANNPE or presumptive FCEM were retrospectively reviewed. A landmarks or raise intracranial pressure. T2 weighted median plane
randomized list was generated of the MRI studies of 87 cases images of the brain and if available spinal cord were reviewed for
matching the inclusion criteria and submitted to two board- the presence of caudal cerebellar indentation, coning, herniation,
certified neurologists (LDR and AS) and one board-certified syringohydromyelia, and fluid accumulation in the middle ear. Area
radiologist (PJ), blinded to any clinical data. Each observer was of the cerebral hemispheres and cerebellum was also measured Blind
requested to make a diagnosis of ANNPE or FCEM based on measurements were taken by two observers and reviewed.
previously published diagnostic criteria. Inter-observer agreement There were 53 feline MRI studies meeting the inclusion criteria.
was evaluated with Kappa statistic. The clinical outcome of the Cerebellar herniation was found in 48% of mesaticephalic and
consensus diagnoses was compared. Recovery of motor and 78% of brachycephalic cats. Syringohydromyelia was not identi-
autonomic function was evaluated via medical records and a fied in any of the MR studies including only the first two cervical
telephone questionnaire with the owners. Clinical re-examinations spinal cord segments (36 cats) or more regions of the spinal cord
were performed when possible. (17 cats). High signal on T2-weighted transverse images of the
Based on the review of the MRI studies, 72 cases were diag- middle ear was detected in 8% of mesaticephalic and 17% of
nosed with ANNPE and 15 with presumptive FCEM. The level of brachycephalic cat. Information on presenting complaint, results
agreement between LDR-AS (95.3%; j = 0.853) or AS-PJ (95.3%; of neurological examination and final diagnosis in cats with and
j = 0.819) was almost perfect while that between LDR-PJ (90.6%; without cerebellar herniation was reviewed.
j = 0.68) was substantial. Mesaticephalic breed of cats show indentation of the caudal
Impaired urinary and/or fecal continence was reported only in aspect of the cerebellum and caudal cerebellar coning similar to
the ANNPE group in 20/71 dogs (28%, P = 0.033); all these dogs brachycephalic breeds of cats. The dimensions of the foramen mag-
had concurrent persistent motor deficits. Four dogs with impaired num planum and the area of the cerebral hemispheres and cerebel-
urinary and/or fecal continence were ambulatory at presentation. lum measured on a T2W sagittal MR image of the brain were also
Inability to control the urge to defecate was the most frequently similar between the two groups. However, brachycephalic cats had
reported deficit in faecal continence. a higher percentage of herniation of the cerebellar vermis through
All but one dog became or remained ambulatory without assis- the foramen magnum. Herniation of the cerebellar vermis does not
tance. One dog diagnosed with presumptive FCEM presented appear to be associated with syringomyelia in cats.
paraplegic without nociception, did not recover an ambulatory sta-
tus after 310 days and was euthanized. Only 20% dogs with
ANNPE and 14% dogs with presumptive FCEM recovered a
completely normal gait according to their owners, including 29%
of the grade 2/5 dogs, 12.5% of the grade 3/5 dogs and none of
the dogs that were plegic at presentation. The percentage of dogs N16
with persistent motor deficits was not statistically different between DIAGNOSTIC INVESTIGATION IN 13 CATS WITH
the two groups. The time to recovery of some motor function in SUSPECTED FELINE HYPERESTHESIA SYNDROME. Pablo
the most affected limb when presented with mono- or paraplegia Amengual1, Clare Rusbridge2, Tim Nuttall1, Sarah Heath3, Katia
was significantly longer in dogs with presumptive FCEM com- Marioni-Henry1. 1Hospital for Small Animals, Royal (Dick)
pared to dogs with ANNPE (P = 0.025); however only two cases School of Veterinary Studies, University of Edinburgh, Roslin,
with this variable were present in the FCEM group. Dogs diag- Scotland, UK, 2Faculty of Health & Medical Sciences, School of
nosed with presumptive FCEM were significantly younger Veterinary Medicine, University of Surrey, Guildford, UK,
3
(P = 0.025) and lighter (P = 0.037) than dogs with ANNPE and Behavioural Referrals Veterinary Practice, Chester, UK
had a longer intramedullary hyperintense lesion in sagittal T2-
weighted MRI images (P = 0.001). Dogs with ANNPE were more Feline hyperesthesia syndrome (FHS) was first reported in 1979
frequently reported to be performing physical activity (P = 0.001) and described as an accentuation of an otherwise normal behavior
and to vocalise (P < 0.0001) at the time of onset of the clinical in cats consisting in episodes of tail chasing, biting or licking the
signs and more frequently received anti-inflammatory drugs lumbar area, flank, anal area or tail; skin rippling and muscle
after diagnosis (P = 0.012) compared to dogs with presumptive spasms; excessive and unusual vocalizations, wild and uncontrolled
FCEM. jumping and running and presumed hallucinations. FHS has been
In conclusion, dogs diagnosed with ANNPE affecting the thora- anecdotally reported in association with dermatological, beha-
columbar spinal cord segment developed impaired urinary/fecal vioural, orthopaedic and neurological conditions. Treatment with
continence significantly more frequently than dogs with presump- phenobarbital, gabapentin, prednisolone, amitriptyline, fluoxetine,
tive FCEM. Impaired urinary/fecal continence can occur also in clomipramine and multivitamin supplements have been used with
dogs that are ambulatory at presentation. The presence of persis- inconsistent responses. However, we are not aware of any clinical
tent motor deficits is extremely common, particularly in dogs that scientific investigation on Feline Hyperesthesia Syndrome.
presented non-ambulatory; however, no statistically significant dif- We retrospectively collected data on the history, signalment,
ference was detected in the degree of recovery of motor function diagnostic workup and treatment from three referral veterinary
between the two groups. centers. The inclusion criteria were a history of attacking or over-
grooming the tail, flank or perineal area associated with either
vocalization or lumbar hyperesthesia, manifested as rippling of the
thoracolumbar skin occurring spontaneously or induced by gentle
touch. Information on physical and neurological examination, and
diagnostic work up were also necessary for inclusion in the study.
N15 Thirteen cats were included in the study. The median age of
MORPHOLOGY OF THE CAUDAL FOSSA IN presentation was 1 year (1–7 years). Eleven cats were attacking or
MESATICEPHALIC AND BRACHYCEPHALIC CATS AND over-grooming their tails and two cats their flank or perineal area.
ASSOCIATED CLINICAL SIGNS. Georgios (Yorgo) Varotsis1, Tail mutilation was reported in 9/13 cats, rippling of the thora-
Tobias Schwarz1, Rodolfo Cappello2, Danielle Gunn-Moore1, Katia columbar skin in 10/13 cats and 6 cats presented with unusual
Marioni-Henry1. 1Hospital for Small Animals, R(D)SVS and the vocalization during the episodes. The episodes occurred multiple
Roslin Institute, University of Edinburgh, Edinburgh, Midlothian, times per day in 12/13 of the cases, and multiple times per week in
UK, 2North Downs Specialist Referrals, Bletchingley, Surrey, UK 1/13. No consistent triggers were reported. Results of CBC and
biochemistry were available for 12/13 cats, spinal radiographs for
Morphological abnormalities of the caudal fossa are increas- 7/13, magnetic resonance imaging for 6/13, cerebrospinal fluid
ingly recognized as a cause of morbidity in many brachycephalic analysis for 3/13, electromyography for 3/13, dermatological
dogs but there is little information about these conditions in cats. assessment for 7/13, and joint fluid analysis for one cat. The diag-
The objective of this study was to investigate presence of similar nostic work up led to the diagnosis of allergic dermatitis in 2 cases
morphological abnormalities of the caudal fossa of mesaticephalic and immune-mediated polyarthritis in one case, but a definitive
and brachycephalic cats and possible association with clinical signs diagnosis was not reached in the remaining 10 cases. Treatment
and final diagnosis. included corticosteroids in 7/13 of the cats, gabapentin in 8/13,
clomipramine in 4/13, topiramate in 2/13, phenobarbital in 2/13
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1439
described, the role these organisms play in clinical diseases of the completed a brief questionnaire as well to identify and verify the
central nervous system of dogs has not been widely explored. The diagnoses of each dog that participated in this study. Fischer’s
purpose of this study was to use polymerase chain reaction (PCR) exact tests were utilized, to assess for differences in behavioral
to amplify Bartonella spp. DNA from cerebrospinal fluid (CSF) of traits exhibited between the epileptic, IVDD and primary care
naturally exposed dogs in endemic areas meeting criteria for groups. If a significant difference between the groups was detected,
inflammatory central nervous system (CNS) disease. then post hoc testing with Fischer’s exact tests for pairwise com-
CSF samples from 175 pure or mixed breed dogs were submit- parisons was performed and a Bonferroni correction was applied
ted to Colorado State University (www.dlab.colostate.edu) from to account for multiple comparisons.
either the Washington State University Neurology Department Dogs in the epilepsy and IVDD groups were more likely to be
between January 2012 and September 2014 or the Colorado State fearful/anxious when approached by an unfamiliar dog than those
University Veterinary Teaching Hospital between January 2012 dogs in the wellness group (P = 0.0011). Epileptic dogs with
and September 2015. The CSF samples were stored at 80°C until increasing seizure severity were significantly more likely to show
evaluated in this study. Dogs with neurologic examinations consis- fear and anxiety when approached by an unfamiliar dog
tent with focal and multifocal neurologic dysfunction and CSF (P = 0.0129) and showed significantly less excitement just before
pleocytosis (total nucleated cell count >5 nucleated cells/µL and just before being taken on a car trip (P = 0.0126). Epileptic dogs
red blood cell <4,000 cells/µL) were included. Animals with nor- receiving polytherapy had a significant decrease in excitement just
mal neurologic examinations were also included if their CSF met before taking a walk (P = 0.0007) and just before being taken on
our criteria. The CSF was thawed and centrifuged at 10,000 X g a car trip when compared to dogs on monotherapy (P = 0.027).
for 15 minutes. The supernatant was removed and the pellet Dogs receiving polytherapy had significantly increased fear and
assayed in a previously published PCR assay that targets the 16S- anxiety when groomed or bathed by a household member
23S rRNA intergenic region. All positive amplicons were (P = 0.0197), and had an increase in shaking, shivering, or trem-
sequenced to determine the infective Bartonella spp. bling when left or are about to be left on their own (P = 0.0004).
A total of 67 dogs met the inclusion criteria, none of which Dogs receiving polytherapy had a significant increase in becoming
were positive for Bartonella spp. DNA in CSF. Of the other 108 agitated when their owner or others show affection for another per-
CSF samples, one was positive for B. henselae DNA. The CSF son during preictal (P = 0.005), postictal (P = 0.001) and interictal
from this dog contained red blood cells (94 RBC/µL). (Pr= 0.0083) period and when their owner or others show affection
As Bartonella spp. have an intra-erythrocytic phase, we specu- for another dog or animal during preictal (P = 0.0068), postictal
late that minimal peripheral RBC contamination in the CSF of (P = 0.0068) and interictal (P = 0.02) period when compared to
dogs with systemic Bartonella spp. infection may lead to positive dogs on monotherapy. The finding of behavioral changes present
Bartonella PCR assay results in the absence of a CNS disease asso- throughout different seizure phases in this study raises further ques-
ciation. Thus, positive PCR for Bartonella spp. DNA in the CSF tions about how epilepsy affects canine patient’s quality of life.
of dogs must be interpreted in light of number of RBCs within the
sample as well as the presence of inflammation or systemic infec-
tion. Failure to amplify Bartonella spp. DNA from the CSF of the
67 dogs with inflammatory disease studied suggests the organism
was not involved, the organism was in CNS tissues but not in the
CSF, or the organism was present but in quantities undetectable O01
by this PCR assay. The combination of PCR and culture has been THE ASSOCIATION OF ENDOTHELIN-1 SIGNALING
found to be the most sensitive way to detect Bartonella spp. in WITH BONE ALKALINE PHOSPHATASE EXPRESSION
samples from dogs and humans and the use of that technique AND PRO-TUMORIGENIC ACTIVITIES IN CANINE
should be considered in future studies. OSTEOSARCOMA (VCS AWARD WINNER). ZL Neumann1,
HC Pondenis1, A Masyr1, ML Byrum1, KL Wycislo2, TM Fan1.
1
Department of Veterinary Clinical Medicine, University of Illi-
nois, Urbana, IL, USA, 2Department of Pathobiology, University
of Illinois, Urbana, IL, USA
lines. Our results highlight a potential chemotherapy protocol for ELISpot analysis at baseline and at each vaccine time point are
the treatment of FISS. Further investigations need to be pursued being performed to elucidate whether repeat vaccinations effec-
to define the effect of this novel therapeutic combination and to tively maintain anti-tumor immunity.
validate our results in vivo.
O10
O09 VITAMIN D STATUS AND ACUTE PHASE PROTEIN
CLINICAL ADVANCEMENT OF A RNA-TRANSFECTED CONCENTRATIONS IN CANINE CANCER PATIENTS.
CD40-B CELL VACCINE FOR THE TREATMENT OF Nicole Weidner1, J. Paul Woods2, Anthony J. Mutsaers2, Julie
CANINE NON-HODGKIN’S LYMPHOMA. Nicola Mason, Bayle3, Adronie Verbrugghe2. 1Department of Biomedical
Martha MaloneyHuss, Josephine Gnanandarajah. University of Sciences, Ontario Veterinary College, University of Guelph,
Pennsylvania, Philadelphia, PA, USA Guelph, ON, Canada, 2Department of Clinical Studies, Ontario
Veterinary College, University of Guelph, Guelph, ON, Canada,
3
Canine Non-Hodgkin’s lymphoma (NHL) occurs in approxi- Royal Canin Research Center, Aimargues, France
mately 30–100/100,000 dogs per year and accounts for up to 83%
of canine hematopoietic cancers. Standard–of-care treatment for Circulating concentrations of acute phase proteins (APP) have
canine NHL comprises multi-drug chemotherapeutic protocols. been used as biomarkers in canine oncology. Increased concentra-
60–85% of dogs enter a complete clinical remission following tions have been observed in cancer patients and decreased concen-
induction chemotherapy, and median first-remission durations trations are linked to patient remission. In humans, increased APP
range from 140 to 385 days. Resistance to chemotherapy increases concentrations have been linked with low vitamin D status in sev-
with each subsequent relapse and less than 10% of patients survive eral disease states. Low vitamin D status has also been observed in
longer than 2 years from diagnosis. To prolong overall survival, human and canine cancer patients. Therefore, there is the possibil-
more effective therapies are required to prevent relapse following ity that increased APP concentrations will be linked with decreased
successful induction chemotherapy. vitamin D status in canine cancer patients. The objective of this
Directing the immune system to specifically target malignant study was to examine the relationship between blood vitamin D
cells is a powerful strategy in the treatment of cancer. We have and APP concentrations in healthy dogs and dogs with cancer.
previously developed a vaccine strategy that utilizes autologous Dogs with lymphoma (n = 34), osteosarcoma (n = 21) and mast
CD40-activated B cells as antigen-presenting cells electroporated cell tumors (n = 26) diagnosed by cytology and/or histology pre-
with autologous tumor RNA as the antigenic payload to stimulate senting to one referral hospital for treatment, as well as client-
anti-tumor immunity in dogs with NHL. In our first clinical trial, owned healthy control dogs (n = 25), were enrolled. Blood samples
we showed that dogs vaccinated three times at three week intervals were collected from all dogs prior to any treatment and analyzed
following successful induction chemotherapy had a tendency for plasma 25-hydroxyvitamin D (25(OH)D) using radioim-
towards prolonged remission times and overall survival when com- munoassays, and haptoglobin (Hp), alpha-1-acid glycoprotein
pared to historical controls. Furthermore, vaccinated dogs that did (AAG) and serum amyloid A (SAA) using ELISA kits. Statistical
relapse showed a statistically significant increase in overall survival analyses were completed with SAS 9.3. Vitamin D and APP con-
following rescue chemotherapy. These results coupled with centrations were compared between groups using ANOVAs fol-
immune analysis from vaccinated patients suggested that while lowed by Tukey-Kramer post-hoc analyses. Pearson correlation
RNA loaded CD40-activated B cells primed an anti-tumor coefficients were performed to determine relationships between
immune response, it was insufficient to maintain remission. Fur- vitamin D and APP concentrations within each group.
thermore, we hypothesized that rescue chemotherapy boosted vac- MeanSD plasma 25(OH)D concentrations were significantly
cine primed tumor-specific immunity and lead to prolonged second lower in dogs with lymphoma (102 33 nmol/L) than in healthy
remission times. We therefore hypothesized that repeat administra- dogs (129 41 nmol/L, P = 0.007). MeanSD plasma Hp and
tions of RNA-loaded CD40-activated B cells given every 2 months AAG concentrations were significantly higher in dogs with lym-
following an initial priming course would maintain anti-tumor phoma (9.6 7.3 ng/mL and 92.4 71.0 ng/mL, respectively)
immunity and prevent relapse. than in healthy dogs (3.0 1.7 ng/mL, P < 0.001 and
To investigate this hypothesis we are currently performing a sec- 43.7 30.8 ng/mL, P < 0.001, respectively). There were no signifi-
ond phase I/II clinical trial using RNA-loaded CD40-activated B cant differences in blood SAA levels among groups. Pearson corre-
cells. Fifteen dogs will be recruited to this study. Eligibility criteria lation coefficients revealed a moderate inverse relationship between
include a recent diagnosis of NHL, no prior treatment with plasma AAG and 25(OH)D concentrations (R = 0.39, P = 0.024)
chemotherapy or steroids, and no evidence of circulating blasts. in lymphoma patients only.
At the time of diagnosis, peripheral blood mononuclear cells and The lower plasma 25(OH)D and higher Hp and AAG concen-
malignant lymph node tissue are harvested to generate CD40-acti- trations in canine lymphoma patients compared to healthy dogs is
vated B cells and whole tumor RNA respectively. Dogs then consistent with previous reports. However, this study is the first to
undergo a 19-week CHOP-based chemotherapy protocol. Only report these observations within the same population. Further
dogs in complete clinical remission following induction chemother- research is needed to investigate whether decreased plasma 25(OH)
apy are eligible to receive the autologous vaccine. Dogs are vacci- D concentration is a factor in cancer development, or a conse-
nated every three weeks for three doses, and then every two quence of cancer, and to determine the clinical relevance of these
months until clinical relapse. Induction and maintenance of anti- findings.
tumor immunity is being determined using an IFN-c ELISpot
assay. The primary endpoint of this trial is time to progression,
and the secondary endpoints include duration of anti-tumor immu-
nity, overall survival and lymphoma-specific survival.
To date, ten dogs have been recruited and CD40-activated B
cells have been successfully generated for nine dogs. Briefly, O11
PBMCs are co-cultured with feeder cells consisting of irradiated RETROSPECTIVE EVALUATION OF METRONOMIC
K562 cells transfected with human CD40L (KtCD40L) in the pres- CYCLOPHOSPHAMIDE IN EPITHELIAL AND MESENCHY-
ence of cyclosporine and IL-4, to generate CD40-activated B cells. MAL MALIGNANT TUMOURS. J Ellis, RD Foale. Dick White
CD40-B cells are then electroporated with RNA extracted from Referrals, Six Mile Bottom, Cambridgeshire, UK
autologous malignant lymph node tissue or with canine distemper
virus Hemagglutinin antigen (CDV-HA) mRNA as a control vac- Continuous low dose chemotherapy administration has been
cine. At the time of writing, 2/10 dogs have completed their induc- reported to have anti-angiogenic effects with efficacy against multi-
tion chemotherapy and have received their initial priming ple tumour types. This study aimed to retrospectively assess the
vaccinations. No adverse events have occurred following vaccine use of metronomic cyclophosphamide for histopathologically con-
administration, and neither dog has yet relapsed. The trial is ongo- firmed solid malignant canine tumours.
ing and the preliminary data confirm the feasibility of autologous Patient records from 2009 to 2014 were reviewed at a multi-
CD40-B cell vaccine generation and safety of administration. disciplinary referral hospital. Dogs without histological
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1444 2016 ACVIM Abstracts
confirmation of diagnosis were excluded. Thirty-seven cases of concurrent radiation or chemotherapy, though a majority
epithelial or mesenchymal malignancy in dogs treated with 10 mg (n = 38) received glucocorticoids during toceranib treatment.
cyclophosphamide daily/every other day were identified. This Mean duration of toceranib treatment in cats experiencing CB
included 14 high grade soft tissue sarcomas, 5 soft tissue sarcomas was 37 weeks (4–106) and 48 weeks (10–199) for cutaneous and
of undefined grade, 4 intermediate grade soft tissue sarcomas, 3 visceral cases, respectively. Toceranib was administered at a
splenic haemangiosarcomas, 3 incompletely excised low grade soft median dose of 2.5 mg/kg in cats with CB; in 91% (39/43) the
tissue sarcomas, 2 thyroid carcinomas, and 1 each of adenocarci- drug was given 3 times per week. Treatment was generally well
noma, bladder haemangiosarcoma, splenic fibrosarcoma, apocrine tolerated with 57% (30/53) cats experiencing adverse effects at
gland carcinoma, metastatic prostate carcinoma, and metastatic some point during toceranib treatment. The majority of these
carcinoma of unknown origin. Two were lost to follow up. signs were low-grade (Grade 1 or 2) gastrointestinal or hemato-
Twenty-two had at least one attempt at surgical excision and three logic toxicities that resolved with treatment break and/or dose
underwent radiotherapy prior to initiation of chemotherapy. adjustment.
Three of the dogs (8.6%) developed haematuria, but no other Toceranib appears to be well-tolerated in feline patients with
adverse effects were reported. The haematuria resolved in all three mast cell neoplasia. Biologic activity of this drug is evident in the
dogs after cessation of cyclophosphamide. studied cats, however further prospective studies are needed to
74% of dogs had stable disease or partial/complete remission fully elucidate its role in treatment of this condition.
>100 days with cyclophosphamide, including two dogs that had
failed previous chemotherapy protocols and one that had received
radiotherapy. Four dogs did not have resection of the primary
tumour, and three of these remained clinically well for >100 days.
20 of 35 dogs (57%) had DFI >6 months with 13 (37%) still alive
over one year later. O13
Of the dogs with intermediate/high grade sarcomas (n = 18) the EXPRESSION OF P GLYCOPROTEIN (ABCB1) IN CATS
median survival time (MST) was 362 days, with one dog lost to WITH T-CELL LYMPHOCYTIC GASTROINTESTINAL
follow up and four still alive. LYMPHOMA. Valter de Medeiros Winkel, Bruno Cogliati,
Of the dogs with carcinomas (n = 6) one was lost to follow up Archivaldo Reche Jr, Ana Luiza Nairismagi Alves, Sılvia Regina
and two are still alive >1 year later with no clinical signs. One dog Ricci Lucas. University of Sao Paulo, Sao Paulo, SP, Brazil
had a reduced rate of progression and stable disease for >100 days
with no clinical signs of disease. Two dogs with thyroid carcinoma Gastrointestinal is the most common anatomical form of lym-
were still alive three years later. This is in contrast to the reported phoma in cats and systemic chemotherapy is indicated for the
MST for invasive thyroid carcinoma treated with cisplatin of treatment. Although most of cats can achieve a complete remission
98 days. with chemotherapy, relapse can occurs and may be associated to
This study adds to the evidence that metronomic cyclophos- the multidrug resistance (MDR). Cell mechanisms of MDR
phamide may have some use in the treatment of malignant mes- include activation of transmembrane proteins, that reduce intracel-
enchymal and epithelial tumours. However, it is important to note lular concentrations of different chemical compounds, and alter-
that even at low doses side effects may occur. ations in drug target. The main protein related to MDR
phenotype is P-glycoprotein. Its overexpression results in reduced
concentration of certain drugs within the cell, which is linked to
the resistance. The aim of this study was to investigate P glycopro-
tein (P-gp) expression in cats with T-cell lymphocytic gastrointesti-
nal lymphoma. Immunohistochemistry was performed in 40
O12 samples using the monoclonal antibodies mouse anti-PAX-5
EVALUATION OF TOCERANIB PHOSPHATE (PALLADIAâ) (PAX5-Invitrogen), polyclonal rabbit anti-CD3 (DAKO) and
IN THE TREATMENT OF FELINE MAST CELL NEO- mouse anti-P-glycoprotein (clone C494-Enzo Life Sciences). P-gp
PLASIA: 53 CASES. Erika Berger1, Chad Johannes1, Gerald immunoreactivity was analysed by degree of staining intensity,
Post2, Gillian Rothchild2, Kai-Biu Shiu3, Sarah Wetzel3, Chelsea between 0 (no expression) to 3 (strong expression). Lymphoma
Tripp4, Theresa Arteaga5, Martin Crawford-Jukubiak6, Anna Rita was considered to be positive for P-gp when more than 10% of
Serras7, Sarah Gillings8, Christine Swanson9, Shawna Greene10, the neoplastic population expressed the protein. Three cats had a
Kelly O’Neill11, Michelle Pressel12. 1Iowa State University College strong and 7 had a moderate expression, comprising 25% of the
of Veterinary Medicine, Ames, IA, USA, 2The Veterinary Cancer cases. The median of overall survival time was 24 months for these
Center, Norwalk, CT, USA, 3Veterinary Specialty Center, Madi- 10 cats; 60% had complete and 40% partial response to the treat-
son, WI, USA, 4Veterinary Cancer Specialty Center, Seattle, WA, ment, and it was the same median observed for all cats studied. In
USA, 5Animal Cancer Center, Monterey, CA, USA, 6Sage Centers conclusion, the expression of P-gp was observed in 25% of the
for Veterinary Specialty and Emergency Care, Concord, CA, cats with T-cell lymphocytic gastrointestinal lymphoma and this
USA, 7Animal Health Trust, Newmarket, Suffolk, UK, 8Summit expression was not related to the treatment response or overall
Veterinary Referral Center, Tacoma, WA, USA, 9Blue Pearl Spe- survival time.
cialty and Emergency Medicine for Pets, Grand Rapids, MI, USA,
10
Iowa Veterinary Specialties, Des Moines, IA, USA, 11Saint Fran-
cis Veterinary Specialists, Decatur, GA, USA, 12Pacific Veterinary
Specialists, Capitola, CA, USA
The purpose of this study was to solicit and compile data from O14
practicing veterinary specialists regarding their use of toceranib in EARLY EXPERIENCES WITH STEREOTACTIC RADIATION
cats with mast cell neoplasia and to provide initial assessment of THERAPY FOR THE TREATMENT OF CANINE NON-
possible clinical benefit and toxicity. LYMPHOMATOUS NASAL TUMORS. Tracy Gieger, Michael
The American College of Veterinary Internal Medicine Oncol- Nolan. Department of Clinical Sciences (College of Veterinary
ogy and Small Animal Internal Medicine listserves were used to Medicine), and Comparative Medicine Institute, Raleigh, NC,
solicit data pertaining to cases in which toceranib was used in the USA
treatment of feline mast cell neoplasia. Cases were included if the
following data were received: signalment (age, gender, breed), ana- The purpose of this study was to describe initial experiences
tomic classification of disease (cutaneous or visceral), previous and with a stereotactic radiation therapy (SRT) protocol (10 Gy x 3
concurrent treatment, toceranib dose (mg/kg) and schedule, dura- daily fractions delivered with 6 MV photons via a linear accelera-
tion of therapy, best response, and documentation of adverse tor) used as treatment for non-lymphomatous nasal tumors in
events. dogs. A retrospective analysis of cases treated from August 2013
Case data from 53 cats with cutaneous (n = 25) or visceral to October 2015 at NC State Veterinary Hospital was per-
(n = 28) mast cell neoplasia were received. Clinical benefit (CB) formed. Dogs were included if they had biopsy-confirmed non-
was seen in 81% (43/53), including 88% (22/25) with cutaneous lymphomatous nasal tumors. Dogs treated with chemotherapy
(8CR, 12PR, 2SD) and 75% (21/28) with visceral (5CR, 13PR, were excluded. The gross tumor volume (GTV) was contoured
3SD) involvement. Most cats (n = 49) did not receive using pre- and post-contrast 1–2 mm slice thickness CT image sets.
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1445
A clinical target volume (CTV) expansion was used to include the was no significant difference in MMP or VEGF (absolute or plate-
ipsilateral nasal cavity and sinuses as well as 0.5–1 cm of the con- let-corrected) at any time point, and there was no correlation of
tralateral nasal cavity. A PTV expansion was not used (CTV = these values with OSA-free survival or OS. Median OSA-free sur-
PTV). Thirty Gray (Gy) was prescribed to 99% of the GTV and > vival was 183 days (range, 55–576) and OS was 250 days (range,
95% of the PTV with a planned simultaneous boost to the center 80–882).
of the GTV. Cone beam CT, indexed bite-block system, and a Although the combination of carboplatin followed by TP was
treatment couch with 6 degrees of freedom were used for set up well-tolerated in dogs with appendicular OSA, survival times did
and delivery. Cases were reviewed and information related to not exceed previously published data from dogs treated with
patient demographics, tumor characteristics, and radiation plan amputation followed by chemotherapy. Serum VEGF and MMP-9
dosimetry was collected. levels remained unchanged from baseline despite the continued
Twenty-five cases were included. Stages included T1 (n = 1), T2 administration of TP. The results of this study do not support
(n = 10), T3 (n = 2), T4 (n = 12). None had evidence of distant ongoing TP administration post amputation and standard-of care
metastasis. Nineteen had regional lymph node aspirates and metas- chemotherapy in dogs with appendicular OSA.
tasis was present in one. Tumor types included adenocarcinomas
(n = 15), chondrosarcomas (n = 5), transitional nasal carcinomas
(n = 3), intranasal squamous cell carcinoma (n = 1), and neuroes-
thesioblastoma (n = 1). Clinical signs improved in all cases. Twelve
cases had recheck CT scans 3–4 months post-SRT and partial or
complete tumor response was seen in all cases. Minimal acute toxi- O16
city was detected. The only late effect noted to date is oronasal fis- SAFETY ASSESSMENT OF A NOVEL ONCOLYTIC
tula development in one dog 4 months post-SRT (this was MARABA VIRUS IN CATS. J. Paul Woods1, Byram Bridle1,
anticipated due to tumor invasion into the palate at diagnosis). Dorothee Bienzle1, Josepha Delay2, Annette Morrison3, Michelle
The median disease progression-free survival time has not been Cieplak3, Jeff Hummel4, Brian Lichty4. 1Ontario Veterinary
reached, and 52% of dogs are progression-free at 1 year. Nine College, University of Guelph, Guelph, ON, Canada, 2Animal
dogs are deceased (median survival time 375 days) and 40% are Health Laboratory, University of Guelph, Guelph, ON, Canada,
3
alive 600 days post SRT. Campus Animal Facilities, University of Guelph, Guelph, ON,
Three fraction SRT has been used to treat non-lymphomatous Canada, 4McMaster Immunology Research Centre, McMaster
nasal tumors in 25 dogs with limited adverse events. Continued University, Hamilton, ON, Canada
accrual and follow-up will be necessary to confirm low toxicity,
further elucidate effects of stage on outcome, and characterize clin- Oncolytic viruses are viruses whose replication is restricted to
ical efficacy. tumour cells leading to cytolysis. A growing number of viruses are
being developed as oncolytic viruses and various strategies have
been utilized to target tumour cells. Our group developed a bio-
therapeutic that combines two emerging cancer treatment modali-
ties, tumour vaccination and oncolytic viruses. We recently
determined that oncolytic viruses expressing tumour antigen trans-
O15 genes are an excellent means to boost and enhance tumour vacci-
TREATMENT OF CANINE APPENDICULAR OSTEOSAR- nation. In this preliminary study, cats were first vaccinated with
COMA WITH AMPUTATION, CARBOPLATIN, AND an adenovirus expressing a cancer gene, and then boosted with
TOCERANIB PHOSPHATE. Tracy Gieger1, Dawn Clarke2, Julie another virus (Maraba) also expressing this cancer gene. This vac-
Nettifee-Osborne1, Chad Johannes3, Brianna Hallman1, Michael cination protocol should elicit strong immunity to cancer cells, but
Nolan1, Laurel Williams4. 1North Carolina State University, should not cause any ill effects to the cats. The purpose of this
Raleigh, NC, USA, 2University of Georgia College of Veterinary study was to determine the safety (or toxicity) of a genetically
Medicine, Athens, GA, USA, 3Iowa State University, Ames, IA, altered oncolytic Maraba virus in cats.
USA, 4Veterinary Specialty Hospital of the Carolinas, Cary, NC, Five young male (6–12 months old) purpose-bred cats were vac-
USA cinated intramuscularly with 9 x 109 PFU of a non-replicating
human serotype 5 adenoviral vaccine vector (prime). Three weeks
Osteosarcoma (OSA) is locally invasive and highly metastatic. later the cats were administered 2.64 x 1011 PFU of MG1 Maraba
We hypothesize that standard-of-care carboplatin chemotherapy virus intravenously (boost). Cats were monitored with physical
followed by continued administration of toceranib phosphate (TP) exams observing for clinical signs, and by complete blood counts
will result in improved survival in dogs with OSA as compared to (CBC). Peripheral blood, saliva, urine, and feces were collected for
historical controls that did not receive TP. In addition, we hypoth- virus isolation on days 1, 2, 3, 4 and 7 post- Maraba virus
esize that TP will decrease circulating levels of pro-angiogenic infusion.
MMP-9, a downstream factor and surrogate marker for VEGF There were no severe adverse events. Two cats had mild tran-
receptor inhibition. sient pyrexia (40 - 41.4 C) between 2 and 5 hours post Maraba
Ten dogs with histologically confirmed OSA with no evidence virus infusion (typical of cytokine induction). The CBCs revealed
of thoracic metastasis at diagnosis were treated with amputation a transient mild neutrophilia in 2 cats one day after Maraba virus
followed by 4 doses of carboplatin chemotherapy (300 mg/m2 IV infusion (14.92 and 8.73; reference interval 2.1–8.3 x 109 /L).
q 3 weeks). Fourteen days after chemotherapy was completed, TP Thrombocytopenia of 27 x 109/L (reference range 93–514 x 109/L)
was initiated at a dose of 2.75 mg/kg PO q 48 hours. Serum sam- was noted in one cat 2 days post Maraba virus infusion, and in
ples for VEGF and MMP-9, bloodwork to evaluate toxicity, another cat thrombocytopenia of 9 x 109/L and 33 x 109/L on
screening for metastasis with thoracic radiographs, and quality-of- days 3 and 7, respectively, post Maraba virus infusion.
life (QOL) scores monitored via owner surveys were performed Viral genomes but not replication-competent viruses were
monthly. The Kaplan-Meier method was used to calculate OSA- detected in secondary lymphoid tissues (i.e. spleen) on day 39.
free survival and overall survival (OS). A Friedman’s test was Replication-competent virus was not detected in peripheral blood,
used to compare VEGF and MMP values at baseline, pre-TP, and saliva, urine, or feces.
end of study. A Kruskal-Wallis test of repeated measures was Viral genomes in secondary lymphoid tissues without concur-
used to compare platelet-corrected VEGF values at baseline, rent replication-competent virus is a finding similar to that in mice
pre-TP, and end of study. P values of <0.1 were considered and primates, and reflects the propensity of Maraba virus to be
significant. taken up by antigen-presenting cells when delivered systemically,
Three dogs required dose reductions of carboplatin secondary making it an ideal vector for boosting immune responses.
to neutropenia, and two required drug holidays during TP treat- The lack of replication-competent virus in saliva, urine, feces or
ment. No dogs were withdrawn from the study due to toxicity. peripheral blood satisfied Canadian Food Inspection Agency
Seven dogs developed local recurrence or metastasis as the first (CFIA) concerns regarding potential shedding, and enabled initia-
event. One dog was withdrawn from the study due to owner tion of a clinical trial utilizing Maraba virus to treat cats with
wishes, one was euthanized due to osteoarthritis, and one devel- mammary cancer. In this trial a heterologous prime:boost strategy
oped lymphoma with no evidence of OSA metastasis. There targeting tumour antigens will be tested.
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1446 2016 ACVIM Abstracts
immunohistochemistry for CD18 to determine the degree of mono- Nubia Lopes2, John Morton3, Nick Jonsson1. 1University of Glas-
cyte infiltration in necropsy samples obtained from several com- gow, Glasgow, Scotland, UK, 2University of Queensland, Gatton,
mon metastatic tumors of dogs, including hemangiosarcoma, Qld, Australia, 3Jemora Pty Ltd., Geelong, Vic., Australia
osteosarcoma, and various carcinomas.
Results: We found that compared to other tumor types, heman- Burmese cats are predisposed to diabetes mellitus in Australia,
giosarcoma metastases had significantly greater infiltration of New Zealand and United Kingdom, and the disease is 3 to 4 times
CD18+ monocytes. Next, migration assays were used to compare more prevalent in this breed compared to domestic cats. Mecha-
the ability of tumor cell lines to stimulate monocyte migration nisms predisposing Burmese cats to diabetes remain unclear. This
in vitro. Hemangiosarcoma cell lines were among the strongest at study compared hormonal and biochemical variables associated
stimulating monocyte migration, and were also found to be the with glucose and lipid metabolism between mixed-age, lean to
highest producers of the monocyte chemoattractant CCL2. In addi- overweight, clinically healthy Burmese and non-Burmese cats. Bur-
tion, hemangiosarcoma metastases in vivo were found to produce mese cats older than 3.5 years had higher fasting glucose com-
large amounts of CCL2, compared to other tumor metastases. pared to non-Burmese (P = 0.02), with 1.3 mmol/L higher at
Conclusion: These results are consistent therefore with the 3.5 years and 3.5 mmol/L higher at 10 years of age (P < 0.001),
hypothesis that overexpression of CCL2 and recruitment of large but not at 2 years of age. Mean and 2-hr glucose concentrations
numbers of monocytes may explain in part the aggressive metastatic during a glucose tolerance test were higher in Burmese than non-
nature of canine hemangiosarcoma. Moreover, these findings suggest Burmese cats (P < 0.006 to 0.031), indicating relative glucose intol-
that immunotherapeutic interventions designed to block monocyte erance. Lean Burmese cats had 4.8 lU/mL higher fasting insulin
recruitment or mobilization may be an effective adjuvant strategy for concentrations than non-Burmese, suggesting they are insulin resis-
suppressing tumor metastasis in dogs with hemangiosarcoma. tant (P = 0.031). At time 10 minutes during the GTT, Burmese
cats had lower insulin concentration compared to non-Burmese,
but were higher at 120 minutes (P = 0.066 and P = 0.046). This is
consistent with diminished first phase, and increased and
prolonged second phase insulin release, a pattern of insulin
secretion described in prediabetic, diabetic, obese humans and obese
O18 cats. Fasting triglyceride concentration was 0.2 mmol/L higher
PHASE I CLINICAL TRIAL OF THE TARGETED (P = 0.015) and fasting NEFA concentration was 0.18 mmol/L
CHEMOTHERAPEUTIC DRUG, FOLATE-TUBULYSIN, IN higher (P = 0.016) in Burmese compared to non-Burmese. These
DOGS WITH URINARY TRACT TRANSITIONAL CELL results demonstrate that Burmese cats have more rapid deterioration
CARCINOMA (VCS AWARD WINNER). Nicholas Szigetvari1, of b-cell function with age, and impaired glucose homeostasis and
Deepika Dhawan1, Jose A. Ramos-Vara1, Christopher P. Leamon2, lipid metabolism occur concurrently in these cats.
Patrick J. Klein2, Hock Gan Heng1, Iontcho R. Vlahov2, Philip S.
Low2, Lindsey M. Fourez1, Deborah W. Knapp1. 1Purdue
University College of Veterinary Medicine, West Lafayette, IN,
USA, 2Purdue University College of Chemistry, West Lafayette, IN,
USA
EN02
Introduction: Targeted chemotherapy can include repurposing PERTURBATIONS IN SERUM FRUCTOSAMINE LEVEL IN
drugs previously considered clinically irrelevant due to marked DIABETIC HYPERTHYROID CATS – A RETROSPECTIVE
toxicity and low therapeutic index. Tubulysin is one such drug STUDY. Arnon Gal1, Brie Trusiano2, Adrienne French3, Nicolas
with compelling antiproliferative activity in vitro, but poor tolera- Lopez-Villalobos1, Amy MacNeill2. 1Institute of Veterinary,
bility in vivo. High affinity folate receptor (FR) expression has pre- Animal and Biomedical Sciences, Palmerston North, New Zealand,
2
viously been found in canine transitional cell carcinoma (TCC) Colorado State University, Ft. Collins, USA, 3New Zealand
and serve as a druggable target. A phase I clinical trial of Folate- Veterinary Pathology, Palmerston North, New Zealand
Tubulysin was conducted in dogs with urinary tract TCC.
Methods: With PACUC approval, eligible dogs were enrolled in Previous studies indicated that serum fructosamine level is
a 3 + 3 dose escalating cohort study of Folate-Tubulysin (Endocyte, decreased in hyperthyroid cats; however, its clinical utility in dia-
West Lafayette, IN). Inclusion criteria were histologic diagnosis of betic hyperthyroid cats was not reported. We hypothesized that
TCC, presence of FRs on the TCC cells detected by immunohisto- hyperthyroidism in diabetic cats will result in a clinically signifi-
chemistry and/or folate uptake in the TCC detected by nuclear cant decrease in serum fructosamine level compared to euthyroid
scintigraphy, and informed pet owner consent. The initial dose was diabetic cats. Data of serum total thyroxine (TT4) and fruc-
0.2 mg/kg given intravenously every two weeks, with intra- and tosamine of hyperthyroid/euthyroid diabetic/nondiabetic cats from
inter-cohort escalation by 0.02 mg/kg after at least two consecutive the New Zealand Veterinary Pathology and Colorado State
treatments. Escalation continued until dose limiting toxicity (DLT) University were retrieved and statistically analyzed. Serum fruc-
was observed and the maximum tolerated dose (MTD) determined. tosamine was significantly lower in hyperthyroid diabetic than
Results: Eleven dogs were enrolled to obtain the maximum tol- euthyroid diabetic cats (mean 332 µmol/L 95% CI 291–379,
erated dose (MTD). A total of twenty seven dogs were enrolled to n = 18 versus mean 527 µmol/L 95% CI 515–553, n = 186) while
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1447
not different between hyperthyroid diabetic and euthyroid nondia- development of large insulin-resistant adipocytes. RORc can be
betic cats (mean 332 µmol/L 95% CI 291–379, n = 18 versus mean inhibited by its ligand tetra-hydroxylated bile acid (THBA). Oral
321 µmol/L 95% CI 296–345, n = 128). There was a significant supplementation of THBA reduces adipocyte size, improves insulin
negative correlation between serum TT4 concentration and serum sensitivity and prevents hyperglycemia in obese mice. The purposes
fructosamine and glucose concentrations (n = 659, P < 0.01, and of this study were to investigate palatability and possible side
n = 297, P < 0.01, respectively). Hyperthyroid cats (diabetic or effects of THBA, and the effects of THBA supplementation on
not) had significantly (P < 0.05) lower serum glucose than euthy- adipocyte size and insulin sensitivity in healthy cats.
roid cats (diabetic or not). Diabetes and random variability Six healthy purpose-bred cats were fed 5 mg/kg/day of THBA
accounted for 49.7% and 45.4% of the change in serum for 8 weeks. THBA was given in a small amount of food to each
fructosamine; whereas, age (3.1%) and population (1.8%) had cat individually before the daily ration was offered. Complete
minimal impact on serum fructosamine. In conclusion, in the blood count, biochemical profile and insulin tolerance test (ITT;
current study, serum fructosamine concentration was significantly 0.1 IU/kg insulin aspart IV) were performed at weeks 0 and 8.
decreased in diabetic hyperthyroid cats and was similar to the After 12–18 hours of fasting blood glucose concentration was
fructosamine concentration in euthyroid nondiabetic cats. In addi- recorded and the rate constant for the disappearance of glucose
tion, approximately 45% of the change in serum fructosamine was (KITT) was calculated. Subcutaneous fat tissue samples were taken
independent of diabetes. Future studies should be undertaken to in the umbilical area by a 4 mm biopsy punch, and adipocyte size
explore specific factors that have an impact on fructosamine level. was determined by histological and image based analysis of at
least 10 sections per animal. Data were analyzed by parametric
tests (P < 0.05).
Oral supplementation of THBA was well accepted in all cats,
and no side effects were noted. None of the cats displayed abnor-
malities on complete blood count and serum biochemical profile.
EN03 Fasting blood glucose concentration and average size of white sub-
PHARMACODYNAMIC AND PHARMACOKINETIC cutaneous adipocytes were significantly lower after 8 weeks of
PROPERTIES OF INSULIN ASPART FOLLOWING THBA administration, whereas KITT did not differ.
SUBCUTANEOUS AND INTRAMUSCULAR INJECTION IN The reduction of adipocyte size in response to THBA treatment
CATS. Hannah Pipe-Martin , Jon Fletcher , Chen Gilor2, Michael
1 1
is in accordance with data from mice and underscores the possible
Kearney3. 1Department of Veterinary Clinical Sciences, School of role of RORc signaling in the control of adipose tissue metabo-
Veterinary Medicine, Louisiana State University, Baton Rouge, lism. While we observed a significant reduction in fasting glucose,
LA, USA, 2Department of Veterinary Clinical Sciences, College of overall insulin sensitivity did not improve. These findings might be
Veterinary Medicine, The Ohio State University, Columbus, OH, explained by the fact that insulin sensitivity in normal weight sub-
USA, 3Department of Pathobiological Sciences, School of Veteri- jects is mainly determined by liver and muscle cell function, while
nary Medicine, Louisiana State University, Baton Rouge, LA, altered adipocyte size would not contribute significantly to the
USA ITT. Future studies in obese cats and altered dosing regimes are
required to assess whether THBA improves insulin resistance in
Insulin aspart (Aspart) is a rapid-acting insulin analog that has cats, in addition to direct effects on adipocyte size.
been shown to be an effective treatment for diabetic ketoacidosis
(DKA) when administered by intermittent subcutaneous (SC)
injection in humans. In cats, rapid-acting insulin analogs have not
yet been evaluated, and the most commonly used protocols for
DKA involve delivery of regular insulin via constant intravenous
infusion, which can be technically challenging. The aim of this EN05
study was to determine the pharmacodynamics (PD) and pharma- THE EFFECT OF ADIPOSITY AND DIET ON SECRETION
cokinetics (PK) of Aspart following SC and intramuscular (IM) OF INCRETIN HORMONES IN CATS. Chen Gilor, Katie
injections in healthy cats. McCool, Adam Rudinsky, Valerie Parker, Prosper Boyaka. The
Using the isoglycemic clamp method, time-action profiles were Ohio State University, Columbus, OH, USA
generated in eight healthy cats to determine pharmacodynamics of
Aspart following SC and IM injection. Pharmacokinetics were Degree of adiposity and dietary macronutrient composition
determined by measuring the plasma Aspart concentration every affect the secretion of incretin hormones but little is known about
15 minutes during the clamp using the MercodiaÒ Iso-insulin their effect in cats.
ELISA kit. In this study, 8 overweight cats were fed a maintenance diet
Mean SEM time to onset of action and duration of action (MD) for 3 weeks followed by a weight control diet (WCD, lower
did not differ significantly between SC (11.12 0.97 minutes and fat, higher in carbohydrates and fiber). Cats were fed ad libitum
154 14.8 minutes) and IM injection (13.75 3.1 minutes and initially and then food was restricted to achieve 1–2% loss of body
176 19.8 minutes), and both methods of administration resulted weight weekly (11 weeks). When lean, cats were fed MD for 2
in acceptable plasma concentrations and blood glucose lowering additional weeks. A standardized meal test (SMT) using a third
effect. Subcutaneous injection resulted in greater plasma Aspart diet was performed after at least 7 days on each diet, before and
concentration at 15 and 30 minutes and greater peak concentra- after weight loss (4 SMT’s total). Glucose, insulin, glucagon-like
tions when compared to IM injection (P < 0.0001 and P = 0.0005 peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide
respectively). (GIP) concentrations were measured immediately before and over
Aspart is rapidly absorbed following SC and IM injection in 6 hours after feeding the SMT. Area under the concentrations
healthy cats. The effective and predictable glucose lowering effect curve (AUC) was compared using non-parametric tests.
of insulin aspart may be advantageous in the treatment of DKA Glucose, insulin and GLP-1 concentrations did not differ
in cats. between SMT’s at the 4 time points. Fasting GIP concentrations
also did not differ but post-prandial GIP secretion was affected by
EN04 degree of adiposity (P = 0.025) with a trend towards an effect of
THE EFFECT OF TETRA-HYDROXYLATED BILE ACID ON diet (P = 0.085). GIP secretion in lean cats fed WCD was higher
ADIPOCYTE SIZE AND INSULIN SENSITIVITY IN than in obese fed MD (P = 0.0062).
HEALTHY CATS. Isabelle Rast1, Elena Salesov1, Thomas Lutz2, In conclusion, compared to the overweight state, GIP secretion
Eric Zini1, Christian Wolfrum3, Claudia Reusch1. 1Clinic for Small was increased in cats in response to SMT in the lean state.
Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, On-going exposure to WCD increased GIP responses to SMT,
Zurich, Switzerland, 2Institute of Veterinary Physiology, Vetsuisse suggesting that dietary macronutrient content is important in
Faculty, University of Zurich, Zurich, Switzerland, 3Laboratory of determining GIP responses not only acutely but also on a long-
Translational Nutrition Biology, Swiss Federal Institute of Tech- term basis.
nology Zurich, Schwerzenbach, Switzerland
EN09 onset form (JADD) occurring in dogs under 1 year of age, and an
VARIABILITY OF P450SCC AUTOANTIBODY PERSISTENCE adult onset form occurring in dogs at 4.5 years of age on average.
IN DOGS AFFECTED WITH HYPOADRENOCORTICISM. JADD differs from adult onset Addison’s disease, as it can be a
Alisdair Boag1, Michael Christie2, Kerry McLaughlin3, Peter multisystemic illness and appears to involve an autoimmune com-
Graham4, Harriet Syme5, Brian Catchpole5. 1Royal (Dick) School ponent. This is supported by the identification of a CD3+ T cell
of Veterinary Studies, Edinburgh, UK, 2University of Lincoln, infiltrate in histologic sections of a JADD affected adrenal gland
Lincoln, UK, 3King’s College, London, UK, 4University of sample and that many cases are often affected with other autoim-
Nottingham, Nottingham, UK, 5Royal Veterinary College, mune diseases, including immune-mediated hemolytic anemia and
London, UK thrombocytopenia, immune-mediated polyarthritis, and hypothy-
roidism. To identify a genetic basis of JADD, a genome-wide asso-
Autoantibodies directed against the P450 side chain cleavage ciation study was performed using the Illumina Canine HD
enzyme (P450scc) have been recently described in a proportion of 173,000 SNP array with 14 NSDTRs diagnosed with Addison’s
dogs affected with hypoadrenocorticism, consistent with an disease less than 1 year of age and 33 healthy control NSDTRs
immune-mediated disease process. In humans affected with Addi- over 6 years of age. All cases were definitively diagnosed through
son’s disease, autoantibodies can have a predictive value, being an adrenocorticotrophic hormone stimulation test. Genome-wide
detected prior to clinical signs developing, and have been shown association analysis identified a 1.7 Mb associated haplotype on
to persist post-diagnosis. Furthermore, an autoantibody positive chromosome 27. Whole genome sequencing was performed on 2
status post-diagnosis has been associated with successful remission NSDTRs with the associated haplotype, as well as 6 unaffected
of Addison’s disease following B-cell depletion with rituximab, NSDTRs and 11 other dogs from 5 different breeds. Analysis of
suggesting active pathology in these cases. variants yielded 5 segregating SNPs in the associated region: 1
The current study explored changes in serum P450scc autoanti- intergenic, 2 intronic, 1 coding, and 1 in the 30 untranslated region
body status over time in dogs diagnosed with spontaneous of a gene. The only coding variant, a missense mutation causing
hypoadrenocorticism. P450scc autoantibodies were measured by an amino acid change from a proline to a leucine, occurs in a cur-
radioimmunoassay in an initial cohort of 213 dogs, indicating a rently uncharacterized gene, but is predicted to be damaging and
prevalence of 24%. Thirty two of these dogs had repeat samples deleterious based on sequence conservation. In summary,
(n = 80 in total) available for analysis. Between two and six sam- genome-wide association and whole genome sequencing analysis has
ples were available for each dog, obtained between two and identified a novel gene and mutation implicated in multi-organ
787 days apart. autoimmunity and juvenile onset Addison’s disease in the NSDTR.
Five dogs were consistently autoantibody positive in all sam-
ples, up to 425 days between sampling times, these comprised one
male and four female dogs, with three crossbreeds, a Dogo
Argentino and an English springer spaniel. Three dogs were ini-
tially autoantibody positive, then became negative at later time
points, a 3 y 11 month old male entire bull terrier, a 4 y 5 month EN11
old female neutered beagle and a 2 y female entire crossbreed VARIABILITY IN POST ACTH STIMULATION SERUM
dog. One dog, a 1 y 8 month old female entire standard poodle, CORTISOL FOLLOWING ADMINISTRATION OF CORTI-
initially negative for P450scc autoantibodies, seroconverted 18 SONE ACETATE IN HEALTHY DOGS. Arnon Gal, Karin
months after diagnosis. The remaining 23 dogs with multiple sam- Weidgraaf, James Bowden, Nicolas Lopez-Villalobos, Nick Cave.
ples available were consistently autoantibody negative. Persistence Institute of Veterinary, Animal and Biomedical Sciences, Massey
was not associated with sex (P = 0.673). University, Palmerston North, New Zealand
This study demonstrates persistence of P450scc autoantibodies
in a subset of dogs affected with hypoadrenocorticism and sero- The adrenocorticotropic hormone stimulation test (AST), often
conversion over one year post-diagnosis. Whilst P450scc autoanti- used for the diagnosis of canine hyperadrenocorticism, has a wide
body positivity has been associated with sex, with females having range of sensitivity and specificity. Thus, we hypothesized that stan-
a higher prevalence, there was no sex difference in persistence dardized negative feedback on the hypothalamic-pituitary-adrenal-
demonstrated. P450scc expression in the ovary may act as an addi- axis will result in large variability in the post AST serum cortisol
tional source of antigenic stimulation in female dogs, explaining concentrations. Therefore, this study aimed to evaluate the variabil-
the later seroconversion observed in one individual. However, par- ity in the post AST serum cortisol in healthy dogs and to statisti-
alleling humans with Addison’s disease, antibody persistence in cally examine parameters that may influence cortisol responses.
dogs with hypoadrenocorticism might represent persistent pathol- Fourteen healthy Harrier Hound dogs (mean age 7.1y3.2;
ogy, due to residual antigenic stimulation and autoimmune inflam- mean body weight 26.5 kg2.7) were randomized by a Latin
mation in the adrenal gland. square design to receive 5 treatments [placebo, 50 mg, 37.5 mg,
25 mg, and 12.5 mg of cortisone acetate (CA)] in each of the five
7-day treatment periods, which were separated by 14-day washout
periods. An AST was performed 24 hours after the last dose of
CA for each of the 5 treatments and serum cortisol was analyzed
by an electrochemiluminescence immunoassay.
EN10 A significant dose dependent decrease in the mean (SEM) post
JUVENILE HYPOADRENOCORTICISM IN THE NOVA AST serum cortisol was observed (placebo 365 13 nmol/L, CA
SCOTIA DUCK TOLLING RETRIEVER: A RECESSIVE 12.5 mg 347 13 nmol/L, CA 25 mg 335 13 nmol/L, CA
MONOGENIC AUTOIMMUNE DISEASE. Emily Brown1, Amy 37.5 mg 326 13 nmol/L, CA 50 mg 308 13 nmol/L). There
Young2, Zena Wolf3, Claire Wade4, Angela Hughes5, Oded was a significant (P < 0.05) between-week variability in post AST
Foreman6, Kartika Jayashankar1, Anita Oberbauer2, Noa Safra1, serum cortisol in the placebo and 25 mg and 37.5 mg CA groups.
Kirstin Linblad-Toh7, Shelley Burton8, Danika Bannasch1. The overall variability in the post AST serum cortisol concentra-
1
University of California, Davis School of Veterinary Medicine, tions was attributed to the individual dog (31%), random unex-
Davis, CA, USA, 2University of California, Davis, Davis, CA, plained variability (31%), dose of CA (16%), age (15%), body
USA, 3Brigham and Women’s Hospital and Harvard Medical weight (4%), and timing of treatment (3%).
School, Boston, MA, USA, 4University of Sydney, Sydney, NSW, The wide range in the published specificity of the AST may be
Australia, 5Mars Veterinary, Germantown, MD, USA, 6Genen- related to large variations in cortisol responses.
tech, Inc., South San Francisco, CA, USA, 7Broad Institute of
Harvard and Massachusetts Institute of Technology, Cambridge,
MA, USA, 8Atlantic Veterinary College, University of Prince
Edward Island, Charlottetown, PE, Canada
EN15 EN17
SPECTROPHOTOMETRY AND ULTRACENTRIFUGATION USING PURIFIED FELINE INSULIN TO EVALUATE
FOR MEASUREMENT OF PLASMA LIPIDS IN DOGS WITH CROSS-REACTIVITY WITH A HUMAN INSULIN ANALOG
DIABETES MELLITUS. Eileen Seage, Kenneth Drobatz, ELISA. Jon Fletcher, Hannah Pipe-Martin, Chin-chi Liu. Depart-
Rebecka Hess. Matthew J. Ryan Veterinary Hospital of the ment of Veterinary Clinical Sciences, School of Veterinary Medi-
University of Pennsylvania, Philadelphia, PA, USA cine, Louisiana State University, Baton Rouge, LA, USA
Conflicting results have been reported regarding lipid concentra- Recombinant DNA technology has been used to modify the
tions in dogs with diabetes mellitus (DM). Some studies have structure of human insulin to yield analogs that are more rapidly-
reported that low-density lipoprotein-cholesterol (LDL-C) is not acting than regular insulin or have a longer duration of action
significantly different in dogs with and without DM. The goal of than NPH insulin. The long-acting insulin analogs have been stud-
this study was to report total cholesterol (TC), total triglycerides ied in cats and are routinely used to manage feline diabetics. More
(TG), high-density lipoprotein-cholesterol (HDL-C), very low- recently, the isoglycemic clamp method has been used to study the
density lipoprotein-cholesterol (VLDL-C), and LDL-C in fasted metabolic effect of a rapid-acting insulin analog in healthy cats.
dogs with and without DM. Generating time-action profiles to study the pharmacodynamic
Twenty-two dogs with DM and nine healthy control dogs with properties of insulin formulations does not require measurement
normocholesterolemia were prospectively enrolled following a min- of plasma insulin concentrations, but if measured, they provide
imum eight-hour fast. Plasma lipid fractions were measured by useful pharmacokinetic data that can be used to validate the time-
ultracentrifugation (TC, HDL-C, VLDL-C, and LDL-C) or direct action profiles. The Iso-Insulin ELISA (Mercodia AB, Uppsala,
sample analysis (TG) coupled with enzymatic reactions and spec- Sweden) is used to measure the concentration of insulin analogs in
trophotometric end points (Roche COBAS c311). Median lipid plasma. A previous study using actual feline serum samples with a
concentrations in dogs with and without DM were compared using wide range of insulin concentrations measured by a commercial
a two-sample Wilcoxon rank-sum test. A P-value <0.05 was con- ELISA failed to detect cross-reactivity of feline insulin with the
sidered significant. Iso-Insulin ELISA.
In dogs with DM, median TC (343 mg/dl), TG (98 mg/dl), The purpose of this study was to evaluate the cross-reactivity of
HDL-C (196 mg/dl), VLDL-C (39.5 mg/dl), and LDL-C (67.5 mg/ feline insulin with the Iso-Insulin ELISA using purified feline insu-
dl) concentrations were significantly higher than concentrations in lin standards. Five purified feline insulin standards with known
healthy dogs (197 mg/dl, 57 mg/dl, 168 mg/dl, 12 mg/dl, 16 mg/dl, concentrations ranging from 9.13 ng/L to 702 ng/L that are used
respectively, P < .05 for all comparisons). The greatest difference as calibrators for the commercial feline insulin ELISA (Mercodia
was measured in LDL-C concentration, which was 4.2 times AB, Uppsala, Sweden) were used. The ELISAs were performed in
higher in dogs with DM compared to controls. VLDL-C, TC, and duplicate according to the manufacturer’s recommendations. The
TG concentrations were 3.3, 1.7, and 1.7 times higher, respectively, mean absorbance values of the feline insulin ELISA calibrators
in dogs with DM compared to healthy dogs. The smallest differ- were below the mean absorbance value of the lowest Iso-Insulin
ence was noted in HDL-C concentrations. calibrator (0.087) except for the first calibrator, which had a
It is concluded that the increase in LDL-C is an important com- slightly higher mean absorbance of 0.099. The slightly higher
ponent of dyslipidemia in dogs with DM. Future studies of thera- absorbance for the first calibrator was likely the result of a minor
peutics focused at decreasing LDL-C in dogs with DM may be technical issue with this very sensitive ELISA since all calibrators
warranted. with higher insulin concentrations consistently had absorbances at
or below the lowest Iso-insulin calibrator.
These results demonstrate that purified feline insulin concentra-
tions up to 702 ng/L are not detected by the Iso-Insulin ELISA,
and therefore will not interfere with insulin analog measurements
in feline plasma.
EN16
EFFECT OF HYDROCORTISONE ADMINISTRATION ON
LEPTIN AND ADIPONECTIN SYNTHESIS IN HEALTHY
DOGS. Hye-Ryung Choo, Changhwan Ahn, Woon-Bum Baek,
Bohye Shin, Hakhyun Kim, Ji-Houn Kang, Eui-Bae Jeung, Mhan-
Pyo Yang. Chungbuk National University College of Veterinary EN18
Medicine, Cheongju, Chungbuk, Republic of Korea STEROID HORMONE PANEL TEST AND TRILOSTANE
AND MELATONIN THERAPY IN POMERANIAN DOGS
The objective of the present study was to examine whether cir- WITH ALOPECIA X. Melissa Sanches1, Marcia Jeric o2, Eric
culating concentrations of leptin and adiponectin, distribution of Januario1. 1Pet Care Centro Veterinario, Sao Paulo, SP, Brazil,
2
abdominal fat, and mRNA expressions of leptin and adiponectin Universidade Anhembi Morumbi and Clinica Veterinaria Alto da
in abdominal adipose tissue were affected by hydrocortisone Lapa Sao Paulo, SP, Brazil
administration. Six laboratory dogs each received hydrocortisone
(8.5 mg/kg) orally every 12 hours for 90 days. We measured the Alopecia X is a skin disease of unknown etiology characterized
serum concentrations of leptin and adiponectin using canine- by non-inflammatory, bilateral and symmetric alopecia, with
specific ELISA kits. We quantified visceral fat using CT scanning, hyperpigmentation and absence of pruritus. This condition is most
and we analyzed the mRNA expressions of leptin and adiponectin frequently observed in young dogs of Nordic breeds, and is
in abdominal fat using real-time PCR. thought to be related to abnormal adrenal gland function, with tri-
Hydrocortisone administration resulted in increased abdominal lostane and melatonin having been proposed as possible treatment
visceral fat mass on days 30, 60, and 90 compared with fat mass alternatives. This study aims to evaluate the comprehensive steroid
before administration (day 0). Additionally, visceral fat area at panel and therapeutic response of Pomeranian dogs diagnosed
the L3 level also was increased during hydrocortisone administra- with Alopecia X. Eighteen Pomeranian dogs admitted at veteri-
tion. Serum leptin concentrations began to increase on day 1 of nary clinics (S~ao Paulo, Brazil) with a chief complaint of symmet-
hydrocortisone administration and were significantly increased on ric and bilateral alopecia were studied. These included 12 males
days 1, 3, 7, 30, 60, and 90 compared with concentrations on and 6 females, 16 of which were neutered, aging from 2 to 5 years.
day 0. Serum adiponectin concentrations on days 1, 3, 7, 30, 60, All animals were subjected to thorough laboratory screening:
and 90 were decreased compared with concentrations on day 0. complete blood count with differential leukocyte count, liver
The mRNA expressions of leptin and adiponectin in the abdomi- function enzymes, urea, creatinine, triglycerides, cholesterol, blood
nal fat were increased on day 30 compared with expressions on glucose, and thyroid panel, as well as urinalysis and abdominal
day 0, but the expressions were decreased on days 60 and 90 ultrasonography; all exam results were within the reference
compared with those on day 30. We identified a correlation values. Subsequently, blood samples were collected to quantify
between serum leptin and adiponectin concentrations and visceral by radioimmunoassay at Provet Laboratories (Brazil) and
fat distribution. This study showed that hydrocortisone adminis- Tennessee University the following hormones, both before and
tration affected visceral fat distribution and serum concentrations after synthetic ACTH stimulation (single dose 0.05 mg/kg/EV):
of leptin and adiponectin by dysregulating leptin and adiponectin 17-hydroxiprogesterone, aldosterone, androstenedione, cortisol,
expression. estradiol, progesterone and testosterone. Eight dogs were then
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1452 2016 ACVIM Abstracts
subjected treatment A (trilostane 1 mg/kg PO BID), seven dogs analyses using GC-MS was performed. Linear modeling was used
were subjected to treatment B (trilostane 1 mg/kg PO BID and to identify statistically significant (adjusted P-value<0.05) metabo-
melatonin 3 mg/dog PO BID) and two dogs received treatment C lites associated with obesity and whether these responses were
(melatonin 3 mg/dog PO BID); three animals were lost to follow- affected by sex and age. Pearson correlations were used to identify
up. In comparison to reference values established by the laborato- relationships between metabolites and other parameters.
ries for both neutered and non-neutered dogs, the animals with GC-MS analyses identified 25 metabolites significantly
Alopecia X presented higher levels in three of the seven hormones (P < 0.05) different between Burmese and non-Burmese cats. In
both before and after the ACTH stimulation test. Abnormally ele- Burmese cats, metabolites that are involved in amino acid metabo-
vated hormone levels were observed prior to and following ACTH lism were either increased (phenylalanine, tyrosine, valine, serine,
stimulation in respectively: 3 (17%) and 16 dogs (89%) for 17- threonine, cysteine, proline and arginine) or decreased (cysteine,
hydroxiprogesterone, 9 (50%) and 10 dogs (55%) for androstene- alanine and b-alanine) compared to non-Burmese cats. Some
dione, and 2 (11%) and 16 dogs (89%) for progesterone. Also, the metabolites in carbohydrate metabolism were decreased (glucose,
abnormally elevated testosterone levels were observed in 6 dogs fructose, lactic acid), as were some involved in lipid metabolism
(33%) prior to ACTH stimulation and 8 dogs (44%) following (glucose 3 phosphate, phosphoric acid, stearic acid, cholesterol).
ACTH stimulation. Two dogs presented abnormally decreased When these metabolites were correlated with known measures of
estradiol levels, both prior to and following ACTH stimulation. glucose metabolism, numerous amino acids were positively corre-
On the other hand, abnormally elevated cortisol levels were lated with insulin and triglyceride (tyrosine, phenylalanine cysteine,
observed in 3 dogs (17%) prior to ACTH stimulation, and these proline, glutamine and arginine were all positively correlated with
elevated levels were maintained by only one dog (6%) following insulin, and tyrosine and phenylalanine were also correlated with
ACTH administration. In contrast, all dogs had aldosterone levels triglyceride). These results agreed with human studies where future
within reference ranges, with the exception of one dog with slightly risk of developing diabetes was found to be associated with these
elevated aldosterone levels prior to ACTH stimulation. Of the changes in metabolites. The amino acid metabolites alanine, thre-
dogs subjected to treatment A, four (50%) had complete hair onine and tyrosine were negatively correlated with adiponectin
regrowth and three (37.5%) had partial regrowth after three and glucose and fructose were positively associated with 2-hr
months of treatment. Of the dogs subjected to treatment B, one blood glucose following a glucose tolerance test. However, some
(14%) had complete hair regrowth, four (57%) had partial metabolites considered discriminators of impaired fasting glucose
regrowth, and one (14%) did not show signs of regrowth. Treat- and increased in humans at risk of diabetes (phosphoric acid, ala-
ment for one of the two dogs subjected to treatment C had to be nine and stearic acid) were decreased in Burmese cats, as were
withdrawn due to emesis. Pomeranian dogs affected by Alopecia metabolites of glycerolipid metabolism (glycerate, glycerol 3 phos-
X presented increased levels of 17-hydroxiprogesterone, phate, glucose and fructose).
androstenedione, testosterone and progesterone, both prior to and This study is the first to report metabolite differences between
following stimulation with synthetic ACTH, suggesting an adrenal healthy non-Burmese and Burmese cats and identifies some
gland increased function in the sex hormones production. Due biomarkers involved in amino acid, carbohydrate and lipid meta-
this, trilostane, as a steroidogenesis blocker, was found to be a bolism that are altered in Burmese cats in a similar pattern to
positive therapeutic option for Alopecia X, with or without the those identified in humans at risk of diabetes. Further research is
association of melatonin. required to determine if these are useful as markers of metabolic
dysfunction in cats at risk of developing diabetes.
EN19
METABOLITE DIFFERENCES BETWEEN HEALTHY EN20
SENIOR BURMESE AND NON-BURMESE CATS, AND A GENOME-WIDE ASSOCIATION STUDY IDENTIFIES
ASSOCIATIONS BETWEEN METABOLITES AND NOVEL CANDIDATE GENES FOR SUSCEPTIBILITY TO
MEASURES OF GLUCOSE METABOLISM. Mia Reeve- DIABETES MELLITUS IN DSH CATS (ESVE AWARD
Johnson , Jacquie Rand , Stephen Anderson , Diane Vankan1,
1 1 2
WINNER). Y Forcada1, M Boursnell2, B Catchpole1, DB Church1.
Daniel Dias3, Berin Boughton3, Alysha De Livera3, Katsumi 1
The Royal Veterinary College, North Mymms, UK, 2Animal
Ishioka4, Ute Roessner4. 1School of Veterinary Science, University Health Trust, Newmarket, UK
of Queensland, Brisbane, Australia, 2School of Biomedical
Sciences, University of Queensland, Brisbane, Australia, 3Centre Diabetes mellitus (DM) is a common feline endocrinopathy and
for Molecular, Environmental, Genetic and Analytic (MEGA) pathophysiologically similar to human type 2 diabetes (T2DM).
Epidemiology, Melbourne School of Population and Global T2DM occurs due to a combination of insulin resistance and b-cell
Health, The University of Melbourne, Melbourne, Australia, dysfunction. Several studies have identified environmental and
4
School of Veterinary Nursing & Technology, Faculty of Veterinary genetic susceptibility factors for T2DM. In cats, environmental
Science, Nippon Veterinary and Life Science University, Tokyo, factors such as obesity and physical inactivity have been linked
Japan with DM; however, identification of genetic factors has been chal-
lenging. To date, MC4R is the only gene shown to be associated
Phenotypic identification of cats at risk of developing diabetes with increased susceptibility to DM in overweight domestic short
has yet to be defined. Burmese cats are reported to have a dyslipi- hair (DSH) cats. The aim of the present study was to perform a
demia and are 3 to 4 times more likely to develop diabetes than genome-wide association study (GWAS) to identify loci associated
other breeds. with DM in lean DSH cats.
To identify plasma metabolite differences between healthy Illumina Infinium 63k iSelect DNA arrays were used to interro-
senior Burmese and matched non-Burmese cats ranging from lean gate genomic DNA samples from 200 lean diabetic DSH cats from
to obese, and to determine if significant correlations exist between the Royal Veterinary College Feline DM Archive and 400 control
these metabolites and measures of glucose metabolism, hormonal DSH cats. The data was analysed using PLINK whole genome
and biochemical related to diabetes. data analysis toolset. Significance was established at P < 1 x 105.
Of the 69 cats tested, 49 non-Burmese; 20 lean (BCS 4-5/9), 12 SNPs with a minor allele frequency below 0.05 and a call rate
overweight (BCS 6-7/9) and 17 obese (BCS 8-9/9) and 20 were below 95% and individuals with a genotyping rate < 90% were
Burmese (6 lean, 12 overweight and 2 obese). excluded from analysis.
Food was withheld 18 - 24 hours, and a cephalic vein catheter A total of 49,930 SNPs were available for analysis. After
implanted. A venous blood sample was collected and the serum excluding cats with low genotypic rate, 389 control DSH and 192
and plasma separated and frozen at 80°C. A glucose tolerance lean diabetic DSH cats were evaluated. Diabetic cats had a mean
test (glucose 0.5 g/kg) was performed. Biochemical (screening, fast- (SD) age of 11.62 (3.44) years; 123 (63%) were male, 71 (37%)
ing and 2-hr blood glucose in the glucose tolerance test, triglyc- female. Nondiabetic cats had a mean (SD) age of 14.83 (2.06)
eride), hormonal (leptin, adiponectin, leptin:adiponectin ratio, years; 216 (54%) were female, 183 (46%) male. Control cats were
insulin, glucose:insulin ratio) and enzymatic (fPLI, MCP-1) analy- significantly older than diabetic cats (P < 0.0001; t-test). Five sig-
ses were performed on plasma and serum samples. After extraction, nificant SNPs were identified: chrA2.4150731 (P = 1.4 x 107);
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1453
chrUn17.115508 (P = 7 x 107); chrUn17.394136 (P = 3 x 107); with linear FBs, and dogs that needed to undergo surgery for FB
chrUn17.314128 (P = 3 x 107) and chrUn17.7283 (P = 9 x 106). removal. A Spec cPL≥ 400 µg/L was noted in both dogs that were
The first SNP is located within chromosome A2; the others are euthanized. Due to this small number, additional studies would be
located within a 0.8 Mb region towards the end of chromosome needed to confirm if an elevated Spec cPL is associated with a neg-
A3. The SNP in chromosome A2 is located 3 kb upstream of ative outcome in dogs with GI FBs.
dipeptidyl-peptidase-9 (DPP9), a peptidase similar to DPP-4,
involved in incretin inactivation. Within the identified region of
chromosome A3, genes of interest include TMEM18 and ACP1;
both have been associated with T2DM in humans, most likely
causing insulin resistance. This is the first GWAS of DM in cats.
A number of significant SNPs have been identified, some of which GI02
are located in proximity to genes that have been associated with SERUM PANCREATIC LIPASE IMMUNOREACTIVITY
T2DM in humans; others could be involved in pathophysiology CONCENTRATIONS AFTER CHRONIC ADMINISTRATION
related to DM. Further investigation of these candidate genes is OF SUPRAPHYSIOLOGIC DOSES OF GLUCOCORTICOIDS
warranted. TO DOGS. Sarah Cocker1, Keith Richter1, Joerg Steiner2,
Disclosures: Disclosures to report. Jonathan Lidbury2, Jan Suchodolski2. 1Veterinary Specialty Hospi-
SNP chips for the GWAS were provided by the Morris Animal tal, San Diego, CA, USA, 2Gastrointestinal Laboratory, Depart-
Foundation. ment of Small Animal Medicine and Surgery, College of
Veterinary Medicine, Texas A&M University, College Station, TX,
USA
GI03 GI05
SERUM IL-2, IL-6, IL-8, AND TNF-Α CONCENTRATIONS IN PERTURBATIONS OF THE INTESTINAL MICROBIOTA
DOGS WITH INCREASED SERUM SPEC CPLâ CONCEN- AND BILE ACID METABOLISM IN DOGS WITH DIABETES
TRATIONS. Agostino Buono1, Andrea Petrelli2, Jonathan MELLITUS. Alana Redfern-Allen1, Blake Guard2, Jan
Lidbury1, Jan Suchodolski1, Joerg Steiner1. 1Gastrointestinal Suchodolski2, Joerg Steiner2, Jonathan Lidbury2, Albert Jergens1.
1
Laboratory, Department of Small Animal Clinical Sciences, Texas Iowa State University, Ames, IA, USA, 2Texas A&M University,
A&M University, College Station, TX, USA, 2Department of College Station, TX, USA
Veterinary Medical Sciences, University of Bologna, Ozzano
dell’Emilia, Italy The intestinal microbiota has been recently linked to the devel-
opment of human metabolic diseases including diabetes mellitus
The role of cytokines in pancreatitis is well characterized in (DM), due to its role in energy balance, gut permeability, and host
human medicine. However, limited information is available about inflammatory state. Microbial imbalances may also affect bile acid
their role in dogs with pancreatitis. The aim of this study was to (BA) metabolism through altered profiles of primary and sec-
describe serum concentrations of interleukin (IL) -2, IL-6, IL-8, ondary BA, which modulate signaling pathways involved in insulin
and tumor necrosis factor-alpha (TNF-a) in dogs with increased resistance via GLP-1 induction. Characterization of the intestinal
serum concentrations of pancreatic lipase immunoreactivity (cPLI; microbiota and BA in dogs with DM has not been systematically
as measured as Spec cPLÒ). evaluated. Therefore, the aim of this study was to investigate the
Forty-nine surplus serum samples from dogs with a serum cPLI fecal microbiota and BA composition of healthy dogs and dogs
concentration >1000 µg/L were used for this study. Ten healthy dogs with DM.
with serum cPLI concentration <200 µg/L were used as controls. Fecal samples were collected from 27 heathy control dogs and
Serum cytokine concentrations were measured using previously ana- 23 diabetic dogs. The fecal microbiota was evaluated prior to
lytically validated electrochemiluminescence immunoassays. Data intervention using quantitative polymerase chain reaction (qPCR)
were analyzed using nonparametric statistics. Significance was set at for E. coli, Streptococcus, Turicibacter, Faecalibacterium, Fusobac-
P < 0.05. terium, and Blautia. The fecal concentrations of primary (i.e.,
The cytokine concentrations were significantly increased in dogs cholic and chenodeoxycholic acid) and secondary (i.e., litho-,
with serum cPLI concentrations >1000 µg/L when compared to deoxy-, and ursodeoxycholic acid) BA were measured using gas
healthy controls, (increased cPLI group median [minimum-maxi- chromatography with mass spectrometry. Non-parametric Mann-
mum] versus healthy group median [minimum-maximum]): IL-2 Whitney U tests were used to compare these parameters between
(18.9 pg/mL [0–559.2] versus 7.4 [1.7–56.8], P = 0.0167); IL-6 healthy dogs and dogs with DM. Statistical significance was set at
(17.0 pg/mL [0–1085] versus 4.5 [0.6–88] P = 0.0003); IL-8 P < 0.05.
(6054.4 pg/mL [667.9–19664.9] versus 2849.8 [1538.5–4247.5], Results indicate that DM dogs exhibit imbalances in their fecal
P = 0.0029); TNF-a (1.2 pg/mL [0–115.1 pg/mL] versus 0.3 [0.1– microbiota characterized by decreased numbers of Turicibacter
0.6], P = 0.0014). No correlation was found between age, sex, or (P = 0.026) and Faecalibacterium (P = 0.002) as compared to
serum cPLI concentration and any of the serum cytokine concen- healthy dogs. Perturbations in BA metabolism were observed in
trations. the DM cohort and involved an increase in primary BAs and a
In conclusion, serum IL-2, IL-6, IL-8, and TNF-a concentra- decrease in secondary BAs (P < 0.001 for both).
tions were significantly increased in dogs with serum cPLI concen- We conclude that dogs with DM have significant imbalances in
trations >1,000 µg/L. Prospective studies are needed to assess the intestinal microbiota and also altered bile acid metabolism, which
utility of these cytokines as early diagnostic markers or prognostic may contribute to disease pathogenesis and morbidity. Further
markers in dogs with pancreatitis. studies are warranted to elucidate mechanisms behind these alter-
ations, and whether they are primarily due to disease or secondary
GI04 to environmental factors including diet and antibiotics.
FISHHOOK FOREIGN BODIES IN DOGS AND CATS: 107
CASES (2004–2015). Austin Hardegree1, James Barr1, Micah
Bishop2, Medora Pashmakova1. 1Texas A&M University, College
Station, TX, USA, 2Animal Specialty Hospital, Naples, FL, USA
duodenum, 62%; ileum, 48%; colon, 9%; rectum, 6%), while transduction mechanisms (P < 0.0001 for all). Metronidazole lead
those of Firmicutes increased (P = 0.032; 20%, 43%, 68%, 69%). to alteration in 98 out of 469 measured fecal metabolites. Major
On the gas chromatography platform, 530 unique compounds changes observed were reduction in secondary bile acids
were detected, and 199 of these were assigned to named metabo- (P < 0.001), increases in oxidative stress pathways (P < 0.0001),
lites. 134 named metabolites had at least one site-pair comparison and changes in tryptophan-indole pathways (P < 0.001). While
reaching statistical significance. Key fermentation compounds such most of the changes were reversed 14 days after the end of antibi-
as sugars and amino acids had varied site distributions: glucose otic administration, some of the evaluated bacterial taxa and
increased progressively along the GIT along with 6-deoxyglucose metabolites remained significantly altered up to 4 weeks after end
(P = 0.047 and 0.034, respectively). Nearly all amino acids exhib- of administration (end of study).
ited a decrease between the ileum and colon (e.g., alanine, citrul- In conclusion, metronidazole has a profound effect on the fecal
line, glutamine, glycine, lysine, methionine, tryptophan, and microbiome and metabolome, which only partially resolves after
valine, all P < 0.03). 4 weeks. Further studies are warranted to assess whether the dys-
In conclusion, the metabolome and microbiome vary along the biosis and these disrupted metabolic pathways due to metronida-
canine GIT and further studies are needed to explore the effect of zole may pose a risk factor for development of some chronic
local disease at specific sites, to determine the host versus micro- diseases. In contrast, the hydrolyzed diet had no noticeable effect
bial origin of these metabolites, and possibly to enhance extrapola- on the microbiome and metabolome of healthy dogs.
tion from fecal assay results to improve our understanding of GI
diseases.
GI08
ALTERED FECAL BILE ACID METABOLISM IN DOGS
GI07 WITH CHRONIC ENTEROPATHY. Blake Guard1, Linda
EFFECTS OF A HYDROLYZED PROTEIN DIET AND Toresson2,3, Julia Honneffer1, Amanda Blake1, Yuri Lawrence1,
METRONIDAZOLE ON THE FECAL MICROBIOME AND Jonathan Lidbury1, Joerg Steiner1, Jan Suchodolski1. 1Texas
METABOLOME IN HEALTHY DOGS. Jan Suchodolski1, Erin A&M University, College Station, TX, USA, 2Evidensia Specialist
Olson2, Julia Honneffer1, Blake Guard1, Amanda Blake1, Animal Hospital, Helsingborg, Sweden, 3Helsinki University,
AlShawaqfeh Mustafa1, J€ org Steiner1, James Barr1, Frederic Helsinki, Finland
Gaschen2. 1Gastrointestinal Laboratory, Texas A&M University,
College Station, TX, USA, 2Louisiana State University, Baton Chronic enteropathy in dogs has been characterized as a multi-
Rouge, LA, USA factorial disease that is thought to involve inappropriate and
ongoing activation of the mucosal immune system in addition to a
The abnormal interaction between the GI microbiome and the microbial dysbiosis. Recently, studies in humans have suggested
immune system is a major contributing factor to IBD. Treatment that in some patients with inflammatory bowel disease, microbial
often includes the use of antimicrobials like metronidazole or the dysbiosis drives bile acid (BA) dysmetabolism. Primary BAs are
use of an elimination diet (i.e., hydrolyzed protein diet), but their synthesized by the liver and secreted into the intestinal lumen,
effects on the intestinal microbiota are not well studied. Recent where enzymatic reactions catalyzed by bacteria lead to BA bio-
epidemiological studies in humans have linked gut dysbiosis due to transformation. Additionally, BAs participate in gastrointestinal
antibiotics as risk factor for various chronic diseases, such as obe- mucosal defense. For example, secondary BAs have been shown to
sity, diabetes, and asthma. A better understanding of the func- be anti-inflammatory as they have the potential to decrease the
tional effects of antibiotics and diets on the microbiome is needed. synthesis of proinflammatory cytokines such as TNF-a. Therefore,
The aim of this study was to prospectively evaluate the impact of the aim of this study was to investigate the fecal BA profiles of
metronidazole administration versus hydrolyzed protein diet on dogs with chronic enteropathy.
the metabolome of healthy dogs. Fecal samples were collected from healthy dogs (n = 13) and
Twenty-four healthy pet dogs were assigned to one of 3 groups dogs with chronic enteropathy with histologically confirmed
(8 dogs each): control dogs with no intervention (group 1, G1), inflammation (n = 13). Fecal bile acids were analyzed by gas chro-
dogs treated with a soy-based hydrolyzed diet (Purina HA) for matography coupled with mass spectrometry. A Mann-Whitney U
12 weeks with administration of metronidazole 15 mg/kg PO test was used to compare concentrations of BAs between groups.
q12 h during weeks 6 to 8 (G2), and dogs maintained on their Cholic acid and chenodeoxycholic acid were among the primary
usual diet and administered the same dose of metronidazole for bile acids measured, while deoxycholic acid, lithocholic acid, and
2 weeks (G3). Feces and blood were collected at day (D) 0, 21 and ursodeoxycholic acid were among the secondary bile acids mea-
42 in G1; and D0, 14, 28 and 42 days in G2 and G3. Microbial sured. Statistical significance was set at P < 0.05.
communities were analyzed by Illumina sequencing of 16S rRNA No significant differences in fecal concentrations of primary bile
genes, and the software PICRUSt was used to predict functional acids were found between healthy dogs and dogs with chronic
gene families. The serum and fecal metabolome was assessed by enteropathy. Deoxycholic acid was significantly decreased in dogs
an untargeted approach combining various mass spectrometry with chronic enteropathy (median [min-max]: 0.26 µg/mg [0.11–
platforms. All assessed parameters were adjusted for multiple com- 13.18 µg/mg]) compared to healthy dogs (median [min-max]:
parisons using the Benjamin Hochberg adjustment, and an 4.64 µg/mg [0.11–18.94 µg/mg]; P = 0.0240). Lithocholic acid was
adjusted P < 0.05 was considered significant. also significantly decreased in the dogs with chronic enteropathy
No significant differences in any of the evaluated parameters (median [min-max]: 0.07 µg/mg [0.01–2.94 µg/mg]) compared to
were observed in G1 (control group). Also, in G2, the dietary healthy dogs (median [min-max]: 1.05 µg/mg [0.03–3.21 µg/mg];
switch to the hydrolyzed diet (between baseline and week 6) did P = 0.0159).
not lead to any significant changes in any of the evaluated param- In conclusion, this study revealed a decrease in fecal secondary
eters. However, when dogs in G2 and the dogs in G3 received bile acids in dogs with chronic enteropathy. Further studies
metronidazole, significant changes were observed. Because the are needed to investigate the interplay between specific bacte-
responses in these 2 groups were similar, they were combined for rial groups and altered bile acid metabolism as well as their
statistical analysis. Microbiome structure and diversity were signifi- relationship with intestinal inflammation in dogs with chronic
cantly altered between baseline and time of completion of metron- enteropathy.
idazole treatment, and also 4 weeks after end of metronidazole
treatment (ANOSIM: P = 0.002). The most significant changes
were increases in E. coli and decreases in Firmicutes. Functional
gene families found to be significantly more abundant during
antibiotic administration included: lipopolysaccharide biosynthesis,
glutathione metabolism, recombination and repair proteins, trypto-
phan metabolism, and fatty acid metabolism (P < 0.0001 for all).
At cessation of antibiotic administration (D14), functional gene
families found to be significantly more abundant included: bile
secretion, xylene degradation, dioxin degradation, and signal
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1456 2016 ACVIM Abstracts
GI09 DNA from fecal samples was used for Illumina sequencing of the
ALTERED FECAL STEROL PROFILES IN DOGS WITH bacterial 16S rRNA gene and analyzed using Quantitative Insights
CHRONIC INFLAMMATORY ENTEROPATHY. JB Honneffer1, Into Microbial Ecology (QIIME). The analysis of similarities
L Toresson2,3, BC Guard1, R Lopes1, AB Blake1, JA Lidbury1, (ANOSIM) function in the statistical software package PRIMER
JM Steiner1, JS Suchodolski1. 1Gastrointestinal Laboratory, Texas 6 (PRIMER-E Ltd., Luton, UK) was used on the unweighted
A&M University, College Station, TX, USA, 2Evidensia Specialist UniFrac distance matrix to determine if any groups of samples
Animal Hospital, Helsingborg, Sweden, 3University of Helsinki, contained significantly different bacterial communities. There was
Finland a significant difference in fecal microbial communities when
healthy dogs were compared to treated (P = 0.001) and untreated
Diseases of chronic inflammation of the gastrointestinal tract, (P = 0.001) dogs with EPI. Quantitative Insights Into Microbial
including idiopathic inflammatory bowel disease (IBD), are Ecology (QIIME). The analysis of similarities (ANOSIM) function
thought to be perpetuated by bacterial dysbiosis and dysregulation in the statistical software package PRIMER 6 (PRIMER-E Ltd.,
of the mucosal immune system in both humans and animals. Gas- Luton, UK) was used on the unweighted UniFrac distance matrix
trointestinal (GI) absorption of metabolites is altered by inflamma- to determine if any groups of samples contained significantly dif-
tion, with concurrent changes in microbial metabolism within the ferent bacterial communities. There was a significant difference in
GI tract. Cholesterol is the primary sterol in mammals; it is incor- fecal microbial communities when healthy dogs were compared to
porated into cell membranes throughout the body and used as a treated (P = 0.001) and untreated (P = 0.001) dogs with EPI.
building block for endogenous hormones, steroids, and bile acids. Alpha diversity was significantly decreased in untreated and trea-
Some phytosterols have shown anti-inflammatory properties and ted EPI dogs when compared to the healthy dogs (P < 0.01). The
have been shown to decrease disease severity in a murine colitis families Bifidobacteriaceae (P = 0.006), Enterococcaceae
model. Therefore, the aim of this study was to compare fecal (P = 0.035), and Lactobacillaceae (P = 0.001) were significantly
sterol profiles of dogs with chronic enteropathy to those of healthy increased in the untreated and treated dogs with EPI when com-
dogs. pared to healthy dogs. In contrast, Lachnospiraceae (P < 0.001),
Fecal samples were collected from healthy dogs (n = 13) and and Blautia (P < 0.001) were significantly decreased in dogs with
dogs with chronic enteropathy (n = 13) with biopsy-confirmed EPI.
inflammation. Sterols in lyophilized feces were subjected to In conclusion, this study suggests that the fecal microbiome of
trimethylsilyl ether derivatization and analyzed by gas chromatog- dogs with EPI (both treated and untreated) is different from that
raphy-mass spectrometry (GC/MS) operating in Single Ion Moni- of healthy dogs.
toring (SIM) mode. Target analytes included cholesterol,
cholestanol, b-sitosterol, sitostanol, fucosterol, stigmaterol, and
campesterol. Fecal concentrations of sterols were expressed as
lg/mg of lyophilized feces. A Mann-Whitney U test was used for
comparison between animal groups with statistical significance set
at P < 0.05. GI11
Fecal cholesterol and cholestanol were not significantly altered EFFECT OF WEIGHT LOSS AND DIET ON FECAL MICRO-
between healthy dogs and dogs with chronic enteropathy. How- BIOTA AND FECAL METABOLOMICS IN CATS. Adam
ever, phytosterols were significantly decreased in dogs with chronic Rudinsky1, Katie McCool1, Valerie Parker1, Prosper Boyaka1,
enteropathy (healthy group median [min-max] versus chronic Josh Daniels1, Rosana Lopes2, Joerg Steiner2, Jan Suchodolski2,
enteropathy group median [min-max]): b-sitosterol (P = 0.0066, Chen Gilor1. 1The Ohio State University College of Veterinary
2.53 µg/mg [1.41–4.62] versus 1.34 [0.084–3.70]); sitostanol Medicine, Columbus, OH, USA, 2Texas A&M University College
(P = 0.0001, 0.54 µg/mg [0.17–1.14] versus 0.08 [0.01–0.45]); fucos- of Veterinary Medicine, College Station, TX, USA
terol (P = 0.0138, 0.23 µg/mg [0.10–0.33] versus 0.09 [0.01–0.80]);
stigmasterol (P = 0.0138, 0.46 µg/mg [0.23–0.66] versus 0.30 [0.01– Intestinal microbiota and short chain fatty acids (SCFA) are
0.52]); and campesterol (P = 0.0313, 0.84 µg/mg [0.45–1.76] versus important in a variety of metabolic disorders. We hypothesized
0.53 [0.14–1.79]). that obesity and diet affect intestinal microbiota and SCFA in cats.
In conclusion, this study suggests that the fecal sterol profile in Eight cats were used in a repeated-measures study. Cats were
dogs with chronic enteropathy is characterized by decreased phy- fed a maintenance diet (M-diet) from study days -21-0 then
tosterols. Additional studies are required to explore the effect of switched to a weight-loss diet (WL-diet) on day 0 without calorie
dietary supplementation of phytosterols and to investigate how restriction until day 7. On days 8–84, daily intake was restricted to
these sterols are related to specific bacterial groups that digest diet- achieve 1–2% weight-loss per week. On days 84–98, feeding the
ary plant material in these patients. M-diet resumed while maintaining stable body condition score
(BCS). Fecal samples were collected and stored at 80°C until
analysis. Samples were collected on day 7 and 0 (Obese/M-diet),
5 and 7 (Obese/WL-diet), 77 and 84 (Lean/WL-diet) and 86, 89,
91 and 98 (Lean/M-diet) for microbiota and SCFA profiles. Body
weight, BCS, muscle condition score, and body fat percentage
GI10 were assessed throughout the study.
THE FECAL MICROBIOME OF DOGS WITH EXOCRINE Microbiota and SCFA profiles revealed changes associated with
PANCREATIC INSUFFICIENCY. Anitha Isaiah, Joseph Cyrus diet and BCS. Microbiota diversity and species richness alterations
Parambeth, Jonathan A Lidbury, Joerg M Steiner, Jan S were noted. Acetic and butyric acid production was significantly
Suchodolski. Gastrointestinal Laboratory, Texas A&M University, different between obese and lean cats. Diet and BCS had signifi-
College Station, TX, USA cant interaction in the statistical model for remaining SCFA. On
post-hoc analysis, isobutyric, valeric and isovaleric acids were
Exocrine pancreatic insufficiency (EPI) in dogs is a syndrome of significantly different between obese and lean cats on the mainte-
inadequate synthesis and secretion of pancreatic enzymes, which nance diet. Valeric and isovaleric were different between the
leads to clinical signs of maldigestion. Previous reports show that M-diet and WL-diet in obese cats.
small intestinal bacterial dysbiosis occurs in dogs with EPI and is Microbiota and SCFA profile alterations were noted based on
reversed with pancreatic enzyme therapy. However, there are no body condition. Further study is warranted to determine the
studies evaluating the fecal microbiome of dogs with EPI. The impact of these changes on inflammation and metabolic disorders.
objective of this study was to compare the fecal microbiome of
healthy dogs (n = 18), untreated (n = 7) dogs with EPI, and dogs
with EPI treated with enzyme replacement therapy (n = 19).
To be included into the study, the dogs had to be at least 1 year
of age, have clinical signs of EPI, a serum cTLI concentration
≤2.5 lg/L, and be free from any other concurrent disease. Three
naturally voided fecal samples collected over three consecutive
days were frozen immediately after collection and pooled. Fecal
samples were collected in a similar manner from healthy dogs
without any clinical signs of gastrointestinal disease. Extracted
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1457
cobalamin (cbl) in dogs call for parenteral (PE) supplementation, date, little is known about plasma ETE status in dogs with CE.
although no protocol has been validated. In humans, several stud- The aim of this study was to determine whether ETE deficiency
ies have reported equal efficacy of per oral (PO) and PE adminis- occurred in dogs with CE.
tration of cbl. Further, this group has previously reported about Dogs with CE that were presented to Hokkaido University
successful PO cbl supplementation in dogs with CE and Veterinary Teaching Hospital between July 2014 and June 2015
hypocobalaminemia in a retrospective study. Thus, the purpose of were recruited. Fourteen laboratory beagles were used as controls.
this prospective randomized study was to validate the current PE Plasma ETE concentrations (Chromium, manganese, iron, cobalt,
and a new PO cbl supplementation protocol and compare the effi- copper, zinc, selenium, molybdenum) were measured by induc-
cacy of PO versus PE cbl supplementation in dogs with tively coupled plasma-mass spectrometry. Plasma ETE concentra-
hypocobalaminemia. tions in CE dogs were compared with those of controls. In CE
Dogs with symptoms of CE and a serum cbl below 285 ng/L dogs, correlation between plasma ETE concentrations and canine
(reference interval: 244–959 ng/L) were included from Evidensia chronic enteropathy activity index (CCECAI), plasma albumin
Specialist Animal Hospital, Helsingborg, Sweden, Helsinki Univer- concentration and histopathologic score calculated according to
sity Hospital, Finland, and from two other Swedish Veterinary the World Small Animal Veterinary Association (WSAVA)
Clinics. Dogs were randomized to treatment with either daily PO criteria.
cbl tablets during the whole study period (cyanocobalamin (Behe- Twenty-two dogs with CE were enrolled in this study. There
pan) 1 mg/tablet; dogs up to 10 kg received ¼ tablet, dogs 10 to were no significant differences between plasma ETE concentrations
20 kg ½ tablet and dogs ≥ 20 kg 1 tablet/day) or PE cbl according of CE dogs and those of controls, except for molybdenum. Plasma
to a protocol currently suggested by a diagnostic laboratory molybdenum concentration in CE dogs (median 6.9 ng/mL, range
(http://vetmed.tamu.edu/gilab/research/cobalamin-information#- 0.38–60 ng/mL) was higher than that of controls (median 3.2 ng/
dosing). A block-randomized schedule was performed by an exter- mL, range 0.72–4.7 ng/mL) (P = .015). However, plasma molybde-
nal statistician prior to the start of the study in March 2014. The num concentration didn’t correlate with CCECAI, albumin con-
study was approved by the Swedish Board of Agriculture and the centration and histopathologic score.
Viikki Campus Research Ethics Committee, Finland. Serum cbl These results indicate that there might be no obvious plasma
for follow-up was analyzed 28 5 days and 90 15 days after ETE deficiency in dogs with CE. Further study is necessary to
initiation of supplementation using an automated chemilumines- clarify the reason for increased plasma molybdenum concentration
cence immunoassay (Immulite 2000, Siemens Healthcare in dogs with CE.
Diagnostics).
41 dogs of 22 breeds were included with a median age of 6.2
(range 1.7–13.1) All of the dogs had symptoms of CE. Concurrent
medical treatment and diet was given based on clinical judgement.
Intestinal biopsies from the small and large intestine confirming
chronic inflammation were available from 25/41 dogs. There was GI19
no statistically significant difference in serum cbl concentrations at VALIDATION OF ULTRASONOGRAPHIC MEASUREMENT
baseline between the two groups (P = 0.25, Mann Whitney test). OF GASTRIC EMPTYING TIME IN HEALTHY CATS USING
Serum cbl increased in all dogs after supplementation. In the RADIONUCLIDE SCINTIGRAPHY. Roman Husnik, Jon
group receiving PO supplementation, median serum cbl concentra- Fletcher, Lorrie Gaschen, Frederic Gaschen. Department of
tions was 245 ng/l (150–285) at inclusion (n = 22), 970 ng/L (564– Veterinary Clinical Sciences, School of Veterinary Medicine,
2026) after 28 days (n = 22), and 1334 ng/L (768–3921) after Louisiana State University, Baton Rouge, LA, USA
3 months (n = 20). The difference between baseline and 28 days
was statistically significant (P < 0.0001; Wilcoxon matched-pairs The prevalence of gastric emptying (GE) disorders in cats is
signed rank test) as well as the difference between 28 days and unknown due to lack of clinically applicable diagnostic test. This
3 months (<0.006; Wilcoxon matched-pairs signed rank test). In study assesses agreement for GE times between ultrasonography
the group receiving PE cbl, mean cbl concentration was and the gold standard in 7 healthy cats.
221 43 ng/L at inclusion (n = 19), 1686 757 ng/L after For scintigraphy, 60-second static acquisitions were performed
28 days (n = 19), and 803 275 ng/L (n = 13) after 3 months. in right and left lateral recumbency at 0, 5, 15, 30, 45, and 60 min-
The difference between baseline and 28 days was statistically sig- utes following a 4 mCi Tc99M-mebrofenin solid test meal (20% of
nificant (P < 0.0001; paired t-test) as well as the difference between daily energy requirements), and at 30-minute intervals thereafter.
28 days and 3 months (P = 0.0003, paired t-test). Comparing the Mean total counts from a gastric region of interest were measured
increase in serum cbl concentrations at 28 days to baseline, the from both images. Geometric means of the decay-corrected counts
increase was significantly higher in the PE group than the PO were calculated, and the amount of gastric radioactivity was
group (mean increase 1465 745 ng/L and 888 449 ng/L, expressed as a percentage of the initial count. Using nonlinear
respectively, P = 0.004, unpaired t-test). However, after 3 months, regression analysis, 25%, 50%, 75% and 90% GE times were
the median (range) increase in serum cbl concentrations compared determined. Sonographic assessment of GE was repeated three
to baseline group were significantly higher in the PO than the PE times after the same meal (non-labeled). Using the same time
group (970 ng/L (538–3663) and 608 ng/L (38–997), respectively, points, mean cross-sectional area of transverse images of the
p = 0.0001, Mann Whitney test). relaxed antrum was obtained and expressed as a percentage of the
We conclude that both PO and PE cbl supplementation appears maximal area. The area under the curve was calculated and 25%,
to effectively increase serum cbl concentrations in dogs with CE 50%, 75% and 90% GE times determined.
and hypocobalaminemia. Further studies comparing cellular cobal- Good correlation was found between scintigraphy and sonogra-
amin status after PO or PE supplementation are warranted. phy for the 75% (287 67 [mean SD] and 306 28 minutes
respectively, r = 0.85, P < 0.02) and 90% GE times (340 77 and
381 29 minutes respectively, r = 0.85; P < 0.02). Ultrasound
evaluation of antral cross-sectional area is a valid alternative to
scintigraphy in the late phase of GE in healthy cats.
GI18
PLASMA ESSENTIAL TRACE ELEMENT
CONCENTRATIONS IN DOGS WITH CHRONIC
ENTEROPATHY. Nozomu Yokoyama, Hiroshi Ohta, Hazuki
Mizukawa, Yumiko Kagawa, Shouta Nakayama, Noboru Sasaki, GI20
Keitaro Morishita, Kensuke Nakamura, Yoshinori Ikenaka, EFFECT OF MOSAPRIDE ON POSTPRANDIAL
Mayumi Ishizuka, Mistuyoshi Takiguchi. Department of GALLBLADDER MOTILITY AND PLASMA LEVELS OF
Veterinary Clinical Sciences, Graduate School of Veterinary MOTILIN IN DOGS. Toshiaki Kakimoto, Hideyuki Kanemoto,
Medicine, Hokkaido University, Sapporo, Hokkaido, Japan Kenjiro Fukushima, Koichi Ohno, Hajime Tsujimoto. The Univer-
sity of Tokyo, Tokyo, Japan
Chronic enteropathy (CE) is a common cause of malnutrition in
dogs. Essential trace elements (ETE) are defined as micronutrients Impairment of gallbladder motility might be responsible for the
that are required for proper biochemical processes in the body. To pathogenesis of gallbladder mucocele and biliary sludge in dogs
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1460 2016 ACVIM Abstracts
and the improvement of the gallbladder motility has a possibility The presence of CP30 in 4 different feline Tf isolates was evalu-
to exert the preventive effects on the progression of the gallbladder ated by indirect immunofluorescence and flow cytometry using a
diseases. However, little has been studied on the treatments to rabbit polyclonal antibody that targets bovine Tf CP30 (a-CP30).
enhance the gallbladder motility in dogs. It was reported that 5- Feline Tf treated with rabbit IgG and/or secondary Ab in the
HT4 receptor agonist improves gallbladder emptying in human absence of a-CP30 Ab and bovine Tf were used as negative and
gallstone patients, and that mosapride, which is a selective 5-HT4 positive controls, respectively. The effect of inhibition of CP30
receptor agonist practically used for prokinetics of canine gastroin- activity on Tf adhesion-dependent cytopathogenicity was deter-
testinal disease, induces the increase of motilin, which is a mined using CFSE-labeled feline Tf that were allowed to adhere
physiological inducer of gallbladder motor activity. In this study, to monolayers of porcine intestinal epithelial cells (IPEC) in co-
we investigated the effects of mosapride on the postprandial gall- culture. The effect of CP30 inhibition on feline Tf adhesion and
bladder motility and the plasma levels of motilin in dogs with or cytotoxicity was evaluated by immunofluorescence quantification
without biliary sludge. Furthermore, we examined the expression assays and crystal violet spectrophotometric analysis. A minimum
of 5-HT4 receptor using gallbladder tissue of a normal dog. of 6 replicates were performed for each co-culture experiment.
Nine apparently healthy beagles, owned by the University of Data were analyzed using Systat software (P < 0.05).
Tokyo, were enrolled in this study. Of these, 5 did not have any CP30 expression was identified in all feline Tf isolates tested by
gallbladder abnormality (group N), and 4 had biliary sludge indirect immunofluorescence and flow cytometry. Treatment of
(group S) based on the assessment by ultrasonography. Gallblad- feline isolates with a-CP30 Ab resulted in significantly decreased
der ejection fractions (EF) were compared between dogs that Tf adhesion to and cytotoxicity towards IPEC-J2 monolayers com-
were given diet with and without simultaneous single oral admin- pared to rabbit IgG-treated Tf isolates.
istration of mosapride 1 mg/kg. EF was estimated by ultrasonog- These studies establish that CP30 is expressed by feline Tf isolates
raphy, as described in the previous study. Briefly, dogs were and may be an important virulence factor in the cytopathogenicity
fasted at least 12 hours before examination. Once the fasting of feline Tf. The results of these studies provide strong evidence-
gallbladder volume was ultrasonographically measured, they were based justification for investigation of CP30 as a novel target for the
given a test diet with and without mosapride. Postprandial gall- prevention and/or treatment of feline trichomonosis.
bladder volume was recorded at an hour after the feeding. Before
each ultrasonography, blood was collected for the measurement
of plasma motilin levels. Experiments and animal care complied
with the policies outlined in the Guide to Animal Use and Care
of the University of Tokyo. The expression of 5-HT4 receptor
was evaluated by Western blotting using an archived canine GI22
gallbladder. EVALUATION OF THE EFFECT OF OMEPRAZOLE ON
In the group N, median EF of the dogs treated with mosapride SERUM CALCIUM, MAGNESIUM, GASTRIN AND BONE IN
was significantly higher than those without the treatment [46.1% CATS. Emily Gould1, Casey Clements1, Ann Reed1, Luca Giori1,
(range: 44.1 to 60.6) versus 38.1% (24.2 to 43.5%), respectively, Joerg M. Steiner2, Jonathan A. Lidbury2, Jan S. Suchodolski2,
P < 0.05]. Such tendency was also observed in the group S, Mabre Brand1, Tamberlyn Moyers1, Lee Emery1, M. Katherine
although the difference was not significant [treatment: 43.3% (33.9 Tolbert1. 1University of Tennessee College of Veterinary Medicine,
to 63.2%) versus without treatment: 34.8% (23.6 to 37.7%), Knoxville, TN, USA, 2Texas A&M University College of
P = 0.06]. However, the median degree of the increase of the Veterinary Medicine & Diagnostic Sciences, College Station, TX,
plasma motilin concentrations after feeding was not significantly USA
different between the dogs with and without mosapride in either
group [Group N: mosaporide: 1.6 pg/mL (range: - 123.3 to Chronic proton pump inhibitor administration has been associ-
168.3 pg/mL) versus feeding only: 65.0 pg/mL (- 25.0 to 415.0 pg/ ated with electrolyte imbalances and cobalamin deficiency, dis-
mL), Group S: mosaporide: 37.0 pg/mL (range: - 273.0 to 95.0 pg/ rupted bone homeostasis, serum hypergastrinemia and rebound
mL) versus feeding only: 173.3 pg/mL (5.0 to 363.3 pg/mL)]. In acid hypersecretion in humans. These side effects could have
Western blotting, an immunoreactive band was observed at the important clinical implications in cats. However, no studies have
position of 45 kDa using the protein purified from the archived explored if cats receiving prolonged oral omeprazole (e.g., >
gallbladder, suggesting that 5-HT4 is expressed in the canine gall- 4 weeks in duration) experience similar side effects. We hypothe-
bladder. sized that prolonged oral omeprazole administration would result
These results suggested that mosapride enhances postprandial in altered bone homeostasis and/or serum calcium, magnesium,
gallbladder motility. Although the mechanisms of this effect are cobalamin and/or gastrin concentrations in healthy cats.
still to be clarified, our results suggested that mosapride enhances In a within subjects, pre to post design, 6 adult healthy colony
gallbladder motility possibly via gallbladder 5-HT4 receptor and cats received either omeprazole (0.83–1.6 mg/kg PO q12 h) or pla-
motilin does not play a role in this effect. Further studies are cebo (250 mg lactulose PO q12 h) for 60 days. Analyses of serum
needed to support our results. calcium, magnesium, cobalamin and gastrin concentrations were
performed on days 0, 30, and 60, with dual energy x-ray absorp-
tiometry performed at days 0 and 60 for each treatment. On day
60 of omeprazole treatment, intragastric pH capsules were placed
GI21 in two of the cats to measure the effects of rapid omeprazole ces-
EVALUATION OF THE PRESENCE AND ROLE OF CYS- sation. Continuous data were analysed using a two-way ANOVA
TEINE PROTEASE 30 IN FELINE T. FOETUS. M. Katherine and tested to account for the effects of phase of treatment, time of
Tolbert, Emily Gould, Mabre Brand, Stephen Kania. University measurement and the interaction of phase and time. Log transfor-
of Tennessee, Knoxville, TN, USA mation of serum gastrin, bone mineral density (BMD) and bone
mineral content (BMC) were required for the data to meet
Tritrichomonas foetus (Tf) is a flagellated protozoan parasite ANOVA normality assumptions. To reduce the possibility of a
that is recognized as a significant cause of diarrhea in domestic Type I error due to analysis of multiple study variables, the Bon-
cats with a prevalence rate as high as 30%. No drugs have been ferroni correction was applied (a = 0.006). SAS 9.4 was used to
shown to consistently eliminate Tf infection in all cats. Cysteine perform all data analyses and generate all descriptive statistics.
proteases (CPs) have been identified as mediators of Tf-induced No significant changes were observed between treatment and
adhesion-dependent cytotoxicity to the intestinal epithelium. Thus, placebo for any parameters, except serum gastrin, which was sig-
CPs represent novel targets for the treatment of feline trichomono- nificantly higher during omeprazole treatment in comparison to
sis. However, cats also produce CPs that are part of life-critical placebo (P < 0.002). Although the change was not significant, all
systems. Thus, parasitic CPs need to be selectively targeted to cats experienced a decrease in BMC by the end of the omeprazole
reduce the potential for host toxicity. Previous studies have treatment arm. Evidence of gastric hyperacidity was seen in both
demonstrated the importance of a specific CP, CP30, in mediating cats following cessation of omeprazole.
bovine and human trichomonad cytopathogenicity. Thus, the aims In conclusion, the results of this study provide evidence that
of this study were to characterize the presence of CP30 in feline Tf omeprazole may be relatively safe when administered to cats for
isolates and to evaluate the effect of targeted inhibition of CP30 60 days or less, but slow withdrawal of the medication is recom-
on feline Tf-induced adhesion dependent cytotoxicity. mended based on the hypergastrinemia and rebound hyperacidity
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1461
GI26 random and separate areas and those 3 values were averaged to
FEASIBILITY OF A NOVEL GASTROINTESTINAL IMAGING give the final immunohistochemical score for each particular mar-
DEVICE FOR USE IN DOGS. Jill S. Pomrantz1, Brian T. Hardy2, ker. Biochemical parameters, FCEAI scores, and histopathologic
Ajay Sharma3, Jeffrey A. Solomon1. 1infiniti Medical, Llc, Menlo grading scores were tested for normality using the Kolmogorov-
Park, CA, USA, 2University of California, Davis, Davis, CA, USA, Smirnov test, and since the vast majority of data was not normally
3
University of Georgia, Athens, GA, USA distributed, non-parametric statistics were used for analysis.
Nonlinear regression analysis demonstrated a significant positive
The purpose of this study was to test the safety and feasibility correlation between the FCEAI score and all 4 IHC markers:
of a disposable and fully automated ingestible camera system that TGF-beta (r2 0.24, P = 0.008), CD3 (r2 0.24, P = 0.011), Foxp3
images the gastrointestinal tract in ambulatory dogs. (r2 0.17, P = 0.026), and MAC 387 (r2 0.25, P = .006). The
Five ambulatory light-based imaging (ALI) devices were con- histopathologic severity score was found to have a significant neg-
structed and contained within a translucent 11x31 mm capsule. ative correlation with the IHC for TGF-beta (r2 0.29, P = 0.004)
The key components were a battery, a light source, 4 auto-focus- and Fox p3 (r2 0.25, P = 0.007) and a significant positive correla-
ing cameras, an internal memory system, and a microprocessor tion with CD3 (r2 0.40, P = 0.0007), but not MAC 387. This study
with an accelerometer that synchronized camera activity with failed to demonstrate a significant correlation between the
device motion. histopathologic severity score and either the fecal score or the
Five client-owned dogs were food restricted for 24 hours before modified FCEAI scoring index.
and 8 hours after capsule administration. Capsules were adminis- As with dogs, there appears to be an absence of a significant
tered using a direct pilling technique. Normal activity and access correlation between histologic severity and clinical scorings such as
to water were permitted throughout the study. After recovery, cap- a clinical severity index or fecal score in cats with chronic
sules were inspected for damage. Images were then downloaded enteropathy. A significant correlation was, however, identified
and independently reviewed by three board-certified internists. between a novel set of IHC markers and both the histopathology
Capsules were successfully administered to 5/5 dogs and were and clinical severity scores. The pathophysiologic relevance and
recovered within 24 to 36 hours. There were no adverse events. clinical utility of these markers remains to be determined.
Median (min-max) study duration was 16 (8–18) hours. Capsules
recorded a median (min-max) of 19,713 (8572–51,683) images.
Median (min-max) gastric and small intestinal transit times were
89 (10–110) minutes and 134 (68–177) minutes respectively. Visual-
ization of the mucosa and image quality were described as excel-
lent for the stomach and small bowel. The colon was poorly GI28
imaged due to retained feces. FECAL D-/L-LACTATE CONCENTRATIONS AND
ALI is safe and feasible in dogs. It produced high quality ABUNDANCE OF LACTIC ACID BACTERIA IN DOGS WITH
images throughout the majority of the gastrointestinal tract. Visu- EXOCRINE PANCREATIC INSUFFICIENCY. Amanda Blake,
alization of the colon might be feasible with additional prepara- Joseph Cyrus Parambeth, Anitha Isaiah, Blake Guard, Jonathan
tion. This non-invasive technique may expand the role of imaging Lidbury, Jorg Steiner, Jan Suchodolski. Gastrointestinal Labora-
in dogs with gastrointestinal signs. tory, Texas A&M University, College Station, TX, USA
GI29 ≤190 µm/L (n = 55). There was a significant, but weak, correlation
EVALUATION OF SERUM BETA-HYDROXYBUTYRATE between creatinine and lipase values across all cats (rho=0.2,
CONCENTRATIONS IN DOGS WITH CHRONIC ENTERO- P < 0.001, n = 1314), but no correlation was present for the group
PATHIES. G Esposito1, K Allenspach2, JM Steiner1, JA of cats with creatinine values >190 µmol/L (n = 162). There was
Lidbury1, JS Suchodolski1. 1Gastrointestinal Laboratory, College no correlation between creatinine and PLI. Multivariate linear
of Veterinary Medicine Texas A&M University, College Station, regression was used to assess the influence of creatinine, hydration,
TX, USA, 2Royal Veterinary College, London, UK and body condition on lipase over all cats for which this informa-
tion was available (n = 313); none of these variables demonstrated
Beta-hydroxybutyrate (BHB), a ketone body, is synthesized in a significant effect (P = 0.09, 0.22, and 0.97, for creatinine, hydra-
the liver from acetyl CoA and is utilized as an energy source when tion, and body condition, respectively). The data were next
glucose supplies are limited. BHB has been demonstrated to play a assessed by MANOVA for variation over time within individual
role in the oxidative stress response by the binding of histone cats for which repeat serum biochemistries and medical record
deacetylase and in the suppression of inflammatory disease by data were available (n = 279). Hydration demonstrated a signifi-
antagonizing the cryopyrin inflammasome (NALP3). Previous cant effect on creatinine (P < 0.001), and a trend towards effect on
untargeted metabolomics studies of both human and canine lipase (P = 0.07). Creatinine did not demonstrate any further rela-
patients with idiopathic inflammatory bowel disease have shown tionship with lipase (P = 0.39). PLI was repeated in 15 cats; values
significantly higher serum concentrations of BHB in diseased moved in the same direction as creatinine in only 4 cases.
patients than in healthy controls, suggesting that BHB may be use- The data indicate that kidney function has a mild effect on
ful as a biomarker for inflammatory bowel disease. In this study, DGGR-lipase level in cats, which may in part be due to hydration
we investigated serum BHB concentrations in healthy dogs and status. The study may be underpowered to show this effect in all
dogs with two types of chronic enteropathy: food responsive diar- analyses and on PLI. Creatinine may underestimate decreased kid-
rhea and steroid-responsive diarrhea. ney function in underweight cats, affecting results, but the overall
Serum samples from dogs with food responsive diarrhea (FRD, weak associations between creatinine and lipase, and creatinine and
n = 30), steroid responsive diarrhea (SRD, n = 14), and a group of PLI, suggest that elevated lipase or PLI should not be attributed
healthy control dogs (n = 30) were used. All samples were surplus solely to decreased kidney function in azotemic cats. This may be
material from a previous study. Dogs were diagnosed as having because the magnitude of increases in lipase and PLI in pancreatic
food responsive or steroid responsive diarrhea based on response disorders overwhelms the magnitude of effect of kidney function.
to treatment. Serum concentrations of BHB were measured in
serum samples using a colorimetric assay kit (beta-hydroxybutyrate
colorimetric assay kit, Cayman Chemicals). A Kruskal-Wallis was
performed to compare serum concentrations between groups.
Median serum BHB concentrations were (minimum – maxi-
mum): 0.45 mmol/L (0.02 – 0.11) for healthy dogs, 0.45 mmol/L GI31
(0.00 – 0.27) for dogs with SRD, and 0.03 mmol/L (0.01 – 0.13) PREVALENCE OF HELICOBACTER SPECIES AND THEIR
for dogs with FRD. There was no significant different between the ASSOCIATION WITH GASTRIC PATHOLOGY IN DOGS
three groups (P = 0.328). WITH GASTROINTESTINAL DISEASE. Roman Husnik1, Jiri
These results suggest that serum concentrations of BHB are not Klimes2, Simona Kralova-Kovarikova3, Petr Fictum4, Michal
significantly increased in dogs with chronic enteropathies com- Kolorz5, Frederic Gaschen1. 1Department of Veterinary Clinical
pared to healthy dogs. Sciences, School of Veterinary Medicine, Louisiana State Univer-
sity, Baton Rouge, LA, USA, 2Department of Biology and Wild-
life Diseases, Faculty of Veterinary Hygiene and Ecology,
University of Veterinary and Pharmaceutical Sciences Brno, Brno,
Czech Republic, 3Department of Small Animal Internal Medicine,
Faculty of Veterinary Medicine, University of Veterinary and
GI30 Pharmaceutical Sciences Brno, Brno, Czech Republic, 4Depart-
EFFECT OF SERUM CREATININE ON FELINE SERUM ment of Pathological Morphology And Parasitology, Faculty of
DGGR-LIPASE AND SERUM PANCREATIC LIPASE Veterinary Medicine, University of Veterinary and Pharmaceutical
IMMUNOREACTIVITY. Ellen Everson, Anthony Abrams-Ogg, Sciences Brno, Brno, Czech Republic, 5Department of Human
Helen Kocmarek, Kristiina Ruotsalo. University of Guelph, Pharmacology and Toxicology, Faculty of Pharmacy, University
Guelph, ON, Canada of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech
Republic
The objective of this study was to examine the influence of kidney
function (indicated by serum creatinine level) on serum The prevalence and pathogenic role of different species of Heli-
1,2-o-dilauryl-rac-glycero-3-glutaric acid-(60 methylresorufin) ester cobacter in the dog have not been definitely documented to date.
(DGGR) lipase and pancreatic lipase immunoreactivity (PLI) in cats. This prospective study included 84 privately owned dogs for which
Using electronic record searches, all cats were identified that had the prevalence of gastric Helicobacter species and associated gas-
had a serum biochemistry profile ordered at the Ontario Veterinary tric lesions was determined, and the accuracy of different diagnos-
College between January 1, 2010 and April 14, 2015. Serum crea- tic techniques was compared.
tinine had been measured at the Animal Health Laboratory Inclusion criteria consisted of chronic GI clinical signs (vomit-
(AHL), University of Guelph, by enzymatic UV method (Randox) ing, diarrhea, anorexia, weight loss), exclusion of non-GI diseases
on a Cobas 6000 c501 analyzer (Roche Diagnostics). Serum lipase and discontinuation of all medications for at least 2 weeks. Biopsy
had been measured at AHL by the DGGR colorimetric assay specimens were obtained by gastroduodenoscopy. The presence of
(Cobas) on the same analyzer. In some cases, an aliquot of the Helicobacter spp. was detected using genus- and species-specific
same serum sample had been submitted for Spec fPLÒ at IDEXX PCR (investigated species were H. heilmannii sensu stricto [HH
laboratories, Markham, ON. Laboratory results were retrieved and s.s.], H. bizzozeronii [HB], H. felis [HF], H. salomonis [HS] and
corresponding medical records reviewed. Data obtained from the H. pylori [HP]), cytology, rapid urease test, and histologic exami-
records included, when available, hydration status and body condi- nation with hematoxylin-eosin and silver staining of gastric biopsy
tion score as assessed by the attending clinician. samples.
Data were first assessed as independent events by analyzing only PCR detected Helicobacter DNA in 60 dogs (71.4%). Compar-
the results of the first serum biochemistry profile obtained for each ing the diagnostic value of cytology, rapid urease test and histol-
cat (n = 1314). The median lipase value in the group of cats with ogy to PCR, cytology yielded a sensitivity of 88.3% and a
creatinine values above reference interval (>190 µmol/L, n = 162) specificity of 91.7%. The rapid urease test had a sensitivity of
was 18.5 U/L (range 7–594 U/L), which was higher (P < 0.001) 85% and a specificity of 91.7% and histology had a sensitivity of
than the median lipase value of 14 U/L (range 5–747 U/L) in the 81.7% and a specificity of 83.3%. Using a combination of diag-
group of cats with creatinine values ≤190 (n = 1152), although nostic tests for Helicobacter spp. including rapid urease test, cytol-
ranges overlapped substantially. The same trend (P = 0.06) was ogy, histology and PCR, 65 dogs (77.4%) had one or more
observed for PLI in these respective groups: median was 16.6 µg/L positive result. For 61 dogs (72.6%) diagnostic tests were concor-
(range 1.5–50 µg/L) for cats with creatinine >190 µmol/L (n = 9); dant. Single infections with HH s.s. was detected by PCR in
median was 3.85 µg/L (range 0.5–50 µg/L) for cats with creatinine 23.3%, HB in 15%, HS in 6.7% and HF in 1.7% of 60 PCR
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1464 2016 ACVIM Abstracts
positive dogs. Mixed infection of HH s.s. and HB was found in pericarditis, and congenital heart diseases) typically related to
38.3% and combination of HH s.s. and HF was detected in 1.7% increased interstitial pressure and intestinal lymphangiectasia in
of the dogs. Helicobacter species remained undetermined in 13.3% humans. Fecal a1-proteinase inhibitor (fa1-PI) is a stable protein
of the patients. No HP was found in animals examined. In most lost into the gastrointestinal tract at a rate comparable to that of
dogs, the endoscopic appearance of the gastric mucosa was nor- albumin and therefore serves as an endogenous marker of gas-
mal. Overall, the most common endoscopic lesions were erosions trointestinal protein loss. While PLE has been suspected in dogs
or ulcers and increased granularity of gastric mucosa. Gastritis with cardiac disease, no published studies are available. The aim
was diagnosed histologically in 36.7% of dogs positive for Heli- of this study was to evaluate fa1-PI concentrations in dogs with
cobacter spp. and in 41.7% of dogs without evidence of Helicobac- variety of cardiac diseases.
ter colonization. Severe lymphocytic-plasmacytic gastritis (11.1%) Single, naturally voided fecal samples from 27 adult dogs
and acute purulent-necrotic gastritis (1.5%) were found in single (≥1 year of age) and 15 puppies (<1 year of age) were collected
HB infections and moderate lymphocytic-plasmacytic gastritis from dogs with congenital and acquired cardiac diseases. Two
(14.3%) in single HH s.s. infections. An association between the dogs, one puppy and one adult, had serial fecal evaluations (i.e.,
presence of mixed infection (including HH s.s. and HB) and the before and after occlusion of their patent ductus arteriosus (PDA)
lower severity of gastric inflammation was detected when com- with an AmplatzÒ canine ductal occluder (ACDO) device). Each
pared to single Helicobacter species infection. dog in the study had an echocardiogram performed by a board
This is a large study evaluating association of the individual certified cardiologist or a resident under the supervision of a board
Helicobacter species with histologically confirmed gastritis in dogs. certified cardiologist. Fecal samples were frozen upon collection
Dogs are frequently colonized by Helicobacter spp. other than HP, and fa1-PI concentration was measured using an in-house radioim-
and may represent a reservoir for human infection with non-HP munoassay and was compared with an established reference inter-
Helicobacter spp. The combination of cytology and rapid urease val for healthy adult dogs. A fa1-PI concentration of ≥21.0 lg/g
test performed on gastric biopsy samples represents a reliable diag- feces was considered abnormal.
nostic method suitable for clinical practice. Competitive inhibition Three of 27 adult dogs (11%) all with congenital cardiac disease
may occur when 2 Helicobacter species are simultaneously detected had an increased fa1-PI concentration (median [minimum - maxi-
in gastric biopsies, and the presence of one Helicobacter species mum]: 10.1 lg/g feces [1.8 - 45.6]). Also, nine of 15 (60%) of the
may interfere with the virulence of other Helicobacter species. puppies, all with congenital heart diease, had an increased fa1-PI
concentration (median [minimum - maximum]: 24.8 lg/g feces [6.6
- 79.1]). Some of the dogs had multiple congenital heart defects on
echocardiographic evaluation. Also, the severity of cardiac disease
varied in each patient. For the two PDA dogs for which samples
from two time points were available, there was a reduction in fa1-
GI32 PI concentration post coil embolization; from 79.1 to 21.5 lg/g
NORMAL AND ABNORMAL FINDINGS IN THE CANINE feces in the puppy, and from 36.5 to 14.1 lg/g feces in the adult.
GASTROINTESTINAL TRACT USING AMBULATORY The increased fa1-PI concentrations in puppies have to be inter-
LIGHT-BASED IMAGING. Jill S. Pomrantz1, Brian T. Hardy2, preted with caution as higher fa1-PI concentrations have been
Jeffrey A. Solomon1. 1Infiniti Medical, LLC, Menlo Park, CA, reported previously in puppies and a specific reference interval for
USA, 2University of California, Davis, Davis, CA, USA puppies has not been established.
Limitations of this study include the small number of dogs, the
Ambulatory light-based imaging (ALI) is a new imaging modality lack of intestinal biopsies to rule out any other causes of increased
that allows for non-invasive endoluminal visualization of the gas- gastrointestinal protein loss, the lack of multiple fecal samples to
trointestinal mucosa. ALI is performed by oral administration of a account for day to day variability in fa1-PI concentrations
capsule containing a fully automated camera (ALICAM) that is pro- reported earlier, the variety of cardiac diseases, and lack of com-
pelled by natural peristalsis. The capsule is retrieved from the dogs’ plete serum chemistry profiles for all dogs. However, this study
feces and images are downloaded. Familiarity with normal and shows that fa1-PI concentrations may be increased in a subset of
abnormal findings is essential to accurate interpretation of these dogs with cardiac disease. Prospective studies are needed to estab-
studies, but these have yet to be documented in veterinary patients. lish if increased fa1-PI concentrations in dogs occur consistently
The aim of this study was to present a gallery of normal and abnor- with congenital heart diseases, are increased in dogs with acquired
mal images of the canine gastrointestinal tract using ALICAM. heart diseases that increase interstitial pressure, and if elevations
ALICAM studies from 65 dogs were evaluated retrospectively have any influence on treatment or prognosis.
by a board-certified internist. The average study consisted of
21,003 images obtained over 16 hours. Patients evaluated included
55 dogs with clinical signs of gastrointestinal disease and 10 asymp-
tomatic dogs. The patients ranged in age from 4.5 months to
13.7 years old and in weight from 7.8 to 72 kg. Images representa-
tive of normal mucosa and common lesions were saved and logged. GI34
The most common reasons for ALICAM administration were EVALUATION OF THE EFFECTS OF PRE-CONDITIONING
vomiting, diarrhea, signs of gastrointestinal bleeding, or a combi- ON FEMALE CANINE ADIPOSE-DERIVED MESENCHYMAL
nation of several gastrointestinal signs. Gastric lesions identified in STEM CELL CYTOKINE PRODUCTION. Rebecca Timmons,
dogs with gastrointestinal signs included irregular mucosa, polyps, Stephanie Smith, Craig Webb, Tracy Webb. Colorado State
ulcers, erosions, masses and foreign material. Small intestinal University, Fort Collins, CO, USA
lesions identified included irregular mucosa, dilated lacteals, ulcers,
erosions, masses, and parasites (tapeworms and hookworms). Clinical use of mesenchymal stem cell (MSC) therapy may be
Colonic lesions included masses and erosions. optimized through pre-conditioning methods that would enhance
Establishing characteristics of normal and abnormal findings is their immunomodulatory functions. We investigated the effects of
an important step in the evolution of ALI as a diagnostic test. pre-conditioning strategies on cytokine production of female
canine adipose-derived MSC that may optimize clinical effects of
MSC application in this species. Adipose-derived MSC were gener-
ated from healthy adult female dogs and subjected to 6 conditions.
Supernatants were harvested after 1, 6, 12, 18, and 24 hours, and
levels of cytokines present in the supernatants were determined by
GI33 ELISA. IL-10 and TGFb were not released in measurable
FECAL a1-PROTEINASE INHIBITOR CONCENTRATIONS levels within a 24 hour period under any of the tested culture
IN DOGS WITH CARDIAC DISEASE. Joseph Cyrus Param- conditions. Large amounts of MCP-1 (mean=10.2 ng/mL) and
beth, Jordon P. Vitt, Jan S. Suchodolski, Jonathan A. Lidbury, VEGF (mean=2.9 ng/mL) and very small amounts of IL-8
Ashley B. Saunders, Joerg M. Steiner. Department of Small (mean=40.9 pg/mL) were constitutively produced by the cells at
Animal Clinical Sciences, College Station, TX, USA 24 hours. All of the pre-conditioning strategies except TGFb
altered measured cytokine production in the MSC from control
Protein-losing enteropathy (PLE) has been documented in vari- levels at 24 hours: poly I:C increased IL-8 and MCP-1 secretion;
ous cardiac diseases (i.e., congestive heart failure, constrictive IFNc increased MCP-1 and decreased VEGF and IL-8 secretion;
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1465
serum-free decreased IL-8, MCP-1, and VEGF secretion; and the A novel bleeding assessment tool, DOGiBAT, was developed
mixed hypoxic environment inhibited MCP-1, VEGF, and IL-8 for canine ITP comprising nine different anatomic site-specific
secretion. All changes in cytokine secretion were evident at the bleeding grades ranging from 0 (none) to 2 (severe). An online
6 hour time point with most at maximal levels by 12 hours sug- training course was developed for application of the DOGiBAT to
gesting that 12 hour culture periods are sufficient to induce rele- score clinical cases. A case-based quiz set of still images was used
vant changes in MSC cytokine secretion. This initial study shows to assess the trainees’ ability to apply the DOGiBAT tool. Addi-
that specific pre-conditioning methods hold promise for tailoring tionally, to assess the efficacy of the training course, 70 veterinary
and augmenting canine MSC immunomodulatory properties to student volunteers were randomized to take the quiz with (n = 35)
treat specific diseases, although further study is necessary and cur- or without (n = 35) the training. All students scored all sites from
rently on going. all cases and site scores were considered correct if they agreed with
the investigators’ pre-specified classification. The frequency of cor-
rect scores was compared between trained and untrained students.
A logistic regression model was used to assess the association
between training and score, while adjusting for correlated
responses from sites within cases.
HM01 Clinicians (n = 13) and technicians (n = 3) taking the quiz fol-
REPRODUCIBILITY, STABILITY AND BIOLOGICAL lowing training were able to correctly apply the DOGiBAT, scoring
VARIABILITY OF THROMBIN GENERATION USING 100% of responses correctly. 86.1% of responses from students
CALIBRATED AUTOMATED THROMBOGRAPHY IN that received training were correctly scored, compared to only
HEALTHY DOGS. Beno^ıt Cuq1, Shauna Blois1, Darren Wood1, 78.2% of responses from students that did not receive training. The
1 2 1
Anthony Abrams-Ogg , Christian Bedard . Ontatio Veterinary odds of trained students giving correct answers were higher than
College, University of Guelph, Guelph, ON, Canada, 2Faculte de untrained students (P < 0.0001). The anatomic site for which train-
Medecine Veterinaire, Universite de Montreal, St Hyacinthe, QC, ing was most important for correct scoring was oral bleeding
Canada (82.9% with training, 47.6% without; P < 0.0001). Similarly, scor-
ing of ocular (75.2% with training, 58.1% without; P = 0.0097)
Thrombin plays a central role in hemostasis and thrombosis, and cutaneous bleeding (84.8% with training, 66.7% without;
and is involved in all in vivo hemostatic pathways. Calibrated P = 0.003) were improved by the training course. Students with
automated thrombography (CAT), a thrombin generation assay, more clinical experience were better able to apply the DOGiBAT
may therefore be a valid physiological test for hemostatic disorders correctly (fourth years, 84.2%; third years, 80.1%; P < 0.0149).
in dogs. Our objectives were to establish reference intervals for Our study suggests that the DOGiBAT is simple scoring tool
CAT thrombin generation, and assess the effects of pre-analytical for classification of bleeding severity in dogs with ITP. A short
and biological variability on this assay in healthy dogs. online training course was shown to improve the accuracy and
Lag time (lag), time to peak (ttpeak), peak thrombin generation consistency of DOGiBAT scoring. Adoption of the DOGiBAT
(peak), and endogenous thrombin potential (ETP) were measured scoring system for future clinical trials of canine ITP patients will
in 41 clinically healthy dogs. Both direct jugular venipuncture and facilitate more rigorous assessment of treatment-effect based on
winged-needle catheter-assisted saphenous venipuncture were used standardized bleeding outcomes.
to collect samples from each dog. Storage stability at 80°C was
assessed over 2 months in a subset of samples. Biological variabil-
ity of CAT was assessed via nested ANOVA using samples
obtained weekly from 9 dogs for 4 consecutive weeks.
Samples for CAT analysis were stable at 80°C for up to
2 months. Samples collected via winged-needle catheter venipunc- HM03
ture showed poor repeatability compared to direct venipuncture EFFECTS OF ASPIRIN DOSE ESCALATION ON CANINE
samples; there was also poor agreement between the two sampling PLATELET FUNCTION AND URINARY THROMBOXANE
methods. Intra-individual variability of CAT variables was low AND PROSTACYCLIN LEVELS. Natalie McLewee, Todd
(≤7.8%); inter-individual variability ranged from 4.8–76.8%. Ana- Archer, Robert Wills, Andrew Mackin, John Thomason.
lytic precision goals were met for ttpeak, peak and ETP. Indices Mississippi State University, MS, USA
of individuality ranged from 0 to 0.12.
In conclusions, thrombin generation seems to be stable and Aspirin is commonly used in an effort to prevent thrombus for-
repeatable in healthy dogs. Direct venipuncture sampling is recom- mation in dogs. High-dose aspirin (10 mg/kg, PO, q 12 h) reliably
mended for CAT. Indices of individuality were low for all CAT inhibits platelet function and thromboxane A2 (TXA2) synthesis,
variables, suggesting limited utility of population-based reference but can be associated with unacceptable side effects, including
intervals for this assay. inhibition of prostacyclin synthesis, which counteracts the effects
of inhibition of TXA2. Lower doses of aspirin, in contrast, inhibit
platelet function and TXA2 synthesis, have few side effects, and
allow ongoing prostacyclin synthesis. However, low-dose aspirin
therapy at standard dosage (0.5–1 mg/kg, PO, q 24 h), does not
reliably inhibit platelet function, a phenomenon known as “aspirin
HM02 resistance”. Aspirin-associated platelet dysfunction has been shown
DEVELOPMENT AND VALIDATION OF A NOVEL CANINE to be highly dose-dependent, suggesting that traditional “low-
IMMUNE THROMBOCYTOPENIA BLEEDING SCORE. Kelly doses” of aspirin may be under-dosing canine patients. Our study
Makielski1, Marjory Brooks2, Chong Wang1, Jonah Cullen1, Ann- used incremental increases in dosages to determine the dose of
ette O’Connor1, Dana LeVine1. 1Iowa State University, College of aspirin that consistently inhibited platelet function and TXA2 syn-
Veterinary Medicine, Ames, IA, USA, 2Cornell University, College thesis without inhibiting prostacyclin synthesis.
of Veterinary Medicine, Ithaca, NY, USA Eight healthy adult research dogs were separated into one of 5
groups, with each group given different oral doses of aspirin: Dose
A method of objective quantification of clinical bleeding in A, 0.5 mg/kg, q24 h; Dose B, 1 mg/kg, q24 h; Dose C, 2 mg/kg,
canine immune-mediated thrombocytopenia (ITP) is needed q24 h; Dose D, 4 mg/kg, q24 h or Dose E, 10 mg/kg, q12 h. Prior
because ITP patients have variable bleeding tendencies that do not to aspirin therapy (Day 0) and again after one week (Day 7) of
directly relate to severity of thrombocytopenia. A consistent drug administration, blood and urine were collected to assess pla-
description of their bleeding would allow more direct comparisons telet function (turbidimetric aggregometry and PFA-100Ò (closure
of this bleeding heterogeneity in multi-institution studies. Applica- time)) and urine 11-dehydro-thromboxane B2 (11-dTXB2, a stable
tion of a standardized bleeding assessment tool would help stratify metabolite of TXA2) and 6-keto-prostaglandin F1a (6-keto-PGF1a,
ITP patients in clinical trials based on their bleeding severity to a stable metabolite of prostacyclin) synthesis. A dog was consid-
provide an objective comparison of patient outcomes among treat- ered to be an aspirin responder if there was >25% reduction in
ment protocols. In this study we aimed to develop and validate a maximal amplitude on aggregometry, or the Day 7 PFA-100Ò
daily canine ITP bleeding assessment tool (DOGiBAT) and to closure time was >300 seconds.
evaluate the utility of a training course for improving accurate On aggregometry, for Doses A-E, there was a mean decrease in
implementation of the DOGiBAT. maximum amplitude of 3.8%, 41.3%, 81.3%, 75.9%, and 87.8%,
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1466 2016 ACVIM Abstracts
respectively. Compared to Day 0, there was a significant decrease untreated pITP, 5 healthy dogs, and 15 dogs with secondary throm-
on Day 7 for Doses B-E. The maximum amplitude was decreased bocytopenia. pITP was defined as dogs that had platelet counts
>25% (indicating aspirin responsiveness) in all dogs receiving Dose <20,000 cells/mL, were PCR and serology negative for Babesia, Ehr-
C or greater. Similar to aggregometry, when the PFA-100Ò closure lichia, and Anaplasma, had no evidence of neoplasia on abdominal
times on Day 0 were compared to Day 7, there was a significant and thoracic imaging, and no history of drug administration (antibi-
increase for Doses B-E. On Day 7, for Doses A-E, mean PFA- otics, corticosteroids, vaccines, or chemotherapeutics). Secondary
100Ò closure time was >300 seconds (indicating aspirin responsive- thrombocytopenic control dogs had platelet counts below the refer-
ness) in 0%, 25%, 62.5%, 87.5%, and 87.5%, respectively. Com- ence interval due to diagnoses other than pITP, and healthy dogs
pared to Day 0, there was a significant decrease on Day 7 for the presented for wellness exams and had normal platelet counts. qRT-
concentrations of 11-dTXB2 (P = 0.0003) and 6-keto-PGF1a PCR was performed using intron-spanning primers to amplify a 129
(P = 0.0075). However, the changes in 11-dTXB2 and 6-keto- base pair region of the mRNA. b-actin was used as a reference gene.
PGF1a were not dependent on aspirin dose. The relative mRNA expression of BAFF in pITP dogs was
The results of our study suggest that an aspirin dose of 2 mg/ increased 12.13-fold and 3.25-fold compared to healthy control
kg, PO, q24 h reliably inhibits platelet function in normal dogs dogs and dogs with secondary thrombocytopenia, respectively
based on the established “gold standard” assay, platelet aggregom- (P < 0.01) (Figure 1).
etry. Additionally, even though all aspirin doses inhibited prosta- These results indicate that relative expression of BAFF mRNA
cyclin synthesis to some degree, there was no difference in is increased significantly and specifically in dogs with pITP com-
prostacyclin concentration between a dose of 2 mg/kg, PO, q24 h pared to both healthy dogs and dogs with other causes of throm-
and the traditionally used lower doses. Based on our results, an bocytopenia, similar to previous findings in people. Thus, BAFF
increased standard aspirin “low-dose” of 2 mg/kg, PO, q24 h may may be a useful biomarker to distinguish dogs with pITP from
minimize the risk of aspirin resistance in dogs. those with other causes of thrombocytopenia. Using these primers
our group has also identified a canine macrophage cell line (030-
D) that expresses BAFF and is utilizing them for protein identifi-
cation and quantitation as well as further characterization of
BAFF mRNA splice variants.
HM04
B CELL ACTIVATING FACTOR AS A BIOMARKER IN
DOGS WITH PRIMARY IMMUNE MEDIATED THROMBO-
CYTOPENIA. Jessica Pritchard1, Michael Wood2, Adam Birken-
heuer1, Henry Marr1. 1Department of Clinical Sciences, College of HM05
Veterinary Medicine, North Carolina State University, Raleigh, COMPARISON OF MULTIPLATE, PLATELET FUNCTION
NC, USA, 2Department of Medical Sciences, School of Veterinary ANALYZER-200, AND PLATELETWORKS IN DOGS TREA-
Medicine, University of Wisconsin – Madison, Madison, WI, USA TED WITH ASPIRIN AND CLOPIDOGREL. Sophie Saati,
Anthony Abrams-Ogg, Shauna Blois, Darren Wood. University of
There is a critical need for a biomarker that differentiates active Guelph, Guelph, ON, Canada
primary immune mediated thrombocytopenia (pITP) from sec-
ondary causes of thrombocytopenia, and the concentration of In dogs, the antiplatelet drugs aspirin (ASA) and clopidogrel
which correlates with disease status in dogs. Such a biomarker may be used in an effort to prevent thromboembolism. Response
would provide a valuable diagnostic tool to modulate therapy, to these drugs might be variable as in humans, therefore platelet
evaluate risk of relapse, and reduce patient exposure to potentially function testing may be warranted to monitor treatment effect.
harmful immunosuppressive medications. B cell activating factor This study aimed to evaluate the effects of ASA, clopidogrel, or
(BAFF) is a cytokine within the tumor necrosis factor family that combination therapy, in healthy laboratory Beagles using three
plays a crucial role in B cell maturation, survival, and class switch- platelet function tests: Multiplate Analyzer (MP), Platelet Func-
ing. Increased concentrations of BAFF in mice and people have tion Analyzer-200 (PFA), and Plateletworks (PW). Secondary
been linked to immune-mediated diseases such as systemic lupus goals were comparison of PW using two hematology analyzers:
erythematosus, rheumatoid arthritis, and ITP. Our central hypoth- Vetscan HM5 (using impedance) and ADVIA 2120 (using flow
esis is that BAFF production will be significantly and specifically cytometry); and evaluation of the novel INNOVANCE P2Y car-
increased in dogs with untreated pITP. tridge for PFA to evaluate clopidogrel-induced platelet inhibition.
The purpose of this pilot study was to quantify and compare the Six dogs were given ASA 1 mg/kg/day and placebo, clopidogrel
transcription of BAFF in the blood of dogs with untreated pITP, 2 mg/kg/day and placebo, or a combination of both drugs, for
dogs with secondary thrombocytopenia, and healthy control dogs. 1 week each. Drugs were given in a randomized crossover design
Quantitative real-time PCR (qRT-PCR) was used to assess BAFF (Latin square). Each dog was randomized to one of the three
mRNA expression. Total RNA was isolated from 6 dogs with treatments in three different phases such that each dog received
each treatment. Investigators were blinded to the treatments. A
washout period of 2 weeks occurred between phases. Blood sam-
ples were collected on days 0 and 7 of each phase, and analyzed
using MP (adenosine diphosphate [ADP], arachidonic acid [AA],
collagen [COL] agonists), PFA (P2Y, COL-ADP, COL-Epinephr-
ine [EPI] cartridges), and PW (ADP, AA, COL agonist tubes)
using the two hematology analyzers.
Significant (P < 0.05) changes in mean values pre and post
treatments were: For MP - Area under the curve (AUC) units (U)
was decreased with COL only with combination therapy (pre 19
U, post 6 U). AUC was decreased with AA with either clopido-
grel (pre 41 U, post 19 U) or combination therapy (pre 44 U, post
9 U). AUC was decreased with ADP with all treatments (ASA
pre 62 U, post 52 U; clopidogrel pre 59 U, post 13 U; combina-
tion pre 58 U, post 12 U). For PFA – closure time (CT) was
increased with the P2Y cartridge with clopidogrel (pre 95 seconds,
post >300 seconds) and combination therapy (pre 119 seconds,
post >300 seconds). CT was increased with the COL-ADP car-
tridge with clopidogrel (pre 65 seconds, post 185 seconds) and
Levels of plasma BAFF mRNA in healthy dogs (control), dogs combination therapy (pre 68 seconds, post 215 seconds). CT was
with secondary thrombocytopenia (other TP), and dogs with ITP. increased with the COL-EPI cartridge only with ASA (pre 167
seconds, post 235 seconds). For PW using the HM5 analyzer - %
The ratios of BAFF mRNA in dogs with ITP compared to those aggregation (% Agg) with AA was decreased for all treatments
with secondary thrombocytopenia and healthy dogs are 3.25 and (ASA pre 80%, post 7%; clopidogrel pre 90%, post 4%; combi-
12.13, respectively. nation pre 78%, post 12%). With ADP, % Agg was decreased for
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1467
clopidogrel (pre 45%, post 9%) and combination therapy (pre HM07
47%, post 9%). PW results for HM5 and ADVIA 2120 showed PREDICTING IN VIVO RESPONSE TO LOW-DOSE
almost perfect agreement (kappa 0.83–0.98). Although the results ASPIRIN IN HEALTHY DOGS USING IN VITRO PLATELET
above revealed changes in mean values with treatments, results AGGREGOMETRY. Rachel Hegedus, Pamela Lee, Michael
were variable for individual dogs. The only tests for which every Court, Jillian Haines. Washington State University, Pullman, WA,
dog’s individual values followed the changes in mean values were: USA
MP with COL with combination therapy; PFA with the P2Y car-
tridge with clopidogrel or combination therapy; PW with ADP for Aspirin, or acetylsalicylic acid (ASA), is a cyclooxygenase inhi-
clopidogrel or combination therapy, and PW with AA for all bitor that prevents the synthesis of hemostatically active prosta-
treatments. glandins. At low doses aspirin is used to inhibit platelet function
All three platelet function tests detected ASA and clopidogrel and ultimately thrombus formation. Some human patients appear
effects in some dogs and may have utility for monitoring antiplate- non-responsive to these antiplatelet effects, termed “aspirin resis-
let therapy. The P2Y cartridge was superior to the COL-ADP car- tance.” This same phenomenon has been identified in dogs and
tridge for detection of clopidogrel effect with PFA. PW can be could be a contributing factor to the formation of thromboemboli
performed with either Vetscan HM5 or ADVIA 2120, and PW in some at risk patients. Accurately predicting aspirin response
using AA was the only test that detected all drug effects. prior to treatment could prevent inappropriate drug therapy and
devastating thrombus formation in otherwise manageable diseases.
The objective of our study was to determine whether the ASA
concentration needed to cause 50% inhibition of platelet aggrega-
tion (EC50) measured using dog blood collected before ASA treat-
ment (i.e. the in vitro EC50) could be used to predict the EC50
HM06 value measured in the same dogs after administration of low-dose
EVALUATION OF THE RISK OF RELAPSE OF CANINE oral aspirin (i.e. the in vivo EC50).
IMMUNE-MEDIATED THROMBOCYTOPENIA AFTER Twenty client-owned healthy dogs were utilized for this study.
ROUTINE VACCINATION. Jenny Ellis, Patricia M. Ward, In vitro testing was performed on two separate occasions at least
Robert D. Foale. Dick White Referrals, Six Mile Bottom, 1 week apart to determine individual repeatability. Blood was
Cambridgeshire, UK incubated with six concentrations of aspirin and aggregation was
measured using a multiple electrode impedance aggregometer
Vaccination has been suggested as a cause of initial develop- (Multiplate instrument). In vivo testing was performed at least
ment and relapse of immune-mediated thrombocytopenia (ITP), 1 week after in vitro testing. The same dogs received a single
although this relationship has not been definitively established in dose of 1 mg/kg aspirin orally and aggregation was assessed at
dogs. This study aimed to identify cases of canine primary ITP baseline prior to administration, then 20 minutes, 40 minutes,
that had been vaccinated after cessation of treatment and to assess and 180 minutes after administration. Additionally, plasma con-
if any of these vaccinated cases showed signs of relapse. centrations of ASA and salicylic acid (SA) were measured at each
Records of animals diagnosed with ITP between 2004 and 2014 time point using liquid chromatography–mass spectrometry (LC-
were retrospectively reviewed at a multi-disciplinary hospital. MS). SA is the major ASA metabolite and may be a better indica-
Cases were included if a diagnosis of presumptive primary ITP tor of ASA exposure (bioavailability) than ASA.
had been made with a platelet count of below 50x109/l (ref 200 – Calculation of an in vitro EC50 allowed dogs to be separated
500). Dogs diagnosed with secondary ITP were excluded, as were into four different response groups. Sixteen of the 20 dogs (80%)
cases that did not have assessment for underlying disease, with had in vitro EC50 values below 250 umol/L consistent with an
minimum investigation required comprising full haematological appropriate aspirin response with mean SD (range) values of
and biochemical assessment including blood film evaluation, 84.5 36.0 (34.8–151.4) umol/L. When these values were evalu-
abdominal ultrasonography and thoracic radiography. Infectious ated for repeatability a mean difference of 44.9% was found with
disease PCR tests were also performed in some cases at the discre- the highest difference between independent measurements for each
tion of the clinician involved. Referring veterinary practices were dog of 95.1%. One dog showed a consistently poor response with
contacted for follow-up information regarding length of treatment, in vitro EC50 values between 250–500 umol/L at both times mea-
ongoing vaccination protocols including dates and vaccination sured. Two dogs had substantial variation in their in vitro EC50
administered, and survival data as required. values between the two time points and were classified as variable
One hundred and forty-six thrombocytopenic dogs were identi- responders. One additional dog showed no significant inhibition of
fied, with 32 dogs not surviving to discharge. Sixty-eight dogs were platelet aggregation at any time up to an ASA concentration of
excluded due to detection of an underlying infectious or neoplastic 3300 umol/L and was classified as a non-responder. In vivo aspirin
disease. Of the dogs with presumptive ITP, 11 were lost to follow- dosing at 1 mg/kg did not cause measureable inhibition of platelet
up and 14 dogs were still receiving prednisolone or other immuno- aggregation in any of the dogs after a single dose at any time
suppressive agents. Four of these dogs remained on long-term point. An in vivo EC50 could not be established based on these
prednisolone due to relapse when the dose was tapered. findings as 50% inhibition was never achieved at this dose. Plasma
Of the 21 dogs that were in remission with all immunosuppres- ASA and SA concentrations were available for 18 of 20 dogs. The
sive treatment withdrawn, 9 did not receive any vaccinations after mean SD (range) maximum plasma concentrations (Cmax) for
diagnosis. None of these dogs showed signs of relapse during the ASA were 0.23 0.21 (0 - 0.77) umol/L and for SA were 21 5
follow-up period. The remaining 12 dogs received at least one vac- (14 - 34) umol/L. Two dogs did not have ASA concentrations
cination a minimum of one month after discontinuing all immuno- above the detection limit (0.03 umol/L).
suppressive treatments. One of these dogs had initially relapsed This study suggests individual variation in aspirin response does
early in the treatment course, prompting a longer treatment proto- exist in dogs as assessed by multiple electrode aggregometry. A
col before withdrawal of treatment. None of the dogs receiving single low dose (1 mg/kg) of aspirin was not sufficient to cause
vaccinations once immunosuppressive treatment was withdrawn measurable inhibition of platelet aggregation in healthy dogs and
showed signs of relapse, including those receiving multiple vaccina- resulted in ASA and SA concentrations that were substantially less
tions over several years. Vaccinations administered included a than the in vitro EC50. Low-dose (1 mg/kg) aspirin therapy may
combination of core boosters, intranasal vaccination for Bordetella not be a reliable antithrombotic therapy after only a single dose
bronchiseptica, and one dog received a Rabies booster for travel. thus necessitating the potential need for additional therapies dur-
These results failed to show an association between relapse of ing the first 24 hours. Further research looking at higher oral
presumptive primary ITP in dogs and vaccination, although the aspirin doses or multiple day dosing is warranted to better estab-
possibility cannot be excluded. Future studies assessing higher lish an in vivo EC50 and determine the predictive value of in vitro
numbers of dogs would be required to further assess a potential EC50 determination prior to commencement of therapy.
association.
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1468 2016 ACVIM Abstracts
A proprietary testing methodology was developed for this antis- and cyclosporine (10 mg/kg/day) for 8 weeks. Good response were
era using known facts about the DEA 5 antigen. The antisera was defined as an absolute reticulocyte count > 60 9 103/ll or increas-
tested against canines previously known to be positive for the ing Hct. Dogs that responded within 8 weeks continued to be trea-
DEA 5 antigen. The antisera proved to identify the DEA 5 anti- ted with gradual tapering of dose, and re-evaluated after 6 month.
gen with 100 percent positivity. Blinded in-house trials were per- Dogs that did not respond to the first regimen proceeded to second
formed as well, and technicians could correctly identify canines regimen including prednisolone and mycophenolate mofetil
with the DEA 5 antigen. (15 mg/kg, twice a day). Similarly, good response for second regi-
Once the testing methodology was codified, and a Standard men was determined as explained above and dogs that did not
Operating Procedure (SOP) written, testing for the DEA 5 antigen respond to both regimens were defined as poor response.
moved into phase two, blind clinical testing. Two closed canine Dogs ranged 5 to 9 years old (median age, 9.5 years), and
colonies were tested for the DEA 5 antigen, one comprised entirely included 5 castrated males, 2 intact females and 1 spayed female.
of unrelated greyhounds, the other of mixed canines. Previously, a There were 6 miniature dachshunds, 1 Shih-tzu and 1 Papillon.
portion of these mixed canines had been typed for the DEA 5 Median Hct and absolute reticulocyte count were 16.3% and
antigen, so the sample set had known positives mixed with 59,640/ll, respectively. Bone marrow erythroid series were evalu-
unknowns. Samples were blinded via identification number. All ated as hyperplasia in 5 dogs, euplasia in 2 dogs and hypoplasia in
canines were infectious disease screened, up to date on vaccina- 1 dog. Erythroid maturation arrest was observed in all dogs. 6 of
tions and physical examinations. Testing on the two canine colo- 8 dogs underwent core biopsy and 2 dogs showed myelofibrosis. 5
nies revealed an interesting find. Previously, it was thought that of 8 dogs responded to the first regimen and time to response was
greyhounds had up to a 30% incidence rate of the DEA 5 anti- between 28 and 52 days. 3 dogs stopped receiving the first regimen
gen3. However, in testing of the closed greyhound colony, the inci- due to anorexia that might be induced by Cyclosporine. 6 month
dence rate proved to be zero. In a mixed breed closed canine prognoses of the other 2 dogs were complete remission (CR: Hct
colony, the incidence of the DEA 5 antigen proved to be 21.6%. increased to reference range) and partial remission (PR: Hct did
All previously known DEA 5 antigen positive mixed canines were not reach the reference range), respectively. 3 dogs that did not
correctly identified by laboratory technicians. respond to first regimen were proceeded to the second regimen. 1
In phase three of the testing methodology, clinical samples sent of 3 dogs showed response after 29 days and 6 month prognosis
to the laboratory were typed for the DEA 5 antigen to establish was PR. The other 3 dogs that discontinued receiving Cyclospor-
an incidence rate. Over a period of two months, the laboratory ine were also proceeded to the second regimen, and 6 month prog-
used convenience sampling to test for the DEA 5 antigen. At the noses were CR in 2 dogs and PR in 1 dog. 2 dogs that did not
closing of phase three, a total of 777 random canine samples were show any response to both treatments had myelofibrosis.
tested, with a total of 63 canines testing positive for the DEA 5 In this research, response to both regimens could be evaluated
antigen, resulting in an incidence rate of 8.1 %, consistent with in 6 dogs and median response time was 35 days (range 28–52).
previously known incidence rates. Therefore, at the conclusion of These results may be valuable for practitioners in consideration of
phase three, it was determined the novel antisera was valid for the changing immunosuppressive agent.
detection of the DEA 5 antigen.
With the re-introduction of a novel anti-DEA 5 reagent, a more
complete profile of canine blood types can be achieved. This can
result in better clinical decision making regarding transfusion in
the canine patient, and therefore better outcomes, including the
avoidance of delayed transfusion reactions when a DEA 5 incom- HM15
patibility exists. VALIDATION OF RAPID THROMBOELASTOGRAPHIC
1. Colling, DT, Saison R: Canine Blood Groups: II. Description ANALYSIS ON CITRATED AND NATIVE WHOLE BLOOD
of a new allele in the Tr Blood Group System. Animal Genetics FROM HEALTHY DOGS. Hye-Bin Wang1, Hyeri Shin1,
11:13–20, 1980. Jin-Young Chung2, Kun-Ho Song1, Kyoung-Won Seo1. 1Chungnam
2. Symons M, Bell K: Canine blood groups: Descriptions of 20 National University, Daejeon, Korea, 2Kangwon National
specificities. Animal Genetics 23:509–515, 1992. University, Chuncheon, Korea
3. Hale, Anne: Canine Blood Groups and Their Importance.
Transfusion Medicine25:6 1995. Thromboelastography (TEG) is rapid and non-invasive diagnos-
tic instrument that has been used in veterinary medicine for evalu-
ation of haemostatic function in whole blood (WB). Recently,
rapid thromboelastography (r-TEG) has been recognized as an
overall evaluation of coagulation abnormalities in human medicine
and become available faster than conventional coagulation tests
HM14 (CCTs). Although r-TEG is becoming more generally used in
PROSPECTIVE STUDY IN THE TREATMENT OF NONRE- human medicine, there are no studies describing the use of r-TEG
GENERATIVE IMMUNE-MEDIATED ANEMIA IN 8 DOGS. in veterinary medicine. The objectives of this study were to 1) vali-
Keitaro Morishita, Kyosuke Takeuchi, Shunsuke Mori, Sayuri dation of r-TEG values with native and citrated WB samples from
Hayakawa, Kensuke Nakamura, Noboru Sasaki, Hiroshi Ohta, healthy dogs, and to compare stability and repeatability between
Mitsuyoshi Takiguchi. Hokkaido University, Sapporo, Japan two types of samples, and 2) examine whether the use of r-TEG
could accelerate the coagulation pathway and decrease in taken
Nonregenerative immune-mediated anemia (NRIMA) is a com- time in comparison to kaolin activated TEG. Blood was collected
mon hematologic disorder in dogs. Because the bone marrow of from 16 clinically healthy Beagle dogs. TEG analysis was per-
the affected dogs shows erythroid hyperplasia and/or erythroid formed on kaolin-activated, citrated r-TEG, and native r-TEG
maturation arrest, it has been recognized as immune-mediated blood samples. TEG activated clotting time (ACT), kappa value
destruction of erythroid precursor cells. A variety of immunosup- (k), alpha angle (a), and maximum amplitude (MA) were
pressive agents have been used in the treatment of this disease, but recorded. Coefficients of variation (CV) of native r-TEG and
information regarding the therapeutic efficacy is limited due to the citrate r-TEG for TEG ACT, K, a angle, and MA were 13.4/
lack of prospective research. The aim of this pilot study was to 18.8%, 11.1/16.6%, 4.2/5.1% and 10.0/10/0%, respectively. The
assess the treatment outcome to the pre designed immunosuppres- mean time for the citrated and native r-TEG were 1313.9 250.9/
sive regimen including corticosteroids, cyclosporine and mycophe- 1351.3 264.6 seconds (mean SD) respectively, in comparison
nolate mofetil. with 1779.9 197.0 seconds for kaolin activated TEG.
8 dogs with NRIMA referred to Hokkaido university teaching The native and citrated r-TEG tests were taken significantly less
hospital between 2012 and 2015 were included. Inclusion criteria in time than the kaolin activated TEG test (P < 0.05). Based on the
this research were a minimum 5-day history of anemia, a severe results of this study, the r-TEG can evaluate haemostatic status
nonregenerative anemia (Hct < 20%) with absolute reticulocyte rapidly than other coagulation tests and it is expected to be use-
count < 60 9 103/ll, and absence of any identifiable underlying fully used in critical setting in veterinary medicine.
disease which could induce severe anemia. The following data were
collected for each dog: age, breed, sex, results of hematological
analyses performed on admission, results of bone marrow examina-
tion. First treatment regimen included prednisolone (2 mg/kg/day)
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1471
lower serum T4 (median 11, range 0–44 nM), T3 (median 0.7, HP04
range 0–1.7 nM), FT4 (median 15, range 1–27 pM), and FT3 (me- EMBOLIZATION OF INTRATRAHEPATIC PORTOSYS-
dian 3, range 0–10.5 pM) compared to control dogs. Relative to TEMIC SHUNTS IN DOGS WITH A PROTOTYPE COIL.
control dogs, dogs with GBM frequently had severely low individ- Matthias Schneider, Andreas Stosic, Stephan Bayer. Small Animal
ual thyroid hormone concentrations. Serum T4 was below refer- Clinic, Giessen, Germany
ence range (RR) in 50% of GBM dogs compared to 8% controls.
Four (10.5%) GBM dogs had a T4 = 0. Serum T3 was below RR Surgical treatment of intrahepatic portosystemic shunts (iPSS) is
in 47% of GBM dogs compared to 25% controls. Three (8%) challenging. Frequently, multiple interventions are needed to avoid
GBM dogs had a T3 = 0. Serum FT4 was below RR in 12% of portal hypertension and to achieve a complete closure. Complica-
GBM dogs compared to 0% controls. Serum FT3 was below RR tions seen in catheter-assisted embolization with commercial coils
in 17% of GBM dogs compared to 0% controls. Significant differ- include coil migration, portal hypertension (rapid thrombotic
ences in T4AA, T3AA or mean TSH were not identified. However occlusion), and incomplete occlusion. Attenuation of hepatic vein
23.5% of GBM dogs and only 8% control dogs had an elevated by means of stent-supported coil embolization may lead to the
TSH. Serum TGAA was elevated in 17% of control dogs and 0% development of intrahepatic venous collaterals. In the present
of GBM dogs. No inflammation was detected in the thyroids of study we postulated that implantation of a single prototype coil
any of 12 dogs with GBM undergoing autopsy. These results iden- combined with immediate unfractionated heparin therapy (UHT)
tify a high prevalence of occult, often severe, decreases in individ- is an effective treatment for iPSS in dogs and has fewer complica-
ual serum thyroid hormone concentrations in GBM dogs. tions than reported with open surgery.
Influence of non-thyroidal illness must be considered for some of Dogs with single iPSS with or without intrahepatic venous col-
these abnormalities. Lack of serum TGAA and absent histologic laterals were included. A percutaneous access to the right jugular
inflammation in thyroids of GBM dogs is noteworthy. These find- vein was used for retrograde portal vein catheterization. Portal
ings suggest that an alternative mechanism for abnormal thyroid vein pressure and iPSS diameter were measured unblocked and
function in dogs with GBM should be considered. blocked (balloon catheter: 8F wedge catheter or 20/27 mm occlu-
sion catheter). The prototype coil with polyester fibers was selected
to be either at least 1 mm larger in diameter than the blocked iPSS
or twice the diameter of the unblocked iPSS, and was implanted
using an 8F guiding catheter. Coagulation times were assessed by
activated coagulation time (ACT) at baseline and during UHT.
HP03 Heparin was started before coil implantation with a bolus of
INTEROBSERVER AGREEMENT FOR HISTOLOGICAL 100 IU/kg (injected into the portal vein), followed by continuous
SCORING OF CANINE HEPATIC FIBROSIS. Jonathan Lid- rate infusion (25 IU/kg/h). Postoperatively, UHT was adminis-
bury1, Aline Rodrigues Hoffmann1, Fabiano Olivera2, Brian Por- tered 150 IU/kg q6 h subcutaneously and intermittent 50 IU/kg
ter1, Thomas Van Winkle3, Jan Suchodolski1, Guy Grinwis4, intravenously to achieve an ACT of 150 to 200 seconds, and then
Renata Ivanek1, John Cullen5, Joerg Steiner1. 1Texas A&M adjusted based on sonographic proven development/resolution of
University, College Station, TX, USA, 2Antech Diagnostics, ascites. Functional closure was judged according to the result of
College Station, TX, USA, 3University of Pennsylvania, Philadel- the oral ammonia tolerance test. Descriptive statistics and Kaplan-
phia, PA, USA, 4Utrecht University, Utrecht, The Netherlands, Meier analysis was used.
5
North Carolina State University, Raleigh, NC, USA The prototype coil was implanted in a total of 25 dogs. Most
common breeds were Hovawart (n = 8) and Golden Retriever
Hepatic fibrosis is an important complication of canine chronic (n = 5). Median age was 10 months (range 6 – 35) and median
hepatitis. To the authors’ knowledge, the interobserver agreement body weight 26 kg (range 12 – 48). iPSS originated from the right
associated with the histological scoring of fibrosis from canine lateral (n = 1), right medial (n = 7) or left portal vein branch
hepatic biopsy specimens has not previously been reported. There- (n = 17). 19/25 dogs showed portal hypertension during shunt
fore, the aim of this study was to evaluate the interobserver agree- blocking. Unblocked and blocked shunt diameter were
ment for the histological scoring of canine hepatic fibrosis. 5.2 - 13.0 mm (median 8.3; n = 25) and 9.0 - 21.0 (median 13.3;
Paraffin-embedded liver specimens from 50 dogs were selected n = 24), respectively. Intervention was successful at the first
from the tissue archives at Texas A&M University and North Car- (n = 24) or second (n = 1) intervention. Major complications devel-
olina State University. Two contiguous sections were cut from oped in 5 dogs leading to death in 2 dogs. Minor complications
each specimen, one was stained with hematoxylin and eosin were common and were mostly associated with bleeding problems.
(H&E) and one with picrosirius red (PR). Six board-certified vet- One dog was lost to follow-up after three months. Of the remaining
erinary pathologists assigned a fibrosis score (0: absent, 1: mild, 2: 22 dogs, 5 experienced complications associated with change to a
moderate, 3: marked, or 4: very marked) to each section using a non-protein restricted diet: severe neurological abnormalities lead-
scoring system adapted from the Ishak scoring system that is used ing to euthanasia (n = 1), moderate symptoms leading to re-inter-
in humans. Interobserver agreement for the H&E and PR stained vention (n = 2), mild symptoms which could be treated successfully
sections was evaluated using the kappa and weighted-kappa statis- by changing to a moderately protein restricted diet (n = 2). All dogs
tics. The median fibrosis score assigned to H&E and PR stained without portal hypertension showed functional closure at 3 months
sections from each dog were compared using the Wilcoxon signed- follow-up. In dogs with portal hypertension the cumulative propor-
rank test. tion of functional closure reached 81% at 24 months follow-up.
Multiuser kappa (95% CI) for H&E stained sections was 0.35 In conclusion, stiffness and size of the prototype coil were
(0.26 0.44) and multiuser weighted-kappa was 0.59 (0.50 responsible for the high procedural success and functional closure
0.70). Pathologists were in complete agreement 49% of the time, rates. Unfractionated heparin treatment needs optimization to
differed by one score level 41% of the time, and differed by more reduce complications, but the general treatment regimen seems
than 1 score level 11% of the time. Multiuser kappa (95% CI) for promising.
PR stained sections was 0.39 (0.30 0.49) and multiuser
weighted-kappa was 0.64 (0.55 0.73). Pathologists were in com-
plete agreement 53% of the time, differed by one score level 42%
of the time, and differed by more than one score level 5% of the
time. There was no significant difference in the median fibrosis
scores assigned by the 6 pathologists between H&E and PR
stained sections (both medians were 2; P = 0.248). HP05
There was only fair interobserver agreement when veterinary INVESTIGATION OF HEPATIC COPPER ACCUMULATION
pathologists assessed canine hepatic fibrosis from H&E or PR IN DOGS FROM TWO TIME PERIODS (1982–1988 AND
stained sections. However, because there was frequent partial 2009–2015). Ryan Schultz, Rebecca Smedley, John Buchweitz,
agreement between pathologists, this scoring system may be Katie Barnes, Sarah Abood, Daniel Langlois. Michigan State
acceptable for clinical use. A clear benefit of the routine staining University College of Veterinary Medicine, East Lansing, MI,
with PR for the assessment of hepatic fibrosis was not demon- USA
strated in this study.
Canine copper-associated hepatitis (CCAH) has become an
increasingly recognized cause of progressive and potentially fatal
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1473
liver disease in dogs; however, the exact etiology remains unclear. system; Antech Diagnostics), were infested for 7 days with 13
To date, no broad epidemiologic investigations quantifying hepatic female and 12 male wild-caught I. scapularis with an estimated 48%
copper concentrations over time in both predisposed (to CCAH) BB infection rate and a 15% AP infection rate. Blood was collected
and non-predisposed breeds have been conducted. The purpose of from all dogs prior to tick attachment and then on Weeks 1–12 and
our study was to determine and compare quantitative hepatic cop- Week 18 after tick attachment and screened for BB and AP anti-
per concentrations in breeds that are, or are not, predisposed to bodies as described. Dogs that seroconverted were assumed to have
CCAH from two study periods. We hypothesized that hepatic cop- been infected. Statistical analyses were performed with commercial
per concentrations have increased for all dogs over time, but the software; P ≤ 0.05 was considered statistically significant.
relative increase will be greater in predisposed breeds. A retrospec- Antibodies against BB were detected in 7 of 24 dogs (29.2%)
tive search of the histopathology database at the Michigan State between 4–8 weeks post-infestation; all positive dogs were females
University Diagnostic Center for Population and Animal Health (P = 0.0003). When positive and negative dogs were compared,
was conducted for two study periods: 1982 through 1988, and there were no significant differences in the ages, number of ticks
2009 through 2015. Doberman Pinschers, Labrador Retrievers, recovered, or number of fed ticks. Antibodies against AP were
and West Highland White Terriers were considered predisposed to detected in the serum of 10 of 24 dogs (41.7%). Results using the
CCAH. Dalmatians, Skye Terriers, and Bedlington Terriers were same source of dogs, ticks, and model in previous publications were
excluded from analysis due to a rarity of cases, limited informa- 77.8% and 55.5%% for BB and AP, respectively. The differences in
tion on predisposition, or a known genetic etiology, respectively. infection rates between the current and historical studies were simi-
Cases with archived liver tissue available were randomly selected, lar for AP but significantly lower in the current study for BB
reviewed, and then classified by breed and presence or absence of (P = 0.004). The most recent common ancestor (MRCA) for 6 of
inflammatory liver disease. Hepatic copper concentrations (parts the 7 (86%) BB-positive dogs was either a sibling or parent. Dogs A
per million, dry weight basis) were measured in all specimens using and B were siblings and had the same father as Dog C. The mother
inductively coupled plasma mass spectrometry. Comparisons were of Dog D was the maternal grandmother of Dogs A and B. The
made within and across groupings using commercially available father of Dog E was the paternal great grandfather of Dogs A, B, C.
statistical software. The mother of Dog F was the maternal grandmother of Dog E. The
A total of 373 cases were evaluated, including 207 dogs predis- MRCA for 8 of the 17 (47.1%) BB-negative dogs was either a sibling
posed to CCAH and 166 non-predisposed dogs. Independent of or parent. None of the BB positive dogs had a MRCA sibling or
breeds groupings and inflammatory activity, mean hepatic copper parent in common with any of the BB negative dogs.
concentrations in the recent time period were 225 ppm greater These findings provide further evidence that a genetic predispo-
than those in the historical time period (P < 0.05). This effect was sition to B. burgdorferi infection exists. As studies have investi-
predominantly due an increase of 386 ppm over time in predis- gated common genotypes and alleles among humans with Lyme
posed breeds (P < 0.001). The mean hepatic copper concentration borreliosis and arthritis, this should also be considered in future
of 338 ppm in non-predisposed breeds in recent years was greater studies of canine Lyme borreliosis.
than the mean hepatic copper concentration of 271 ppm in non-
predisposed breeds in the historical period, but this trend did not
reach significance (P = 0.08). In the recent period, the mean hep-
atic copper concentration of 519 ppm in predisposed breeds with
non-inflammatory liver histology was greater than the mean hep-
atic copper concentration of 297 ppm in non-predisposed breeds ID02
with non-inflammatory liver histology (P < 0.001). This difference RAPID DIAGNOSIS OF BABESIA GIBSONI USING POINT-
was not observed in the historical time period. In both periods, OF-CARE INSULATED ISOTHERMIC POLYMERASE
dogs with hepatitis had higher hepatic copper concentrations than CHAIN REACTION ASSAY. Kirsten Cooke1, Patrick Frenzer1,
those without hepatitis, but this difference was magnified in recent Julie K. Levy1, Sylvia Tucker1, P. Cynda Crawford1, Sarah Kirk2.
1
years. In the aggregate, these findings confirm that hepatic copper University of Florida, Gainesville, FL, USA, 2The American
concentrations have changed over time. The etiology of these Society for the Prevention of Cruelty to Animals, New York, NY,
changes is unknown, but suggestive of changes in environmental USA
copper exposure. Detailed investigations of potential sources of
copper exposure, namely drinking water and diet, are needed to Babesia gibsoni is commonly identified in pit bull-type dogs,
further elucidate a potential environmental etiology. Additional particularly those involved in dogfights. Dogs seized from fighting
investigations also are needed to determine if these changes are operations undergo health and behavior evaluations to assess suit-
important for all breeds of dog. ability for adoption. Adoption carries the risk for sending dogs
harboring infectious diseases to unsuspecting owners or to regions
where the infections are not endemic. Screening large numbers of
dogs for infectious diseases is expensive and it may be days before
results are available. A more rapid and cost-effective diagnostic
test would make identification and treatment of B. gibsoni infected
ID01 dogs more feasible for rescue organizations. Recently, the develop-
EVIDENCE FOR GENETIC PREDISPOSITON TO BORRE- ment of insulated isothermic PCR (iiPCR) has made mobile PCR
LIA BURGDORFERI INFECTION IN PURPOSE BRED a reality. The purpose of this study was to determine performance
BEAGLES. Elena Contreras1, Scott Moroff2, Michael Lappin1. of the POCKITÒ iiPCR system for diagnosis of B. gibsoni in dogs
1
Department of Clinical Sciences, Colorado State University rescued from fighting organizations.
Veterinary Teaching Hospital, Fort Collins, CO, USA, 2Antech Whole blood was collected from 260 pit bull-type dogs rescued
Diagnostics, Lake Success, NY, USA during a federal dogfighting investigation. Real-time PCR was per-
formed for Babesia species, and positive samples underwent a sec-
Borrelia burgdorferi (BB) and Anaplasma phagocytophilum (AP) ond round of species-specific PCR in a commercial diagnostic
are transmitted by Ixodes spp., and seroprevalence rates in ende- laboratory (IDEXX Laboratories, Inc.). Residual whole blood
mic areas can be greater than 15% in dogs. A genetic predisposi- samples were frozen and stored at -80 C pending subsequent anal-
tion to infection (Bernese mountain dogs) or clinical illness ysis. POCKITÒ iiPCR was performed twice on each sample, once
associated with BB has been suggested, particularly in people and with a kit specific for B. gibsoni and once with a kit that detects
dogs with Lyme nephritis (Retriever breeds). In vaccine studies, both B. gibsoni and Babesia canis (Babesiosis). The sensitivity and
wild caught I. scapularis adults placed in feeding chambers and specificity of each test were calculated using the commercial test as
allowed to feed for seven days usually results in at least a 75% BB the gold standard. Positive (PPV) and negative (NPV) predictive
infection rate. Recently, an I. scapularis infestation study using a values were calculated for theoretical 5%, 15%, and 30% preva-
previously reported model and ticks with a similar BB carriage lences. The study was approved by the UF IACUC.
rate from the same collection area previously used, resulted in only A total of 80 dogs (31%) were positive for B. gibsoni by the gold
a 29.2% infection rate. The purpose of this report is to describe standard commercial PCR test. Of these, 72 were identified as posi-
the genetic relatedness of the dogs used in that study. tive by the POCKITÒ iiPCR B. gibsoni kit, and 70 were identified
A total of 10 female and 14 male purpose-bred beagles, as positive by the POCKITâ iiPCR Babesiosis kit. Sensitivity and
9–12 months of age, and negative for antibodies against A. phago- specificity of the B. gibsoni kit were 90% and 99%, respectively.
cytophilum, B. burgdorferi, and E. canis (Accuplex 4 BioCD Sensitivity and specificity of the Babesiosis kit were 88% and 98%,
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1474 2016 ACVIM Abstracts
respectively. The PPVs of the B. gibsoni kit at 5%, 15%, and 30% demonstrated by negative antibody in all sarolaner-treated dogs.
prevalence were 82%, 94%, and 97% respectively. The NPVs of There were no adverse reactions to treatment with sarolaner.
the B. gibsoni kit were 99%, 98%, and 96% respectively. The PPVs
of the Babesiosis kit were 70%, 89%, and 96% respectively. The
NPVs of the Babesiosis kit were 99%, 98%, and 95% respectively.
The POCKITÒ iiPCR system was quick to learn, portable, and
had a short run time of approximately 1 hour. There were few
false-positive results, indicating that positive results are likely to ID04
represent true infections when tested in high-risk animals. Approx- MOLECULAR ANALYSIS ON CANINE BABESIA PREVA-
imately 10–15% of infected dogs would be missed by the LENCES AND EXPOSURE TO ANAPLASMA, EHRLICHIA,
POCKITÒ iiPCR system. However, the portability and speed with BORRELIA AND DIROFILARIA IN MOST POPULATED
which results can be obtained may result in more infected dogs SERBIAN REGION – BELGRADE AREA. Milica Kovacevic
being diagnosed than in the current situation in which testing is Filipovic1, Anja Ilic1, Zorana Milanovic1, Dragan Bogdanovic2,
rarely performed in dog-fighting cases due to cost and logistics of Vladimir Radonjic3, Jelena Francuski Andric1, Nenad Andric1,
sending samples to outside laboratories. This system may also be Brendon Thatcher4, Christian Leutenegger4, Phyllis Tyrrell4,
used for B. gibsoni treatment monitoring using a hybrid approach. Antony Mestek4, Chandrashekar Ramaswamy4. 1Faculty of
For example, following initial diagnosis with either the POCKITÒ Veterinary Medicine, University of Belgrade, Belgrade, Serbia,
2
system or a commercial laboratory, the POCKITÒ system could State University of Novi Pazar, Novi Pazar, Serbia, 3Private
be used for testing during treatment. Once a negative result was Veterinary Practice Petrovac”, Belgrade, Serbia, 4IDEXX
obtained, a sample could be submitted to a commercial laboratory Laboratories, Westbrook, Maine, USA
to confirm treatment efficacy. Although this study focused on mass
screening for B. gibsoni, the portable iiPCR platform has potential Babesiosis is endemic in many parts of Serbia. Other tick borne
to aid in rapid detection of a variety of infections under field diseases are less commonly diagnosed because their clinical signs
conditions. are nonspecific and there is no published data indicating their
prevalence. The aim of this study was to determine molecular
prevalence of Babesia canis canis and B. gibsoni, molecular and
seroprevalence of Anaplasma phagocytophilum, A. platys, Ehrlichia
canis, E. ewingii, E. chaffeensis and Borrelia burgdorferi and Dirofi-
laria sp. microfilariae in different outdoor canine populations.
ID03 Blood samples from apparently healthy stray (n = 38), shelter
PREVENTION OF BORRELIA BURGDORFERI AND ANA- (n = 39) and hunting dogs (n = 35) and outdoor pet dogs sus-
PLASMA PHAGOCYTOPHILUM TRANSMISSION FROM pected to have tick borne diseases (n = 50) were tested using real
IXODES SCAPULARIS TO DOGS BY SAROLANER. Nicole time PCR and serological assays. Real-Time PCR assays were
Honsberger, Robert Six, Thomas Heinz, Angela Weber, Sean used to amplify Babesia, Anaplasma and Ehrlichia DNA from
Mahabir, Thomas Berg. Zoetis, Kalamazoo, MI, USA blood samples. An experimental SNAPÒ Multi-Analyte Assay
(SNAPÒ M-A) (IDEXX Laboratories, Inc. Westbrook, Maine,
The efficacy of sarolaner (SimparicaTM, Zoetis) to prevent trans- USA) was used to screen all sera for antibodies to Anaplasma and
mission of Borrelia burgdorferi and Anaplasma phagocytophilum Ehrlichia genus peptides and A. phagocytophilum, A. platys, B.
from infected wild-caught Ixodes scapularis to dogs was evaluated burgdorferi, E. canis, E. ewingii, and E. chaffeensis species-specific
in a well-controlled laboratory study. Twenty-four purpose-bred peptides. Modified Knott test was used to identify dogs with Diro-
laboratory Beagle dogs seronegative for B. burgdorferi and A. filaria sp. microfilaria presence.
phagocytophilum antibody were allocated randomly to one of three In total, prevalence of Babesia sp. infections among apparently
oral treatment groups: placebo administered on Days 0 and 7, sar- healthy dogs was 16% and among sick pet dogs, was 65%. Preva-
olaner administered on Day 0 (28 days prior to tick infestation), lence of B. canis was the highest in shelter (25%) and the lowest in
or sarolaner administered on Day 7 (21 days prior to tick infesta- stray dogs (8%). B. gibsoni was rare among shelter, stray and pet
tion). Sarolaner tablets were shaved and/or sanded based on each dogs, while it was not detected among hunting dogs. Molecular
dog’s individual bodyweight to provide a dosage of 2 mg/kg. On analysis did not reveal the presence of dogs with active anaplasmo-
Day 28 each dog was infested with approximately 25 female and sis, ehrlichiosis or borreliosis. However, 32% of stray and shelter
25 male wild caught adult I. scapularis that were determined by dogs, 12% of hunting dogs and 4% of sick pet dogs had antibod-
random sampling to have infection rates of 57% for B. burgdorferi ies to A. phagocytophilum. Only one dog (hunting group) was
and 6.7% for A. phagocytophilum by PCR. In situ tick counts were seropositive to A. platys, one dog to E. ewingii (stray group) and
conducted on Days 29 and 30. On Day 33, all ticks were counted two dogs to B. burgdorferi (stray group). None of the dogs was
and removed. Blood samples collected from each dog on Days 27, seropositive to E. canis and E. chaffeensis. Also, 33% of pet, 18%
49, 63, 77, 91 and 104 were tested for the presence of B. burgdor- of hunting, 11% of stray and 3% of shelter dogs had microfilariae
feri and A. phagocytophilum antibodies using the SNAPÒ 4DxÒ in the blood. Number of dogs exposed to two and three pathogens
Plus Test, and quantitatively assayed for B. burgdorferi antibodies was the highest among shelter dogs (31% and 10%, respectively),
using an ELISA test. Skin biopsies collected on Day 104 were and number of dogs exposed to four pathogens was the highest
tested for the presence of B. burgdorferi by bacterial culture and among stray dogs (5%).
PCR. Acaricidal efficacy was calculated based on the reduction of In Belgrade area, B. canis and A. phagocytophilum are the most
geometric mean live tick counts in the sarolaner-treated groups prevalent vector-borne pathogens in apparently healthy outdoor
compared to the placebo-treated group for each tick count. dog population, while B. canis and Dirofilaria sp. are the most
Geometric mean live tick counts for placebo-treated dogs were important pathogens among sick pet dogs.
14.8, 12.8 and 19.1 on Days 29, 30 and 33, respectively. For the
group treated with sarolaner 21 days prior to infestation, the per-
cent reductions in mean live tick counts on Days 29, 30, and 33
were 86.3%, 100%, and 100%, and for the group treated with sar-
olaner 28 days prior to infestation were 90.9%, 97.1%, and 100%.
Geometric mean live tick counts for both sarolaner-treated groups ID05
were significantly lower than those for the placebo group on all ENHANCED SEROLOGIC SURVEILLANCE TO DETECT
count days (P < 0.0001). PREVALENCE OF CANINE VECTOR-BORNE INFECTIONS
Successful transmission of B. burgdorferi to all eight placebo- ON THE ISLAND OF ST. KITTS, WEST INDIES. Diana
treated dogs was confirmed by positive antibody (6 of 8 dogs), Scorpio1, Jennifer Ketzis1, Linda Shell1, Brendon Thatcher2,
PCR (7 of 8 dogs), and/or culture result (7 of 8 dogs). Similarly, Ramaswamy Chandrashekar2. 1Ross University School of
transmission of A. phagocytophilum was confirmed by the presence Veterinary Medicine, Basseterre, Saint Kitts and Nevis, 2Idexx
of antibodies in four placebo-treated dogs. In contrast, a single Laboratories, Westbrook, Maine, USA
oral dose of sarolaner prevented transmission of B. burgdorferi
from infected ticks to dogs infested 21 or 28 days after treatment The island of St. Kitts (West Indies) has a large feral and semi-
as demonstrated by negative antibody, PCR, and culture results. feral dog population. Semi-feral dogs present a unique opportunity
Prevention of A. phagocytophilum transmission was also for study since they are mostly outdoors but are comparatively well
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1475
taken care of compared to feral dogs. Care tends to range from Ab Test, WITNESSÒ FeLV-FIV Test Kit, AnigenÒ Rapid FIV
minimal to adequate, though many owners use the Ministry of Ab/FeLV Ag Test Kit, VetScanÒ Feline FeLV/FIV Rapid Test.
Agriculture Veterinary Services for preventative medicine rather All test results were visually read by two blinded observers.
than a veterinary hospital setting. Historically, dogs on the island
are endemically infected and infested with internal and ectopara-
sites, which are also associated with a number of vector-borne dis-
eases. Due to the high prevalence of the vector Rhipicephalus SNAP® WITNESS® ANIGEN® VETSCAN®
sanguineus, it is not unusual to see high prevalence of Ehrlichia 100% 89.0% 91.8% 85.6%
canis and Anaplasma platys. Samples collected from an island-wide FeLV Sensitivity (95% CI)
(96.9-100) (82.8-93.2) (86.1-95.4) (78.9-90.5)
field study from last year revealed an abundance of serologic data.
These samples have been further tested utilizing a research-based FeLV Specificity (95% CI)
100% 95.5% 95.5% 85.7%
serology platform (IDEXX Laboratories) and additional canine (97.1-100) (90.8-98.0) (90.8-98.0) (79.3-90.48)
vector-borne infections data has been collected from these analyses. 97.9% 94.7% 96.8% 91.5%
Over a period of 3 months, veterinarians and students from FIV Sensitivity (95% CI)
(92.1-99.9) (87.9-98.0) (90.6-99.3) (83.9-95.8)
RUSVM visited all 9 parishes of St. Kitts, covering a diverse geo-
graphic area with a wide diversity in ecosystem landscape. One hun- FIV Specificity (95% CI)
99% 100% 99% 99%
dred and eleven dogs were identified and visited, and were given a (93.8-100) (95.4-100) (93.8-100) (93.8-100)
complete physical exam, then blood and feces were collected.
Demographic data was collected, including breed, age, housing,
other animals in household, evidence of ticks or fleas, deworming The SNAPÒ test had the overall best performance. In high-
and vaccine administration. Blood was analyzed using a research- stakes testing, test kits should be selected for both high sensitivity
based broader canine vector-borne infection serologic platform and specificity. When tests lack sensitivity, infected cats may
(SNAPÒ M-A, IDEXX Laboratories), which tests for specific anti- escape detection and remain at risk for infecting other cats. When
bodies against E. ewingii, E. canis, E. chaffeensis, Anaplasma platys, specificity falls, uninfected cats may be unnecessarily segregated or
A. phagocytophilum, and Borrelia burgdorferi. This testing platform even euthanized. In low infection prevalence, such as observed in
is also based on a rapid ELISA SNAPÒ technology. FeLV and FIV, decreased specificity has the largest impact on
Analyses using the new SNAPÒ M-A serologic platform erroneous test results, leading to decreased positive predictive
revealed no evidence of exposure to E. ewingii, E. chaffeensis, or value (increased false-positives).
Borrelia burgdorferi. However, as expected due to the endemic nat-
ure of the tick vector, the platform identified A. platys exposures
of approximately 20.7%. E. canis exposures were detected at a
prevalence of approximately 32%. Of interest is that the SNAPÒ
M-A test also identified 19 dogs (17%) with antibodies to A.
phagocytophilum, not previously described on St. Kitts due to the ID07
absence of Ixodes tick vectors. DOES A DIVA TEST EXIST FOR DIFFERENTIATING FIV
Using the SNAPÒ M-A serologic platform, there was a robust INFECTION FROM FIV VACCINATION?. Cynda Crawford.
capacity to detect up to 2 Anaplasma species, in addition to having Maddie’s Shelter Medicine Program, University of Florida,
a sensitivity which corroborates previously published prevalence Gainesville, FL, USA
rates of E. canis. Of note is the presence of A. phagocytophilum
exposures, and additional studies are warranted to understand and Diagnosis of FIV infection is based on detection of circulating
explain these findings. The data collected in this study supports FIV antibodies. Introduction of FIV vaccines created a diagnostic
the importance of including an exhaustive list of differentials when dilemma because vaccine antibodies were indistinguishable from
suspecting canine vector-borne infections, in addition to aggressive those induced by infection using existing serological assays. New
and consistent use of environmental and topical parasiticides for point-of-care tests for FIV antibody are now available to practi-
tick control. tioners. The purpose of this study was to determine the accuracy
of FIV diagnostic tests in FIV-vaccinated cats and whether any of
the tests could serve as a DIVA test to differentiate infected from
vaccinated animals.
Plasma samples were collected from 104 uninfected SPF
cats vaccinated 3 times with a killed dual-subtype FIV vaccine
ID06 (Fel-O-Vax, Boehringer Ingelheim) according to manufacturer
PERFORMANCE OF POINT-OF-CARE ASSAYS FOR FELV instructions. Age at vaccination ranged from 2.5 to 13 months.
AND FIV. Julie Levy. Maddie’s Shelter Medicine Program, The interval between vaccination and sample collection ranged
University of Florida, Gainesville, FL, USA from 1.75 to 14 months. The FIV-free infection status of all cats
was confirmed by virus culture. Three FIV-infected cats were simi-
At least 5% of cats in the US are infected with FeLV or FIV, larly vaccinated and tested. The plasma samples were tested in 4
contagious retroviruses that predispose to bone marrow suppres- commercial point-of-care assays: SNAPÒ Feline Combo FeLV
sion, cancer, chronic inflammatory conditions, immune dysfunc- Ag/FIV Ab Test, WITNESSÒ FeLV-FIV Test, AnigenÒ Rapid
tion, and wasting syndromes. This equates to more than 5 million FIV Ab/FeLV Ag Test Kit, and VetScanÒ Feline FeLV/FIV Rapid
cats affected by these preventable viruses and at risk for disease Test. All testing was performed by personnel blinded to sample sta-
and premature death. Although vaccination plays a role in preven- tus. Each test result was independently interpreted by 2 personnel.
tion, the cornerstone of control is identification and segregation of The SNAPÒ and VetScanÒ tests detected FIV antibodies in 102/
infected cats. Recently, new point-of-care screening tests have 104 and 88/104 uninfected vaccinated cats, respectively. This
become available, but independent comparison of test performance would lead to misclassification of most of the vaccinated cats as
is needed. The purpose of this study was to determine the perfor- infected. The WITNESSÒ and AnigenÒ tests had very high speci-
mance of currently available FeLV antigen/FIV antibody combi- ficity, indicating that nearly all vaccinated cats were correctly
nation test kits. identified as uninfected. All 4 tests correctly identified the 3
For assessment of FeLV tests, serum or EDTA whole blood FIV-infected cats that were vaccinated against FIV.
samples were collected from animal shelters or reference labora-
tory and tested with two microtiter plate ELISAs for the detection
of FeLV p27 antigen (ViraCHEKÒ/FeLV and PetChekÒ FeLV
Antigen Test) to establish a gold standard. Only samples with con-
cordant results were included in the study. For assessment of FIV Specificity and 95% Confidence Intervals for 4 Point-of-Care Tests for FIV
tests, plasma samples previously collected from naturally or experi- Infection Performed in 104 Uninfected Cats that were Vaccinated against FIV
mentally infected cats and verified by virus culture and from unin- WITNESS® ANIGEN® VETSCAN® SNAP®
fected SPF cats were included. None of the cats had been
vaccinated against FIV. The final study set included 146 FeLV+, 98.1% 98.1% 21.2% 1.9%
154 FeLV-, 94 FIV+, and 97 FIV- samples. Point-of-care tests (92.8-99.9) (92.8-99.9) (14.3-30.0) (0.1-7.2)
evaluated in this study included SNAPÒ Combo FeLV Ag/ FIV
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1476 2016 ACVIM Abstracts
N-acyl-homoserine lactones (PA-AHLs). The use of QS blockers microtiter plate assay. ViraCHEKÒ was used as the reference test
or quorum quenching (QQ) to attenuate bacterial growth and vir- because it was reported in a published study to have high sensitiv-
ulence is a new strategy for treatment of resistant bacterial patho- ity and specificity (Hartmann et al. 2007) and it detects the same
gens. Azithromycin (AZ) expresses in-vitro and in-vivo QQ effect, FeLV antigen as does each of the in-clinic tests evaluated in this
and is used clinically to reduce PA virulence. Hypotheses were study.
tested that topical treatment with AZ will: 1) Attenuate the forma- When compared to the ViraCHEKÒ microtiter plate assay
tion of most common PA-AHLs: N-butyryl-L-homoserine lactone results, the SNAPÒ Feline TripleÒ Test had the highest sensitivity
(BHL), N-decanoyl-L- homoserine lactone (HHL) and N-(3-oxo- among all in-clinic tests evaluated (Table below).
dodecanoyl)-L-homoserine-lactone (OdDHL); 2) Enhance PA
clearance from the ear canal; 3) Have a positive effect on ear canal
sample cytology; and 4) Reduce the severity of clinical signs
In-clinic Test Comparative Sensitivity (95% CI) Comparative Specificity (95% CI)
related to PA associated otitis externa/media (PAOEM) in dogs. SNAP® Feline Triple FeLV Test 97.6% (91.1-99.8) 100% (95.5-100)
This was a randomized double blind placebo controlled study. WITNESS® FeLV Test 76.2% (66.0-84.0) 97.0% (91.2-99.3)
Samples were collected from 21 dogs with PAOEM, which were VetScan® FeLV Test 69.0% (58.5-77.9) 97.0% (91.2-99.3)
Anigen® FeLV Test 66.7% (56.0-75.8) 97.0% (91.2-99.3)
treated with topical AZ (1 mL AZ solution at the concentration of Speed Duo® FeLV Test 51.2% (40.7-61.6) 99.0% (94.0-100)
50 µg/mL, SID) or placebo (1 mL sterile 0.9% saline) for 56 days.
All dogs were prescribed standard PAOEM treatment and regu-
larly evaluated by their veterinarians. For the purpose of this
study dogs were clinically evaluated and ear canal samples taken These findings are important because in a clinical setting posi-
on days 0, 7, 14, 21, 28, 42 and 56. Samples were obtained by rins- tive test results may be the only mechanism to identify infected
ing ear canals with 30 mL of sterile saline. The concentration of cats – false negative results could delay supportive care and result
BHL, HHL and OdDHL in ng/mL was determined by liquid chro- in transmission to causal-contact na€ıve cats. Additional studies are
matography coupled with tandem mass spectrometry. Bacteriologi- needed to determine the clinical sensitivity and specificity of these
cal and cytological analyses were performed. Clinical signs (ear tests using samples from cats characterized by PCR and/or viral
canal edema, pain, stenosis and erythema) were graded from 0–4; culture.
grades were then summarized to form a single clinical sign grade.
Data were analyzed using linear mixed effects model for continu-
ous outcomes and general linear mixed effects model for the bin-
ary outcomes; a P-value of <0.05 was considered significant.
The concentration of BHL, HHL and OdDHL were not
affected by time (P ≥ 0.1) or AZ (P ≥ 0.2). The presence of PA in ID15
ear canal samples was affected by time (P = 0.002) but not AZ DETECTION OF GIARDIASIS IN DOGS:COMPARISON OF
(P = 0.06). The presence of rod shaped bacteria, cocci and neu- THREE RAPID DIAGNOSTIC TESTS. Hannah Bewsey, Jan
trophils in the sample were affected by time (P ≤ 0.02) but not AZ Drexel, Jiayou Liu, Brendon Thatcher, Tom O’Connor,
(P ≥ 0.08). Macrophages were not affected by time or AZ. Clinical Ramaswamy Chandrashekar. IDEXX Laboratories, Westbrook,
signs and, therefore, the duration of the disease was influenced by ME, USA
time (P < 0.0001). Azithromycin had no effect on clinical signs
and the duration of the disease (P = 0.5). Giardiasis is one of the most common intestinal parasitic infec-
Detection of PA-AHLs in this study showed that QS acts as a tions affecting both dogs and cats. Infections may be subclinical or
promoter of PA virulence in otitis externa/media. PAOEM in dogs cause severe diarrhea. Dogs become infected by ingestion of Giar-
is, therefore, an appropriate disease model to study the effects of dia cysts in contaminated water or feces. A single fecal flotation
QQ on PA. Neither of our hypotheses was verified. Azithromycin has a diagnostic sensitivity of approximately 70% because cysts
had no effect on PA-AHLs and the elimination of PA from the can be few in number, are shed intermittently, and can be difficult
ear canal, nor had any effect on cytology of the sample or the out- to distinguish from other fecal matter by inexperienced observers.
come of the disease. Only a weak tendency towards quicker elimi- Fecal flotation combined with fecal antigen tests that detect sol-
nation of PA from the ear canal was noted in this study. uble cyst wall antigen results in a diagnostic sensitivity of approxi-
mately 97%. While new Giardia antigen assays are now available
for veterinary use, comparison studies are for the most part
lacking.
The present study compared the performance of three in-clinic
tests, the SNAPÒ Giardia Test, the VetScanÒ Canine Giardia
ID14 Rapid Test (Abaxis), and the AnigenÒ Rapid CPV/CCV/Giardia
COMPARATIVE EVALUATION OF FIVE IN-CLINIC Antigen Test (BioNote). Canine fecal samples used were submitted
RAPID TESTS FOR FELINE LEUKEMIA VIRUS to IDEXX Reference Laboratories for ova and parasite testing by
INFECTION. Jiayou Liu1, Melissa Beall1, Tom O’Connor1, centrifugal flotation. After testing, the samples were stored at
1 2 1
Ramaswamy Chandrashekar , Mike Lappin . IDEXX Laborato- 20°C. The samples were then evaluated for soluble cyst wall anti-
ries, Westbrook, ME, USA, 2Colorado State University, Fort Col- gen using the Thermo ScientificTM ProSpecTTM Giardia Microplate
lins, CO, USA Assay. Positive samples were defined as those testing positive by
both reference methods while negative samples were defined as
The feline leukemia virus is a potentially life-threatening onco- those testing negative on both reference methods. A total of 95
genic retrovirus that is transmitted horizontally by close contact or positive samples and 81 negative samples were identified and tested
vertically by in-utero transmission. The p27 viral core protein is on all three in-clinic tests. Six samples were excluded from sensitiv-
produced by the virus in infected cells and is found in the cyto- ity/specificity analysis because they failed to produce positive con-
plasm in several blood cells as well as free in the serum and trol lines on the VetScanÒ Test, despite producing valid results on
plasma of infected cats. Reference laboratories and veterinary clin- the other two in-clinic tests. Results were compared to the consen-
ics commonly use some form of enzyme-linked immunoassay sus reference method results for calculation of sensitivity and
(ELISA) or particle-based immunoassay to detect the presence of specificity.
the p27 protein antigen in samples obtained from blood. The
purpose of this study was to compare the performance of several
in-clinic tests: the SNAPÒ Feline TripleÒ Test (IDEXX), the
VetScanÒ FeLV/FIV Rapid Test (Abaxis), the WitnessÒ
FeLV-FIV Test (Zoetis), AnigenÒ Rapid FIV/FeLV Test In-clinic Test Comparative Sensitivity Comparative Specificity
(BioNote), Speed DuoÒ FeLV/FIV Test (Virbac).
(95% CI) (95% CI)
The sample population (84 positive and 101 negative) consisted
of serum and plasma samples submitted to IDEXX’s worldwide ®
SNAP Giardia Test 89.2% (81.1-94.2) 100.0% (94.2-100.0)
Reference Laboratory for feline retrovirus testing. Virus isolation
and reverse transcriptase polymerase chain reaction results were VetScan® Giardia Test 71.0% (61.0-79.2) 83.1% (73.0-89.9)
not available and so samples were judged to be positive or nega- Anigen® Giardia Test 78.5% (69.0-85.7) 70.1% (59.1-79.2)
tive based on the results of the ViraCHEKÒ FeLV (Zoetis)
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1479
Using these criteria, the SNAP Giardia Test had numerically ELISA designed specifically to maintain performance while
greater sensitivity and specificity than the other 2 tests. This study enhancing throughput in a reference laboratory setting.
used another antigen test in the definition of true positive and true The FeLV microtiter plate format ELISA method validated in
negative results since the samples were not fresh fecals; and not this study facilitates high throughput operation by combining par-
tested using a different test method like immunofluorescent anti- allel fluid transfer processes with automated data acquisition and
body assay. results interpretation. The assay method is based on sequential
orthogonal screening and confirmatory protocols. The screening
protocol utilizes two distinct anti-FeLV p27 mouse monoclonal
antibodies that produce a colorimetric response in samples con-
taining FeLV p27 antigen. The confirmatory protocol requires
neutralization of positive samples in a separate set of controlled
ID16 assays using an anti-FeLV polyclonal antibody that blocks binding
SEROPREVALENCE OF ANTIBODIES TO ANAPLASMA of the mouse monoclonal antibodies to FeLV p27 antigen and
PHAGOCYTOPHILUM AND BORRELIA BURGDORFERI IN thereby inhibits color generation. The confirmatory step offers
DOMESTIC CATS. Jill Saucier1, Bryan Leonard1, Kristine increased assurance of specificity by enabling discrimination
Hoyt2, Michael R. Lappin3, Ramaswamy Chandrashekar1, Jesse S. between infected true positives and false positives associated with
Buch1. 1IDEXX Laboratories, Inc., Westbrook, Maine, USA, several factors including anti-mouse heterophilic antibodies in
2
Cats on Call Clinic, Scarborough, Maine, USA, 3Colorado State patient samples.
University, Fort Collins, CO, USA Precision of the screening assay was determined using 3 samples
(negative, low positive, and high positive). The intra-assay coeffi-
Anaplasma phagocytophilum (Aph) and Borrelia burgdorferi (Bb) cient of variation (CV) ranged from 3.9% to 7.9% while the inter-
are pathogenic bacteria vectored by Ixodes spp. and are known to assay CV ranged from 6.0% to 8.6%. For the confirmatory assay,
infect cats. While associations between Bb infections and feline the same low positive and high positives samples were used
clinical syndromes are unclear, studies have demonstrated Aph demonstrating an intra-assay CV which ranged from 3.0% to
infection to be associated with fever, severe lethargy, and throm- 4.7% and an inter-assay CV between 7.4% and 9.7%. No interfer-
bocytopenia in cats. The present study aimed to evaluate the sero- ence was observed for either protocol at bilirubin, hemoglobin,
prevalence of antibodies to Aph and Bb in a large population of and lipid concentrations up to 14.4 mg/dl, 550 mg/dl, and 6.4
domestic cats from across the United States to better understand OD660 nm, respectively. The analytical sensitivity for FeLV p27
their risk of exposure to these agents. antigen was established at 1.7 ng/mL for inactivated whole FeLV
A total of 5,416 samples submitted between September 2014 and at 1.0 ng/mL for purified recombinant FeLV p27. Discrimi-
and February 2015 for Complete Blood Count (CBC)-inclusive nating analytical specificity was demonstrated based on the
test profiles were obtained from IDEXX Reference Laboratories absence of cross-reactivity to related retrovirus antigen from mur-
located in Ixodes spp.-endemic areas. Samples originated from 26 ine leukemia virus and Feline RD-114. Overall, the assay exhibited
states with California (24%), Illinois (19%), and Massachusetts 100% diagnostic accuracy in 83 patient samples (n = 63 negative;
(13%) contributing most to the study population. The population n = 20 positive) with FeLV status defined on the combined basis
had a median age of 12.0 years (range: 1 month – 25 years) with of PCR (FeLV RealPCR; IDEXX Laboratories, Inc.) and inde-
similar representation between males (51%) and females (49%). pendent ELISA (ViraCHEK FeLV; Zoetis, Inc.).
All samples were screened by Aph-specific and Bb-specific peptide Results of this study validate that the new microtiter plate for-
immunoassays and the results were evaluated based on various test mat ELISA is a highly specific, precise, and accurate method for
and demographic parameters. detection of FeLV p27 antigen in feline patient samples and is
Overall, 9.7% of the feline sera tested in this study population appropriate for high-throughput applications in a reference labora-
contained antibodies to Aph while 2.8% had antibodies to Bb. tory setting.
Additionally, 1.2% of cats tested had antibodies to both Aph and
Bb. As observed in dogs and humans, antibody prevalence rates
among domestic cats varied by geography. The highest positive
rates for Aph and Bb were observed in Connecticut (20.2%,
n = 337) and Maine (14.0%, n = 50), respectively, while the lowest
seroprevalance for both Aph and Bb was observed in Nevada (Aph ID18
= 2.1%, Bb = 0.0%, n = 47). INVESTIGATION OF WHETHER LEPTOSPIRA VACCINAL
These results corroborate findings in previous studies which ANTIBODIES REACT WITH BORRELIA PEPTIDES USED
indicate that cats can be infected with Aph and Bb and suggest IN A COMMERCIAL ASSAY. Amber Caress1, Scott Moroff2,
that tick prevention is an important consideration in cats as well Michael Lappin1. 1Colorado State University, Fort Collins, CO,
as dogs. USA, 2Antech Diagnostics, Lake Success, NY, USA
The Week 4 sera from all 31 dogs had an MAT titer of 1:100 ID20
for at least 1 Leptospira spp. serovar. MAT titers of 1:800 or SERUM NEUTRALIZATION OF US FELINE CALICIVIRUS
greater were detected against serovar Gryppotyphosa and serovar ISOLATES FOLLOWING VACCINATION WITH A NON-
Pomona in 27 dogs. None of these 31 samples contained antibod- ADJUVANTED, KILLED, FCV-BIVALENT VACCINE. LeMac
ies against the B. burgdorferi OspA, OspC, and OspF peptides Morris2, Jennifer Hess2, Michael Lappin1. 1Colorado State
used in the commercially available assay. University, Fort Collins, CO, USA, 2Boehringer Ingelheim, St.
In conclusion, the B. burgdorferi peptides used in the Accuplex Joseph, KS, USA
4 BioCD system do not recognize antibodies induced by the com-
mercially available Leptospira spp. vaccines administered in this The objective of this study was to determine the proportion of
study. However, lateral flow device manufacturers and laboratories feline calicivirus (FCV) field isolates that would be neutralized
providing B. burgdorferi serological assays have specific sources of in vitro by sera from cats that were routinely vaccinated with a
peptides that may vary antigenically from those used here and so product containing two caliciviruses. Serum from cats hyperinocu-
the results of this study may not be the same for all laboratories. lated against 2 feline caliciviruses (FCV) has been shown to cross
neutralize a greater proportion (90.2%) of 61 FCV field isolates
from the United States when compared to serum from cats hyper-
inoculated with 1 FCV isolate (23.0%)
At 8 and 11 weeks of age, each of the 44 kittens was adminis-
tered an experimental vaccine containing modified-live pan-
ID19 leukopenia, modified-live feline herpesvirus 1, and non-adjuvanted
CLINICAL AND LABORATORY FINDINGS IN DOGS WITH inactivated calicivirus strains FCV-255 and FCV-DD1. Serum was
IXODES-INDUCED CHRONIC ANAPLASMA PHAGOCY- collected from each kitten 7 and 14 days after the second dose of
TOPHILUM INFECTION AFTER PREDNISOLONE ADMIN- vaccine and pooled by day.
ISTRATION. Elena Contreras1, Kristy Dowers1, Scott Moroff2, The ability of the pooled sera to neutralize a total of 33 FCV
Michael Lappin1. 1Department of Clinical Sciences, Colorado strains collected from cats in the USA was determined. The speci-
State University Veterinary Teaching Hospital, Ft Collins, CO, fic FCV serum neutralization titer for each FCV was defined as
USA, 2Antech Diagnostics, Lake Success, NY, USA the serum dilution causing a 50% inhibition of virus replication.
Using the Day 7 post-vaccine pooled sera, 24 of 33 (72.7%) FCV
Anaplasma phagocytophilum (AP) is transmitted by Ixodes spp. isolates were neutralized. Using the Day 14 post-vaccine pooled
and is the cause of granulocytic anaplasmosis in many species sera, 20 of 33 (60.6%) FCV isolates were neutralized. The placebo
including dogs, cats, horses, and people. In endemic areas, anti- serum pool had undetectable antibody titers against all 33 FCV
bodies against AP are detected in the serum of up to 40% of dogs field strains that were screened.
and some healthy dogs are AP PCR positive. The effect of pred- Cross-neutralization of USA field strains of FCV was > 60%
nisolone administration on dogs infected with AP after I. scapu- using pooled sera from kittens that were only administered 2 doses
laris infestation has not been determined. of an inactivated non-adjuvant vaccine containing FCV-DD1 and
A total of six young laboratory-reared beagles that were FCV-255 strains. These results suggest that cats vaccinated with
infected by AP, but no other vector borne agents, as evidenced by products containing more than one FCV isolate will likely have
detection of AP DNA in blood by PCR assay (FastPanel, Antech broad heterologous protection if exposed to field strains of FCV.
Diagnostics) and AP antibodies in serum (Accuplex 4 BioCD sys-
tem; Antech Diagnostics) after infestation with wild-caught I.
scapularis were selected for study. On Week 20 after I. scapularis
infestation, the dogs were placed into two Groups, each containing
one AP PCR positive, AP antibody positive dog and two AP PCR
negative, AP antibody positive dogs. Group 1 was administered ID21
doxycycline at 5 mg/kg, PO, twice daily for 4 weeks. After sample RISK FACTORS ASSOCIATED WITH GIARDIA AND CRYP-
collection the morning of Week 24, all dogs were administered TOSPORIDIUM IN PET DOGS AND CATS IN THE USA.
prednisolone at 2 mg/kg, PO, daily for 2 weeks. The dogs were Hanaa Thigeel1, Francisco Olea-Popelka1, Valeria Scorza1, David
evaluated daily for clinical abnormalities and by CBC, AP PCR Aucoin2, Michael Lappin1. 1Colorado State University, Fort
and AP antibody assay Weeks 24–28. Sera from 5 dogs was Collins, CO, USA, 2Antech Diagnostics, Irvine, CA, USA
assayed for AP antibodies on Week 48.
Clinical abnormalities were not detected over the course of the Giardia spp. and Cryptosporidium spp. are protozoans that colo-
study. The only CBC abnormalities noted were anemia, thrombo- nize and reproduce in the intestines of many domesticated animals,
cytosis and neutropenia in one Group 1 dog and one Group 2 dog including dogs and cats. Outcomes range from subclinical infection
on Week 24, prior to prednisolone administration. After Week 20, to severe diarrhea. Cryptosporidium spp. infection rates in dogs
only one dog was positive for AP DNA in blood (Group 2; Week and cats are largely unknown as sensitive diagnostic procedures
24 and Week 25). One Group 1 dog was negative for AP antibod- were not previously available. Polymerase chain reaction (PCR)
ies in all samples collected after Week 20, and the other two assays are now available to amplify Giardia spp. and Cryptosporid-
Group 1 dogs were negative for AP antibodies Week 48. In con- ium spp. DNA from feces. The purpose of this study was to report
trast, all dogs in Group 2 were AP antibody positive on Week 48. fecal PCR assay results for Giardia or Cryptosporidium in a sample
The 2 dogs with anemia, thrombocytosis and neutropenia on set of dogs and cats in the USA.
the day prednisolone was initiated were clinically normal, AP PCR All fecal samples that were submitted to a commercial labora-
negative, and were normal in all other CBC evaluations, suggest- tory (ANTECHÒ Diagnostics) between 2010 and 2015 for evalua-
ing these results were spurious. The one dog in Group 2 that was tion with a PCR panel of assays that amply DNA of a select
positive for AP DNA on Week 25, was also positive on Week 24 group of infectious agents including Giardia spp. (dogs and cats),
prior to prednisolone administration. None of the other samples Cryptosporidium spp. (dogs and cats), and Cryptosporidium felis
assessed by CBC and AP PCR assay after initiation of pred- (cats only) were analyzed. Descriptive, univariable, and multivari-
nisolone administration showed evidence for activation of AP able logistic regression analyses were conducted to assess associa-
infection, suggesting that this protocol is unlikely to adversely tions amongst age, sex, region, and season and the probability of
affect dogs with chronic AP infection in the field. Whether other testing positive to either Giardia spp. or Cryptosporidium spp. in
immune suppressive protocols would activate chronic AP infection pet dogs and cats.
remains to be proven. The only dogs that became AP seronegative Giardia spp. and Cryptosporidium spp. fecal PCR assay results
by Week 48 were administered doxycycline, suggesting treatment were available for 23,042 dogs and 16,326 cats.
may aid in the elimination of chronic AP infection, even after Cryptosporidium spp. DNA was amplified from feces of 336 of
prednisolone administration. 1,762 Giardia spp. DNA positive dogs (19.1%) and 132 of 843 Giar-
dia spp. DNA positive cats (15.7%). Of the 843 Giardia spp. DNA
positive cats, 97 (11.8%) were positive for Cryptosporidium felis
DNA. Logistic regression models results showed that age (young)
and region were associated with presence of Giardia spp. DNA and
Cryptosporidium spp. DNA in feces of dogs and cats. In addition,
presence of Giardia spp. DNA in feces of dogs varied by season.
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1481
Pathogen Percent 95% CI Independent evaluation of SNAP 4Dx Plus and VetScan Ana-
Species plasma Tests was performed in three different veterinary practices
(Maine, New York and Minnesota) using samples obtained from
pet dogs. Similar results were obtained - the VetScan Test failed to
Dog Giardia spp. 7.7 7.3-8.0 detect over half of the IFA positive dogs detected by the SNAP
4Dx Plus Test in each of the three clinics.
Cryptosporidium spp. 5.4 5.1-5.7 These results demonstrate the SNAP 4Dx Plus Test has better
sensitivity for the detection of antibodies to both A. phagocy-
Cat Giardia spp. 5.2 4.9-5.5 tophilum and A. platys when compared to the Abaxis VetScan
Anaplasma Test.
Cryptosporidium spp. 7.4 7.0-7.9 1. Carrade et al. J Vet Intern Med. 2009, 23:1129.
2. Bowman DD, Topics in Companion Anim Med. 2011,
Cryptosporidium felis 5.1 4.7-5.4 26:173.
3. Qurollo BA et al. Infect Ecol Epidemiol. 2014, 4: 24699.
ID24 information gathered from the records included breed, age, sex
COXIELLA BURNETII DNA NOT IDENTIFIED IN FLEAS and spay/neuter status, location (by zip code), and the average
FROM DOMESTIC CATS IN AUSTRALIA AND THE USA. number of hours the dog spent outdoors. If a dog did meet the
Alison Manchester1, Jennifer Hawley1, Julia Beatty2, Vanessa study criteria then blood was drawn and tested for the presence
Barrs2, Michael Lappin1. 1Colorado State University, Fort Collins, of D. immitis using a commercially available ELISA test (IDEXX
CO, USA, 2Valentine Charlton Cat Centre, University of Sydney, Snap 4Dx Plus).
Sydney, Australia A total of 5,103 dogs were surrendered to the Oregon Humane
Society during this period. Of these, 298 met the inclusion criteria
Coxiella burnetii is a rickettsial pathogen with serious zoonotic and were included in the study. None of these 298 dogs tested pos-
implications (Q fever) transmitted by direct contact and vectored itive for Dirofilaria immitis. The tested dogs had spent a median of
by numerous tick species. Cats infected C. burnetii have been 2 years with their previous owners (range 6 months to 16 years)
implicated in human infections in Australia and the United States for a combined total of 1300.45 years of exposure. Using a likeli-
but minimal information exists concerning routes of feline infec- hood-based method, the maximum likelihood estimate (MLE) for
tion. Recently, C. burnetii DNA was isolated from Ctenocephalides the risk is 0 (95% CI: [0, 0.0023]) per year.
felis collected from wildlife in Cyprus; this flea commonly infests The findings of this study suggest that the likelihood of unpro-
cats. The purpose of this study was to evaluate select groups of tected Northwestern Oregon dogs developing heartworm infection
fleas from cats in the Australia and United States for the presence is currently very low. Heartworm transmission prediction models
of C. burnetii DNA using a previously optimized PCR assay. based on climate data (Knight/Lok) have shown that the climate
The DNA samples utilized in the study had been extracted from conditions in the area can support heartworm transmission. Data
fleas infesting 96 cats in previously published Bartonella spp., compiled by the Companion Animal Parasite Council (Capcve-
hemoplasmas, and Rickettsia felis studies. They were maintained t.org) confirm that Dirofilaria immitis has been diagnosed within
at 80°C until the present study. The fleas were collected from the state of Oregon, although only 0.18% of all positive cases of
cats in eastern Australia (86) and the southern United States (4 heartworm in the U.S. are in the state of Oregon. It is important
Alabama, 6 Florida) and pooled in groups comprised of a maxi- to consider that these data reflect a point in time. As the popula-
mum of 5 fleas before DNA extraction. A previously reported con- tion of Oregon continues to grow, more heartworm infected dogs
ventional PCR assay utilizing primers pairs targeting the IS-1111 will invariably arrive. Changes in climate patterns will also influ-
(IS-5, IS-9, IS-14 and IS-20) insertion sequences transposase ele- ence the transmission of this disease. Continued monitoring and
ments in the C. burnetii genome was used. If positive amplicon vigilance are recommended.
was detected, genetic sequencing would be performed to confirm
the presence of the pathogen.
For this study, fleas were not speciated before DNA extraction.
However, previous studies in both countries suggest C. felis was
most likely. The detection sensitivity of the assay was shown to be
3.14 ng total C. burnetii genomic DNA per PCR reaction utilized ID26
in all 4 primer sets. While all positive and negative controls per- ECTOPARASITES AND VECTOR-BORNE PATHOGENS OF
formed as expected, none of the 96 pooled flea extracts were posi- DOGS IN BAJA CALIFORNIA SUR. Cody Minor, Dana Hill,
tive for C. burnetii DNA. Danielle Straatmann, Michael Lappin. Colorado State University,
Coxiella burnetii DNA was not recovered from fleas collected Fort Collins, CO, USA
from cats in eastern Australia or the southern United States. The
results suggest that fleas infesting domestic cats in these regions In the last several years, clinical illness in a number of people in
are not important vectors for C. burnetii and are unlikely to play a Baja California Sur, Mexico, has been suspected to be associated
role in the transmission of the organism to humans with Q fever. with rickettsial disease agents such as Rickettsia rickettsii, Rick-
ettsia felis, and/or Ehrlichia species. The objective of this study is
to determine the prevalence of select vectors and vector-borne dis-
ease agents carried by companion dogs of the region.
During planned community outreach sterilization and vaccina-
tion clinics for local dogs with consenting owners, samples of
ID25 ectoparasites were collected from infested dogs and preserved in
RISK OF HEARTWORM INFECTION IN DOMESTIC CANI- alcohol for identification, and blood samples were collected in
NES OF NORTHWESTERN OREGON. Kirk Miller1, William EDTA and non-additive tubes retained for testing. Sera were
Rausch2. 1Oregon State University College of Veterinary assayed for antigen of Dirofilaria immitis and antibodies against
Medicine, Corvallis, OR, USA, 2Portland Veterinary Cardiology, Ehrlichia canis/E. ewingii, Anaplasma phagocytophilum/A. platys,
Portland, OR, USA and Borrelia burgdorferi using a commercial kit (SNAPÒ
4DXPlusÒ, IDEXX Laboratories). Sera were also assayed for
Canine infection with Dirofilaria immitis, the parasitic agent antibodies against Rickettsia species by indirect fluorescent anti-
responsible for causing heartworm disease, is easily and safely pre- body (IFA) testing (R. rickettsia antigen source). Total DNA was
vented via the periodic administration of one of a number of pre- extracted from blood and evaluated with conventional polymerase
ventative agents. Many veterinarians in Oregon do not routinely chain reaction (PCR) assays to amplify DNA of Anaplasma spe-
recommend the use of heartworm prophylactics; therefore, dogs cies, Babesia species, Bartonella species, Ehrlichia species, Rick-
are commonly not on a preventative. Confusion regarding the use ettsia species, and hemotropic Mycoplasma species
of heartworm preventatives in Oregon is understandable, given the (Hemoplasmas). Positive amplicons were sequenced to ascertain
paucity of incidence data in our region. The decision between a the species.
veterinarian and a client on whether or not to start a preventative Samples from 67 dogs were available. From these, ectoparasites
is often made based on a cost-benefit analysis, where only the cost Rhipicephalus sanguineus (33 dogs; 49.3%), Ctenocephalides felis
is known. The purpose of this study was to evaluate the risk of (11 dogs; 16.4%), and Pulex irritans/simulans (four dogs; 6.0%)
developing heartworm infection amongst unprotected dogs in were identified. Dirofilaria immitis antigen (one dog; 1.5%) and
Northwestern Oregon. This information will enable veterinarians antibodies against A. phagocytophilum/A. platys (10 dogs; 14.9%)
and their clients to make more informed decisions regarding heart- and E. canis/E. ewingii (31 dogs; 46.3%) were detected in the
worm prevention. serum of some dogs. Two samples had probable antibodies against
Between March 2010 and August 2015 owners of all dogs sur- R. rickettsii through IFA testing and are being confirmed. Evalua-
rendered to the Oregon Humane Society filled out a short ques- tion of DNA from 41 dogs has been completed to date; E. canis
tionnaire relating to their dogs’ histories. This questionnaire was DNA was amplified from eight dogs (19.5%), A. platys DNA from
used to determine the eligibility of each dog for this study. Criteria six dogs (14.6%), Babesia canis vogeli DNA from three dogs
for inclusion in the study included that the dogs: (1) had been in (7.3%), and Mycoplasma haemocanis DNA from three dogs
the possession of the surrendering party since they were 6 months (7.3%). Coinfections were confirmed in four dogs (9.8%) and con-
of age or younger; (2) were at least 12 months of age; (3) had no sisted of D. immitis/E. canis (one dog), E. canis/A. platys (one
history of travel outside of the state of Oregon; and (4) were never
administered heartworm preventative. Dogs that did not meet all
four of these criteria were excluded from the study. Additional
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1483
dog), E. canis/M. haemocanis (one dog), and E. canis/A. platys/ a grading scheme from 0 - 9. The samples were evaluated using a
M. haemocanis (one dog). previously validated qPCR to determine the Mycoplasma copy
Vector-borne agents detected to date likely reflect common number. Statistical methods consisted of using the Spearman’s rho
exposure to R. sanguineus, as this tick vectors each of the PCR- test to determine if severity of conjunctivitis was correlated to
confirmed agents. Further information will be gained by comple- qPCR Mycoplasma species copy number.
tion of the PCR assay analysis of the blood, fleas, and ticks. The results revealed the severity of conjunctivitis significantly
correlated to qPCR Mycoplasma copy number (Spearman’s corre-
lation coefficient 0.32, P = 0.0042), however, the strength of this
correlation was only mild to moderate.
Based on the results of this study, future investigation of the
impact of Mycoplasma species other than M. felis on the correla-
ID27 tion of qPCR and severity of conjunctivitis in cats should be
IDENTIFYING AGREEMENT AND BARRIERS TO performed.
PROPOSED CANINE INFECTIOUS DISEASE GUIDELINES
FOR DOG GROUP SETTINGS. Jason Stull , Michelle Evason2,
1
of life, with significantly greater weight gain compared with S only A controlled trial was conducted with clinically healthy cats
during the 1st week (S = 116 g [66; 172 g]; P = 0.001). Whatever (n = 24). Mean body weight was 4.9 kg and all cats had ideal
the period concerned, supplemented L gained more weight during body condition score of 3 on a 5-point scale. All cats were fed a
the entire neonatal period than the controls (841 g [485; 1087 g] “washout” diet (commercial feline diet) for five weeks, and were
versus 623 g [436; 858 g]; P = 0.048). No difference was evidenced then fed one of three test diets high in one of protein, fat or car-
between supplemented and control S (P = 1). bohydrate for five weeks. Diets were dry extruded formulations,
In our study large breed puppies supplemented at birth with the and each test diet provided approximately 50% of energy from the
hyper-immune egg yolk had greater weight gain during the entire test macronutrient, and 25% of energy from each of the other two
neonatal period. Retarded growth at the early stage of life test macronutrients. Leptin concentrations were measured during
increases the risk of morbidity and mortality in puppies4. Thus it two feeding patterns: a meal-feeding test (once daily feeding) and
could be hypothesized that better growth in supplemented puppies an ad libitum-feeding test, conducted 4 weeks after commencement
reflects a better health. Nevertheless, further studies are needed in of the test diets. During the meal-feeding test, cats ate 90 - 100%
order to confirm our findings in other breeding kennels and on of the 12 hour ad libitum intake as a single meal in 0.5 hour.
large number of individuals. Blood samples (4 mL), were collected over 24 hours in the meal
1
Poffenbarger et al., 1991; 2“Canine health product containing feeding test and 12 hours in the ad libitum test.
antibodies against canine parvovirus type 2” WO2015004181 A1.; Distributions of leptin variables in the ad libitum and meal-
3
Van Nguyen et al., 2006; 4Mila et al., 2012. feeding tests were similar across dietary groups after consumption
of the washout diet for 5 weeks. Mean baseline concentrations (av-
NM02 erage of 30 and 5 minutes values), mean concentrations over
EFFECTS OF DIETARY MEDIUM CHAIN TRIGLYCERIDES 24 hours (mean 24-h), and peak leptin concentrations in the meal
ON VOLUNTARY ACTIVITY IN DOGS AND CATS. Yuanlong feeding test varied significantly by diet (overall P < 0.001 to
Pan, Hui Xu, Sandeep Bhatnagar, Janet Jackson. Nestle Purina 0.027). Baseline, mean 24-h and peak leptin concentrations for the
Research, St Louis, MO, USA high fat diet were significantly higher than for the high protein
diet, and for baseline and mean 24-h, for the high carbohydrate
Decline in cerebral glucose metabolism is a common feature of diet. A similar pattern was observed in the ad libitum feeding test
aging in people and animals including rats, dogs, and monkeys, with highest leptin concentrations in cats consuming the high fat
and it is closely associated with age-dependent cognitive decline. diet. In general, leptin concentrations after consuming the high
We had confirmed in a previous study that dietary medium chain carbohydrate diet were not significantly different from the
triglycerides (MCTs) can enhance cognitive functions in dogs by high protein diet, but if they differed, leptin concentration for the
providing the brain with an alternative energy source. In this high carbohydrate diet was higher compared to the high protein.
study, we investigated the effects of dietary MCTs on voluntary There was no significant effect of diet on the time to peak leptin
activity in dogs and cats. concentration in the meal-feeding test (overall P = 0.855), and
In the cat study, sixteen middle-aged and senior cats were fed median times to peak leptin concentration were 15 hours for all
100% of their maintenance energy requirements (MERs) with a diets. In the meal-feeding test, only 3/8 cats significantly exceeded
control diet for one week, and then were switched to the MCT- their baseline leptin concentration for each of the high protein and
containing diet for 28 days. Their daily activity was monitored high fat diets, but 7/8 did so for the high carbohydrate diet. In
during the feeding trial with activity monitors. In the dog study, general, leptin concentrations decreased significantly approximately
twenty senior dogs were fed 100% of their MERs with a control 2 hr after eating in the meal feeding test, but remained relatively
diet for 6 days, and then were assigned to one of 2 MCT-contain- constant during ad libitum feeding. When data for all diets were
ing diets with 10 dogs per diet for 27 days. Then the dogs were combined, leptin was significantly positively correlated with insulin
switched to the alternative MCT diet for 32 days. Daily activity concentrations during ad libitum feeding (P = 0.008 to 0.036), but
was recorded with activity monitors during the feeding trial. In only at baseline and at 24 hours in the meal feeding test
cats, the MCT-containing diet significantly increased both daytime (P = 0.025 and <0.001, respectively). There were no correlations
(17381.23 2551.18 versus 22628.55 2790.61, P < 0.0001) and between leptin and either glucose or NEFA across all diets. Glu-
night time activity (4415.56 654.71 versus 5926.66 786.88, cose, insulin and NEFA did not account for the decline in leptin
P = 0.002). Interestingly, in dogs, both MCT diets significantly soon after feeding in the meal feeding test.
increased only daytime activity (80349.46 9703.34 versus In conclusion, independent of feeding pattern, leptin concentra-
99254.33 12163.83; 80349.46 9703.34 versus 105120.38 tions tend to be highest in lean cats consuming a diet with 50% of
11550.91, P < 0.05). The results show that both dogs and cats energy from fat, compared to diets high in protein or carbohy-
became more active when fed a diet containing MCTs drate. Leptin concentrations vary minimally over 12 hours of ad li-
bitum feeding, whereas leptin decreases approximately 2 hours
after feeding following a fast, and this decrease is not accounted
for by changes in insulin, glucose or NEFA concentrations. Fur-
ther investigation is needed to understand the interactions between
hormones associated with satiety, dietary factors and weight gain
NM03 in cats.
EFFECTS OF DIETARY MACRONUTRIENT CONTENT AND
FEEDING PATTERN ON LEPTIN CONCENTRATIONS IN
LEAN HEALTHY CATS. Dagmar Tarkosova1, Jacquie Rand2,
Heidi Farrow2, Marcia Coradini2, John Morton3. 1University of
Veterinary and Pharmaceutical Sciences, Brno, Czech Republic,
2
The University of Queensland, Brisbane, Australia, 3Jemora Pty NM04
Ltd, Geelong, Australia EFFECT OF HIGH SODIUM DIET ON BLOOD PRESSURE
AND CARDIAC FUNCTION IN HEALTHY ADULT DOGS.
Excessive weight gain is associated with metabolic and hor- Hui Xu, Dottie Laflamme, Sandeep Bhatnagar, Xuemei Si, Grace
monal changes that predispose cats to insulin resistance and other Long. Nestle Purina PetCare Research, St. Louis, MO, USA
disorders. The adipokine leptin is an important regulator of energy
metabolism, and circulating leptin concentrations correlate with Promoting water intake is recommended for managing dogs
fat mass in cats and other species. In cats, leptin is associated with with lower urinary tract disease. Increased dietary salt has been
insulin resistance, independent of bodyweight. Although dietary used for this purpose in veterinary therapeutic diets. The objective
factors such as energy density, fat content and feeding pattern of this study was to evaluate potential adverse effects of dietary
increase the risk of obesity, there is limited information on how salt (sodium chloride) on blood pressure and cardiac function in
dietary factors such as feeding, fasting, and macronutrient content dogs.
influence leptin concentrations in cats. The aims of this study were Following a two week baseline period where dogs were fed a
to compare leptin concentrations in lean, healthy cats fed diets Control Diet containing 0.13 g sodium/100 kcal ME, twenty
high in protein, fat and carbohydrate, to assess associations healthy dogs (6–10 years old) were allocated to two groups and fed
between leptin concentrations and insulin, glucose, and NEFA diets differing only in total sodium chloride content: CONTROL
concentrations, and to determine the effects of feeding pattern on (CON) = 0.13 g sodium /100 kcal ME, or High Sodium Diet
baseline and postprandial leptin concentrations. (HNA) = 0.41 g sodium/100 kcal ME. Dogs were fed their
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1485
respective diet for 6 months. During this period, indirect systolic as well as presence or absence of specific taste imparting com-
blood pressure was recorded monthly. Overall health, cardiac func- pounds (palatability enhancers). This study investigated the rela-
tion evaluated by echocardiography (performed by boarded veteri- tionship of food choice on macronutrient composition and that
nary cardiologist), plasma B-type natriuretic peptide (BNP), serum choice on subsequent plasma amino acid concentrations. Experi-
biochemistry and urinalyses were assessed at 0 and 6 months on mental foods for dogs and cats were individually prepared to have
test. Body composition was analyzed by dual energy X-ray absorp- similar palatability through manipulations of factors independent
tiometry (DEXA) at 0, 3 and 6 months. Treatment effects were of macronutrients. Foods with similar palatability preference for
analyzed using t-test and Generalized Linear Mixed Models. their respective populations as a whole were then investigated for
Overall, dietary sodium level had no significant effect on blood intake choice using 20 dogs with varying body fat composition
pressure, cardiac function, plasma BNP, serum biochemical pro- (mean, 3.9 kg; SD, 0.9 kg; range, 2.4–6.2 kg;) and 27 cats (mean
files or urinalyses. There were no dietary effects or diet by time body fat composition, 1.4 kg; SD, 0.9 kg; range 0.3–2.2 kg). Sub-
interactions on bone mineral content or body composition. In con- sequent effects of food choice on serum amino acids were also
clusion, consumption of a diet containing 0.41 g sodium/100 kcal determined. Four completely balanced foods were available to
ME had no adverse effects on blood pressure or cardiac function dogs and cats at all times. The four varied in macronutrient con-
in healthy adult dogs over a 6-month period. tent: Food 1: high protein (33% of calories from protein for dogs;
42% for cats); Food 2: high fat (54% of calories from fat for
NM05 dogs; 44% for cats); Food 3: high carbohydrates (56% of calories
DETERMINING THE LACTATE AND GLUCOSE THRESH- from carbohydrate for dogs; 52% for cats); and Food 4: blended
OLDS AND THE ACID-BASE IMBALANCES IN BEAGLES macronutrients. Dogs on average chose to consume 23.0% calories
DOGS. Alejandro Zamora Restan, Evandro Zacche, Jaislaine from protein (SD, 1.5%; range 20–26%) whereas cats chose
Braz, Raphaela Marques Canola, Samara Beretta, Antonio 30.3% of calories from protein (SD, 4%; range 24–38%). Body
Queiroz-Neto, Guilherme Camargo Ferraz, Aparecido Antonio composition influenced their choice of calories from protein. In
Camacho. Universidade Estadual Paulista – UNESP, Jaboticabal, dogs, there was a positive relationship between body fat and per-
Brazil cent calories consumed as protein (r = 0.56; P = 0.02). There was
no relationship between lean body mass and percent calories con-
The determination of lactate and glucose threshold in dogs sub- sumed as protein (r = 0.06; P = 0.82). Overall, dogs with high
mitted to incremental exercise test (IET) is scarce. This study body fat showed the highest preference for dietary calories from
aimed (1) to determine the lactate and glucose thresholds (2) to protein. In cats, both body fat and lean body mass were negatively
investigate the acid-base responses of untrained dogs submitted to associated with calories consumed as protein (P = 0.04; P = 0.02,
incremental exercise test. Fourteen Beagle dogs, 1–2 years old, respectively), with a positive association for the interaction
healthy and untrained were used for determination of lactate and (P = 0.02). Overall, cats with high body fat and high lean body
glucose thresholds and submitted to IET using treadmill, with slop mass showed the highest preference for dietary calories from pro-
from 5 to 7.5% and increasing speeds of 0.5 m/s every 5 minutes. tein. Dogs had higher circulating amino acid concentrations of
The test was concluded when dogs presented fatigue signals. Blood threonine, methionine, isoleucine, and valine (P < 0.05) compared
samples were collected after 90 seconds of each effort step, though with cats, the later which had higher circulating amino acid con-
venous catheter placed in the jugular vein. The samples used for centrations of isoleucine, valine, tyrosine, phenylalanine, and his-
determination of acid-base alterations were collected in the tidine (P < 0.05). In both dogs and cats there was no effect of
moments before of IET, immediately and five minutes after the protein intake on circulating essential amino acid concentrations.
fatigue. Data were submitted to Shapiro-Wilk test, and the Pear- Increased intake of calories as protein was associated with increas-
son was used to correlate the running velocities corresponding to ing plasma ornithine (dogs only) and citrulline (dogs and cats)
the lactate and glucose threshold and analysis between moments concentrations (P < 0.05). In summary, given the opportunity to
of assessment was performed by using repeated measures one-way choose between foods with similar palatability, cats chose to con-
ANOVA (P < 0.05). It was found high correlation between lactate sume 30.3% and dogs 23.0% of their calories as protein. Although
and glucose threshold velocities, r = 0.84 (P < 0.01), and for pH, there were species differences between circulating amino acid con-
PCO2, HCO3 strong ions difference (SID) were found moment centrations indicating metabolic shifts associated with protein
effect (P < 0.001). The basal values of pH increased (P < 0.001) in intake, there were no changes in circulating essential amino acid
fatigue (7.341 0.02 to 7.390 0.04, respectively), and the PCO2 concentrations.
presented reduction (P < 0.001) in the fatigue and 5 minutes after
fatigue (31.74 5.9, and 37.01 5.8), in comparison with basal
value (41.4 2.2). The HCO3 decreased in fatigue and 5 minutes
after IET (18.2 2.3 and 19.1 2.5) when compared with basal
(21.9 1.1). The values of SID showed decreased in fatigue com-
pared to values before exercise (36,2 1,7 e 36,6 2.1) respec- NM07
tively. Running velocities corresponding to the lactate and glucose A DOUBLE MASKED CLINICAL TRIAL OF A THERAPEU-
threshold showed accordance between them, what has been TIC FOOD IN THE MANAGEMENT OF CANINE ATOPY.
already shown in horses and humans, besides results showed respi- Jennifer Macleay, Heidi Schiefelbein, Kathy Gross. Hill’s Pet
ratory alkalosis and metabolic acidosis, which is considered a Nutrition Inc., Topeka, KS, USA
change due to hyperventilation and strenuous anaerobic activity,
decreasing PCO2 concentrations, which leads to increase pH The purpose of this double masked, controlled multicenter clini-
through the increase of the relation of HCO3 and PCO2. SID cal trial was to determine the impact of a food with ingredients
showed a metabolic acidosis possibly from lactate values increase. designed to have skin and coat health benefits and immune modu-
Results of this study suggest that glucose threshold can be used as lating effects on clinical signs of seasonal atopic dermatitis versus
a marker of aerobics capacity in dogs as it is used in humans and a control food. Dogs with a history of seasonal dermatitis, but
horses, besides, maximum exercises in dogs cause acid basic without current clinical signs consistent with atopy (CADESI and
alterations. pruritis scores = 0) were recruited in the spring from 11 general
practices in the United States. Dogs currently on foods designed
for adverse food reactions were excluded. Eligible dogs were ran-
domly assigned to Test or Control groups and evaluated by their
veterinarian at 0, 4, 8, 12 and 16 weeks. Consistent with accepted
standards of care, treatment was not withheld, therefore, pre-
NM06 scribed medications and dosing information was collected; only
WHEN FED FOODS WITH SIMILAR PALATABILITY, CATS oclacitinib which was not uniformly available to all practices was
CHOOSE 30%, DOGS 23% OF CALORIES AS PROTEIN. disallowed. Veterinarians graded skin lesions using a modified
Dennis Jewell1, Jodi Vondran1, Melissa Vanchina1, Jean Hall2. CADESI (0:absent - 4:severe for erythema, alopecia, excoriations
1
Hill’s Pet Nutrition, Inc., Topeka, KS, USA, 2Oregon State and lichenification for 27 body sites, max score of 432) and a pru-
University, Corvallis, OR, USA ritis score (0:absent - 4:severe).
Forty-four adult dogs (22 Test, 22 Control) were enrolled and
Dogs and cats have specific taste preferences that are influenced completed the study. During the course of the study 18% of all
by macronutrient composition and physical characteristics of food, dogs had no reported dermatological clinical signs whereas 82%
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1486 2016 ACVIM Abstracts
upper range of normal dogs. Based on healthy dog phosphorus most effective dose. PRCA was a possible adverse event in 1/34
concentrations, 11 (32%) CKD dogs had elevated phosphorus dogs (2.9%).
concentrations. Only eight (24%) CKD dogs had hyperparathy-
roidism.
These findings suggest that FGF-23 concentrations rise in
canine CKD before other traditional markers of RHPT do. Conse-
quently, FGF-23 concentrations should be considered as an early
indicator of disease progression, RHPT, and potential target for NU05
therapeutic intervention. VITAMIN D-BINDING PROTEIN – EARLY MARKER OF
TUBULAR INJURY IN DOGS WITH CHRONIC KIDNEY
DISEASE. Fernanda Chacar1, Marcia Kogika1, Talita Sanches2,
Douglas Caragelasco1, Cinthia Martorelli1, Camila Rodrigues2,
Jose Capcha2, L
ucia Andrade2. 1School of Veterinary Medicine
and Animal Science, University of Sao Paulo, SP, Brazil, 2School
NU04 of Medicine, University of Sao Paulo, Sao Paulo, Sao Paulo,
THE USE OF DARBEPOETIN ALFA TO STIMULATE Brazil
ERYTHROPOIESIS IN DOGS WITH CHRONIC KIDNEY
DISEASE. E. Hathaway Fiocchi1, Dorothy Brown1, Larry Vitamin D-binding protein (VDBP) is the main carrier of vita-
Cowgill2, Samuel Tucker3, Jessica Markovich3, Mary Ann min D metabolites into circulation, and it is freely filtrated
Labato3, Mary Beth Callan1. 1University of Pennsylvania, School through glomerulus, and the complex VDBP-25-OH-vitamin D is
of Veterinary Medicine, Philadelphia, PA, USA, 2University of uptaken by megalin-cubilin receptors in proximal tubules. Once
California, Davis School of Veterinary Medicine, Davis, CA, the presence of VDBP in urine, it may indicate proximal tubular
USA, 3Tufts University School of Veterinary Medicine, North dysfunction/injury as well as interstitial tubular fibrosis. Also it
Grafton, MA, USA still remains to be proven whether loss of VDBP in urine may lead
to vitamin D deficiency and its contribution to the progression of
Erythropoiesis-stimulating agents are currently recommended chronic kidney disease (CKD) in dogs. The hypothesis and the
for veterinary patients with anemia secondary to chronic kidney aim of this study were to investigate whether VDBP could be pre-
disease (CKD). Darbepoetin alfa (darbepoetin) has replaced epo- viously detected in urine of dogs with CKD regardless of urinary-
etin due to a three-fold longer half-life allowing for less frequent to-protein ratio (UPC) values, and it will be an early and specific
dosing. Also, darbepoetin is perceived to be less likely to elicit for- marker of proximal tubular injury. Forty dogs according to IRIS
mation of anti-erythropoietin antibodies resulting in pure red cell staging of CKD (stage 1 n = 10; stage 2 n = 10; stage 3 n = 10;
aplasia (PRCA). A previous study examined the efficacy of darbe- stage 4 n = 10) were enrolled, various breeds and age, and with no
poetin in cats with CKD; 14 of 25 cats responded, with adverse proteinuric-associated disease. Nine clinically healthy dogs, differ-
events observed in 12 cats, including two with possible PRCA. ent breeds and age, composed the control group. Dogs with CKD
This retrospective study evaluated response to darbepoetin ther- were classified according to IRIS guidelines based on UPC as non-
apy, protocols for administration, and potential adverse events in proteinuric (UPC<0.2), borderline proteinuric (UPC= 0.2 to 0.5)
dogs with CKD. and proteinuric (UPC>0.5). Western blotting was performed to
Thirty-four dogs with IRIS stage 3 or 4 CKD met the inclusion investigate VDBP in canine urine (Anti-Vitamin D Binding Protein
criteria and their medical records were reviewed. Data recorded antibody, ab95469, Abcam© 1:500). No urinary VDBP was
included CBC, serum biochemistry panel, reticulocyte count, detected in control dogs and UPC was 0.14 0.04 (meanSEM)
serum iron parameters, systolic blood pressure, packed red blood and min= 0.028 and max= 0.41. In CKD dogs, urinary VDBP was
cell (pRBC) transfusion, iron supplementation, darbepoetin dose observed since the early stages of CKD, stages 1 and 2, and the
and frequency of administration, comorbidities, adverse events, UPC was 0.39 0.29; 0.02–3.01 and 0.33 0.12; 0.14–1.14 (mean
and survival. SEM; min - max), respectively. In stage 1 CKD dogs, urinary
Starting HCT ranged from 9.6–28.9% (mean of 19.7%). The VDBP was detected in 7 out of 10 dogs and in 4 of those 7 dogs,
starting dose of darbepoetin ranged from 0.4 - 2.08 mcg/kg (me- UPC was into the non-proteinuric range, 2 dogs in borderline
dian 0.5 mcg/kg). The initial dosing frequency was every 7 days in range and only one was proteinuric. In stage 2 CKD dogs, VDBP
31/34 dogs. Nine of 34 dogs received a pRBC transfusion and 27/ in urine was noticed in 9 out of 10 CKD dogs and 5 of them had
34 dogs received iron supplementation in the form of a pRBC UPC < 0.2, one dog was in borderline (UPC= 0.42) and 3 dogs
transfusion, intramuscular iron dextran, oral supplementation, or were slightly proteinuric (UPC of 0.67, 0.72 and 1.14). In CKD
a combination thereof at the start of darbepoetin therapy. Sixteen dogs in stage 3, UPC was 1.51 0.54 (0.07–4.57) and VDBP in
of 34 dogs received on-going iron supplementation throughout urine was immunodetected in 8 out of 10 dogs and in 3 of those 8
treatment. dogs, UPC was ≤ 0.28 and the left 5 dogs were proteinuric. All
Survival following initiation of darbepoetin therapy ranged from CKD dogs in stage 4 were proteinuric (UPC = 4.37 0.47; 1.4–
30 – 546 days (median 118 days). An estimated 442 doses of darbe- 6.94) and showed VDBP in urine. In conclusion, the immunode-
poetin were administered over that course of treatment; the range tection of VDBP in urine noticed in the early stages of CKD in
of doses administered per dog was 2 - 61 (median 11.5 doses per dogs, mainly in stages 1 or 2, associated with UPC into non or
dog). Dogs were considered responders if they achieved a HCT of borderline proteinuric range, it reinforces that urinary VDBP
30% over the course of treatment. Twenty-nine of 34 dogs were could be a potential early marker of kidney injury as well as to
responders. Time to response ranged from 6 - 106 days (median detect the specific segment (proximal) of the nephron affected.
28 days). There was no association between starting HCT, dose or
frequency of administration of darbepoetin, or initial iron supple-
mentation between responders and non-responders. Dogs that
received a pRBC transfusion at the onset of treatment were more
likely to be non-responders (P = 0.013). Twenty-two dogs were
transitioned to an extended dosing interval following response, and NU06
15 of those dogs subsequently required the dosing interval to be ASSESSMENT OF REPEATED ADMINISTRATION OF A
shortened to maintain target HCT. No dog sustained a response at FELINE FVRCP VACCINE AS A MODEL FOR INTERSTI-
a dosing interval greater than every 21 days. Potential adverse TIAL NEPHRITIS. Stacie Summers, Shannon McLeland, Jennifer
events were documented in 19/34 dogs and included increased sys- Hawley, Jessica Quimby, Randall Basaraba, Catriona MacPhail,
tolic blood pressure requiring treatment (n = 12), seizures (n = 5), Michael Lappin. Colorado State University, Fort Collins, CO,
vomiting (n = 3), diarrhea (n = 3), hypersensitivity reaction to iron USA
injection (n = 1), and possible PRCA (1). Development of potential
adverse events resulted in discontinuation of darbepoetin only with Progressive interstitial nephritis (IN) is the primary cause of
respect to possible PRCA; in all other cases, adverse events were feline chronic kidney disease which is considered to be the leading
more likely attributed to underlying disease. cause of death in adult cats. The Crandell Rees feline kidney
Darbepoetin is an effective treatment for anemia secondary to (CRFK) cell line is commonly used to grow feline herpesvirus 1
CKD. A dosing interval of >21 days is not effective at maintaining (FHV-1), calicivirus, and panleukopenia virus used in (FVRCP)
a response to therapy. Further studies are needed to define the vaccine production. Previous studies have shown that cats
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1488 2016 ACVIM Abstracts
administered FVRCP vaccines parenterally develop antibodies creatinine concentrations were measured using a Hitachi 911
against CRFK lysates and alpha enolase (glycolytic pathway Chemistry Analyzer (Boehringer Mannheim Corp.); the glucose
enzyme in all mammalian cells) and these antibodies can bind to measurements were considered to be the true concentration (gold
feline renal cell lysates. In addition, three of six cats that were standard). Spearman’s rank order correlation was used to evaluate
hyperinoculated (11 injections) with CRFK lysates over two years the relationship between: 1. glucose concentration and automated
had IN on renal biopsy collected two weeks after the last booster. readings; 2. glucose concentration and visual reading; 3. auto-
The primary objective of this study was to determine whether IN mated and visual readings; 4. automated readings and UGCR;
could be induced over 16 weeks by repeatedly administering a and 5. visual readings and UGCR. Significance was set at
market leading parenteral FVRCP vaccine to potentially use as a P < 0.05. Correlation was classified as excellent for r = 0.93–0.99,
short term model to study biomarkers associated with IN in cats. good for r = 0.8–0.92, fair for r = 0.59–0.79 and poor for r < 0.59.
A total of six (three male; three female) one-year-old purpose Reference intervals that correlated with the colors on the test strip
bred cats were included in the IACUC approved study. The cats were devised based on the package insert (trace=76–175 mg/dL;
were previously maintained as unvaccinated controls in a FHV-1 1 + = 176–375 mg/dL; 2 + = 376–750 mg/dL; 3 + = 751–
study at five months of age and none of the cats had clinical signs 1500 mg/dL; 4 + = >1500 mg/dL).
of FHV-1 when enrolled in the current study. On Week 0, blood, Significant correlation was detected between both automated
serum, urine were collected for biomarker assays and a wedge kid- and visual readings and glucose concentration (P < 0.0001). The
ney biopsy for histopathological evaluation and alpha-enolase correlation for automated readings was good (r = 0.834) but fair
immunohistochemistry was obtained. After sample collection on for visual readings (r = 0.761). Overall, the underestimations and
Week 0 and again on Weeks 2, 4, 6, 8, 10, 12, and 14, all cats overestimations of glucose concentration for the automated read-
were administered a commercially available FVRCP vaccine ings was 56.4% and 15.4%, respectively. For the visual readings,
shown previously to induce anti-CRFK and anti-enolase antibod- they were 13.2% and 36.8%, respectively. Significant correlation
ies and samples were collected for biomarker assays. After sample was detected between both automated and visual readings and
collection on Week 16, similarly sized renal biopsies were made, UGCR (P < 0.0001). However, correlation for automated readings
avoiding the previous biopsy sites. Haematoxylin and eosin stained was classified as good (r = 0.801) but for visual readings was fair
sections were provided to two board-certified pathologists that (r = 0.719). Furthermore, automated and visual readings had a
were masked to the timing of the biopsies. Anti-CRFK and anti- significant (P < 0.0001) and good correlation (r = 0.817).
enolase antibodies levels in serum were determined by ELISAs. Our results indicate that despite a good correlation between
All 6 cats developed progressively increasing anti-enolase and automated and visual reading of Bayer Multistix, automated read-
anti-CRFK serum antibodies. ing may be better. Interestingly the automated readings tend to
underestimate glucose concentration while with visual reading,
overestimations are more common. The UGCR is a valid way to
Mean and SD of ELISA absorbance values of 6 cats administered an FVRCP assess urinary glucose excretion; however, it offers no advantage
vaccine
over measurement of glucose concentration in urine.
Antibody Week 0 Week 4 Week 8 Week 12 Week 16
Enolase 0.57 ± 0.16 2.00 ± 0.74 3.48 ± 0.72 3.82 ± 0.47 3.88 ± 0.43
CRFK 0.28 ± 0.03 0.66 ± 0.23 1.38 ± 0.39 1.63 ± 0.37 1.81 ± 0.4
NU08
IMPACT OF CANINE PANCREAS-SPECIFIC LIPASE ON
THE OUTCOME OF DOGS WITH HEMODIALYSIS-DEPEN-
DENT ACUTE KIDNEY INJURY. Kanae Takada, Carrie Palm,
Histological evidence of interstitial nephritis was not detected
Steven Epstein, Larry Cowgill. University of California-Davis
by light microscopy in any of the tissue biopsies. Significant bio-
Veterinary Medical Teaching Hospital, Davis, CA, USA
chemical or urinalysis changes during the study were not detected
and the cats were adopted to private homes for long term moni-
Acute pancreatitis (AP) and acute kidney injury (AKI) are com-
toring.
mon co-morbidities in both dogs and humans. In human patients
While anti-CRFK and anti-enolase antibodies were induced in
the presence of AP with AKI is a negative prognostic factor; how-
this model, biochemical or histopathology abnormalities were not
ever, a similar relationship has not been evaluated in dogs. When
detected. Results of selected biomarkers and enolase immunohisto-
considering hemodialysis for management of AKI in dogs, this
chemical staining will be used to further evaluate this potential IN
prognostic information could be important for therapeutic deci-
model.
sions. Canine pancreas-specific lipase (SPEC) is used commonly to
support the diagnosis of AP in dogs. The purpose of this study
was to investigate elevated SPEC on the outcome of dogs with
AKI treated with hemodialysis.
Medical records were evaluated retrospectively from August
NU07 2011 to June 2015 to identify dogs presented to the UC Davis
COMPARISON OF VISUAL AND AUTOMATED INTERPRE- VMTH that received intermittent hemodialysis for management of
TATION OF URINARY DIPSTICKS WITH GLUCOSE:CREA- AKI and also had a SPEC (Spec cPLTM, IDEXX Laboratories)
TININE RATIO AND GLUCOSE CONCENTRATION. Caroline measured during the course of therapy. Outcome was assessed at
Aldridge1, Ellen N. Behrend1, Jo Smith2, Elizabeth G. Welles1, 30 days from admission, and dogs were classified as died/eutha-
Hollie P. Lee1. 1Auburn University, Auburn, AL, USA, 2Univer- nized or alive. Surviving dogs were stratified further into non dial-
sity of Georgia, Athens, GA, USA ysis-dependent or dialysis-dependent. An elevated SPEC was
defined as ≥ 400 mcg/L. Median values of SPEC were compared
The accuracy of Bayer Multistix with visual reading for deter- with a Mann-Whitney U test for each outcome category, above.
mination of the glucose concentration in canine urine is only 59% Categorical data were compared with a Fisher’s exact test. A P-
(Behrend et al, J Vet Int Med, 2009). The correlation between value of <0.05 was considered significant. Data are presented as
visual and automated assessment has not been investigated. Fur- median [range].
thermore, urine glucose:creatinine ratio (UGCR) may be a useful Forty-three client-owned dogs were included. Median initial
method in quantifying glucosuria similar to urine protein:crea- serum creatinine (iSCr) was 8.5 [3.6 - 16.6] mg/dl and median age
tinine ratio but has not been assessed. The purpose of this study at presentation was 5.6 [0.70 - 13.5] years. Eighteen were male neu-
was to compare automated readings, visual readings and UGCR tered, 14 were female spayed, 4 were intact male, and 7 were intact
for quantification of glucosuria in canine urine. female dogs. At 30 days, 30/43 dogs (70%) were alive (iSCr, 8.6
Urine samples submitted to the Auburn University Clinical [4.7 - 16.6] mg/dl) and 13/43 (30%) had died or been euthanized
Pathology Laboratory for urinalysis and that were naturally gluco- (iSCr, 8.0 [3.6 - 15.3] mg/dl). Nine of 30 dogs (30%) were still dial-
suric (n = 39) were included. Multistix (Bayer) were used accord- ysis dependent at 30 days (iSCr, 10.9 [6.1 - 15.4] mg/dl), and 21/30
ing to manufacturer instructions and were read visually by a single (70%) were non dialysis-dependent (iSCr, 8.3 [4.7 - 16.6] mg/dl).
trained investigator (“visual reading”) and by the CLINITEK 50 SPEC was not significantly different between dogs alive at 30 days
analyzer (Bayer; “automated reading”). Urine glucose and urine and dogs that had died or were euthanized (SPEC 627.5 [29 -
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1489
2001] mcg/L versus 455.0 [30 - 2001] mcg/L, P = 0.50). SPEC in research is needed to determine if antibiotic therapy is indicated in
dialysis-dependent dogs was significantly higher than non dialysis- dogs with CKD and SBU. Additionally, renal biomarkers may
dependent dogs (SPEC 1001.0 [177 - 2001] mcg/L versus 379.0 [29 allow for better characterization of patients with SBU and occult
- 1001] mcg/L, P = 0.008). The proportion of dogs alive at 30 days pyelonephritis and improve antibiotic stewardship.
with SPEC ≥ 400 mcg/L during the treatment course was not dif-
ferent from alive dogs with SPEC < 400 mcg/L (71% versus 68%, NU10
P = 1.0). In addition, the proportion of the non dialysis-dependent INITIAL OUTCOMES AND COMPLICATIONS OF THE
dogs with SPEC ≥ 400 mcg/L during the treatment course was not SUBCUTANEOUS URETERAL BYPASS PROCEDURE AT
different from non dialysis-dependent dogs with SPEC < 400 mcg/ TWO UNIVERSITY HOSPITALS (2012–2015). Ewan D.S.
L (42% versus 58%, P = 0.36). Wolff1, Roswitha Dorsch2, Julia Knebel2, Daniel J. Duffy1,
These results suggest the presence of pancreatitis assessed as Lynetta J. Freeman1, Lynn Guptill1, Larry G. Adams1. 1Purdue
SPEC ≥ 400 mcg/L did not affect survival outcome at 30 days. University, West Lafayette, IN, USA, 2Ludwig Maximilians
However, pancreatitis may be a more common co-morbidity in University Munchen, Munich, Bavaria, Germany
dogs with more severe (dialysis-dependent) AKI and it may influ-
ence renal recovery. The aim of this study was to report combined experience of two
institutions placing subcutaneous ureteral bypass systems (SUBs).
We compared our data to historical data from cats with ureteral
stents for ureteral obstruction. Hypotheses included 1) Patients
with SUBs would have the same or better 7–14 day and 3–
4 month post-operative creatinine as historic ureteral stent
NU09 patients, 2) SUB patients would experience the same or improved
CHARACTERIZATION OF SUBCLINICAL BACTERIURIA, peri-operative, post-operative and recurrent urinary tract infection
URINARY TRACT INFECTION, AND PYELONEPHRITIS IN rates as ureteral stent cats, 3) clinical signs related to implants
DOGS WITH CHRONIC KIDNEY DISEASE. Jonathan Foster, would be similar or better with the SUB system versus ureteral
Harathi Krishnan, Stephen Cole. University of Pennsylvania, stenting.
School of Veterinary Medicine, Philadelphia, PA, USA Adult cats were enrolled retrospectively, subsequent to the 2012
alteration to SUB placement procedure. All cats were managed
Bacterial urinary tract infection (UTI) is common in dogs, how- per clinician preference pre-operatively. Flushes of SUB systems
ever the prevalence of subclinical bacteriuria (SBU) in healthy were performed every 3–6 months for the majority of patients.
dogs has recently been demonstrated to be substantially lower. Records from 19 cats from Purdue and Munich Universities
Following standards created by human infectious disease special- were reviewed. Median age was 9 years at Purdue and 7.7 years at
ists, there has been more initiative put towards identifying and Munich. There were 12 spayed female and 7 castrated male cats;
characterizing SBU in dogs. Although it has been considered a 13 domestic short-haired cats, 2 domestic longhaired cats, and
risk factor for UTI, the prevalence of UTI and SBU in dogs with three other breeds. 17% of cats had preexisting IRIS Stage II
chronic kidney disease (CKD) is not known. The objectives of this CKD. Lethargy, vomiting and inappetence were the most common
study were to retrospectively evaluate the prevalence of positive clinical signs (>25% of patients). Median renal pelvic diameter in
urine cultures in dogs with CKD, and to further categorize these affected kidneys was >0.5 cm at both institutions. Median crea-
patients as having SBU, clinical UTI, or pyelonephritis. tinine immediately post-operatively was 2.6 mg/dL (0.9–2.3 mg/
Medical records were reviewed retrospectively from 1/2010–7/ dL) at Purdue and 1.43 mg/dL at Munich. Major peri-operative
2015 for dogs with a diagnosis of CKD who had a urine culture complications were uncommon; one cat had cardiac arrest and
submitted. The diagnosis of CKD was based on International another was transfusion dependent. Post-operative complications
Renal Interest Society (IRIS) guidelines. Patients were excluded if included 2 cats with fluid overload and pleural effusion. 8/19 cats
they had another reason to develop UTI, namely endocrine disease required a blood transfusion in the peri- or post-operative period.
(hyperadrenocorticism, diabetes mellitus), urolithiasis, urinary The median creatinine was 3.6 mg/dL at 3 months and 1.8 mg/dL
incontinence, urinary bladder neoplasia, had a nidus for infection at 6 months. 3 patients had repeat surgeries; median time to repeat
such as ureteral stent or subcutaneous ureteral bypass, or were surgery was 225 days. Causes of repeated surgery were SUB port
receiving systemic immunosuppression. Based on previously obstruction or encrustation of SUB tubing. Total mortality was
reported definitions, patients were placed into one of the following 21% with a median disease free interval of 180 days and a 1 year
three categories based on the review of their medial record: SBU, survival of 83%.
pyelonephritis, or UTI. The frequency of negative culture, SBU, No cats had active urine sediment or culture prior to SUB
pyelonephritis, and UTI were compared across IRIS stages using placement, but post-operative and follow up urinary tract infec-
Fisher’s exact analysis. P < 0.05 was considered significant for all tions occurred. 21% of patients had urinary tract infection within
comparisons. 10 days of surgery. Two patients had recurrent multi-drug resis-
Two hundred and eighty-two cultures were submitted on 195 tant E. coli infection, one was cultured as a biofilm. Another
patients during the study time period. Forty-seven cultures per- patient developed encrustation 10 months post-procedure. Man-
formed on 13 patients were excluded due to the presence of uret- delic acid, EDTA, antibiotic infusions into SUBs failed to resolve
eral stents (5 patients), chemotherapy (2 patients), diabetes UTI in 2 cats.
mellitus (2 patients), transitional cell carcinoma (2 patients), uri- Comparing SUB outcomes to ureteral stenting, 6 month post-
nary incontinence and cystic calculi (1 patient each). A total of procedural creatinine was better in the SUB group (1.8 mg/dL)
235 cultures submitted on 182 patients were included in the final than that reported for stents (2.6 mg/dL). One year survival was
analysis. There were 8 intact males, 52 castrated males, 5 intact similar for stent cats (86%) and SUB cats (83%). Long-term infec-
females, and 117 spayed females. There were 40 positive urine cul- tion rates were similar (around 31%). Only one SUB patient expe-
tures (17.0% of all cultures) obtained on 33 patients (18.1% of all rienced dysuria beyond the post-operative period whereas this is
dogs). Of all positive cultures, the most frequently determined more common in cats with stents.
diagnosis was SBU (18 cultures, 45%), followed by pyelonephritis This study suggests that the SUB system carries similar poten-
(16 cultures, 40%), then UTI (6 cultures, 15%). There were no sta- tial complications of re-obstruction, encrustation and infection to
tistically significant observed relationships between any IRIS stage ureteral stenting. Recurrent and resistant infections and the poten-
and diagnosis (P = 0.635). The number of positive cultures, tial for biofilms is a significant concern in SUB patients. Protocols
regardless of patient diagnosis, was not statistically significant for treatment of resistant UTIs utilizing local instillation and
between IRIS stages (P = 0.432). Escherichia coli was the most fre- indwelling bladder treatment should be developed in a prospective
quently observed isolate (29/40 cultures, 72.5%). fashion. Further work with more cases could explore risk factors
In this population of dogs with CKD the prevalence of dogs for UTI and obstruction.
with positive urine culture was 18.1%. The most frequently
observed diagnosis associated with a positive culture was SBU.
Increasing IRIS stage of CKD was not found to be associated with
a higher frequency of any particular diagnosis. E. coli was the most
commonly observed isolate. Despite the rigorous criteria for defin-
ing SBU, pyelonephritis, and UTI in the current study, it is possi-
ble that some patients were incorrectly categorized. Prospective
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1490 2016 ACVIM Abstracts
and monitor therapeutic outcomes. The objective of this study was NU16
to investigate use of a video recording system (VRS) to more reli- POSITIVE IMPACT OF NUTRITIONAL INTERVENTIONS
ably assess and quantify urination behaviors in cats. Litter box IN CLIENT-OWNED DOGS WITH IRIS STAGE-1 CHRONIC
urination behaviors were quantified in 11 healthy cats and 8 cats KIDNEY DISEASE. Jean Hall1, Dale Fritsch2, Maha Yerramilli3,
with abnormal urination patterns using a VRS for 14 days and Edward Obare3, Murthy Yerramilli3, Dennis Jewell2. 1Oregon
compared to daily caregiver observations. Video recordings were State University, Corvallis, OR, USA, 2Hill’s Pet Nutrition, Inc.,
analyzed using a behavior analysis software program. Topeka, KS, USA, 3IDEXX Laboratories, Inc., Westbrook, ME,
The mean number of urinations per day detected by VRS USA
(2.5 0.2) was significantly greater compared to caregiver obser-
vations (0.6 0.2; P < 0.0001). Five of 19 cats were never A prospective 12-month clinical trial was performed in client-
observed by their caregivers in the litter box. The mean number of owned dogs with IRIS stage 1 chronic kidney disease (CKD) to
urinations per day detected by VRS was significantly higher for measure their ease of transition to a commercial renal protective
abnormal cats (2.9 0.3) compared to healthy cats (2.1 0.2; food and to assess the effects of food on renal biomarkers and
P = 0.02); there were no apparent differences in frequency between quality of life attributes. Dogs with IRIS stage 1 CKD (n = 36)
healthy and abnormal cats reported by caregivers (0.7 0.3 and were transitioned over 1 week from various grocery brand foods
0.5 0.3 respectively). There were no differences in mean urina- to a modified protein, low phosphorus, antioxidant enriched test
tion time between normal and abnormal cats determined by VRS food (Prescription DietÒ k/dÒ, Hill’s Pet Nutrition, Inc.). At
or caregivers. Mean cover-up time determined by VRS was signifi- months 0, 3, 6, 9, and 12 owners completed a questionnaire to
cantly longer in normal cats (23 4 seconds/urination compared assess their pet’s acceptance of the test food and their dog’s qual-
to abnormal cats (9 5 seconds/urination; P = 0.03); differences ity of life. Renal biomarkers, including serum creatinine (Cr),
in cover-up time were not detected by caregiver observations. blood urea nitrogen (BUN), and symmetric dimethylarginine
In conclusion, there was considerable disparity between care- (SDMA), and urinalysis parameters, including urine specific grav-
giver and video observations with caregivers commonly underesti- ity (USG) and urine protein:creatinine ratio (UPC), were mea-
mating urination frequency. VRS appears to facilitate objective sured. Of the 36 dogs initially enrolled, 35 (97%) transitioned to
assessment of urination behavior and could be of value in future the test food. Pets moderately or extremely liked the test food
clinical studies of feline urinary disorders. 88% of the time, ate most or all of the food 84% of the time, and
were moderately or extremely enthusiastic while eating 76% of the
time. Dogs consuming test food showed a decrease in serum Cr
and BUN concentrations across time (both P = 0.01) and a
decrease in serum SDMA concentration and USG across time
(both P = 0.09). All serum renal biomarkers (Cr, BUN, SDMA)
NU15 were decreased (P ≤ 0.05) from baseline at 3 months, and
EVALUATION OF THE EFFECT OF URINE DIP VERSUS remained decreased from baseline at 12 months in dogs complet-
URINE DRIP ON MULTITEST STRIP RESULTS. Alisdair ing the study (n = 20). This study shows that dogs with IRIS stage
Boag, Craig Breheny, Adam Gow. Royal (Dick) School of Veteri- 1 CKD readily transition to a commercial renal food, and decreas-
nary Studies, Edinburgh, UK ing serum biomarker concentrations suggest improvement in kid-
ney function. In addition, owners reported improvement in a
Standard operating procedures (SOPs) have been established for consortium of overall health and quality of life attributes
in-clinic laboratory tests, such as the World Health Organisation (P < 0.01) and hair and coat quality attributes (P < 0.01).
guidelines for packed cell volume. No independent evidence based
guidelines exist for dipstick urinalysis, however manufacturer’s
instructions state to dip the stick into urine. In veterinary medi-
cine, occasionally urine samples of such small volume are obtained
that this is impractical and dripping urine on the stick from a pip-
ette or syringe is performed. This also has the advantage of con- NU17
serving the sample for additional tests. FIBROBLAST GROWTH FACTOR 23 (FGF-23) IN DOGS
The hypothesis of this study was that the method of drip or WITH NATURALLY OCCURRING CHRONIC KIDNEY
drip would have no effect on the test results. Siemens Multistix DISEASE. Marcia Kogika1, Cinthia Martorelli1, Douglas Carage-
10SG strips were used. To standardise the method of strip analy- lasco1, Fernanda Chacar1, Luciano Giovaninni2, Dennis Chew3,
sis, a Siemens Clinitek Status+ analyser was used to read the Ramiro Toribio3, Katarzyna Dembek3, Camila Rodrigues4, Talita
strips; controlling time of reading the results and user variability Sanches4, Lucia Andrade4. 1School of Veterinary Medicine,
in interpretation of colourimetric changes. Three individuals tested University of S~ao Paulo, SP, Brazil, 2Sao Paulo, SP, Brazil,
3
25 aliquots of urine from dogs with a range of disease processes College of Veterinary Medicine, The Ohio State University,
by both the dip and drip method. Results were compared for each Columbus, OH, USA, 4School of Medicine, University of S~ao
variable between drip and dip using Wilcoxon-signed rank test. Paulo, Sao Paulo, SP, Brazil
Across the nine variables assessed (SG was not), a significant
difference between methods was found for one variable, bilirubin Decreased glomerular filtration rate in chronic kidney disease
(P = 0.046). This difference was accounted for by one dog who (CKD) reduces renal phosphorus excretion, leading to increased
tested negative for bilirubin for all three users using a dip method total body phosphorus retention and eventually hyperphos-
and had a trace value for all three users using a drip methodology. phatemia. In addition of promoting parathyroid hormone synthe-
No other significant differences were found between variables. sis, hyperphosphatemia stimulates the synthesis of fibroblast
This study demonstrated a significant difference between dip- growth factor 23 (FGF-23), a phosphaturic/hypophosphatemic
ping and dripping for bilirubin, caused by one dog with the same hormone. There are no reports on serum FGF-23 in healthy dogs
level of variability for all three users. This difference is, in the or in dogs with CKD. The goal of this study was to measure
authors’ opinion, clinically insignificant. This study therefore sup- serum FGF-23 concentrations in healthy dogs and in dogs with
ports the use of either a dipping or dripping approach to urinaly- CKD, and to determine its association with serum phosphorus
sis. Further studies are required to more fully assess the role of concentrations and severity of renal disease based on IRIS staging
individual variation when performing the test including level of of CKD. We hypothesized that serum FGF-23 will be increased in
experience. dogs with CKD, that its concentrations will be proportional to
CKD severity, and that it will be an early marker of altered phos-
phorus metabolism.
A total of 17 dogs of various breeds and age with CKD (n = 6
in IRIS stage 2; n = 11 in IRIS stage 3) that were being fed a
renal diet, and 15 healthy dogs of different breeds and age, being
fed a maintenance diet, were included. Dogs with CKD were fol-
lowed for up to 12 months or until death. A human-specific FGF-
23 ELISA was validated for this study, showing linearity and
2.8% and 8.8% intra and inter-assay coefficients of variation,
respectively. Serum FGF-23 concentrations were higher in CKD
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1492 2016 ACVIM Abstracts
Serum NT-proBNP concentration was significantly more ele- perforation was the cause of SP in 16/55 cats. Thirty of 44
vated from baseline in dogs receiving 90 mL/kg/hr of crystalloid (68.18%) cats that were surgically managed and 5/11 (45.45%)
solution compared to dogs receiving hypertonic saline or hydrox- that were medically managed survived to discharge. In this popula-
yethyl starch boluses. None of the fluid therapy protocols caused tion, there was no association between leukocytosis, leukopenia,
elevations of serum NT-proBNP above the previously reported anemia, hypoalbuminemia, hyperlactatemia, ionized hypocalcemia,
cut-off concentration used to discriminate between dogs with con- or band neutrophilia and survival. Cats with increased creatinine
gestive heart failure and dogs with primary respiratory disease. were 4.68 times more likely to die (95%CI: 1.40–15.69; P = 0.012).
Resuscitative fluid therapy does increase serum NT-proBNP Hypothermic cats were 4.67 more likely to die (95% CI: 1.36–
concentrations but does not impact the ability to use serum NT- 15.98; P = 0.014), while febrile cats were 5.409 times more likely
proBNP concentration to discriminate between cardiac failure and to live (95% CI: 1.58–18.58; P = 0.0063).
respiratory disease in healthy dogs. The origin of SP was undetermined in half of the cats in this
study. Survival was in agreement with previous reports. Azotemia
and hypothermia, which may reflect persistence of shock in this
species, should be closely monitored in septic cats.
OT02
DEXMEDETOMIDINE OROMUCOSAL GEL FOR
ALLEVIATION OF ACUTE ANXIETY AND FEAR
ASSOCIATED WITH NOISE IN DOGS. Mira Korpivaara1, OT04
Kaisa Laapas1, Mirja Huhtinen1, Barbara Sch€ oning2, Karen RELIABILITY OF THERMOMETER PROTECTIVE
Overall3. 1Orion Corporation, Espoo, Finland, 2Veterinary SHEATHS FOR MEASUREMENT OF RECTAL TEMPERA-
Specialty Practice for Behavior, Hamburg, Germany, 3Biology TURE IN DOGS. Franck Jolivet , Maud Pic , Didier Concordet2,
1 1
Department, University of Pennsylvania, Philadelphia, PA, USA Olivier Dossin3. 1Department of Small Animal Clinical Sciences,
INP – National Veterinary School and Federal University of
Distress, fear, and anxiety during exposure to loud noises (e.g., Toulouse Midi Pyrenees, Toulouse, France, 2UMR1331 Toxalim,
storms, fireworks) are behavioral and welfare concerns for dogs, INP - National Veterinary School and Federal University of Tou-
and affect up to 50% of dogs over their lifetime. Our objective louse Midi Pyrenees, Toulouse, France, 3Department of Small
was to confirm that a sub-sedative dose of dexmedetomidine, an Animal Clinical Sciences and IRSD INSERM 1220, INP –
alpha-2 adrenoceptor agonist, alleviates acute anxiety and fear National Veterinary School and Federal University of Toulouse
associated with noise in dogs. Midi Pyrenees, Toulouse, France
This randomized, double-blind, placebo-controlled, parallel-
group study was conducted at 17 sites in 2 European countries on Rectal temperature is commonly used in clinical evaluation of
New Year’s Eve. 182 dogs with a history of anxiety or fear due to canine patients. Single-use lubricated protective thermometer
fireworks received 125 lg/m2 dexmedetomidine as an oromucosal sheaths are largely used in human medicine but this practice is not
gel (89 dogs) or placebo (93 dogs). Owners applied the first dose routinely reported in veterinary medicine. Therefore the aim of
before or at the onset of distress associated with fireworks. Dosing our study was to compare rectal temperature measured with the
could be repeated up to 4 times, every 2 hours. Owners assessed same thermometer with and without protective sheaths in a large
treatment effect and dog’s behavior. They also reported oral muco- canine population.
sal color, observational and functional alertness, adverse events, Three hundred and eighty two dogs were included in the study.
and ease of use. Rectal temperature was assessed in a standardized manner by two
An excellent or good treatment effect was seen in 64 (72%) persons (FJ and MP) with two identical digital rectal thermome-
dexmedetomidine-treated dogs and in 34 (37%) placebo-treated ters. The thermometers were validated for accuracy and repeatabil-
dogs. The overall treatment effect was superior with dexmedeto- ity (within-day variability) with a high precision thermometer. The
midine (P < 0.0001). Dogs on dexmedetomidine displayed less thermometers validation was performed with and without protec-
panting, trembling, and hiding. Transient pale mucous membranes tive sheaths. The rectal temperature was measured consecutively in
were observed more frequently with dexmedetomidine, but no each dog with and without protective sheaths in a randomized
mucosal irritation was reported. Most dogs (82/89, 92%) remained order. The difference of temperature measured with the two meth-
functional and no adverse events of concern were observed. Most ods was analyzed with a generalized linear model with order of
owners (154/182, 85%) considered the product very easy or quite temperature measurement, age, body condition score (underweight,
easy to use. normal and overweight), format (stratified as mini, medium and
This study confirms that oromucosal dexmedetomidine at a sub- large) and conscience level (conscious, sedated and anesthetized) as
sedative dose alleviates acute anxiety and fear associated with explanatory variables. Results are presented as mean SD.
noise in dogs. The accuracy of the study thermometers was excellent with
average temperature differences of 0.067 0.064 and
0.066 0.054 and ranging from 0.28 to +0.15 and from 0.22
to +0.1 with and without sheath respectively. In the field study,
the difference of the temperatures measured with and without
sheaths were within the 0.1 and +0.1 °C range for 80% of the
OT03 measurements. Moreover, these differences were ≤0.5°C and ≥
PROGNOSTIC INDICATORS IN CATS WITH SEPTIC PERI- +0.5°C for 3 and 5 dogs respectively. Except for the body condi-
TONITIS: 44 CASES (2002–2015). Katherine Scotti1, James tion score none of the explanatory variables studied were signifi-
Barr1, Micah Bishop2, Michael Kato3, Matthew Mellema3, cantly associated with the differences measured suggesting that the
Medora Pashmakova1. 1Texas A&M, College Station, TX, USA, differences were more important in overweight dogs that in normal
2
Animal Specialty Hospital of Florida, Naples, FL, USA, 3UC dogs with average differences of 0.087 and 0.009°C respectively
Davis, Davis, CA, USA (P = 0.013).
This study shows that thermometer protective sheaths can be
Septic peritonitis (SP) in cats carries significant mortality (12– used reliably to measure rectal temperature in dogs in a clinical
70%) and etiologies may be indeterminate. The aim of this study setting. Therefore, it is strongly advised to use this hygienic protec-
was to identify etiologies and prognostic factors in cats with SP. tive measure in daily clinical practice because even in overweight
Medical records of cats hospitalized for SP between 2002 and dogs the differences between the two methods are clinically non
2015 at Texas A&M University and University of California significant.
(Davis) were reviewed. Septic peritonitis was diagnosed by intra-
cellular bacteria on cytology or positive bacterial culture. Data
was checked for normality and compared using an unpaired t-test
and a Mann-Whitney test. Fisher’s exact test and Odds ratios were
used to compare variables. Alpha was set at 0.05.
Seventy-nine cats were identified and 55 met inclusion criteria.
The source of SP was undetermined in 28/55 cats. Gastrointestinal
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1494 2016 ACVIM Abstracts
After a 12 hour fast, 8 cats received 50 mg (~12.7 mg/kg) of Table 2 Effects of Novel SAMe Salt with Food Consumption
itraconazole (SporanoxÒ capsule, SporanoxÒ solution, com- Compared to SAMe Tosylate Fasted.
pounded capsule, and compounded suspension) in a randomized
crossover with a 21-day washout. Capsules were administered with
a small meal whereas solution was not. Plasma was collected at
pre-determined intervals for analysis using high pressure liquid SAMe Tosylate Novel Salt NMXSS75A™
chromatography. Compartmental and non-compartmental phar- Chewable Tablet Chewable Tablet
macokinetic analyses were performed using PhoenixÒ software (Mean ± Std) (Mean ± Std)
(Certara) on the proprietary SporanoxÒ and compounded formu-
lation data, respectively. Fasted (n=6) Fed (n=6)
For the SporanoxÒ capsule, the peak concentration (CMAX)
and half-life (t½) were 0.54 µg/mL (37% CV) and 18 hours (21% Cmax (ng/ml) 1,202 ± 365 1,157 ± 683
CV), respectively. These values for SporanoxÒ solution were
1.82 µg/mL (50% CV) and 23.7 hours (42%CV), respectively. Tmax (hr) 1.5 ± 0.5 1.9 ± 2.0
Absorption of the SporanoxÒ solution was 4.2 times greater than
for the SporanoxÒ capsule based on AUC ratios, and CMAX was AUC0-24 (ng•hr/ml) 7,060 ± 1,431 4,579 ± 1,454
3.4 times higher for the solution. Compounded formulations were
absorbed inconsistently, commonly resulting in undetectable con- t1/2 (hr) 9.03 ± 3.39 10.78 ± 4.57
centrations. Complete pharmacokinetic results were obtained from
only 3 and 1 cats in the compounded capsule and suspension
groups, respectively. Relative absorption of compounded itracona-
zole was 8% from capsule and 2% from suspension. P03
The long half-life of itraconazole in cats allows once daily oral POSACONAZOLE PHARMACOKINETICS IN CATS AFTER
dosing. Due to much higher absorption of SporanoxÒ solution, ORAL AND IV ADMINISTRATION. Dianne Mawby1, Leanne
versus capsules, the oral solution dose can be substantially Fowler1, Mark Papich2, Jacqueline Whittemore1. 1University of
reduced. Compounded itraconazole should not be used in cats Tennessee, Knoxville, TN, USA, 2North Carolina State Univer-
because of poor oral absorption. sity, Raleigh, NC, USA
Grams of Cmax ± Std Mycophenolic acid (MPA) is the active moiety of the prodrug
Food mycophenolate mofetil (MMF). It is a selective non-competitive
inhibitor of inosine-5ʹ-monophosphate dehydrogenase. MPA is an
attractive immunosuppressant option in veterinary medicine due
0 1,736 907 to its rapid onset and commercial availability in multiple formula-
tions. Although MPA is used routinely in humans and canines,
100 713 350 there is a paucity of literature supporting MPA’s use in feline
patients, likely from cats’ limited ability to glucuronidate certain
225 562 512 medications. Our goal for this study was to evaluate the pharma-
cokinetics, pharmacodynamics, and safety of MPA in 9 healthy
cats.
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1496 2016 ACVIM Abstracts
The pharmacokinetics of MPA was evaluated following an intra- and severe neurologic toxicity in predisposed breeds. Bioavailabil-
venous infusion of 5 mg/kg (n = 2) and 10 mg/kg (n = 1) of MMF ity and clinical efficacy of compounded MO suspensions still
(CellCeptÒ intravenous, Roche Lab Inc.) Surprisingly, the plasma remain unknown, and the use of these products should be discour-
concentration of MPA in cats at these doses were remarkably low aged at this time.
compared with the plasma levels consistent with immunosuppres-
sive levels in humans. Therefore, we evaluated the PK of MPA
using 20 mg/kg of MMF administered twice 12 hs apart (n = 6).
Following the infusion, all cats metabolized MMF into MPA. The
maximum observed MPA plasma concentration ranged between
3.4 and 22 µg/mL after the first dose and between 6.7 and 20 µg/ P06
mL, following the second dose. The evaluation of the concentration PHARMACOKINETICS OF INTRAVENOUS AND SUBCUTA-
time profile of MPA in plasma revealed additional peaks of MPA NEOUS DOLASETRON AND PHARMACODYNAMICS OF
which could correspond to enterohepatic recycling of MPA. SUBCUTANEOUS DOLASETRON IN PURPOSE-BRED
Mycophenolic acid is eliminated by liver biotransformation. CATS. Andrea Herndon, Liberty Sieberg, Leigh Davis, Amber
Unexpectedly, the concentration of MPA in plasma decayed Caress, Ryan Hansen, Luke Wittenburg, Daniel Gustafson, Jessica
quickly (terminal half-life ~1.5 hs) in all the cats, suggesting a fast Quimby. Colorado State University, Fort Collins, CO, USA
rate of biotransformation, explaining the higher dose of MMF.
The metabolite MPA phenol glucuronide was quantifiable in 2 out Dolasetron is a 5-HT3 receptor antagonist anti-emetic and is
of 6 cats while acyl glucuronide was not detected in any of the typically dosed at 0.5–1 mg/kg IV or SQ once daily. Pharmacoki-
cats. In contrast, the metabolite MPA phenol glucoside was quan- netic (PK) and pharmacodynamic (PD) studies in cats have not
tifiable in plasma from all the cats, suggesting that glucosidation been previously performed. The purpose of this study was to eval-
of MPA is a key route for MPA elimination in cats. uate these parameters in purpose-bred cats.
The administration of MMF showed a rapid effect on immune Five purpose-bred cats with unremarkable complete blood
cells. After the second dose of MMF, there was a reduction of the count, serum biochemistry and urinalyses were utilized. PK study:
peripheral blood mononuclear cells (PBMC) by ~24%. The Each cat received 0.8 mg/kg subcutaneous (SQ) and intravenous
PBMCs recovered to baseline levels ~36 hs after stopping the infu- (IV) dolasetron in a cross-over manner. Serum samples were
sion of MMF. This indicates that repeated administrations of obtained via jugular catheter at 0, 0.25, 0.5, 1, 2, 4, 8, 12, 24, 36
MMF are required to maintain a constant suppression of immune and 48 hours after administration of dolasetron. Dolasetron and
cells in cats. Importantly, there were neither serum biochemistry the active metabolite hydrodolasetron were measured using liquid
changes nor significant adverse events associated with the adminis- chromatography/tandem mass spectrometry. Non-compartmental
tration of MMF in any of the cats. pharmacokinetic analysis was performed. PD study: Subcutaneous
This study is the first step towards improving treatment of vari- dolasetron (0.8 mg/kg or 1.0 mg/kg) or placebo was administered
ous autoimmune diseases in cats. The results of this study suggest 30 minutes prior to intramuscular administration of 0.44 mg/kg
that the infusion of MMF once at 20 mg/kg 12 hs apart, provides xylazine in a randomized crossover manner. Number of emetic
a safe and rapid immunosuppressive effect in cats. Future studies events, lip licks, time to onset of vomiting or visual nausea score
will evaluate the pharmacokinetics and the effect of MPA on tar- were scored by a blinded observer.
get lymphocyte subpopulations (CD25+CD8+ and CD25+CD4+ PK: Dolasetron was quickly metabolized to hydrodolasetron with
T cells) following multi-day intravenous and oral dosing of MMF. only two cats in each administration route having measurable con-
centrations beyond 2 hours, limiting the assessment of dolasetron
PK parameters. There was no significant difference in exposure to
the active metabolite between the two routes of administration.
Pharmacokinetic parameters are summarized below.
Tmax (hr) 0.3 ± 0.1 0.4 ± 0.1 0.3 ± 0.1 0.63 ± 0.3
Production of a veterinary proprietary product solely containing
milbemycin oxime (MO) for use in the United States was tempo- Tlast (hr) 5 ± 4.8 13.6 ± 6.1 3.8 ± 3.1 18 ± 6.9
rally ceased in 2011, resulting in use of compounded MO formula- T1/2 λ (hr) NP 4.2 ± 1.8 NP 4.0 ± 1.0
tions for the treatment of canine generalized demodicosis. Despite
the return of a labeled single agent product to the veterinary mar- AUC 0-T (hr*ng/mL) 325.0 ± 314.0 ± 130.9 92.0 ± 86.7 429.4 ± 165.4
ketplace, compounded formulations are still available through 210.0
national compounding pharmacies. This study describes the accu-
racy, precision and stability of MO strength when compounded as PD: When dolasetron or placebo was administered prior to
an aqueous suspension (20 mg/mL). xylazine, there was no significant difference in the mean number of
Preparation choice reflected current prescribing practices and emetic events, lip licks, time to onset of vomiting or visual nausea
routinely utilized concentration. Samples were acquired by pre- score when compared to placebo.
scription from two national veterinary compounding pharmacies At 0.8 mg/kg dolasetron does not maintain serum concentra-
at three time points spanning a 30-day period. Two different stor- tions for 24 hours and does not adequately control xylazine-
age conditions were evaluated and sampled at four time points induced vomiting when given SQ even at 1 mg/kg. Additional dose
from the order date (Day 7, 14, 21, and 28). MO recovery was studies are needed to determine if a higher dose is more effective.
performed by solid-phase extraction and concentration strength
measured via high-performance liquid chromatography.
Overall, accuracy ranged from 67.5 to 135.5% with pharmacy
A having a range of 67.5 to 91.5% and pharmacy B 78.5 to
135.5%. Of the initial Day 7 samples, only 3 of 12 were within the
United States Pharmacopeia’s guideline defining acceptable range P07
of 90 to 110% compared with labeled strength. The precision for INVESTIGATION OF THE PHARMACOKINETICS OF
pharmacy A was 1.0 to 16.9% while for pharmacy B it was 3.9 to TRANSDERMAL ONDANSETRON IN NORMAL PURPOSE-
32.8%. Storage condition did not affect stability in the tested BRED CATS. Lara Zajic, Andrea Herndon, Liberty Sieberg,
aqueous suspensions. The average decrease in MO concentration Amber Caress, Ryan Hansen, Daniel Gustafson, Jessica Quimby.
in pharmacy A’s samples was 21.8% (13.3 to 26.1%) while from Colorado State University, Fort Collins, CO, USA
pharmacy B it was 18.6% (9.6 to 27.7%).
Compounded MO suspension deviated by more than 10% from Ondansetron is a 5-HT3 receptor antagonist used as an anti-
their labeled strength, which could lead to potential over-dosage emetic in ill cats. Ondansetron can be dosed orally, IV, or
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1497
55.0 70.0 The objective of this study was to determine the pharmacokinet-
Proportion of BALF retrieved
(%)
0.008* ics and pulmonary disposition of minocycline in adult horses after
(20.0-80.0) (10.0-100.0)
multiple intragastric doses.
81.6 90.3 Minocycline (4 mg/kg) was administered via the intragastric
Depth of wedging (mm) <0.001*
(67.0-93.0) (72.8-122.0) route to 6 healthy adult horses every 12 hours for a total of 5
doses. Minocycline concentrations were measured in plasma, pul-
Macrophages 68.5 (24.0-90.0) 70.0 (41.0-91.0) 0.851
monary epithelial lining fluid (PELF), and bronchoalveolar lavage
Differential Eosinophils 13.0 (0.0-73.0) 10.0 (0.0-28.0) 0.451 (BAL) cells via liquid chromatography mass spectrometry at multi-
cell count
(%) Lymphocytes 5.0 (1.0-17.0) 5.5 (1.0-23.0) 0.853
ple time points over a 96 h time period. Pharmacokinetic variables
were determined after the last dose using a noncompartmental
Neutrophils 8.5 (0.0-36.0) 9.5 (2.0-36.0) 0.270
approach. Comparison of minocycline concentrations between
* p<0.05 sampling sites was done using a Friedman repeated measures
ANOVA and significance was set at P < 0.05.
After the last dose, the mean + SD maximum plasma concentra-
Complications included transient hemoglobin desaturation (24/ tion (Cmax) of minocycline was 2.3 + 1.3 µg/mL and the terminal
24 BALs) and prolonged anesthetic recovery time (4/24 BALs). half-life (T1/2) was 11.8 + 0.5 hours. The median (25th and 75th
However, anesthetic recovery scores did not differ significantly percentiles) time to peak concentration (Tmax) was 1.3 (1.0 – 1.5)
between techniques. hrs. The Cmax and Tmax of minocycline in the PELF were
The results suggest that NB-BAL procedure provided BALF 10.5 + 12.8 µg/mL and 9.0 (5.5 – 12.0) hrs, respectively. The
samples of equivalent quality to B-BAL procedure in cats clinically Cmax and Tmax for BAL cells were 0.24 + 0.1 µg/mL and 6.0
free of respiratory disease. (0.0 – 6.0) hrs, respectively. Peak and trough minocycline
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1498 2016 ACVIM Abstracts
selection. High quality sequence data were mapped to the equine inflammatory disease in horses. LDGs appear to be mostly
genome and annotated using the miRNA database miRBase 21. constituted of mature cells in both healthy and heaves-affected
Differential expression was analyzed with generalized linear mod- horses. The significance of these findings remains to be ascer-
els, using the Benjamini-Hochberg procedure to control the false tained.
discovery rate at 0.1.
327 mature miRNAs were detected, with 191 present in all
samples. Basal expression was highly consistent between horses.
The most abundant miRNAs in baseline samples were miR-21,
let-7 g and miR-150, miRNAs associated with cell cycle regulation
and both innate and adaptive immunity in other species. TNFa E06
expression was significantly higher in the supernatants from LPS- CAN LEVAMISOLE UPREGULATE THE EQUINE CELL-
treated cells than controls at both 2 and 4 hours (P = 0.016 and MEDIATED IMMUNE RESPONSE IN VITRO?. Amy San-
0.0003 respectively). After correction for multiple comparisons, tonastaso1, Bettina Wagner2, Siobhan Ellison3, Virginia Maxwell1,
only miR-155 was significantly upregulated by LPS (P = 0.00018, Scott Pleasant1, David Lindsay4, Sharon Witonsky1. 1Virginia-
1.5 to 1.6 fold change versus controls). 9 miRNAs showed statisti- Maryland Regional College of Veterinary Medicine, Blacksburg,
cally significant expression changes with time. These included VA, USA, 2College of Veterinary Medicine, Cornell University,
miR-146a and miR-146b, which are induced by LPS in other spe- Ithaca, NY, USA, 3Pathogenes, Inc., Reddick, FL, USA, 4Depart-
cies but had non-significant upregulation by LPS here. MiR-155 ment of Biomedical Sciences and Pathobiology, Virginia Tech,
expression was significantly correlated to supernatant TNFa Blacksburg, VA, USA
(R2=0.78).
The basal expression characterized by these data provide a Equine Protozoal Myeloencephalitis (EPM) is arguably the
foundation for future research into the roles of specific miRNAs most common and costly equine neurologic diseases in the United
in equine inflammatory responses. miR-155 is the principal LPS- States. The national seroprevalence is >50%, but only 0.5–1% of
induced miRNA in horses, as in humans and mice. This miRNA all horses develops disease during their lifetimes. Some EPM
has documented roles in TLR4 signaling regulation, including affected horses have decreased immune responses. A cell-mediated
enhancement of TNFa translation and suppression of intermediate immune response appears to be protective for development of
signal transduction proteins. It is thus likely to influence the mag- EPM after infection with S. neurona in mouse models. Therefore,
nitude and nature of the acute inflammatory response to LPS in in addition to specific anti-protozoal medications, levamisole has
the horse, and could be a target for immune modulatory interven- been proposed as an adjunctive therapy to upregulate the immune
tions. It may also prove a useful marker of TLR activation. Fur- response in EPM affected horses. Studies have been performed in
ther research will be necessary to validate expression changes in a other species to address whether levamisole alters immune function
wider sample set, investigate targets and functions of these miR- in vitro or in vivo, but there are very limited studies in equids. We
NAs in horses, and to establish roles in naturally occurring hypothesized that We hypothesized that levamisole can upregulate
disease. a cell mediated macrophage (M1) dendritic cell (DC1) CD4 T-
helper 1 (Th1) CD8 Tc1 immune response in vitro.
The first aim was to determine both the optimal conditions and
effects of levamisole on cellular proliferation. Equine PBMCs were
harvested from ten horses seronegative for S. neurona. Cells were
cultured alone, or with each of the following mitogens: con-
E05 canavalin A (conA), phorbol 12-myristate 13-acetate and iono-
SEVERE EQUINE ASTHMA (HEAVES) IS ASSOCIATED mycin (PMA/I), or with a combination of the above mitogens and
WITH AN INCREASED NUMBER OF CIRCULATING LOW- levamisole at several conditions. Cellular proliferation was assessed
DENSITY GRANULOCYTES. Nicolas Herteman, Amandine using a colorimetric bromodeoxyuridine ELISA assay (Roche Life
Vargas, Jean-Pierre Lavoie. Department of Clinical Sciences, Fac- Sciences, 11647229001).
ulty of Veterinary Medicine, University of Montreal, Saint-Hya- The second aim was to determine the ability of levamisole,
cinthe, QC, Canada under optimized conditions, to upregulate the M1 DC1 CD4Th1
CD8 Tc1 response in vitro, based on activation and function.
Airway neutrophilia is a characteristic finding of severe equine PBMCs from the same 10 horses were cultured with each of the
asthma (heaves), a common and incurable condition of horses. following, no stimulation, conA, and levamisole with and without
However, how polymorphonuclear neutrophils (PMNs) contribute conA. To determine proliferation of each specific subset, cells were
to the disease remains poorly understood. “Low-Density Granulo- labelled with a fluorescent dye (CellTrace Violet, ThermoFisher
cytes” (LDGs), a subpopulation of PMNs, have been suggested to Scientific, C34557). Proliferation of each subset was determined
have strong pro-inflammatory properties, which can promote the based on dye dilution using flow cytometry (FacsAria Flow
recruitment of PMNs in an autocrine manner and thus amplifying Cytometer). To determine the ability of levamisole to upregulate
the inflammatory response. We therefore hypothesized that LDGs or alter the immune response, immune subsets were identified
are increased in the blood of heaves-affected horses compared to (CD4, CD8, CD21, CD172a, CD14) using fluorescent labelled
healthy subjects. antibodies. Activation was assessed for macrophages and DCs
We studied 8 horses with heaves during disease exacerbation using MHC class II and CD86 expression. Induction of T-regs
and remission, and 6 healthy animals. LDGs and normal-density was based on CD4, foxp3 expression. Specific immune phenotypes
neutrophils were isolated from peripheral blood using Ficoll. were determined based on intracellular cytokine expression of
Quantification and morphological characterization of LDGs were specific subsets (M1 DC1 CD4 Th1 CD8: IFN-gamma) versus
performed blindly using an optical microscope. LDGs were further (M2 DC2 CD4 Th2: IL4) versus (CD4 T-reg: IL-10). Significant
characterized by flow cytometry using anti-CD90 and anti-myelo- differences in response were determined using a mixed model
peroxidase (MPO) antibodies. ANOVA with significance set at P < 0.05.
The number of LDGs was significantly elevated in horses with Study results indicated that cells cultured with levamisole alone
heaves during both exacerbation and remission compared to did not alter PBMC proliferation compared to the response of
healthy horses (P = 0.005 and P = 0.029, respectively). No signifi- unstimulated cells. Cells cultured with either conA or PMA/I
cant difference was found between disease exacerbation and remis- resulted in a statistically significant (P < .05) increase in prolifera-
sion (P > 0.1). LDGs displayed a significantly greater percentage of tion compared to unstimulated cells. Cells cultured with conA and
normally segmented than hyposegmented nuclei in heaves-affected levamisole at 1 µg/mL resulted in a significant (P < .05) decrease
and control horses (P = 0.0002 and P = 0.0022, respectively). in proliferation compared with cells cultured with conA alone.
MPO’s mean fluorescence intensity of LDGs was significantly lower Flow cytometry data analysis results to assess how levamisole
during heaves exacerbation when compared to control horses directs the immune phenotype are currently pending.
(P = 0.0442). PMNs counts in BAL and LDG levels in blood of These data demonstrate that, under these conditions, levamisole
horses with heaves were not correlated (P > 0.1 for both disease downregulates conA stimulated PBMC proliferation. Based on
exacerbation and remission). these in vitro results, further studies to determine the effectiveness
This study describes for the first time an association between an of levamisole on modulating the equine immune system in vivo are
increased subpopulation of PMNs, namely the LDGs, and an warranted.
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1500 2016 ACVIM Abstracts
mean QRS duration and LV mass were found for the new modi- withdrawn in 5 cm steps and pressure measurements were
fied method (P < 0.005, R2=0.22) but not for the existing method recorded at each location. The time delay of the pulse waves
(P = 0.54, R2=0.01). between the two sensors was used to calculate PWV. Histology of
This study shows that the new method were better correlated the PA trunk and main branches was performed to investigate the
with left atrial size and LV mass suggesting that the correction of presence of medial lesions and calcification.
Einthoven’s triangle WCT gives better results when obtaining 12- The PSC placement was successfully achieved in all horses (9/9),
lead ECGs in horses. without significant complications, aside from transient arrhyth-
mias. The catheter was more commonly located on the left PA
(8/9). At the time of pressure measurements, the level of sedation
was variable between horses. The mean (SD) PWV, was
2.3 0.7 m/s in the proximal PA trunk and 1.1 0.1 m/s further
distal (20 cm), in a main PA branch. The mean (SD) of mean
E10 arterial pressures in the proximal PA trunk was 30.1 5.2 mmHg,
HUMORAL HYPERCALCEMIA OF MALIGNANCY IN and 22.0 6.0 mmHg further distal (20 cm), in a main PA
HORSES: A RETROSPECTIVE STUDY (2010–2015). Kate Hep- branch. The mean (SD) pulse pressure in the proximal PA trunk
worth-Warren1, Stephanie Caston2. 1Rancocas Veterinary Associ- was 15.0 4.7 mmHg, and 13.5 3.3 mmHg further distal
ates, Mount Holly, NJ, USA, 2Iowa State University, Ames, IA, (20 cm), in a main PA branch. Five out of nine horses presented
USA moderate to severe lesions and calcification of the tunica media of
the PA trunk and/or main branches.
The reported frequency of neoplasia in the horse is low but is This study demonstrated the feasibility of a technique to deter-
likely under-reported due to the difficulty of establishing a defini- mine PA-PWV in standing horses. The technique developed may
tive diagnosis. Clinical signs may be vague, and neoplasia is often allow further investigation of the effect of calcification of large
identified only at post-mortem examination. Delays in diagnosis pulmonary arteries in the development of pulmonary microvascu-
may lead to increased morbidity whereas definitive diagnoses in lar disorders in horses.
terminal cases provide objective evidence in electing for humane
euthanasia. Humoral hypercalcemia of malignancy is a common
paraneoplastic syndrome in other species, and could be utilized to
aid in the identification of equine neoplasia. The objectives of this
study were to identify the prevalence of hypercalcemia among
horses with neoplasia, and to compare calcium, albumin, and the E12
relationship between these values in horses with neoplasia, systemi- REPEATED MEASUREMENTS OF AUTONOMIC TONE
cally ill horses without neoplasia, and healthy animals. MARKERS OVER A TRAINING SEASON IN EVENTING
An electronic medical record search was performed to identify AND ENDURANCE HORSES. Olivia Lorello1, Alessandra Ram-
all horses over 6 months of age on which serum total calcium and seyer1, Dominik Burger1, Vinzenz Gerber1, Rupert Bruckmaier1,
albumin were measured. Eligible cases grouped by diagnosis: Han Van der Kolk1, Cristobal Navas de Solis2. 1University of
neoplasia (n = 43), sick non-neoplasia (n = 466), and healthy/ Bern, Bern, Switzerland, 2Texas A&M University, College Station,
orthopedic (n = 55). The sick non-neoplasia group was further TX, USA
sub-divided based on the body system affected by disease for addi-
tional comparisons. Exclusion criteria included lack of definitive The purpose of this study was to describe normal values and
diagnosis or a diagnosis of renal disease or rhabdomyolysis. changes over a competition season of markers of autonomic tone
Preliminary data identified higher calcium and lower albumin in in competing eventing (EV) and endurance (EN) horses, in con-
the neoplasia group when compared to the sick non-neoplasia junction with previously reported variables to monitor training
group. The calcium:albumin ratio was higher in the neoplasia and compare these to non-competitive breed-matched controls
group than in the healthy/orthopedic group, and lower than the (EVc and ENc).
sick non-neoplasia group. This data suggests that hypercalcemia 26 EV, 13 EVc, 11 EN and 7ENc started the project. Heart rate
may support a diagnosis of neoplasia in equine patients. variability (HRV), non-invasive blood pressure (NIBP), splenic
volume, pre- and post-exercise hematocrit and cortisol, standard-
ized exercise tests (SETs) and muscle enzyme activities, were mea-
sured pre-season (T1), mid-season (T2) and at the peak/end of the
competition season (T3).
HRV was lower (P < 0.05) in EV than in EVc at all times and
E11 post-exercise cortisol lower at T3. There were no significant differ-
DEVELOPMENT OF A TECHNIQUE FOR DETERMINA- ences in EN versus ENc. HRV and post-exercise cortisol did not
TION OF PULMONARY ARTERY PULSE WAVE VELOCITY change over the season in any group. EV had higher fitness markers
IN HORSES. Goncßalo Silva1, Bruce Guest2, Diego Gomez1, during SETs compared to EVc, but there was no difference between
Martine McGregor2, John Runciman2, Laurent Viel1, Luis EN and ENc. NIBP, splenic volume, hematocrit, pre-exercise corti-
Arroyo1. 1Departement of Clinical Studies, University of Guelph, sol, muscle enzyme activities, and weight were not significantly dif-
Guelph, ON, Canada, 2School of Engineering, University of ferent between groups and did not change over the season.
Guelph, Guelph, ON, Canada In conclusion, competing eventing horses showed higher sympa-
thetic tone and lower post-exercise cortisol than controls. NIBP,
Calcification of the tunica media of the main pulmonary arteries splenic volume and resting or post-exercise hematocrit did not
has been observed in a large proportion of young racehorses. In detect changes in autonomic tone in this population. The studied
humans, medial calcification is the most important cause of markers of autonomic tone did not change significantly through-
increased arterial stiffness, and has been implicated in the patho- out the season in any group and did not detect changes in compet-
genesis of cerebral and renal microvascular diseases. Pulse wave ing endurance horses compared to controls.
velocity (PWV) is a marker of arterial stiffness. This study aimed
to develop a technique for determination of pulse wave velocity of
the main pulmonary arteries of horses.
A convenience sample of 9 adult horses with no history of respi-
ratory or cardiovascular disease were used. The horses were
sedated for catheter placement, and continuously monitored with E13
electrocardiography during the procedure. The pulmonary artery EPIDEMIOLOGICAL CHARACTERISTICS OF HORSES
(PA) trunk was cannulated via right heart catheterization, with a WITH HYPERINSULINEMIA IN A LARGE POPULATION
catheter introducer sheath (9Fr x 100 cm). Introducer placement OF HORSES. Steven Grubbs1, Dwana Neal1, Thomas Keefe2.
1
was guided with echocardiography. A custom-made dual pressure Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO, USA,
2
sensor catheter (PSC) (7Fr x 170 cm) was inserted through the Colorado State University, Fort Collins, CO, USA
introducer sheath, and into one of the main branches of the PA.
The position of the PSC in one of the main branches of the PA Pituitary pars intermedia dysfunction (PPID) and Equine Meta-
was confirmed with thoracic radiography. The catheter was bolic Syndrome (EMS) have been described as the most common
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1502 2016 ACVIM Abstracts
endocrinologic disorders in horses. Few large studies exist that epaxial muscle mass (topline), regional adiposity, and laminitis.
describe the epidemiological characteristics of horses with these One of the major limitations of diagnostic testing for PPID is the
endocrine diseases. The purpose of this study was to obtain infor- sensitivity of available diagnostic assays. Thyrotropin-releasing
mation that included age, breed, sex, clinical signs, and ACTH/in- hormone (TRH) stimulation test has been shown to have an
sulin/glucose status at initial diagnosis of potential endocrine cases increased sensitivity of detecting horses with early PPID compared
(new cases) to determine the epidemiological characteristics of to resting ACTH. Few studies exist concerning endocrinologic test-
horses with hyperinsulinemia. ing and follow-up monitoring the clinical progression and diagnos-
Horses of any age, breed, and sex from the continental US were tic assay results following treatment in horses with early PPID.
eligible for study enrollment as long as they were documented to The purpose of this study was to identify cases of early PPID
be exhibiting one or more of the following clinical signs: general- based on clinical signs and laboratory testing then determine
ized or regional hypertrichosis, muscle wasting, abnormal fat dis- improvements in ACTH levels using resting ACTH, TRH stimula-
tribution, lethargy, laminitis (unknown etiology), polyuria, tion test, and clinical signs over time.
polydipsia, susceptibility to infections, abnormal sweating, and/or Sixteen horses were enrolled (January) with at least one clinical
inappropriate lactation. Normal horses were excluded from the sign of early PPID listed above and diagnostically confirmed by
study. At initial visit, demographic data, signalment, a physical the TRH stimulation test measuring ACTH at 0 (T0ACTH;
examination was conducted. Clinical signs were documented and pre-TRH) and 10 (T10ACTH) min following 1 mg i.v. TRH
blood was drawn for basal ACTH, fasting insulin, and glucose. administration. Fasting insulin and glucose was also determined
Blood samples were processed and shipped overnight to the Ani- pre-treatment and at each follow-up visit. Each horse was adminis-
mal Health Diagnostic Center, Cornell University, Ithaca, NY for tered PrascendÒ (pergolide mesylate) orally at a starting dosage of
analysis. The association between hyperinsulinemia (based on fast- 2 mcg/kg once daily, dosage adjusted to effect if required, but not
ing insulin results), clinical signs and glucose were statistically to exceed 4 mcg/kg daily, per manufacturers label recommenda-
evaluated individually using the Pearson chi-square test. Odds tions. A history, physical examination, and TRH stimulation test
ratios for significant predictors of hyperinsulinemia were computed evaluating T0ACTH and T10ACTH was conducted for 5 months
using corresponding 95% confidence intervals when applying mul- (February through June) following initial treatment administra-
tiple logistic regression analysis. tion. The comparative changes to the baseline ACTH levels over
Four-hundred eighteen of nine-hundred eighty two horses with time were evaluated using descriptive statistics. The statistical sig-
complete epidemiological information were included in the final data nificance of the change in ACTH levels to be evaluated using a
analysis. Of the 418 horses, 221 (52.8%) were HI+. Further, horses confidence interval of 95%.
were stratified into 1 of 3 groups based on ACTH and insulin labo- At initial examination, the most common clinical signs at initial
ratory results (PPID+/HI+), (PPID-/HI+), and (PPID-/HI-). Of the diagnosis were regional hypertrichosis (9/16), delayed shedding
418 horses, 115 (27.5%) were PPID+/HI+, 106 (25.3%) were (5/16) and muscle wasting (4/16). The baseline (arithmetic mean)
PPID-/HI+, and 197 (47.1%) were (PPID-/HI-). Of the 418 horses for T0ACTH and T10ACTH for all horses was 44.6 pg/mL and
evaluated, 9.6% of horses <15 years of age were PPID+HI+, 23.5% 360.5 pg/mL, respectively. Following six-months of treatment, the
of horses 15 to 19.9 years of age were PPID+HI+, 27.8% of horses resting T0ACTH in 12 of 16 (75%) horses were less than normal
20 to 24.9 years of age were PPID+HI+, and 39.1% of horses reference range (35 pg/mL), whereas 7 of 16 (44%) of horses had
>25 years of age were PPID+HI+. Further, 47.3% of horses T10ACTH less than the recommended T10ACTH reference range
<15 years of age were HI+, 61.2% of horses 15 to 19.9 years of age (110 pg/mL). In June, the decrease from baseline for T0ACTH
were HI+, 46.7% of horses 20 to 24.9 years of age were HI+, and was 7.1%; whereas the decrease from baseline for T10ACTH was
44.8% of horses >25 years of age were HI+. One-hundred ninety 49.1%. All horses with regional hypertrichosis and delayed shed-
seven of 418 horses were PPID-HI-. ding were considered improved or resolved, whereas body condi-
Analysis for PPID+/HI+ and PPID-/HI+ horses was evaluated. tion and muscle wasting was slightly improved. Four adverse
Based on the data for clinical signs only in the PPID-/HI+ horses, events not related to treatment were reported and considered
HI was significantly (P < 0.000) greater among horses with cresty resolved within 24 hours.
neck and laminitis present. Although not statistically significant All horses had improvements in clinical signs following treat-
(P > 0.025), HI was greater in horses with 2 other clinical signs; ment. No significant changes from baseline were observed in insu-
abnormal sweating and pot belly/weight gain. Based on clinical lin or glucose parameters. Following 5 months of treatment, 12 of
signs data, the odds of HI in horses with cresty neck was more 16 (75%) horses T0ACTH decreased below normal range com-
than twice (2.3X) that for horses without this clinical sign. Simi- pared to 7/16 (44%) T10ACTH that decreased below the recom-
larly for horses with laminitis, the odds ratio of HI was more than mended reference range. Although all horses responded clinically,
twice (2.2X) that for horses without this clinical sign. the T10ACTH in 9/16 (54%) horses remained positive. Even
Of the 418 enrolled horses, 52.8% were diagnosed with hyperin- though T10ACTH did not decrease below reference range, the
sulinemia. Based on the combined data of clinical signs (11 inter- option to hold the treatment dosage at the same level is justifiable
pretable), glucose levels and fasting status, cresty neck, laminitis based on clinical sign improvement. Further long term studies in
and high glucose were significant predictors of HI. Specifically, large numbers of horses should be conducted in horses with early
horses with high glucose levels were seen to have almost four times PPID.
the odds (3.5X) of HI compared to those with normal glucose
levels. Therefore, when evaluating horses with suspected endocrine
disease, at a minimum, ACTH, insulin and glucose should be eval-
uated. Long term studies need to be conducted in large popula-
tions of horses to further evaluate endocrinopathies in horses.
E15
DEVELOPMENT OF AN OCTREOTIDE RESPONSE TEST
FOR DETECTION OF INSULIN DYSREGULATION IN
HORSES. Nicholas Frank1, Pilar Hermida1, Alfredo Sanchez-
Londono1, Cassandra Uricchio2, Ranee Singh3. 1Cummings
E14 School of Veterinary Medicine at Tufts University, North Grafton,
MANAGEMENT OF EARLY PPID IN HORSES. John Haffner1, MA, USA, 2Stockbridge School of Agriculture, University of Mas-
Christine Cocquyt2, Dwana Neal3, Steven Grubbs3, Thomas sachusetts, Amherst, MA, USA, 3Veterinary Medicine Faculty,
Keefe4. 1Middle Tennessee State University, Murfreesboro, TN, Khon Kaen University, Khon Kaen, Thailand
USA, 2Tennessee Equine Hospital, Thompson Station, TN, USA,
3
Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO, USA, Octreotide is a somatostatin analog that suppresses insulin
4
Colorado State University, Fort Collins, CO, USA secretion and we hypothesized that an octreotide response test
(ORT) could be developed to detect insulin dysregulation (ID).
Pituitary Pars Intermedia Dysfunction (PPID) has previously Twelve Morgan horses were included and insulin status was
been diagnosed and managed as an older horse disease with assessed with the oral sugar test (OST). An ORT was then per-
advanced clinical signs. However, in early PPID, the clinical signs formed by fasting horses overnight and administering octreotide
are typically more subtle. Clinical signs of early PPID include: IV at a dosage of 1 lg/kg. Blood was collected at 0, 5, 10, 15,
decreased athletic performance, change in attitude/lethargy, 20, 25, 30, 45, 60, 75, and 90 minutes, and 2, 3, 4, 6, 8, 12,
delayed hair coat shedding (subtle), regional hypertrichosis, loss of and 24 h.
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1503
Mean AUCg did not differ significantly between normal (n = 5) mortality and severity of disease in foals. Most studies investigat-
and ID (n = 7) groups, but mean glucose concentrations at 75, ing RAI in equine patients have been focused on cortisol, while
180, 240, and 360 minutes were significantly (P < 0.05) higher in other adrenocortical steroids have been overlooked.
the ID group, when compared with t-tests. Mean AUCi was signif- We hypothesized that a high dose ACTH stimulation test will
icantly higher (P = 0.003) in the ID group when compared with stimulate the release of multiple adrenocortical steroids; however,
the normal group. Mean plasma insulin concentrations differed RAI in septic foals will be characterized by a weak glucocorticoid
significantly between groups at 180, 240, 360, and 480 minutes. A and mineralocorticoid response, but normal androgen and preg-
significant time effect (P < 0.001) was detected and there was a nane response when compared to healthy foals and sick foals with
trend towards higher insulin concentrations over time (group 9 normal adrenocortical function. We also proposed that the steroid
time; P = 0.091). response to ACTH will be associated with severity of disease.
Results show that insulin concentrations decrease within Foals <1 day of age (n = 25) were categorized into 3 groups:
60 minutes of octreotide administration and hyperglycemia devel- septic (n = 5), sick non-septic (SNS; n = 10) and healthy (n = 10).
ops as a result. As the effects of octreotide wane, insulin concen- After baseline blood sample collection on admission (time 0), foals
trations increase above the pre-injection baseline as more insulin is received ACTH (100 µg, IV). Additional samples were collected at
secreted to regain glycemic control. The magnitude of the increase 30 and 90 minutes post-ACTH. Hormone concentrations were
in insulin concentrations reflects insulin sensitivity, as evidenced by determined by immunoassays. The delta hormone was defined as
the higher AUCi values detected in horses from the ID group. the percent concentration change between time 0 and 30 minutes
(Delta0–30).
Septic and SNS foals had higher pregnenolone, progesterone,
17a-OH-progesterone and estradiol compared to healthy foals at
all 3 time points (P < 0.05). Cortisol, aldosterone and androstene-
dione concentrations were higher in septic and SNS than healthy
E16 foals at time 0 and 90 minutes (P < 0.05). The Delta0–30 was lower
INSULIN AND INCRETIN HORMONE CONCENTRATIONS in septic compared to healthy foals for cortisol and aldosterone
IN HORSES DURING AN ORAL SUGAR TEST AND (P < 0.05). Septic foals had higher dehydroepiandrosterone
PASTURE CHALLENGE. Nicholas Frank1, Pilar Hermida1, (DHEA) Delta0–30 than healthy foals (P < 0.05).
Alfredo Sanchez-Londono1, Cassandra Uricchio2. 1Cummings This study shows that an impaired response to ACTH in septic
School of Veterinary Medicine at Tufts University, North Grafton, foals involves multiple adrenocortical steroids. The increased
MA, USA, 2Stockbridge School of Agriculture, University of DHEA response to ACTH stimulation might be a good indicator
Massachusetts, Amherst, MA, USA of RAI in septic foals.
An oral sugar test (OST) is used to assess insulin status in
horses and this study was undertaken to test the hypothesis that
test results are closely correlated with blood insulin responses to
grazing on pasture grass. Correlations among insulin and incretin
hormone concentrations were also assessed to better understand E18
mechanisms of hyperinsulinemia in horses. ASSOCIATION OF OXYTOCIN AND NEUROSTEROIDS
Eight Morgan horses from the University of Massachusetts herd WITH NEONATAL MALADJUSTMENT SYNDROME (NMS)
were fasted overnight and then subjected to an OST over 180 min- IN HOSPITALIZED FOALS. Katarzyna Dembek1, Caroline
utes, immediately followed by turnout on pasture grass. Blood Brown1, Margaret Mudge1, Steven Reed2, Barry David3, Ramiro
samples were collected at 0, 30, 60, 75, 90, 120, 150, 180, 240, 300, Toribio1. 1The Ohio State University, College Of Veterinary Medi-
360, 420, and 540 minutes. Plasma active and total glucagon-like cine, Columbus, USA, 2Rood and Riddle Equine Hospital, Lex-
peptide-1 (aGLP-1 and tGLP-1, respectively) and glucose- ington, USA, 3Hagyard Equine Medical Institute, Lexington, USA
dependent insulinotropic polypeptide (GIP) concentrations were
measured, along with glucose and insulin concentrations. Peak Neonatal maladjustment syndrome (NMS) is a common illness
concentrations and area under the curve values were compared of newborn foals. Neuroactive steroids (pregnanes, androgens)
between the OST (0 to 180 minutes) and pasture challenge (180 to participate in neurological development; imbalances have been
540 minutes). implicated in human disorders, and more recently in the pathogen-
Peak insulin concentration (rs = 0.83; P = 0.015) and area under esis of NMS. Oxytocin regulates uterine contraction, lactation,
the insulin curve values (rs = 0.95; P = 0.001) were positively cor- and social functioning. Oxytocin modulates neurosteroid actions
related between the OST and pasture challenge. Area under the and neurosteroids (pregnanes) can stimulate oxytocin release in
tGLP-1 curve (0–540 minutes) and area under the GIP curve were growing animals. Oxytocin release may be altered in human
correlated with one another (rs = 0.76; P = 0.037), but did not cor- patients with a variety of neurological disorders; however, the role
relate with area under the insulin curve. Active GLP-1 concentra- of oxytocin in pathologies of newborn foals, including sepsis and
tions are pending. NMS, has not been investigated.
Our hypothesis was supported and we conclude that the OST can We hypothesized that foals with NMS and sepsis will have
be used to predict insulin responses to grazing on pasture grass. higher oxytocin and neurosteroids concentrations compared to
healthy foals. We also proposed that concentrations of neuroactive
steroids and oxytocin will be associated with outcome.
Blood samples were collected on admission from 23 foals with
NMS, 37 foals with other neonatal diseases and 15 healthy foals
of <3 days of age. Blood concentrations of steroids and oxytocin
E17 were determined by immunoassays.
ASSOCIATION OF ANDROGENS AND PREGNANES Oxytocin concentrations were higher in foals with NMS com-
RESPONSE TO ACTH STIMULATION WITH ADRENAL pared to healthy foals but lower in foals with other disorders
DYSFUNCTION IN HOSPITALIZED FOALS. Katarzyna including sepsis compared to healthy and NMS foals (P < 0.05).
Dembek1, Jillian Minuto1, Teresa Burns1, Bonnie Barr2, Nathan Sick foals (NMS and other diseases) had increased cortisol, aldos-
Slovis3, Ramiro Toribio1. 1The Ohio State University, College of terone, 17a-OH-progesterone, progesterone and pregnenolone con-
Veterinary Medicine, Columbus, USA, 2Rood and Riddle Equine centrations compared to healthy foals (P < 0.05). There were no
Hospital, Lexington, USA, 3Hagyard Equine Medical Institute, differences in steroid concentrations between foals with NMS and
Lexington, USA other diseases. Progesterone concentration was higher in sick non-
surviving foals compared to survivors (P < 0.05). Androstenedione
Sepsis continues to cause high mortality in human and equine and dehydepiandrosterone concentrations were not different
neonates. The hypothalamic-pituitary-adrenal axis is activated dur- between groups of foals.
ing sepsis to increase cortisol concentrations; however, the secre- Due to its neuronal modulatory actions, our study suggests that
tion of cortisol can be insufficient for the severity of disease in a oxytocin concentration may be involved in the pathogenesis of
number of sick foals. Our group and others have shown that rela- NMS and other disorders of the equine neonate. Hyperproges-
tive adrenal insufficiency (RAI), characterized by a poor cortisol teronemia was associated with NMS, sepsis, and poor prognosis
response to adrenocorticotropin (ACTH), is associated with for survival in hospitalized foals.
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1504 2016 ACVIM Abstracts
inflammation. Regional adiposity in horses is characterized by sub- effect. The objective of this study was to test the hypothesis that
cutaneous fat deposits at the nuchal ligament, behind the shoulder, the supplementation of a proprietary yeast fermentation product
and at the tail head, and increased neck circumference is associated would ameliorate the disruptive effects of a sudden increase in
with insulin resistance. In humans and mice, visceral fat is associ- concentrate intake on the cecum.
ated with insulin resistance and development of diabetes, and is Nine cecally-cannulated Quarter horses (6–7 years, 4 mares, 5
more metabolically active than other fat depots. In contrast, candi- geldings, approximately 500 kg) were divided into control (n = 4)
date gene expression studies in horses have suggested that nuchal and treatment (n = 5) groups based on gender and body weight
fat may be more metabolically active than visceral fat. We have and acclimated for 19 d to the diets and housing. The control diet
collected samples from six adipose tissue depots within the horse; consisted of 1.5% BW/d prairie grass hay (divided into 2 feedings
nuchal, shoulder, tail head, (subcutaneous, SQ) and visceral, omen- at 0700 & 1900) and 0.5% BW/d of a 12% protein commercially-
tal, and retroperitoneal (internal) in six horses of varying age, available concentrate (Omolene 200Ò, Purina Animal Nutrition)
breed, and sex. To quantify the differences in gene expression in top-dressed with 10 g/45.5 kg BW alfalfa pellet placebo (1 feeding
the various depots, an average of 19,085,946 paired-end RNA at 0700). The treatment diet was identical but concentrate was top-
sequencing reads per sample were generated on the Illumina HiSeq dressed with 10 g/45.5 kg BW of a pelleted proprietary yeast fer-
platform. Limma-voom and linear modeling identified 4,252 genes mentation product. On d 19, cecal fluid samples were collected 1 h
that were differentially expressed between SQ and internal adipose before and after feeding (1 h, +1 h) and at + 4 h, +8 h, +12 h,
tissue depots. Interestingly, several pathways, including PPAR and +16 h, +20 h and +24 h for 2 additional days to establish baseline
PTEN, associated with metabolically active beige/brown fat were levels. On d 22, the morning meal consisted of 1.25% BW concen-
highly expressed in SQ compared to internal fat depots. Further, trate (challenge) followed by 0.75% BW hay. Cecal samples were
SHOX2 (P = 1.54E-10), a marker for beige fat whose subcutaneous collected as on previous days. Cecal fluid pH was measured in sam-
expression levels are also positively correlated with central obesity ples at the time of collection. Lactate was later assessed using col-
in humans, was overexpressed in SQ. TBX15 (P = 4.72E-8) and orimetric analysis. A completely randomized split-split-plot design
ZIC1 (P = 5.03E-5), genes expressed in brown adipose tissue, were was used to test the effects of the yeast fermentation product. Anal-
also overexpressed in subcutaneous tissue. Several differences in SQ ysis of variance was done with mixed models (SAS 9.3, SAS Insti-
gene expression were driven by differences in the nuchal fat. tute Inc., Cary, NC, USA) and least squares means were compared
using Fisher’s least significant difference (P < 0.05).
No adverse clinical effects were noted following dietary chal-
lenge. Mean cecal pH was decreased at +8 h and +16 h (P = 0.017
& 0.001 respectively) and mean cecal lactate was increased at
+1 h, +8 h and +24 h (P = 0.046, <0.0001 & 0.031 respectively)
E23 after challenge as compared to baseline regardless of treatment.
EFFECTS OF A COMMERCIAL ANIONIC SUPPLEMENT Treatment group horses had increased mean cecal pH at +4 h
ON URINARY ACIDIFICATION IN HORSES. Elizabeth (P = 0.042) and decreased mean cecal lactate at +16 h (P = 0.026)
Nelson, Martha Mallicote, Lori Warren, Ariel Robelen, Sarah compared to control group. There were no significant differences
Reuss. University of Florida, Gainesville, FL, USA between control and treatment horses’ mean cecal pH and lactate
at other sampling times.
There are multiple clinical applications for the acidification of The sudden increase in concentrate intake, from 0.5% BW to
equine urine, including prevention of reoccurrence of urolithiasis. 1.25% BW, induced a significant, transient decrease in cecal pH
This study evaluated the efficacy of a commercial anionic supple- and increase in cecal lactate which was inconsistently blunted by
ment (SoyChlorÒ) for urinary acidification without altering sys- consumption of a proprietary yeast fermentation product.
temic pH. Eight horses were administered SoyChlorÒ to achieve a
DCAD of 0 mEq/kg or 40 mEq/kg or fed a control diet for
14 days in a randomized crossover trial. Urine and plasma pH,
plasma strong ion difference, plasma anion gap and fractional
excretion of calcium were measured and compared between treat-
ment groups. Mean urine pH across each collection period was E25
significantly greater in control horses compared to either treatment EFFECTS OF A SUPPLEMENT (ALFA-LOX FORAGEâ) ON
group but there was no difference between treatment groups. EQUINE GASTRIC ULCER SCORES AND GASTRIC JUICE
Blood pH and anion gap were not affected by treatment, but PH. Frank Andrews1, Pilar Camacho-Luna1, Kelsey Bailey1, Isa-
blood pH decreased and anion gap increased over time. Mean belle Nesen2, Michael Keowen1, Frank Garza Jr1?^!"number(boo-
bicarbonate concentration was lower in the 0 mEq/kg group than lean(following-ibling::degrees))",1, Chin-Chi Liu1. 1Equine Health
the control group, but did not differ between the 0 mEq and Studies Program, Louisiana State University School of Veterinary
40 mEq/kg treatments. Strong ion difference of the 0 mEq treat- Medicine, Baton Rouge, LA, USA, 2Ecole Nationale Veterinaire,
ment was lower than the control group. The mean fractional Toulouse, France
excretion of calcium over all time points did not differ between
treatment groups but there was an effect of time and treatment. Gastric ulcers are common in stall-confined horses under inter-
Both treatment groups had increased fractional excretion of cal- mittent feeding conditions. Alfalfa hay feeding has been shown to
cium relative to the control group at trial day 7 only. This study buffer stomach contents and decrease gastric ulcer scores. The pur-
shows SoyChlor supplementation can decrease equine urinary pH. pose of this study was to determine the effects of a supplement
Systemic pH was not affected but an increase in fractional excre- (ALF; Alfa-Lox Forage, Triple Crown Nutrition, Inc., Wayzata,
tion of calcium did occur. MN), containing chopped alfalfa hay, mannanoligosaccharides,
Omega 3 Fatty Acids, and L-Carnitine, top-dressed on grain on
nonglandular gastric ulcer scores and gastric juice pH in horses
after omeprazole treatment and after intermittent feeding. Eight
healthy Thoroughbreds (7 geldings and 1 mare; ages 2–12 years.)
were used in a 2-period crossover study, where horses were fed
E24 ALF (2.0 lbs. [0.91 Kg], twice daily, for 56 days) top dressed on
EFFECTS OF ABRUPT CONCENTRATE INCREASE AND grain (2.5 Kg; OmeleneÒ 100, Purina Animal Nutrition, LLC.,
PREBIOTIC SUPPLEMENTATION ON EQUINE CECAL PH Grey Summit, MO) or control (grain alone). While being treated
AND LACTATE. Katherine Williamson1, Amanda Reeg2, Teresa the horses had their stomach scoped on day 0 (before treatment
Douthit2, Murali Raghavendra Rao1, Mary Beth Gordon1. 1Pur- with ALF or grain only) and the on days 14, 28, 42, 49 and 56. In
ina Animal Nutrition, LLC, Gray Summit, MO, USA, 2Kansas addition horses were weighed, body condition score (BCS) recorded
State University, Manhattan, KS, USA and gastric juice pH measured. During the 56 day periods, from
days 14 to 28 horses were treated with omeprazole paste (OME;
Abrupt changes in diet have been shown to cause gastrointesti- 4.0 mg/kg, P.O., Q.D.; GastroGardÒ, Merial Ltd., Duluth, GA)
nal upset in horses. In particular, sudden large increases in concen- and from days 42 to 49 horses underwent an intermittent feeding
trate intake can lead to hindgut disruption due to acidosis. model.1 Stomach nonglandular gastric ulcer number (NGN) and
Various dietary additives have been studied to determine if this severity (NGS) scores were assigned at each scoping by the PI
response may be ameliorated or blunted by exerting a prebiotic (FMA), who was masked to treatment. Previous forage analysis
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1506 2016 ACVIM Abstracts
data was used to compare nutritional quality between the two peri- E27
ods. Data were analyzed statistically using an ANOVA for COMPARISON OF TUBE, GEL, AND IMMUNOCHRO-
repeated measures and when significant differences were found in MATOGRAPHIC STRIP METHODS FOR EVALUATION OF
the main model, a post-hoc Least Squares Means test was per- EQUINE BLOOD TRANSFUSION COMPATIBILITY. Daniela
formed to determine significant differences at P < 0.05. Alfa-Lox Luethy1, Sean Owens2, Urs Giger3, Darko Stefanovski1, Rose
ForageÒ top-dressed on grain was readily eaten by all horses, and Nolen-Walston1. 1School of Veterinary Medicine, University of
did not result in any adverse effects. When period data were Pennsylvania, Clinical Studies-New Bolton Center, Kennett
pooled, Alfa-Lox ForageÒ did not have a treatment by day effect Square, PA, USA, 2Department of Pathology, Microbiology and
on gastric ulcer scores or gastric juice pH during the study period. Immunology, School of Veterinary Medicine, University of Cali-
However, there was an overall period effect on treatment, in that fornia, Davis, CA, USA, 3School of Veterinary Medicine, Univer-
BCS was higher and gastric ulcer scores were lower in the AFL- sity of Pennsylvania, Ryan Small Animal Hospital, Philadelphia,
treated horses during the first period of the study, but no treatment PA, USA
by day effect was seen. Forage analysis showed lower digestible
energy in the first period of the study. Other significant effects seen Assessment of compatibility is recommended prior to blood
during the study included OME-treatment significantly decreased transfusion in horses, typically using gross or microscopic tube
gastric ulcer scores and increased gastric juice pH in both ALF- agglutination and hemolysin crossmatch, or less commonly, as pre-
treated and control horses and gastric ulcers healed in 6/8 (75%) dicted by blood type and alloantibody assay. In contrast, gel col-
horses after 14 days of treatment. In addition, gastric ulcer scores umn and immunochromatographic strip methods are the preferred
significantly increased 2 weeks after OME treatment and after techniques for compatibility testing in small animals. The purpose
feed-deprivation regardless of treatment. Alfa-Lox ForageÒ had no of this study was to determine agreement between novel and stan-
effect on gastric ulcers scores after OME treatment or during feed- dard crossmatch and typing methods. 33 blood typed and alloanti-
deprivation when compared to untreated controls. However, when body screened horses were evaluated. TUBE and GEL
forage had lower digestible energy and higher fiber content, Alfa- crossmatches were performed on 144 recipient-donor pairs and
LoxÒ Forage-fed horses had better BCS and fewer ulcers. Thus, compared using non-parametric area under the curve (AUC) recei-
Alfa-Lox ForageÒ might provide gastric support when forage has ver operating characteristic (ROC) analysis. With TUBE assigned
marginal nutritional value. It should be pointed out that the quan- as the reference variable, TUBE and GEL had excellent agreement
tity of Alfa-Lox ForageÒ fed may not have been adequate to affect for agglutination (AUC ROC = 0.87), but borderline for hemolysis
gastric ulcer scores or gastric juice pH in horses in this study, but (AUC ROC = 0.64). There was outstanding agreement between
other nutritional benefits might result. TUBE (gross) and TUBE (microscopic) scores for agglutination
1
Murray MJ and Eichorn ES. (1996) Am J Vet Res. 57 (AUC ROC = 0.91). The predicted crossmatch compatibility based
(11):1599–1603. on blood type and alloantibody assay showed excellent agreement
with TUBE and GEL (AUC ROC = 0.84 and 0.89, respectively).
However, there were more recipient-donor pairs identified as
incompatible by both TUBE and GEL than predicted by blood
type and antibody screen, suggesting unidentified alloantibodies. A
blood typing STRIP assay was performed on each aliquot and
E26 exhibited 100% sensitivity and specificity for 30 Ca+ and 3 Ca-
CHANGES OF THE EQUINE NEONATAL INTESTINAL horses. These findings show that gel column crossmatch techniques
MICROBIOTA ASSOCIATED WITH AGE AND DIARRHEA. appear to be a practical and accurate equine blood compatibility
Angelika Schoster1, Henry Staempfli2, Mohammad Jalali3, Luca test method, and that immunochromatographic strips are accurate
Guardabassi4, Scott Weese3. 1University of Zurich, Vetsuisse fac- at identifying the Ca blood type.
ulty, Clinic of Equine Internal Medicine, Zurich, Switzerland,
2
University of Guelph, Ontario Veterinary College, Departemnt of
Clinical Science, Guelph, ON, Canada, 3University of Guelph,
Ontario Veterinary College, Departmnet of Pathobiology, Guelph,
ON, Canada, 4Departement of Veterinary Disease Biology, Fac-
ulty of Health and Medical Sciences, University of Copenhagen, E28
Frederiksberg, Copenhagen, Denmark INFLUENZA-SPECIFIC IMMUNE RESPONSES TO A
COMBINATION VACCINE IN NA€IVE PONIES. Amanda
Neonatal diarrhea is an important disease complex in foals. Adams1, Stephanie Reedy1, Melissa Siard1, Sarah Elzinga1,
Diarrhea is associated with significant changes in composition and Thomas Chambers1, Steven Grubbs2. 1Department of Veterinary
structure of the microbiota in adult horses. The changes associated Science, Gluck Equine Research Center, University of Kentucky,
with diarrhea in neonatal foals are unknown. Lexington, KY, USA, 2Boehringer Ingelheim Vetmedica, Inc.,
The objective was to investigate changes of the equine neonatal St. Joseph, MO, USA
microbiota associated with age and occurrence of diarrhea in a
field trial. Equids, like humans and swine, are recognized as natural hosts
Fecal samples were collected from 20 foals at 2, 4 and 6 weeks for a variety of common viral pathogens, in particular equine
of age and assessed via metagenomic sequencing. Foals were moni- influenza virus (EIV). EIV has resulted in worldwide disease out-
tored and occurrence of diarrhea was recorded. The Wilcoxon and breaks. Vaccination is essential to prevent or limit disease spread.
Steelman-Dwass tests were used to assess differences between age Many commercially available vaccines are sold as single pathogen
groups and between foals with diarrhea and healthy foals within vaccines, however nowadays several are available as multi-patho-
an age group. gen or combination vaccines. A significant amount of equine
Age had a significant effect on relative abundance of bacterial research has been conducted to measure immune responses to
taxa on the phylum, order and class level. There was a significant single pathogen vaccines however data is lacking to determine if
increase in richness over time (P = 0.02). 9/20 (45%) foals developed combination vaccines stimulate the immune system in particular
diarrhea. The structure of the microbiota was significantly different cell-mediated immunity. Thus, the objective of this study was to
at Week 2 compared to Week 4 (P = 0.09) and Week 6 (P = 0.02). characterize the cell-mediated immunity (CMI) and humoral
Diarrhea had a significant effect on relative abundance of orders immune responses to a combination vaccine in influenza na€ıve ani-
and classes. Foals with diarrhea had reduced bacterial richness at mals. A total of 16 influenza na€ıve yearling ponies were randomly
four weeks of age (P = 0.04). Diarrhea did not have a significant assigned to receive one of two treatment groups: (Group 1)
effect on the beta diversity in any age group (all P > 0.36). (n = 8) VeteraÒ EWT + EIV/EHV (BIVI) vaccination and (Group
The composition and richness of the equine neonatal microbiota 2) (n = 8) controls to receive a saline vaccination. All vaccinate
is changing rapidly after birth. Similar to adults, foals with diar- ponies received a primary vaccination on day 0, followed by a
rhea have changes in composition and richness of the microbiota. booster vaccination on day 28. Peripheral blood was collected
Further studies are needed to assess whether these changes are the from all ponies prior to vaccination on day 0 and every 2 weeks
cause or effect of diarrhea. following for an 8 week period. Serum and peripheral blood
mononuclear cells were isolated to measure influenza specific
antibody and cell-mediated immune responses by the following
assays: HI, ELISA, interferon-gamma intracellular staining by
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1507
flow cytometry, and Real-Time PCR. Statistical analysis was per- when comparing the vaccinated ponies to the controls. Overall,
formed using SIGMA Plotv12.0TM (Systat Inc., Richmond, CA) the combination killed vaccine induced significant WNV-specific
with significance determined at the level of (P ≤ 0.05). Non-nor- humoral and cell-mediated immune responses in na€ıve animals.
mally distributed data was log transformed prior to statistical anal-
ysis. For each variable measured (cell-mediated immunity, etc.), a
mixed model two way ANOVA with repeated measures was used.
In measuring the humoral immune response to the EIV component
of the vaccine, results showed an overall significant (P < 0.05)
increase in the change of HI antibody titers in vaccinated ponies E30
compared to non-vaccinated saline controls. Further, there was an CHARACTERISTICS OF INFECTION CONTROL PRAC-
increase in EIV-specific IgGa and IgGb antibody titers in the vacci- TICES AT NORTH AMERICAN VETERINARY TEACHING
nated group of ponies compared to the saline controls, there was HOSPITALS. Cristine S. De La Hoz Ulloa1, Katharine M. Bene-
no change in IgGT responses in the vaccinated ponies. Measure- dict2, Paul S. Morley2, Brandy A. Burgess1. 1Virginia Tech,
ment of CMI responses by flow cytometry showed a significant Blacksburg, VA, USA, 2Colorado State University, Fort Collins,
increase in EIV-specific interferon-gamma being produced per cell CO, USA
from the vaccinated ponies compared to the saline controls. Mea-
surement of EIV specific CMI responses by Real-Time PCR Infection control is crucial in the operation of all veterinary
showed a significant increase in EIV-specific interferon gamma and hospitals to not only protect the patients and hospital, but to pro-
granzyme B gene expression in the vaccinated ponies compared to tect personnel as those in the veterinary field have an increased
controls. There was no significant difference in the gene expression risk of occupational exposure to zoonotic diseases. In a 2008
of perforin, IL-2 or IL-18 when comparing the vaccinated ponies study, 50% of Veterinary Teaching Hospitals (VTHs) surveyed
to the controls. Overall, the combination killed vaccine induced sig- reported significant health problems due to zoonotic infections
nificant humoral and cell-mediated responses in na€ıve animals. among hospital personnel. Cryptosporidium parvum infections
accounted for 68% of these infections. The objective of this study
was to characterize current infection control practices in place for
the prevention of zoonotic disease infection, specifically infection
of C. parvum, in VTHs.
All VTHs located in North America (n = 35) that had been
E29
operational for at least one year were eligible to participate in this
WNV-SPECIFIC IMMUNE RESPONSES TO A COMBINA- study. Phone surveys of biosecurity experts were conducted from
TION VACCINE IN NA€IVE PONIES. Amanda Adams1, Alex July - October 2015 which addressed policies for hygiene, surveil-
Betancourt1, Day Barker1, Melissa Siard1, Sarah Elzinga1, Stepha-
lance, patient contact, education, awareness, and enteric infectious
nie Reedy1, Steven Grubbs2. 1Department of Veterinary Science, disease control.
M.H. Gluck Equine Research Center, University of Kentucky, Among participating VTHs (n = 20/35; 57.1%), greater than
Lexington, KY, USA, 2Boehringer Ingelheim Vetmedica, Inc., St.
half reported significant outbreaks of disease among hospitalized
Joseph, MO, USA patients in the previous 5 years; most commonly due to Salmonella
enterica or equine herpesvirus-1. In addition, 50% reported signifi-
West Nile virus (WNV) mosquito-borne flavivirus and is the cant health problems in personnel, in the previous 2 years, that
leading cause of arbovirus encephalitis in horses in the United most likely resulted from zoonotic infection. Of these, Cryp-
States. WNV infection can cause severe acute illness, with devas-
tosporidium was identified as the most common agent. The major-
tating clinical signs of illness affecting gait and behavioural abnor- ity of VTHs surveyed had a committee that oversaw biosecurity
malities often times resulting in a high case fatality rate. Thus, program activities as well as written biosecurity policy documents.
WNV vaccination is a recommended core vaccine and is an essen-
However, only half conducted mandatory training on the biosecu-
tial standard of care for all horses in North America as recom- rity and infectious disease control program.
mended by the AAEP. Many commercially available vaccines are The results of this study will help to improve strategies for pre-
sold as single pathogen vaccines, however nowadays several are venting healthcare-associated infection, including zoonotic diseases,
available as multi-pathogen or combination vaccines. Little data among patients and veterinary personnel; and allow for targeted
exists to characterize the immune response to the WNV antigen
educational tools to promote a safety culture in veterinary medicine.
following a combination vaccination. We hypothesize that a multi-
pathogen “combination” vaccine will elicit significant cell-mediated
and humoral immune responses in na€ıve ponies. A total of 16
influenza na€ıve yearling ponies were randomly assigned to receive
one of two treatment groups: (Group 1) (n = 8) VeteraÒ EWT +
EIV + WNV (BIVI) vaccination and (Group 2) (n = 8) controls to E31
receive a saline vaccination. All vaccinate ponies received a pri- ANTI-ENDOTOXIC PROPERTIES OF KETOROLAC TRO-
mary vaccination on day 0, followed by a booster vaccination on METHAMINE AND FLUNIXIN MEGLUMINE IN HORSES.
day 28. Peripheral blood was collected from all ponies prior to Alexandra Bianco, George Moore, Sandra Taylor. Purdue Univer-
vaccination on day 0 and every 2 weeks following for an 8 week sity, West Lafayette, IN, USA
period. Serum and peripheral blood mononuclear cells were iso-
lated to measure WNV-specific antibody and cell-mediated Non-steroidal anti-inflammatory drugs (NSAIDs) play an inte-
immune responses by the following assays: ELISA, interferon- gral role in equine medicine due to their combined analgesic and
gamma intracellular staining by flow cytometry, and Real-Time anti-inflammatory properties. Despite their widespread use, there
PCR. Statistical analysis was performed using SIGMA are limited NSAIDs available that demonstrate variable adverse
Plotv12.0TM (Systat Inc., Richmond, CA) with significance deter- effects and safety. While several NSAIDs have been proven to be
mined at the level of (P ≤ 0.05). Non-normally distributed data adequate analgesics, few have undergone rigorous evaluation for
were log transformed prior to statistical analysis. For each variable anti-inflammatory efficacy. Ketorolac tromethamine (KT) is a non-
measured (cell-mediated immunity, etc.), a mixed model two way selective cyclooxygenase inhibitor that has been used in human
ANOVA with repeated measures was used. In measuring the patients since 1989. The pharmacokinetic properties of KT have
humoral immune response to the WNV component of the vaccine, recently been determined in the horse, and have been previously
results showed a significant (P < 0.05) increase in WNV IgG titers determined in several other species. However, there have been only
in vaccinated ponies compared to non-vaccinated saline controls. two previous studies examining KT’s anti-inflammatory properties
Measurement of CMI responses by flow cytometry showed a sig- in animals, both of which were in vivo. There have been no published
nificant (P < 0.05) increase in the percentage of WNV-specific studies evaluating the in vitro anti-inflammatory effects of KT in any
interferon-gamma producing cells from the vaccinated ponies com- veterinary species. The purpose of this study was to evaluate the
pared to the saline controls. Measurement of WNV-specific CMI anti-inflammatory effects of KT compared to flunixin meglumine
responses by RT-PCR showed a significant (P < 0.05) increase in using an in vitro model of LPS-stimulated equine monocytes.
WNV-specific interferon gamma and IL-2 gene expression in the Equine monocytes were isolated from whole blood from a single
vaccinated ponies compared to controls. There was no significant horse and incubated with either KT or flunixin meglumine at six
(P > 0.05) difference in the gene expression of GrzB, IL-6 or IL-18 concentrations ranging from 2.5 µg/mL to 80 µg/mL for 1 hour.
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1508 2016 ACVIM Abstracts
After the initial incubation, E. coli 055:B5 LPS was added to each E33
well at a concentration of 1 µg/mL, which has been shown to con- COMPARISON OF THE CLINICOPATHOLOGIC SIGNA-
sistently activate monocytes. The wells were incubated at 37°C and TURES OF EQUINE CORONAVIRUS AND SALMONELLA
5% CO2 for 4, 8, 12, and 24 hours. Samples were collected at each ENTEROCOLITIS. Arlie Manship, Johanna Elfenbein. North
time point and stored at 80°C until analysis. Equine-specific Carolina State University College of Veterinary Medicine, Raleigh,
ELISAs were used to measure the eicosanoids PGE2 and TXB2 as NC, USA
well as the cytokines TNFa, IL-6, and IL-8.
Preliminary results demonstrated that flunixin meglumine sup- Recent worldwide outbreaks of Equine Corona Virus (ECoV)
pressed PGE2 production up to 12 hours at concentrations ≥5 µg/ have led to an increased awareness of this pathogen as a cause of
mL and up to 24 hours at concentrations ≥40 µg/mL. Flunixin colitis in adult horses. The objective of this study was to determine
meglumine suppressed TXB2 production up to 12 hours at all con- whether ECoV enterocolitis has a distinct clinical and/or clinico-
centrations and up to 24 hours at concentrations ≥20 µg/mL. pathologic signature that can distinguish it from enteric salmonel-
Ketorolac tromethamine suppressed PGE2 production up to losis or unknown causes of fever and neutropenia.
12 hours at all concentrations and up to 24 hours at concentra- Data were collected from medical records from North Carolina
tions ≥20 µg/mL. Ketorolac tromethamine also suppressed TXB2 State University (2003–2015). Horses >1 year old were divided into
production up to 12 hours at all concentrations but did not sup- 3 groups based on diagnosis: ECoV (fecal PCR), enteric salmonel-
press production up to 24 hours at any concentration. Peak eico- losis (fecal culture or PCR), or unknown diagnosis by ruling out
sanoid concentration in the non-treated samples occurred at ECoV and Salmonella (3 negative Salmonella cultures, negative
4 hours for PGE2 and 12 hours for TXB2. ECoV and Salmonella PCR). Clinical features, diagnostic test
While in vitro results cannot be directly correlated to in vivo effi- results, and outcome were compared between groups. Statistical
cacy, the results thus far indicate both drugs effectively suppress significance was determined using a Mann-Whitney U test with
eicosanoid production after LPS stimulation, with an effect of P < 0.05.
both time and drug concentration. Based on the results of this Data were obtained from 7 horses with ECoV, 11 horses with
study, a therapeutic dose of 2.5 µg/mL KT would effectively sup- Salmonella, and 11 horses without a diagnosis. ECoV cases had
press eicosanoid production in cases of endotoxemia. Further significantly fewer neutrophils (median 569/uL; range 105-1,029/
research is needed to correlate in vitro results with in vivo efficacy. uL) compared with all other diagnoses (1,310/uL; 337-9,720/uL)
but there was no difference in neutrophil count when compared
with Salmonella or unknown diagnosis. There were no differences
in temperature, lymphocyte or platelet counts, fibrinogen, or any
biochemical parameter between groups.
The results suggest that disease with ECoV and Salmonella share
E32 clinical features and should be included together on a differential
EFFECTS ON SWEATING OF CHLORAMPHENICOL AND list for fever and neutropenia. Further investigation is warranted to
THE MACROLIDE GAMITHROMYCIN: COMPARISON determine whether there is an unknown pathogen as the cause of
WITH ERYTHROMYCIN. Amy Stieler1, Chris Sanchez2, Martha the fever and leukopenia in the group without a diagnosis.
Mallicote2, Amy Smith2, Jim Burrow2, Rob MacKay2. 1University
of Georgia, Athens, GA, USA, 2Department of Large Animal
Clinical Sciences, University of Florida, Gainesville, FL, USA
cells, glial cells, and astrocytes and this was performed on 12/14 horses, bronchial collapse often limits retrieval of BALF. N-
EPM cases that had SN+ and adjacent SN- tissue formalin fixed tis- butylscopolammonium bromide (BuscopanÒ), a parasympatholy-
sue (FFPE) blocks. Eleven normal control horses were used and gic agent, safely produces short term bronchodilation, reversing
sections were location matched to lesion sections. All sections were airway obstruction RAO-affected horses.
compared for significant differences by ANOVA (P < 0.05). The Based upon the hypothesis that syringe aspiration would
number of CD3+ T cells and microglia/macrophage cells of SN+ improve BALF retrieval, we performed BAL in the left and right
tissues were significantly increased compared with its adjacent sec- lungs of 8 sedated summer pasture associated RAO-affected horses
tion and the sections from the normal horses. Although present in using a flexible endoscope. Saline (300 cc) was instilled via a poly-
extremely limited numbers (< 10 cells per site), macrophage only urethane tube inserted through the biopsy port using a 60 cc syr-
staining cells had statistically higher cell counts in affected horses inge and aspirated using gentle manual suction (SS) with a 60 cc
compared to normal horses. Because CD3 + cells were the most syringe or with mechanical suction (MS) using a pressure regulated
numerous, differentiation of CD4 + and CD8 + cells was attempted suction pump. Pressures of 15–75 mm H2O retrieved BALF with-
using IHC by several markers, none of which worked on FFPE sec- out airway collapse. Bilateral BAL was performed twice in each
tions. CD4 + and CD8 + relative expression was investigated by horse with or without BuscopanÒ (0.3 mg/kg IV) in a crossover
quantitative PCR and the most significant change was that of fashion with a 21 day washout period. The effects of suction type
CD4 + cell marker expression at 144.6 fold (log2) over controls. and BuscopanÒ administration on volume yield, cellularlity and
The fold change of CD8 + between the lesion group and the normal cell viability were determined.
group was 10.8. In conclusion, the presence of SN was only present BAL performed using SS demonstrated higher volume yield,
within inflammatory nodules and the presence of parasite burden with lower RBC and lower nucleated cell counts. There was a ten-
was associated with the presence of CD3 + CD4 + T cell markers dency for improved viability with MS. Differences in yield, nucle-
compared to that of CD8 + T cells. Based on the presence of ated cell count and red blood cell count were not identified with
inflammatory markers, the presence of SN was not detected outside BuscopanÒ, with the exception of horses demonstrating profound
of aggregates of either resident or infiltrating inflammatory cells. collapse.
Use of a modified BAL technique that includes manual syringe
suction with BuscopanÒ administration may provide an advantage
in horses with significant airway hyper-reactivity by limiting air-
way collapse and enhancing the diagnostic utility of BALF
obtained.
E35
NORMAL ULTRASONOGRAPHIC PLEURAL THICKNESS
IN CLINICALLY HEALTHY ADULT HORSES. Breanna Shea-
han, Kara Lascola, Scott Austin. University of Illinois, Veterinary
Teaching Hospital, Urbana, IL, USA
E37
The objectives of this study were to establish reference ranges PREVALENCE OF FUNGI IN RESPIRATORY SAMPLES OF
for normal pleural thickness measurements in healthy adult horses HORSES WITH INFLAMMATORY AIRWAY DISEASE. Julie
and to compare measurements between horses < 15 years of age Dauvillier, Emmanuelle van Erck. Equine Sports Medicine Prac-
(YOUNG) and ≥ 15 years of age (OLD). Pleural thickness is tice, Waterloo, Belgium
assessed as part of a complete thoracic ultrasonographic examina-
tion but no normal measurements have previously been reported. Inflammatory Airway Disease (IAD) is a common cause of res-
We hypothesized that measurements of pleural thickness would be piratory problems and poor performance in horses. It has recently
< 2 mm. been suggested that IAD and Recurrent Airway Obstruction
18 clinically healthy adult horses (11 YOUNG; 7 OLD) were (RAO) could be two forms of a same inflammatory process and
examined with a curvilinear 3.5–8 mHz probe in eight thoracic recent evidence tends to establish a close parallel between these
locations (four per side): cranioventral (intercostal space (ICS) 6), equine diseases and asthma in humans. Fungi have been shown to
mid-thoracic (15 cm dorsal to point of shoulder (POS) in ICS 10), contribute to the inflammatory response of lungs in RAO horses
caudoventral (ICS 10 at POS), and caudodorsal (ICS 14). All mea- and in some forms of asthma in humans. The role of fungi in IAD
surements were performed post hoc by two observers on three has not yet been assessed to the knowledge of the authors.
recorded images from each site. Differences among locations were The purpose of this prospective observational clinical study was
evaluated with Kruskal-Wallis. Difference between age groups was (1) to evaluate the prevalence of fungal isolates in the respiratory
evaluated with Mann Whitney U. Inter-observer reliability was samples of horses diagnosed with IAD, (2) to describe clinical
evaluated using intraclass correlation (ICC). Significance was set signs associated with the presence of fungi in respiratory samples
at P < 0.05. of horses diagnosed with IAD and (3) to assess the risk factors
Pleural thickness median (range) was 1.5 (1.11–2.33) mm in all associated with IAD and positive fungal culture and proliferation.
horses, 1.47 (1.11–2.09) mm in YOUNG horses and 1.55 (1.18– The study was performed in a population of working sport, race
2.33) mm in OLD horses. Significant differences among locations and leisure horses based in France, Belgium and the Netherlands.
and between age groups were not noted. Mild pleural irregularities A total of 482 cases horses, referred to a specialized ambulatory
were subjectively more common in older horses. ICC was signifi- internal medicine practice in Europe, were assessed between June
cant for measurements at each location. 2013 and December 2014. The horses were referred either for res-
Older horses did not have significantly greater pleural thickness piratory problems or loss of performance. For each case, an envi-
measurements. Measurements were reproducible. Measurements ronmental evaluation, a clinical examination, an airway
above the normal variation should be cause for further investiga- endoscopy, a tracheal wash (TW) and a bronchoalveolar lavage
tion of respiratory disease. (BAL) were performed. The TW and the BAL underwent cyto-
logic evaluation and the TW was submitted for bacteriology and
mycology. Diagnosis of IAD was established based on BAL fluid
cytology, according to the ACVIM consensus statement definition.
On both cytologic examinations, the presence of fungal elements
(spores, conidiophores, hyphae) was recorded, as well as signs of
E36 active proliferation.
SYRINGE VERSUS MECHANICAL SUCTION WITH In the population studied, a diagnosis of IAD was established
N-BUTYLSCOPOLAMMONIUM EFFECTS ON BAL PARAM- in 84% of cases. A positive fungal culture was obtained in 49% of
ETERS IN HORSES WITH PASTURE RAO. Jacquelyn Bowser, IAD+ cases and in 44% of IAD- cases. The most commonly iso-
Lais Costa, Christine Lopp, Rachel Wilson, Rebecca Byrne, lated fungus were Aspergillus sp, Penicillium and Rhizomucor. No
Melissa Steichen, Santosh Kumar TK, Alba Rodil, Michael Brash- relationship could be established between positive mycology and
ier, Cyprianna Swiderski. Mississippi State University College of cytologic evidence of fungal elements or active proliferation of
Veterinary Medicine, Mississippi State, MS, USA fungi in the airways. However horses with fungal elements on the
TW cytology had 3.8 more chances of having IAD than horses
Bronchoalveolar lavage (BAL) is frequently employed to evalu- with no fungi (OR=3.8; 95% CI 1.8–7.8; P = 0.0003). Twenty
ate lower airway inflammation in horses with RAO. In these IAD horses had signs of fungal proliferation in their TW and/or
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1510 2016 ACVIM Abstracts
BAL, but all mycologies remained negative in these cases. Distinc- include gastric ulceration and right dorsal colitis. To prevent and
tive respiratory clinical signs such as cough, breathlessness or nasal treat NSAID-associated GI injury, equine practitioners commonly
discharge showed low sensitivity and high specificity for IAD diag- administer the PGE1 analog, misoprostol. In addition to serving as
nosis. Concomitant bacterial infection did not increase the risk of a gastroprotectant, misoprostol has been shown to have anti-
fungal isolation. The degree of inflammation (% inflammatory inflammatory effects in cell models, potentially by increasing intra-
cells in BAL) was higher when horses were housed indoors, bed- cellular cyclic AMP (cAMP). Elevated cAMP is known to dampen
ded on straw versus shavings (Mann-Whitney test, 25.53 + /-17.14 leukocyte effector functions that can damage host tissues, including
versus 19.9 + /-17.5; P < 0.001) or fed dry hay versus steamed hay cellular adhesion, tissue infiltration, and cytokine and superoxide
(23.2 + /- 17.5 versus 18.8 + /-18.9; P < 0.001). production. The effects of misoprostol on equine leukocyte effector
The prevalence of fungal contamination in IAD cases is high in functions are undetermined. Thus, the purpose of this study was to
Europe. Horses inhaling aerosolized fungal particles are at a sig- determine the effects of misoprostol on equine leukocyte pro-
nificantly higher risk of developing IAD. The type of bedding and inflammatory cytokine and superoxide production in vitro. Equine
forage as well as other environmental conditions represent signifi- leukocytes were isolated from whole blood and stimulated with
cant risk factors for IAD and fungal contamination of equine air- lipopolysaccharide (LPS) in the presence or absence of misoprostol.
ways. The identification of proliferating fungi in the airways is a Misoprostol at concentrations of 1–10 lM significantly inhibited
sign of fungal infection and warrants further investigation. In the tumor necrosis factor-a, interleukin-1b, and interleukin-6 mRNA
current study, mycology culture seems to lack sensitivity in the production, as measured by qPCR. Misoprostol also elicited con-
detection of fungi in respiratory samples. centration-dependent decreases in neutrophil superoxide produc-
tion in response to granulocyte-monocyte colony-stimulating factor
priming and LPS stimulation, as measured by luminol-enhanced
chemiluminescence. From this data we conclude that misoprostol
produces anti-inflammatory effects in equine leukocytes in vitro,
paving the way for in vivo studies investigating misoprostol as an
E38 anti-inflammatory treatment in horses.
INTRAVENOUS MAGNESIUM SULFATE AS A RESCUE
THERAPEUTIC FOR BRONCHOCONSTRICTION IN
HORSES. Jacquelyn Bowser, Caitlin Wenzel, Robert Wills, Noel
Bondi, Rachel Wilson, Rebecca Byrne, Cyprianna Swiderski. Mis-
sissippi State University College of Veterinary Medicine, Missis-
sippi State, MS, USA E40
DO ENDOCRINE DISRUPTING CHEMICALS PLAY A ROLE
Horses with RAO exhibit exacerbations of acute airway IN HORSES WITH EQUINE METABOLIC SYNDROME?.
obstruction that cause respiratory distress resulting from bron- Sian Durward-Akhurst1, Nichol Schulz1, Elaine Norton1, Ray-
chospasm, mucus accumulation, and airway inflammation. Emer- mond Geor2, James Mickelson1, Molly Mccue1. 1University of
gency therapeutic options for control and reversal of airway Minnesota, MN, USA, 2Mmassey University, Palmerston North,
bronchoconstriction in equine airways include parasympatholytic New Zealand
agents which inhibit gastrointestinal motility, b2-adrenergic ago-
nists, as well as systemic corticosteroids, which require 4–6 hours Equine Metabolic Syndrome (EMS) is characterized by abnor-
for full effect. Meta-analysis of emergency intervention for asth- malities in insulin regulation, increased adiposity and laminitis. In
matic adults found that adjunctive infusion of magnesium sulfate a large across-breed study (610 individuals) of 11 morphometric
(MgSO4) improves lung function and reduces hospital admissions. and biochemical metabolic traits, our lab has demonstrated that
This study examined utility and effectiveness of intravenous 51–77% of the phenotypic variability is due to individual factors
MgSO4 as a novel, inexpensive, easily administered bronchodila- including age, breed, sex and genetics and 23–49% of the pheno-
tory agent for horses with a naturally occurring pasture-associated typic variability is the result of shared environment. Despite up to
form of RAO (SPARAO). 49% of the variability in EMS phenotype being related to shared
Six SPARAO-affected horses exhibiting naturally occurring dis- environment; only 4–18% of this variability is explained by diet,
ease exacerbation (CSRE ≥5, DPplmax > 15 cm H2O) were treated amount and intensity of exercise and season, suggesting that other
with three doubling dosages of MgSO4 by rapid IV infusion using environmental factors play a role in EMS development. Recent
three way cross-over design. Horses were instrumented for contin- work has identified associations between Endocrine Disrupting
uous ECG and blood gas monitoring. Tidal volume (TV), pul- Chemicals (EDCs) and human metabolic syndrome and other
monary resistance (RL), dynamic compliance (Cdyn), and endocrine abnormalities. Our preliminary data demonstrated that
maximum change in pleural pressure (DPplmax) were monitored at horses from farms within 30 miles of EDC disposal sites (EPA
5 minute intervals using conventional pulmonary mechanics. “Superfund sites”) were more likely to have had laminitis
Mixed models were fit for percent change from baseline values (P = 0.002) and had higher post oral sugar challenge insulin con-
for each outcome using PROC MIXED (SAS, SAS Institute. centrations (OST INS) (P = 0.00005), suggesting EDC exposure is
Cary, NC). Significant decreases in DPplmax, RL and significant an EMS risk factor. The objective of this study was to determine
increases in Cdyn were identified at all dosages and were accompa- if plasma EDC concentration is correlated to metabolic measure-
nied by increased PaO2 and decreased PaCO2, substantiating ments. Plasma EDC concentrations were measured using the
improved ventilation. We conclude that intravenous infusion of CALUX-DR bioassay in 158 Morgans and 137 Welsh Ponies from
MgSO4 has immediate bronchodilatory effects in horses making 32 farms. Grams fat extracted from plasma and sex (female) were
this therapy a valuable adjunct in horses with signs of respiratory negatively correlated with EDC concentration. EDC concentration
distress referable to bronchoconstriction. was positively associated with OST INS (P = 0.03). The results
suggest that some of the unexplained environmental variance iden-
tified in individuals with EMS is due to exposure to EDCs.
E39
INVESTIGATION OF MISOPROSTOL AS A NOVEL ANTI-
INFLAMMATORY IN EQUINE LEUKOCYTES. Emily Medlin E41
Martin, Samuel Jones. North Carolina State University, College of EVALUATION OF AN ORAL SUGAR TEST FOR DYNAMIC
Veterinary Medicine, Raleigh, NC, USA ASSESSMENT OF FIVE EQUINE BREEDS’ INSULIN
RESPONSE/SENSITIVITY. Jane Manfredi1, Raymond Geor2,
E-type prostaglandins (PGEs) play diverse roles throughout the Patty Sue Weber1, Bo Norby1, L Jill McCutcheon2. 1Michigan
body, including regulation of gastrointestinal (GI) homeostasis and State University, East Lansing, MI, USA, 2Massey University,
modulation of inflammation. To treat inflammation, anti-inflam- Palmerston North, New Zealand
matory medications including nonsteroidal anti-inflammatory
drugs (NSAIDs) are designed to inhibit prostaglandin production. Veterinarians have identified equine metabolic syndrome (EMS)
Unfortunately, potential adverse effects of NSAID use in horses as the most common cause of laminitis within equine practice. An
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1511
oral sugar test (OST) has been used clinically to identify “at risk” Median age was not different between horses sampled for each
horses although it has not been rigorously compared to a “gold breed. Although the Clydesdale breed had a lower BCS as com-
standard” frequently sampled intravenous glucose tolerance test pared to the Belgian breed, there was no difference in median INS
(FSIGTT) in a large number of horses or across different breeds. between breeds or the proportion of horses with an elevated INS
Eighty-nine horses/ponies of five different breeds (Quarter (>50 µU/mL). Further, there were significant, albeit weak, positive
Horses [QH], Arabians, Morgans, Welsh Ponies, and Thorough- correlations between age and INS (R = 0.32, P < 0.01), BCS and
breds) had both an OST (0.25 mL/kg Karo syrup) and an INS (R = 0.19, P < 0.02), and age and BCS (R = 0.36, P < 0.01).
FSIGTT performed at least 24 hours apart. Optimal time for sam- However, of greatest interest, one-third to nearly half (varying
pling was determined with a repeated measures ANOVA. A ROC with breed) of all horses tested had an elevated INS, supportive of
curve used to identify an optimal threshold insulin value for insu- insulin dysregulation despite horses being trained for competition
lin resistant (IR) equids (insulin sensitivity [SI] < 1). Spearman cor- and without evidence of laminitis. In conclusion, this convenience
relations were utilized to examine possible correlations between sampling study of draft horses provides support that INS may
OST outcome measures (area under the curve for insulin [AUCi] vary between light breeds and draft breeds and that breed needs to
and peak insulin concentration) and SI and the acute insulin be considered when interpreting INS results.
response to glucose (AIRg) (the latter two determined by Minimal
Model analysis of the FSIGTT). E43
IR horses had OST insulin but not glucose concentrations from MATRIX METALLOPROTEINASE-2 AND -9 LEVELS IN
60–120 minutes that were significantly higher than insulin sensitive HORSES WITH EXPERIMENTAL SMALL COLON INTRA-
horses. In this cohort, a single time point insulin concentration of LUMINAL OBSTRUCTION. Kamila Gravena1, Beatriz de Assis
≥30.2 IU/mL was indicative of insulin resistance. Moderate cor- Pimenta1, Lina Maria Wehrle Gomide2, Vinicius Athaydes
relations (rho = 0.6) to SI and strong correlations to AIRg Canello1, Nara Saraiva Bernardi1, Amanda Festa Sabes1, Guil-
(rho≥0.74) were evident for AUCi and peak insulin concentration. herme Dias Melo2, Paulo Ricardo Dell’Armelina Rocha2, Gisele
Weak correlations existed between glucose concentrations and SI Fabrino Machado2, Jose Corr^ea Lacerda-Neto1. 1FCAV – Univer-
and AIRg. QHs have significantly lower OST AUCi than all sity of Estadual Paulista – Unesp, Jaboticabal, S~ao Paulo, Brazil,
breeds except Morgans. 2
FMVA – University of Estadual Paulista, Aracßatuba, S~ao Paulo,
Different from what is currently recommended in the literature, Brazil
we advise measuring the insulin concentration of a single blood
sample at 60, 75, 90, or 120 minutes post–Karo syrup administra- Among different causes of colic, intestinal obstruction has been
tion and using a ≥ 30.2 IU/mL threshold. Practitioners should be identified as the major cause of hospitalization and death in horses
aware that breed may play a role in insulin concentrations that are around the world. In small colon occurs mainly due to fecalomas
achieved during the OST. or enteroliths. During ischemic process, decreases in oxygen ten-
sion inside the cell occur, reducing the generation of adenosine
triphosphate (ATP) and resulting in cellular homeostasis disorders.
Calcium accumulation inside the cell produces significant increase
in the phospholipase A2 activity, which directly damage cell mem-
brane through increased production of arachidonic acid, lysophos-
E42 phatidylcholine and platelet aggregating factor. The platelet
BASAL INSULIN CONCENTRATION IN COMPETITION aggregation factor is a potent inflammatory mediator, which has
DRAFT HORSES. Harold Schott1, Lisanne Gallant1, Elizabeth an important effect on vascular permeability and on neutrophil
Tadros1, Sarah Jacob1, Jane Woodrow2, Melissa Hines2, Susan activity. Neutrophils adhesion to endothelium may also cause
Ewart1. 1Michigan State University, East Lansing, MI, USA, damage to endothelial cells, thus amplifying the reaction. This
2
University of Tennessee, Knoxville, TN, USA occurs due to release of reactive oxygen species (ROS), proteogly-
cans enzymes such as matrix metalloproteinases (MMPs) and elas-
Measurement of basal insulin (INS) concentration is currently tase from lysosomes during cell degeneration. Therefore, the aim
advocated as the endocrine test of choice for screening horses for of this study was to evaluate neutrophil migration and matrix met-
insulin dysregulation. Values >20 µU/mL after overnight fasting alloproteinase-2 and -9 activity in horses with experimental intralu-
and >50 µU/mL in hay fed horses are considered supportive of insu- minal obstruction.
lin dysregulation. Although it is well recognized that INS increases For this purpose, eight healthy adult mixed-breed horses were
with body condition (fat mass), recent evidence suggests that there subjected to small colon distension using a surgically implanted
may also be age and breed differences with regard to basal insulin latex ball in the lumen (Ethical approval: CEBEA- Protocol
concentrations. However, little data exists for draft breeds. Conse- #007568-09). Blood and peritoneal fluid samples were obtained
quently, we tested the hypothesis that INS differs in various breeds before intestinal distension (M0), after 4 hours of distension (M4 -
of draft horses, independent of age and body condition. Age was when the ball was deflated and removed) and 72 hours after
obtained from owners/trainers and body condition score (BCS) was decompression (M72). Twelve hours after the ball removal was
assessed and basal (resting but not fasting) INS was measured in 164 also collected peritoneal fluid sample for neutrophils count. Data
draft horses participating in an international competition, including were submitted to Friedman’s test followed by post-hoc Dunn’s
48 Belgians, 52 Clydesdales, and 64 Percherons. INS was measured Multiple Comparison Test.
using a radioimmunoassay validated for equine serum (with average This model induced alterations in neutrophils migration
intra- and inter-assays CVs of 3.4% & 6.9% and 4.7% & 7.2% for into peritoneal fluid, the concentration (x103/lL) at M12 and
low and high equine control sera, respectively). None of the horses M72 was significantly higher when compared to M0
examined had a history or current evidence of laminitis. Age, BCS, (M0 = 0.55 0.14; M4 = 3.21 1.24; M12 = 133.18 35.80;
and INS were not normally distributed; thus, median values and M72 = 35.07 6.08). There was also alterations in plasma pro-
25% and 75% confidence intervals were determined (Table). Data enzyme form of MMP-2 (pro-MMP-2) at M4 and in peritoneal
were analyzed using ANOVA on ranks, Chi square analysis, and fluid pro-MMP-2 at M72 and pro-MMP-9 was significantly
Spearman rank order correlation. increase in M4 when compared to M0. Mean ( standard error)
in arbitrary units of plasma pro-MMP-2 was M0 = 94.25 6.14;
M4 = 63.72 4.57 and M72 = 89.52 6.70. Peritoneal
Belgian Clydesdale Percheron P value fluid Pro-MMP-2 was M0 = 53.07 10.90; M4 = 89.42 6.23
Age 5 (3-7.5) 6 (3-8.5) 6 (4-9.5) 0.33 and M72 = 128.13 10.86. Plasma Pro-MMP-9 was
M0 = 46.75 6.77; M4 = 50.65 6.45 and M72 = 44.92 4.74.
BCS 6 (6-7)a 6 (5-6)b 6 (6-7)a,b 0.007 Peritoneal fluid Pro-MMP-9 was M0 = 16.70 5.10;
Insulin 37.1 (29.5-72.0) 36.7 (23.4- 38.0 (29.2- 0.30
M4 = 155.77 5.77 and M72 = 90.21 13.14.
53.5) 62.5) Knowing that multiple proteinases are present in the granules
of neutrophils, it was conclude that increase in pro-enzyme form
# (%) >50 µU/mL 17 (35%) 15 (29%) 39 (47%) 0.07 after small colon decompression may be associated with neutrophil
migration.
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1512 2016 ACVIM Abstracts
(cresty neck score) compared to non-EMS controls, they had mod- was to compare the detection of C. pseudotuberculosis antibodies
erate general obesity (body condition score), which may have not in equine serum by SHI and a small ruminant ELISA test that
been sufficient to impact immune response to vaccination. uses exotoxin and cell wall antigens. Sera from 7 ponies experi-
mentally infected with C. pseudotuberculosis were analyzed by both
tests. Correlation and agreement were calculated by Pearson and
Kappa coefficients, respectively. Receiver operating characteristic
analysis was used to obtain the optimal cut-off value for the calcu-
lated ELISA score (Patient optical density/Negative control optical
E47 density x 100). Antigen reactivity to the sera was evaluated by
IMMUNOLOGICAL COMPARISONS OF AGED HORSES immunoblotting. When SHI titers ≥1:128 were considered a posi-
WITH VERSUS WITHOUT PITUITARY PARS INTERMEDIA tive result, the optimal ELISA score cut-off to determine positive
DYSFUNCTION. Melissa H. Siard, Virgina D. Barker, Stephanie status was 106%, with 73% sensitivity and 72% specificity with
E. Reedy, Amanda A. Adams. Gluck Equine Research Center, respect to SHI. Correlation between both tests was strong
Lexington, KY, USA [r = 0.904; (95%CI 0.472–0.986, P = 0.005)]. Agreement in deter-
mining positive status was poor (Kappa=0.439; (95%CI 0.226–
Pituitary pars intermedia dysfunction (PPID) is an endocrinopa- 0.652). Correlation and agreement were strong in 3/7 ponies, but
thy affecting 15–30% of the aged equid population. PPID is charac- weak in 4/7. Immunoblot showed a band 13.4 times more intense
terized by various clinical manifestations, the hallmark of which is in infected compared to pre-infected sera corresponding with the
hypertrichosis. Additionally, PPID horses exhibit immunosuppres- exotoxin antigen, but only non-specific reactivity with the cell wall
sion, making them more susceptible to opportunistic infections. Our antigen. The use of this ELISA test in horses is not recommended.
lab has established that aged horses exhibit both immunosenescence Development of an ELISA test with specific antigens from C.
and inflamm-aging, the low-grade chronic inflammation occurring pseudotuberculosis biovar equi is needed.
systemically with aging. To determine whether these age-related
changes in cell-mediated immune responses may be affected by the
presence of PPID, peripheral blood mononuclear cell (PBMC) pro-
liferation and cytokine production were compared in age-matched
PPID and non-PPID horses. PPID status was determined using thy-
rotropin releasing hormone (TRH) stimulation testing. E49
Sixteen aged horses (18–27 yrs), including n = 8 PPID horses EFFECTS OF ERYTHROMYCIN ON RESPONSES INDUCED
(mean = 24.5 2.2 yrs) and n = 8 non-PPID horses (mean = IN FOALS BY INTRAVENOUS EPINEPHRINE. Amy Stieler1,
23.1 3.1 yrs) of mixed breeds and sex, were sampled to determine Chris Sanchez2, Martha Mallicote2, Ashley Coxen2, Jim Burrow2,
immune function. Heparinized blood was collected aseptically, and Rob MacKay2. 1University of Georgia, Athens, GA, USA,
2
PBMCs were isolated, stimulated with Phorbol 12-myristate 13-acet- Department of Large Animal Clinical Sciences, University of
ate (PMA), and stained intracellularly for pro-inflammatory cytoki- Florida, Gainesville, FL, USA
nes interferon-c (IFNc) and tumor necrosis factor-a (TNFa). Flow
cytometry was performed to determine the percent of lymphocytes Macrolide-induced anhidrosis is a concern in foals treated for
producing IFNc and TNFa. Real-time polymerase chain reaction Rhodococcus equi pneumonia. Because sweating in horses is caused
(RT-PCR) was used to determine PBMC gene expression of cytoki- by activation of b2-adrenergic receptors on sweat glands, it was of
nes interleukin (IL)-2, IL-4, IL-6, IFNc, and TNFa. PBMC prolifer- interest to evaluate responses to IV epinephrine in foals given ery-
ation was also determined using carboxyfluorescein succinimidyl thromycin. Four pony-cross foals were treated for 3 days prior to
ester (CFSE) staining and stimulation with various amount of con- epinephrine infusion with either erythromycin (25 mg/kg orally, 3
canavalin A (Con A; 2.5, 5, and 10 L/mL). TRH stimulation test- times daily) or a control preparation according to a 2-period ran-
ing was performed, in which adrenocorticotropin hormone (ACTH) domized masked design. Epinephrine was given by CRI over
levels were measured in plasma 10 minutes post (T-10) intravenous 10 minutes at 0.5 lg/kg/minute and the following data were col-
administration of TRH (1 mg/mL saline/horse). lected before and at intervals for 180 minutes after onset of infusion:
Data was analyzed using the statistical software program Sig- sweat (absorbed into absorbent pads), heart and respiratory rates,
maPlot version 12.3. To analyze flow cytometry and RT-PCR data systemic arterial BP, pupil size, PCV, plasma protein, and blood glu-
for differences between PPID and non-PPID horses, t-tests were cose concentration. Cardiac rhythm was monitored continuously by
performed. To analyze lymphocyte proliferation data at various ECG. Univariate and 2-factor repeated measures ANOVA were
concentrations of Con A stimulation, two-way analysis of variance used to analyze data. Friedman tests were used for data sets that
with repeated measures was performed. No significant differences failed assumptions for ANOVA. Post hoc pairwise analyses were
between PPID and non-PPID horses were found for any of the performed after ANOVA indicated significant (P < 0.05) effect. In
immune measures examined including flow cytometry, RT-PCR, foals given either treatment, there were significant (P < 0.05) effects
and proliferation data (P > 0.05). These results indicate that the of epinephrine on heart rate, pupil size, PCV and blood glucose.
immunosuppression associated with PPID does not appear to be Sweating and arterial BP also increased significantly in control- but
due to differences in PBMC proliferation or cytokine production not erythromycin-treated foals. Significant treatment x time interac-
when comparing aged PPID horses with aged non-PPID horses. tion was found only for sweating; pairwise comparisons were signifi-
Thus, more research is warranted to further understand the cant at every point after time 0. These results suggest that
immunological mechanisms responsible for immunosuppression erythromycin does not cause generalized suppression of a- and b-
and susceptibility to opportunistic infections in the PPID horse. adrenergic responses. Anhidrosis may be a tissue-specific receptor or
post-receptor effect of erythromycin and other macrolides.
E48
CORYNEBACTERIUM PSEUDOTUBERCULOSIS ANTIBODY E50
DETECTION IN HORSES: SYNERGISTIC HEMOLYSIS EQUINE VECTOR-BORNE DISEASES DETERMINED BY
INHIBITION TEST AND SMALL RUMINANT ELISA COM- SEROLOGICAL AND MOLECULAR DIAGNSOTICS. Barbara
PARISON. Marta Barba1, Anne A. Wooldridge1, Robert Glass2, Qurollo1, Barbara Hegarty1, Jeffrey Tyrrell1, Edward Breitschw-
Thomas Passler1, Allison J. Stewart1. 1Auburn University, erdt1, Susan Tornquist2, Kathryn Schlaich2, Jennifer Kelsey2,
Auburn, AL, USA, 2Pan American Veterinary Laboratories, Melissa Beall3, Ramaswamy Chandrashekar3. 1Intracelluar Patho-
Hutto, TX, USA gens Research Laboratory, College of Veterinary Medicine, North
Carolina State University, Raleigh, NC, USA, 2Oregon State
False positive results may occur when testing horses for anti- University, College of Veterinary Medicine, Corvallis, OR, USA,
3
bodies against Corynebacterium pseudotuberculosis by synergistic IDEXX Laboratories, Inc., Westbrook, Maine, USA
hemolysis inhibition (SHI). In small ruminants, ELISA tests based
on exotoxin and cell wall antigens have greater accuracy than SHI Vector-borne disease impacts the health and welfare of horses,
in diagnosis of caseous lymphadenitis. The purpose of this study worldwide. Recognized vector-borne diseases among horses
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1514 2016 ACVIM Abstracts
include Anaplasmosis (Anaplasma phagocytophilum), Lyme Disease secondary to selenium deficiency. Although unusual, selenium defi-
(Borrelia burgdorferi), Potomac Horse Fever (Neorickettsia risticii) ciency should be considered a rule out with adult horses showing
and Piroplasmosis (Babesia caballi /Theleria equi). Additionally, signs of ventral edema, weakness, and abrupt death.
Bartonella, Ehrlichia, Rickettsia, and hemotropic Mycoplasma spe-
cies have been detected in horses with clinical disease spectrums
ranging from nonclinical to fatal. The goal of this study is to
investigate serological and molecular (PCR) tests that will detect
vector-borne disease (VBD) pathogens in horses and apply a
broad diagnostic panel to gain a more definitive picture of vector- E52
borne equine pathogens, including novel species and co-infections. EFFECTS OF ALFA-LOX FORAGEâ ON BLOOD GLUCOSE
Three populations of horses were used to test serological and AND INSULIN ACTIVITY AFTER GRAIN FEEDING IN
molecular diagnostic tests. Group I (n = 16): EDTA-whole blood HORSES. Frank Garza Jr1, Pilar Camacho-Luna1, Kelsey Bailey1,
(WB) and serum (S) sets from clinically healthy horses pastured in Isabelle Nesen2, Michael Keowen1, Liu Chin-Chi1, Frank
North Carolina with no clinical suspicion of VBD; Group II Andrews1. 1Equine Health Studies Program, Louisiana State
(n = 20): WB and S sets from horses submitted for diagnostic test- University School of Veterinary Medicine, Baton Rouge, LA,
ing to the VBDDL, where presumably the clinician suspected vec- USA, 2Ecole Nationale Veterinaire, Toulouse, France
tor-borne disease; Group III (n = 15): WB from horses in Merida,
Nicaragua with a high degree of tick exposure. Serologic and PCR Processed concentrate feeds contain a high concentration of
testing were performed retrospectively. DNA was extracted from sugars and in some cases non-structural carbohydrates (NSC)
WB, and qPCR assays were performed to test samples for infec- exceed 35%. These feeds are commonly fed to stall-confined
tion by bacterial species within the following genera: Anaplasma, horses, especially those in competition. Grains, high in NSC, can
Babesia, Bartonella, Ehrlichia, Mycoplasma, Neorickettsia, Rick- overwhelm glucose receptors in the proximal small intestine and
ettsia and Theilera. For samples with positive results, the infec- increase delivery of sugars to the hindgut leading to fermentation
tious agent was speciated by species-specific qPCR assay of the and colonic acidosis. Feed supplements, that might enhance glu-
sample and/or DNA sequencing of the PCR amplicon. Seroreac- cose absorption in the small intestine, would provide more energy
tivity to Babesia, Bartonella, Neorickettsia and Rickettsia antigens substrate for exercise and decrease delivery of sugars to the hind-
was determined using IFA, and seroreactivity to 3 Ehrlichia spe- gut. The purpose of this study was to determine effects of a feed
cies, 2 Anaplasma species and B. burgdorferi antigens was deter- supplement (ALF; Alfa-Lox Forage, Triple Crown Nutrition, Inc.,
mined using both a commercially available SNAPÒ4DXÒPlus Wayzata, MN), containing chopped alfalfa hay, mannanoligosac-
ELISA and a research-based SNAPÒ MA ELISA. The combined charides, Omega 3 Fatty Acids, and L-Carnitine, top-dressed on
use of serological and molecular assays in this study gave evidence grain, on plasma glucose concentration and serum insulin activity
of infection (by PCR) or exposure (by seroreactivity) to Ana- in horses before and after grain feeding. Eight healthy Thorough-
plasma, Babesia, Bartonella, Borrelia, Ehrlichia spp., Theileria, and breds (7 geldings and 1 mare; ages 2–12 yrs.) were used in a 2-per-
Rickettsia spp. None of the samples contained DNA from Myco- iod cross over study, where horses were fed ALF (2.0 lbs. [0.91
plasma spp. and two samples were positive for infection by Rick- Kg], twice daily) top dressed on a sweet feed grain (2.5 Kg; Ome-
ettsia felis, constituting the first reported instances of equine leneÒ 100, Purina Animal Nutrition, LLC., Grey Summit, MO) or
infection with R. felis detected by PCR. A novel Equine Ehrlichia control (grain alone) for 56 days, as part of another study. On
species, reported in horses from Nicaragua, was detected in addi- Days 41 and 48, after withdrawing feed overnight, blood samples
tional Nicaraguan horse samples from this study by both PCR, were drawn at 8 am, before the morning grain feeding, with or
IFA and ELISA. This study highlights the wide-range of exposure without ALF, and then again 2 hours after ALF was top-dressed
to and infection with vector-borne pathogens in horses. on grain (treated) or grain alone (control) was fed. Plasma and
serum were separated within 30 minutes of collection and samples
frozen at 70°C for shipment to the Diagnostic Center for Popu-
lation Animal Health (DCPAH; Michigan State University, East
Lansing, MI). Plasma glucose and serum insulin were analyzed
using an automated chemistry analyzer. Data were analyzed statis-
E51 tically using an ANOVA (PROC Mixed; SAS, Cary, NC) for
SELENIUM DEFICIENCY ASSOCIATED WITH THE repeated measures and when significant differences (P < 0.05) were
DEATHS OF FIFTEEN ADULT HORSES. Andrew Allen, Debra found in the main model, post-hoc t-tests were performed to deter-
Sellon, Fairfield Bain, Danielle Nelson. Washington State Univer- mine significant differences. Alfa-Lox ForageÒ top-dressed on
sity, Pullman, WA, USA grain was readily eaten by all horses, and did not result in any
adverse effects. When period data were pooled, on day 42, fasting
Nutritional myopathy due to selenium (Se) deficiency typically mean (SEM) serum insulin activity significantly increased from
presents itself in young rapidly growing calves, lambs, kids, and 65.1 (3.5) pmol/L and 61.9 (5.1) pmol/L in control and ALF-trea-
foals. Reports of myodegeneration secondary to selenium defi- ted horses, respectively, to 126.3 (24.2) pmol/L and 203.1 (30.1)
ciency in adult horses are less frequent. We investigated 2 herds pmol/L, respectively, 2 hours after feeding sweet feed. In addition,
with nutritional myopathy with generalized skeletal muscle degen- on day 48, mean serum insulin activity significantly increased from
eration and significant death loss in adult horses. In 2014, two mean (SEM) serum insulin concentrations of 76.3 (4.3) pmol/L
American Paint horses from the same farm presented to our diag- and 69.9 (3.8) pmol/L in control and ALF-treated horses, respec-
nostic laboratory for post mortem evaluation. Significant necropsy tively to 194.6 pmol/L and 290.0 pmol/L, respectively, two hours
and histopathology findings included myonecrosis of the cardiac after feeding sweet feed. Mean serum insulin activity was signifi-
and skeletal muscles, widespread subcutaneous edema, pleural cantly higher in ALF-treated horses compared to control horses
effusion and ulcerative glossitis. An on farm investigation was per- 2 hours after feeding sweet feed. Mean plasma glucose concentra-
formed where it was discovered that 13 horses, including the two tions did not significantly increase 2 hours after feeding. Alfa-
presented horses, had died on this farm with similar clinical signs LoxÒ Forage top-dressed on grain resulted in higher blood insulin
over the last year. Complete blood counts and serum chemistry values, but not significantly increased blood glucose concentrations
panels were performed on 4 of the 12 remaining horses and physi- 2 hours after feeding sweet feed. Alfa-Lox ForageÒ resulted in
cal examinations were performed on the entire herd. All four increased absorption of sugars from the small intestine and more
horses had elevated creatinine kinase activity (CK) and aspartate efficient utilization for glucose for energy, which likely decreased
aminotransferase (AST) levels, the herd had an overall low body the amount of sugars delivered to the large colon.
condition score, 3 horses had elevated heart rates, and one horse
had pitting ventral edema. All of the horses had extremely low
blood selenium levels, no box elder trees were found on the farm
and gastric contents of the dead horses and feed supplements were
found to be free of ionophores. An on farm echocardiographic
study was performed 6 months post initial investigation on three
of the most severely affected horses. All findings appeared within
normal limits. In 2015 a second investigation of two dead horses
revealed a very similar scenario and herd wide myodegeneration
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1515
E53 F01
VENOUS BLOOD GAS, ELECTROLYTE AND METABOLITE PREVALENCE OF COAGULASE-NEGATIVE STAPHYLO-
FINDINGS IN HEALTHY NEONATAL FOALS RECEIVING COCCI SPECIES IN INTRAMAMMARY INFECTION IN
SODIUM LACTATE INFUSIONS. Breanna Sheahan1, Pamela DAIRY GOATS. Véronique Bernier Gosselin, Pamela R.F.
Wilkins1, Ray Boston2, Kara Lascola1, Igor Canisso1, Kevin Adkins, John R. Middleton. University of Missouri, Columbia,
Kline3, Scott Austin1, Levent Dirikolu1, Brian Aldridge1. 1Univer- MO, USA
sity of Illinois College of Veterinary Medicine, Urbana, IL, USA,
2
University of Pennsylvania School of Veterinary Medicine, New Coagulase negative staphylococci (CNS) are the most prevalent
Bolton Center, Kennett Square, USA, 3University of Illinois pathogens isolated from intramammary infection in goats, with
Department of Animal Science, Urbana, IL, USA more than 15 different species being identified in goat milk. Unlike
cows, the relationship between CNS infection, somatic cell count
Exogenous sodium L-lactate (LAC) (1 mmol/kg BWT over and milk loss in goats is less clear. The conflicting results between
15 minutes) was administered to 6 healthy neonatal foals to deter- studies on CNS mastitis in goats may be explained by the varia-
mine LAC clearance variables at 12 hours (12Hr) and again at tion between studies in regard to distribution of CNS species,
60 hours (60Hr) of age. We hypothesized there would be differ- varying pathogenicity between species, the presence of confound-
ences in some venous blood gas (VBG) variables associated with ing factors affecting outcome measures, and variation between
both age (12Hr versus 60Hr) and sample time. studies in regard to speciation methods. Phenotypic speciation was
Venous blood was collected into heparinized syringes via a used in most studies; however genotyping is considered more reli-
catheter in the right jugular vein prior to lactate infusion for blood able than phenotyping for identification of CNS species in goats.
gas (BG), electrolyte and metabolite analyses and repeated at 0, The objective of this study was to estimate the prevalence of spe-
15, and 60 minutes after infusion completion using the NOVA cies-specific CNS intramammary infections in a large dairy goat
Critical Care Express. Statistical comparisons were by Friedman herd in Missouri.
analysis between time points of the same infusion, and Wilcoxon Composite milk samples were aseptically collected from all 940
Rank Sum between age groups, P < 0.05. Two-way ANOVA by lactating goats and aerobic bacteriological culture was performed.
general linear model was also used to assess differences and inter- A culture yielding 100 CFU/mL CNS was considered positive. Iso-
actions associated with age at testing and sample time. lates from milk samples yielding a single colony morphology iden-
There were no appreciable deleterious clinical effects of infusion. tified as CNS were used to prepare lysates for PCR amplification.
Sodium LAC infusion in normal neonatal foals resulted in clini- Species identification was based on PCR amplification and
cally unimportant changes in VBG measures. HCT, O2CT, Cl-, sequencing of either the rpoB, tuf gene, or 16S rRNA. Sequences
LAC, creatinine and BUN were significantly greater in 12Hr foals. were compared with the GenBank database using the NCBI
pH, O2SAT, HCO3-, BEecf, K+ and Ca++ were significantly Nucleotide-BLAST algorithm. For rpoB, species identification was
greater in 60Hr foals. Only LAC was different related to sample assigned with ≥ 97% identity and ≥ 5% separation between differ-
time, being largest at end infusion. No differences were found for ent species. For tuf, species identification was assigned with ≥ 98%
pCO2, pO2, Mg++, glucose, TCO2, Gap, or osmolarity. identity and > 0.8% separation between different species. For 16S,
Infusion of sodium LAC does not importantly impact VBG, species identification was assigned with ≥ 99% identity and >
electrolyte or metabolite measures in healthy 12Hr and 60Hr foals, 0.8% separation between different species. PCR amplification and
with the identified differences primarily due to age. sequencing of rpoB, tuf and 16S were performed sequentially until
identification was assigned. For instance, tuf was performed on
isolates for which rpoB either yielded unsuccessful amplification,
or criterion for identification with sequence analysis were not met,
followed by 16S if tuf amplification or sequence analysis failed.
From 940 milk samples cultured, 214 yielded growth of CNS of
E54 a single colony morphology. Of these 214 isolates, 184 were suc-
GROWTH AND FUNCTION OF EQUINE ENDOTHELIAL cessfully speciated, of which 157 were identified with rpoB, 26 with
PROGENITOR CELLS LABELED WITH SEMICONDUCTOR tuf, and 1 with 16S. The remaining 30 isolates were unable to be
QUANTUM DOTS. Randolph L. Winter1, Wen Seeto2, Yuan speciated based on the criteria listed above. Overall, 13 different
Tian2, Fred J. Caldwell1, Elizabeth A. Lipke2, Anne. A Wool- species were identified (Table 1). Among isolates that could not be
dridge1. 1Department of Clinical Sciences, Auburn University Col- assigned an identification, 3 met the criterion for identity but
lege of Veterinary Medicine, Auburn, AL, USA, 2Department of insufficient separation between the species (S. warneri and S. pas-
Chemical Engineering, Auburn University, Auburn, AL, USA teuri) with both rpoB and tuf sequencing.
Endothelial progenitor cells (EPCs) contribute to neovascular- Table 1. Species-specific prevalence among 184 CNS isolates and
ization and vascular repair in vivo and are attractive for clinical number of isolates successfully speciated by each gene, per species.
use in ischemic disease. EPC tracking is essential to determine
engraftment after administration. Semiconductor quantum dots
(QD) are promising for cell labeling due to ease of uptake by Number of
many cell lines and their continued presence after many cell gener- Species isolates % rpoB tuf 16S
ations. The purpose of this study was to evaluate function and S. simulans 69 37.5 65 4 0
growth of equine EPCs after QD label.
Equine EPCs were incubated with QD (2 – 20 nM) for 12-hr or S. caprae 31 16.8 30 1 0
24-hr, and intensity of label was assessed with fluorescent micro- S. chromogenes 26 14.1 25 0 1
scopy. Cell proliferation of EPCs labeled with QD for optimum
time and concentration was then assessed by comparing the num- S. epidermidis 19 10.3 17 2 0
ber of cell doublings per day (NCD) and the population doubling 16 8.7 12 4 0
S. xylosus
time (PDT) in labeled and unlabeled cells. EPC function was
assessed by comparing uptake of acetylated low-density lipopro- S. equorum 7 3.8 0 7 0
tein (DiO-Ac-LDL) and in vitro tubule formation in labeled and
S. cohnii 6 3.3 3 3 0
unlabeled cells.
Equine EPCs readily labeled with QD, showing maximum fluo- S. lentus 5 2.7 1 4 0
rescence using 20 nM QD, with a 24-hr incubation time. NCD
S. arlettae 1 0.5 1 0 0
and PDT were unchanged with QD label (P = 0.95, P = 0.99).
Uptake of DiO-Ac-LDL by EPCs was not affected by the presence S. aureus 1 0.5 1 0 0
of QD label (97.9% labeled cells; 97.0% unlabeled cells). Tubule
S. auricularis 1 0.5 1 0 0
formation on Matrigel was not affected by the presence of QD
label. S. gallinarum 1 0.5 1 0 0
Equine EPCs are effectively labeled with QD, and QD concen-
trations up to 20 nM do not affect cell growth or function. The S. sciuri 1 0.5 0 1 0
use of QD labeling with equine EPCs may help track engraftment Total 184 100 157 26 0
of EPCs in clinical applications.
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1516 2016 ACVIM Abstracts
Typeability of CNS isolates from goat milk in this study using difference in the prevalence of BCoV between healthy (54%) and
gene sequencing was 86%. Typeability with rpoB gene sequencing diarrheic (69%) calves (P = 0.039). Multivariable logistic regres-
alone was 73%, which was lower than expected. This may result sion revealed that calves positive for BCoV were more likely to be
from underrepresentation of isolates of caprine origin in the refer- older than 10 days of age (OR: 2.2, CI, 1.21 to 3.95; P = 0.009)
ence database. Unsuccessful PCR amplification in a proportion of and have diarrhea (OR: 1.73, CI, 1.07 to 2.81; P = 0.025).
isolates could reflect imperfect match between the primer and the This study determined that BCoV can be detected in both
target sequence. Relative prevalence of different species was similar healthy and diarrheic calves; however, the likelihood of BCoV is
to that of previous studies using genotyping or phenotyping. higher in diarrheic calves. Future studies investigating whether
BCoV strains detected in healthy and diarrheic calves are geneti-
cally different are warranted.
F02
ASSESSMENT OF AN ANTIMICROBIAL-USE ALGORITHM
FOR TREATMENT OF DIARRHEA IN DAIRY CALVES. F04
Diego E. Gomez1, Luis G. Arroyo2, Laurent Viel2, J. Scott USE OF AN ALIVECOR HEART MONITOR FOR HEART
Weese1. 1Department of Pathobiology, Ontario Veterinary College, RATE AND RHYTHM EVALUATION IN DOMESTIC
University of Guelph, Guelph, ON, Canada, 2Department of Clin- GOATS. Joe Smith1, Meera Heller2, Fauna Smith2, Mikaela
ical Studies, Ontario Veterinary College, University of Guelph, Mueller3, Jessica Ward1. 1Iowa State University, Ames, IA, USA,
2
Guelph, ON, Canada University of California Davis, Davis, California, USA, 3Blue
Pearl Veterinary Partners, Seattle, WA, USA
The objective of this study was to evaluate the impact of imple-
menting an antimicrobial-use algorithm on antimicrobial (AB) The AliveCor Heart Monitor, a smartphone-based electrocar-
treatment and mortality rates of diarrheic calves. diogram (ECG) recording device, is a promising new diagnostic
Three commercial dairy farms (F1, F2, F3) were enrolled. Farm tool in veterinary medicine. While this device has been validated
records were obtained to collect data about the incidence of diar- for canine, feline, and equine species, its clinical utility in domestic
rhea, AB treatment and mortality rates for the preceding goats has not yet been evaluated.
18 months. Then, an antimicrobial-use algorithm for farm person- Eight healthy adult dairy breed and eight healthy adult meat
nel based on the presence of three clinical signs (diarrhea, fever breed goats had simultaneous AliveCor and standard base apex
and decreased milk intake) was developed to direct AB therapy in ECGs performed in a standing position. The AliveCor ECG was
diarrheic calves (<30 day-old) and the same farm data were col- recorded using two different device positions (over the left cardiac
lected from the same records systems for 5, 2 and 2 months for apex and over the brisket region). Paper speed was 25 mm/sec and
F1, F2 and F3, respectively. amplitude was 10 mm/mV. All ECGs were evaluated unpaired and
Treatment records of 1208 (F1), 1051 (F2) and 296 (F3) calves independently by a data-blinded veterinary cardiologist. The aver-
were available for the pre-intervention period. The incidence of age heart rate was determined using 6 seconds of ECG recording,
diarrhea was 86, 90 and 57%, AB were administered to 99, 95 and rhythm diagnosis was recorded for each tracing, and each ECG
33% of diarrheic calves and mortality rates attributed to diarrhea was given a quality score (0–3). The findings were then reviewed
were 3, 3 and 2% in F1, F2 and F3, respectively. After the algo- to determine if the AliveCor device was comparable to the base
rithm implementation, data were available for 105 (F1), 282 (F2) apex ECG for rate and rhythm diagnosis via a paired t-test. Dif-
and 31(F3) calves. Diarrhea developed in 74, 89 and 67% calves ferences in quality scores between the readings for each goat were
on the three farms, but treatment rates were significantly lower; assessed via a Mann-Whitney U-test. Quality score differences
39, 14 and 0% (P < 0.0001), with no impact on mortality (1.3, 0.8 were assessed with a Mann-Whitney U-test between breeds and
and 0%, respectively, P > 0.05). location of AliveCor ECG. Rhythm agreement was assessed by
The use of a simple and practical antimicrobial-use algorithm comparing the blinded rhythm diagnoses made by the cardiologist.
can provided a significant reduction in the use of antimicrobials, No significant differences were found between heart rates collected
decreasing treatment costs and improving antimicrobial steward- via AliveCor or standard base apex ECGs (P = 0.8151). Quality
ship with no negative impacts on calf health. scores were significantly higher for AliveCor tracings (1.85 + /- 0.66)
compared to standard base apex tracings (0.94 + /- 0.78)
(P < 0.0001). No significant difference in AliveCor quality score was
noted between meat and dairy breeds (P = 0.094). No significant
differences were noted between quality scores of AliveCor readings
taken from the left cardiac apex or sternal region (P = 1.000).
F03 Normal sinus rhythm was present in all goats, and could be diag-
PREVALENCE OF BOVINE CORONAVIRUS IN FECES OF nosed via the AliveCor tracings in 93.75% of cases. Based on this
HEALTHY AND DIARRHEIC CALVES. Diego E. Gomez1, Luis study, the AliveCor ECG was clinically useful for heart rate determi-
G. Arroyo2, Laurent Viel2, J. Scott Weese1. 1Department of nation and diagnosis of normal sinus rhythm in goats. Interestingly,
Pathobiology, Ontario Veterinary College, University of Guelph., AliveCor ECGs had higher quality scores compared to standard
Guelph, Ontario, Canada, 2Department of Clinical Studies, base apex ECGs.
Ontario Veterinary College, University of Guelph, Guelph, ON,
Canada
treated for LDA between November 2013 and March 2015. All F07
four calves had a history of decreased appetite and left-sided CONCENTRATIONS OF CHLORTETRACYCLINE IN FETAL
abdominal distention; two had recently been treated for necrotic TISSUES FOLLOWING ORAL ADMINISTRATION IN THE
laryngitis and one calf was being treated for suspected clostridial EWE. Kevin Washburn1, Virginia Fajt1, Hans Coetzee2, Shannon
abomasitis. A high-pitched ping and splash were ausculted with Washburn1. 1Texas A&M University, College Station, USA, 2Iowa
percussion and succussion of the left abdomen. Ultrasonography State University, Ames, IA, USA
confirmed the abomasum to be displaced between the rumen and
the left body wall in all four calves. Blood gas analysis revealed The objective of this study was to determine the disposition of
hypokalemic, hypochloremic metabolic alkalosis in three of the chlortetracycline (CTC) in pregnant ewes and their unborn fetuses
calves. following oral administration of 500 mg/head/day during the last
All four calves were initially treated by rolling to correct the left trimester of gestation.
abomasal displacement, and facilitate correction of metabolic Five pregnant sheep were administered 500 mg of CTC in
abnormalities. Following rolling, the abomasum re-displaced in divided doses for 8 days. On day 7, the fetus was surgically
three of the calves within one hour to 11 days; one calf became implanted with venous lines for sampling, and placenta and amni-
acutely colicky as a result of a mesenteric volvulus. A right para- otic fluid were harvested. Fetal plasma was sampled for 36 hours
median abomasopexy was preformed in all cases. Three of four after the last dose of CTC. Subsequently, ewes were sacrificed and
calves grew well and remained in the herd six to 18 months later; samples of amniotic fluid, placenta, fetal kidneys, fetal liver, and
one calf was euthanized 10 days after surgery due to complications fetal stomach contents were collected.
associated with necrotic laryngitis. Observed CTC concentrations were below the limit of quantifi-
Based on these findings, LDA is likely more common in beef cation for all fetal tissues with the exception of liver and kidney in
calves than many veterinarians recognize and it should be consid- all but two fetuses. Fetal liver concentrations ranged from 4.6
ered as a differential for calves that present with abdominal disten- to125.9 ng/mL, while fetal kidney concentrations ranged from 8.1
tion. Concurrent laryngeal dysfunction has not been previously to 17.4 ng/mL 36 hours after the last dose of CTC.
described in beef calves with LDA and may be a contributing fac- Although our study indicated that CTC crosses the placental
tor in the pathogenesis of this disorder. Ultrasonography is a barrier based on accumulation in the fetal kidney and liver, con-
widely available chute-side diagnostic technique that can rapidly centrations achieved were far below the minimum inhibitory con-
confirm the diagnosis in beef calves. Rolling is a useful adjunctive centrations (MIC) reported in the literature for isolates from
measure for allowing temporary improvement in cases with severe abortion outbreaks and below our limit of quantification in amni-
metabolic alterations, but may be associated with catastrophic otic fluid, fetal stomach contents and placenta. No studies demon-
intestinal complications in calves as has been reported in adult strate the concentrations of CTC that are preventative for
cows. Therefore, surgical correction is recommended, and right abortion from Campylobacter spp.; our findings suggest that either
paramedian abomasopexy under sedation and local block is a fea- the dosage used in this study is not high enough or that the phar-
sible method of correction of LDA in beef calves. macodynamic parameter relating preventive dose to pathogen
MICs is yet to be determined.
F06
APPARENT EFFICIENCY OF COLOSTRAL IMMUNOGLOB- F08
ULIN ABSORPTION IN HOLSTEIN HEIFERS. Jennifer Hal- HYPERKETONEMIA AS A TOOL TO PREDICT MORTAL-
leran1,2, Derek Foster1,2. 1Oklahoma State University, Stillwater, ITY IN DAIRY GOAT DURING LAST MONTH OF PREG-
OK, USA, 2North Carolina State University, Raleigh, NC, USA NANCY. Vincent Dore1, Jocelyn Dubuc2, Anne-Marie Belanger2,
Sebastien Buczinski2. 1North Carolina State University, Raleigh,
Adequate absorption of bovine colostrum correlates with North Carolina, USA, 2Universite de Montreal, Saint-Hyacinthe,
improved neonatal health. The apparent efficiency of absorption QC, Canada
(AEA) of immunoglobulins can be measured using a mathematical
equation based on serum and colostral IgG concentration levels, Increased ketone bodies concentration in blood has been used
as well as the volume of colostrum being fed and the body weight to monitor goat during last month of pregnancy to diagnose ani-
of the calf. While commonly measured in research projects, little mal with subclinical and/or clinical cases pregnancy toxemia (PT).
information is available on the normal AEA across a large group Since clinical cases of PT are highly fatal, early diagnostic tool to
of healthy calves on multiple farms. The purpose of this study was predict mortality on farm would be useful to producer to save
to observe how contributing factors (volume of feeding, birth- money on animal with lower chance of survival or to initiate more
weight and time of feeding) can alter AEA, and to establish a nor- aggressive therapy depending on the value of the animal and its
mal range of AEA in healthy calves. fetuses.
One hundred and two Holstein heifer calves from 5 different The objective of this study was to determine if increased ketone
dairies in North Carolina and Colorado were sampled. After a bodies concentration were associated with mortality in goats from
normal calving, an aliquot of colostrum being fed to the heifer herds with a history of pregnancy toxemia.
was saved and the heifer received either 4 liters or 5.6 liters of A prospective cohort study was performed on 1242 lactating
colostrum within 6 hours of birth and a blood sample was col- goats from 10 commercial herds in Quebec, Canada. Each goat
lected between 24 and 36 hours after birth. Birthweights were mea- was followed weekly during the 5 last weeks of pregnancy or until
sured using the same weight tape on each farm. Radial parturition. During each farm visit all pregnant goats were sam-
immunodiffusion assay was performed to obtain IgG concentra- pled until more than 95% of the group had kidded. Blood samples
tions in the colostrum and serum samples. From this data, the from jugular vessel were collected and were analyzed directly on
AEA was calculated. farm using an electronic on-farm test for the quantification of
AEA ranged from 7.7% to 59.9% with mean of 28.1% 9.5 blood b-hydroxybutyrate acid (BHBA) concentration (Precision
and median of 27.5%. AEA of 69% (70/102) of the calves fell Xtra, Abbott Diabetes Care, Saint-Laurent, Canada). Producers
between 21–40%. There was a significant correlation (P = 0.033, evaluated each goat for presence of PT based on a 4 degrees scale
r = 0.21) between birthweight and AEA and volume fed and AEA (absence, low, moderate, or strong suspicion of PT) using a stan-
(P = 0.030, r = 0.22). There was no correlation between time of dardized definition. Number of fetuses, mortality, difficulty of kid-
feeding and AEA or total IgG mass fed and AEA. ding, and presence of treatment, anorexia, lethargy and isolation
AEA varies widely between calves even when feeding is stan- from the rest of the herd were evaluated during the first week fol-
dardized. There appears to be opportunities to improve the serum lowing parturition.
IgG concentration in calves by feeding increased volumes of colos- Pregnancy toxemia was diagnosis in 108 goats. Prevalence of
trum, as in this study we were unable to saturate the absorption mortality was 5.0% during prepartum and first week of lactation
process. With the wide range of AEA values obtained, there may period. There were 26 cases of mortality during prepartum period
be opportunities to improve AEA through genetic selection. (96.2% associated with PT) and 28 cases of mortality during the
first week of lactation (71.4% associated with PT). Critical cut-
points for predicting mortality during last month of pregnancy
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1518 2016 ACVIM Abstracts
and first week of lactation were determined based on the highest study indicate that famotidine administered at 0.4 mg/kg IV is
sum of sensitivity and specificity every week. Blood concentration effective at raising the abomasal pH and may be an effective treat-
above 0.6 mmol/L during week 4 before kidding (sensitivity (Se): ment for abomasal ulceration in adult cattle. However, the efficacy
44.7%; specificity (Sp): 86.7%), 3 (Se: 65.4% ; Sp: 82.7%), and 2 of treatment may decrease over time or may require more frequent
(Se: 70.8%; Sp: 76.1%) before kidding, above 1.4 mmol/L during dosing to sustain elevated abomasal pH.
week 1 before kidding (Se: 51.3% ; Sp: 93.5%) and above 1.7 for
the first week of lactation (Se: 28.6% ; Sp: 95.0%) were selected as
the optimal cutpoints in this study. Presence of treatment during
the last month of pregnancy was associated with increased mortal-
ity in dairy goat (OR: 11.79, P < 0.01)
In conclusion, even if hyperketonemia is associated with low to F10
moderate sensitivity from week to week, the test shows good speci- THE PHARMACOKINETICS OF INTRAVENOUS
ficity with relatively low prevalence of mortality. For this reason GENTAMICIN IN HEALTHY YOUNG-ADULT VERSUS
hyperketonemia appeared as a cheap test to assess the risk of mor- AGED ALPACAS. Andrew Gestrich , Daniela Bedenice1, Michelle
1
tality during the last month of pregnancy. However, others param- Ceresia2, Cheryl Stockman1, Iman Zaghloul2. 1Cummings School
eters should be evaluated to access prognosis in goat with PT. of Veterinary Medicine at Tufts University, North Grafton, MA,
USA, 2School of Pharmacy, MCPHS University, Boston, MA,
USA
ment*hour as fixed effects and steer and treatment period as ran- Aged (n=8) 65.2±13.2 90.4±17.6 0.12±0.04 2.1±0.5 0.21±0.02 75.6±16.1
dom effects. Least square means were separated using least
significant difference. Serum was separated and stored at 20°C C0–Initial plasma concentration; AUC–Area under the curve; T1/2 α and β–Distribution and
elimination half-life; Vss–Volume of distribution at steady state; Cl–Clearance
until pharmacokinetic analysis. Serum famotidine analysis was per-
formed using tandem liquid chromatography mass spectrometry
and pharmacokinetic analysis was performed using commercial
software.
The treatment*sampling hour interaction affected abomasal out-
flow pH for both a single dose and multiple doses of famotidine
(P < 0.001). A single dose of intravenous famotidine resulted in a F11
significant increase of abomasal outflow pH as compared to the PROGNOSIS ASSOCIATED WITH CEREBROSPINAL FLUID
control group for 4 hours after administration (P < 0.05). When ANALYSIS RESULTS IN RECUMBENT DAIRY CATTLE:
administered every 8 hours, the abomasal outflow pH of the famo- RETROSPECTIVE STUDY (2006–2014). Marie-Ève Bilodeau,
tidine treated group was greater than the control group for David Francoz, Damien Achard, Andre Desrochers, Sylvain
4 hours after the first dose (P < 0.05), 2 hours after the second Nichols, Marie Babkine, Helene Larde, Carolyn Grimes, Gilles
dose, and 1 hour after the third dose (P < 0.05). Pharmacokinetic Fecteau. Universite de Montreal, Saint-Hyacinthe, QC, Canada
analysis demonstrated that famotidine had a terminal half-life of
3.33 (3.21 – 3.54; median and range) hours, a volume of distribu- In recumbent dairy cows, the analysis of the cerebrospinal fluid
tion of 0.042 (0.014 – 1.89) L/kg and a clearance of 1.26 (0.625 – (CSF) is an ancillary test frequently used at our referral center.
11.5) mL/min/kg. Interpretation of the CSF analysis results in cattle is challenging,
In conclusion, an H2-antagonist, famotidine increases gastric in part, because reported intervals for this species differ. In a pre-
pH by reducing acid production by parietal cells. This study vious retrospective study, we demonstrated that recumbent cows
showed that a single intravenous dose of famotidine administered with a CSF total nucleated cells count (TNCC) ≥ 4.5 cells/µL and/
at 0.4 mg/kg is effective at increasing the abomasal outflow pH of or a protein concentration ≥ 0.40 g/L had a spinal cord lesion on
adult cattle for up to 4 hours as compared to saline control. When post mortem examination. However, CSF results below those
administered every 8 hours, to mimic clinical therapeutic recom- threshold values did not exclude the presence of such a lesion.
mendation, the abomasal outflow pH was significantly higher for The objective of this study was to determine the short-term and
4 hours after administration of the first dose; however, the effect long-term prognosis in recumbent adult dairy cows who underwent
seemed to decrease after each subsequent dose. Results of this
19391676, 2016, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jvim.13952 by CAPES, Wiley Online Library on [02/08/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
2016 ACVIM Abstracts 1519
CSF analysis. The previously mentioned threshold values for prognosis in recumbent dairy cattle. Indeed, 53% of cows with
TNCC and protein concentration were used. We hypothesized that CSF values below the pre-determined threshold values were dis-
recumbent cows with CSF values higher than the pre-determined charged from the hospital, which is comparable to the survival rate
threshold values would have a less favorable short-term and long- of all recumbent adult dairy cows that present to our referral center
term prognosis. All dairy cattle, of 2 years or more of age, that (survival rate of 48% between 1994 and 2014, n = 1271). The
were recumbent and who have had a CSF analysis were included short-term survival rate was 30% in cows where only the TNCC
in the study (n = 214 cases). CSF analysis was performed by board value was above the threshold (P = 0.035), 28% if only the protein
certified pathologists, and only CSF analysis which contained both concentration was above the threshold (P = 0.012), and 34% if
the TNCC and protein concentration were included in the study. both CSF parameters were above the thresholds (P = 0.024). How-
A successful short-term prognosis was based on the return to the ever, in cows discharged from the hospital (n = 104), the long-term
farm. A successful long-term prognosis was based on the comple- prognosis was comparable amongst groups; 60% (53/88) of cows
tion of at least one lactation using the Canadian Dairy Network with CSF values below the thresholds, and 75% (12/16) of cows
database. Statistical analysis was performed using the Chi-squared with one or more CSF value above the thresholds completed at
test to compare numbers of cows in each group. least one lactation after their return to the farm (P = 0.37).
Age of patients ranged from 2.0 to 14.5 years (median Based on this study, we conclude that the short-term prognosis
5.6 years). Two hundred and eight cows were Holstein, 4 were of recumbent adult dairy cattle with CSF TNCC ≥ 4.5 cells/µL
Ayrshire and 2 were Jersey. The duration of hospitalization ranged and/or a protein concentration ≥0.40 g/L is lower than that of
from 1 to 48 days (median 7 days). In cows for which the infor- cows with CSF values below those thresholds. However, some cat-
mation was available, days in milk ranged from 1 to 516 days (me- tle with CSF values above the thresholds survive and their long-
dian 25 days) and 18% of the cows (23/130) were dried. Of the term prognosis seems to be acceptable suggesting that these cows
214 cases studied, 167 cows had CSF values for TNCC and pro- may have a spinal cord lesion that is reversible.
tein concentration below the threshold values, and 47 cows had
CSF values above the pre-determined threshold values.
The results showed that TNCC ≥ 4.5 cells/µL and/or a protein
concentration ≥ 0.40 g/L was associated with a worse short-term